,Gene Symbol,Gene ID (HGNC),Disease Label,Disease ID (MONDO),MOI_x,SOP,Classification,Online Report_x,Classification Date,GCEP,Gene/Region,HGNC/ISCA,GRCh37,GRCh38,Haploinsufficiency,Triplosensitivity,Online Report_y,Date,gene_symbol,gene_url,disease_label,mondo_id,disease_url,MOI_y
0,KRAS,HGNC:6407,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_248e0d6b-9300-4d17-a350-f742fa92c82c-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,KRAS,HGNC:6407,chr12:25358180-25403863,chr12:25205246-25250929,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KRAS&subject=,2015-10-08T19:53:52Z,KRAS,https://search.clinicalgenome.org/kb/genes/HGNC:6407,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
1,KRAS,HGNC:6407,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_248e0d6b-9300-4d17-a350-f742fa92c82c-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,KRAS,HGNC:6407,chr12:25358180-25403863,chr12:25205246-25250929,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KRAS&subject=,2015-10-08T19:53:52Z,KRAS,https://search.clinicalgenome.org/kb/genes/HGNC:6407,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
2,KRAS,HGNC:6407,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_248e0d6b-9300-4d17-a350-f742fa92c82c-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,KRAS,HGNC:6407,chr12:25358180-25403863,chr12:25205246-25250929,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KRAS&subject=,2015-10-08T19:53:52Z,KRAS,https://search.clinicalgenome.org/kb/genes/HGNC:6407,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
3,KRAS,HGNC:6407,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_248e0d6b-9300-4d17-a350-f742fa92c82c-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,KRAS,HGNC:6407,chr12:25358180-25403863,chr12:25205246-25250929,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KRAS&subject=,2015-10-08T19:53:52Z,KRAS,https://search.clinicalgenome.org/kb/genes/HGNC:6407,Noonan syndrome 3,MONDO:0012371,https://search.clinicalgenome.org/kb/conditions/MONDO:0012371,
4,KRAS,HGNC:6407,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc9a82d0-8447-454c-8d54-def792d20e1d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,KRAS,HGNC:6407,chr12:25358180-25403863,chr12:25205246-25250929,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KRAS&subject=,2015-10-08T19:53:52Z,KRAS,https://search.clinicalgenome.org/kb/genes/HGNC:6407,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
5,KRAS,HGNC:6407,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc9a82d0-8447-454c-8d54-def792d20e1d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,KRAS,HGNC:6407,chr12:25358180-25403863,chr12:25205246-25250929,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KRAS&subject=,2015-10-08T19:53:52Z,KRAS,https://search.clinicalgenome.org/kb/genes/HGNC:6407,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
6,KRAS,HGNC:6407,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc9a82d0-8447-454c-8d54-def792d20e1d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,KRAS,HGNC:6407,chr12:25358180-25403863,chr12:25205246-25250929,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KRAS&subject=,2015-10-08T19:53:52Z,KRAS,https://search.clinicalgenome.org/kb/genes/HGNC:6407,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
7,KRAS,HGNC:6407,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc9a82d0-8447-454c-8d54-def792d20e1d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,KRAS,HGNC:6407,chr12:25358180-25403863,chr12:25205246-25250929,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KRAS&subject=,2015-10-08T19:53:52Z,KRAS,https://search.clinicalgenome.org/kb/genes/HGNC:6407,Noonan syndrome 3,MONDO:0012371,https://search.clinicalgenome.org/kb/conditions/MONDO:0012371,
8,CEP78,HGNC:25740,cone-rod dystrophy and hearing loss,MONDO:0014980,AR,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8149,2017-04-12T00:00:00,Hearing Loss Gene Curation Expert Panel,CEP78,HGNC:25740,chr9:80850991-80894606,chr9:78236075-78279690,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CEP78&subject=,2017-10-23T19:35:05Z,CEP78,https://search.clinicalgenome.org/kb/genes/HGNC:25740,cone-rod dystrophy and hearing loss,MONDO:0014980,https://search.clinicalgenome.org/kb/conditions/MONDO:0014980,Autosomal recessive inheritance
9,CEP78,HGNC:25740,cone-rod dystrophy and hearing loss,MONDO:0014980,AR,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8149,2017-04-12T00:00:00,Hearing Loss Gene Curation Expert Panel,CEP78,HGNC:25740,chr9:80850991-80894606,chr9:78236075-78279690,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CEP78&subject=,2017-10-23T19:35:05Z,CEP78,https://search.clinicalgenome.org/kb/genes/HGNC:25740,cone-rod dystrophy and hearing loss 1,MONDO:0020778,https://search.clinicalgenome.org/kb/conditions/MONDO:0020778,
10,TP73,HGNC:12003,"ciliary dyskinesia, primary, 47, and lissencephaly",MONDO:0030346,AR,SOP10,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_96b17463-2bd0-431c-a8df-0c1ac28a97ab-2023-09-14T160000.000Z,2023-09-14T16:00:00.000Z,Motile Ciliopathy Gene Curation Expert Panel,TP73,HGNC:12003,chr1:3569080-3652765,chr1:3652516-3736201,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TP73&subject=,2012-07-06T20:45:02Z,TP73,https://search.clinicalgenome.org/kb/genes/HGNC:12003,"ciliary dyskinesia, primary, 47, and lissencephaly",MONDO:0030346,https://search.clinicalgenome.org/kb/conditions/MONDO:0030346,Autosomal recessive inheritance
11,ALG2,HGNC:23159,ALG2-congenital disorder of glycosylation,MONDO:0011933,AR,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f7cb8bd0-58b2-4644-a041-76f42f564fbc-2023-11-15T170000.000Z,2023-11-15T17:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,ALG2,HGNC:23159,chr9:101978707-101984224,chr9:99216425-99221942,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ALG2&subject=,2016-08-22T17:45:56Z,ALG2,https://search.clinicalgenome.org/kb/genes/HGNC:23159,ALG2-congenital disorder of glycosylation,MONDO:0011933,https://search.clinicalgenome.org/kb/conditions/MONDO:0011933,Autosomal recessive inheritance
12,ALG2,HGNC:23159,ALG2-congenital disorder of glycosylation,MONDO:0011933,AR,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f7cb8bd0-58b2-4644-a041-76f42f564fbc-2023-11-15T170000.000Z,2023-11-15T17:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,ALG2,HGNC:23159,chr9:101978707-101984224,chr9:99216425-99221942,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ALG2&subject=,2016-08-22T17:45:56Z,ALG2,https://search.clinicalgenome.org/kb/genes/HGNC:23159,congenital myasthenic syndrome 14,MONDO:0014543,https://search.clinicalgenome.org/kb/conditions/MONDO:0014543,
13,TRDN,HGNC:12261,long QT syndrome,MONDO:0002442,AR,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1278bd6a-6ac7-4556-87ea-f860027b2da5-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,TRDN,HGNC:12261,chr6:123537484-123958095,chr6:123216339-123636950,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TRDN&subject=,2016-08-22T17:52:59Z,TRDN,https://search.clinicalgenome.org/kb/genes/HGNC:12261,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal recessive inheritance
14,TRDN,HGNC:12261,long QT syndrome,MONDO:0002442,AR,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1278bd6a-6ac7-4556-87ea-f860027b2da5-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,TRDN,HGNC:12261,chr6:123537484-123958095,chr6:123216339-123636950,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TRDN&subject=,2016-08-22T17:52:59Z,TRDN,https://search.clinicalgenome.org/kb/genes/HGNC:12261,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal recessive inheritance
15,TRDN,HGNC:12261,long QT syndrome,MONDO:0002442,AR,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1278bd6a-6ac7-4556-87ea-f860027b2da5-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,TRDN,HGNC:12261,chr6:123537484-123958095,chr6:123216339-123636950,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TRDN&subject=,2016-08-22T17:52:59Z,TRDN,https://search.clinicalgenome.org/kb/genes/HGNC:12261,catecholaminergic polymorphic ventricular tachycardia 5,MONDO:0014191,https://search.clinicalgenome.org/kb/conditions/MONDO:0014191,
16,KCNQ1,HGNC:6294,short QT syndrome,MONDO:0000453,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5000dde0-156c-45b0-87db-35a935c69cb7-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
17,KCNQ1,HGNC:6294,short QT syndrome,MONDO:0000453,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5000dde0-156c-45b0-87db-35a935c69cb7-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,Jervell and Lange-Nielsen syndrome,MONDO:0002441,https://search.clinicalgenome.org/kb/conditions/MONDO:0002441,Autosomal recessive inheritance
18,KCNQ1,HGNC:6294,short QT syndrome,MONDO:0000453,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5000dde0-156c-45b0-87db-35a935c69cb7-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
19,KCNQ1,HGNC:6294,short QT syndrome,MONDO:0000453,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5000dde0-156c-45b0-87db-35a935c69cb7-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
20,KCNQ1,HGNC:6294,short QT syndrome,MONDO:0000453,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5000dde0-156c-45b0-87db-35a935c69cb7-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,familial long QT syndrome,MONDO:0019171,https://search.clinicalgenome.org/kb/conditions/MONDO:0019171,
21,KCNQ1,HGNC:6294,short QT syndrome,MONDO:0000453,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5000dde0-156c-45b0-87db-35a935c69cb7-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,long QT syndrome 1,MONDO:0100316,https://search.clinicalgenome.org/kb/conditions/MONDO:0100316,
22,KCNQ1,HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b44eee3-56ea-4596-8d3e-e4d5c0ad8d60-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
23,KCNQ1,HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b44eee3-56ea-4596-8d3e-e4d5c0ad8d60-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,Jervell and Lange-Nielsen syndrome,MONDO:0002441,https://search.clinicalgenome.org/kb/conditions/MONDO:0002441,Autosomal recessive inheritance
24,KCNQ1,HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b44eee3-56ea-4596-8d3e-e4d5c0ad8d60-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
25,KCNQ1,HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b44eee3-56ea-4596-8d3e-e4d5c0ad8d60-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
26,KCNQ1,HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b44eee3-56ea-4596-8d3e-e4d5c0ad8d60-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,familial long QT syndrome,MONDO:0019171,https://search.clinicalgenome.org/kb/conditions/MONDO:0019171,
27,KCNQ1,HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b44eee3-56ea-4596-8d3e-e4d5c0ad8d60-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,KCNQ1,HGNC:6294,chr11:2466238-2870340,chr11:2445008-2849105,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNQ1&subject=,2020-10-13T16:21:49Z,KCNQ1,https://search.clinicalgenome.org/kb/genes/HGNC:6294,long QT syndrome 1,MONDO:0100316,https://search.clinicalgenome.org/kb/conditions/MONDO:0100316,
28,GCSH,HGNC:4208,glycine encephalopathy,MONDO:0011612,AR,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d360db9d-24e7-415e-b4bc-59a2c6231189-2023-02-10T170000.000Z,2023-02-10T17:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,GCSH,HGNC:4208,chr16:81115550-81130000,chr16:81081945-81096395,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GCSH&subject=,2016-08-22T17:48:52Z,GCSH,https://search.clinicalgenome.org/kb/genes/HGNC:4208,glycine encephalopathy,MONDO:0011612,https://search.clinicalgenome.org/kb/conditions/MONDO:0011612,Autosomal recessive inheritance
29,ACOX1,HGNC:119,Mitchell syndrome,MONDO:0030073,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2efeef00-0803-472b-8e25-080e4728c018-2022-12-29T170000.000Z,2022-12-29T17:00:00.000Z,Peroxisomal Disorders Gene Curation Expert Panel,ACOX1,HGNC:119,chr17:73937588-73975247,chr17:75941507-75979166,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACOX1&subject=,2014-11-20T14:37:29Z,ACOX1,https://search.clinicalgenome.org/kb/genes/HGNC:119,peroxisomal acyl-CoA oxidase deficiency,MONDO:0009919,https://search.clinicalgenome.org/kb/conditions/MONDO:0009919,Autosomal recessive inheritance
30,ACOX1,HGNC:119,Mitchell syndrome,MONDO:0030073,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2efeef00-0803-472b-8e25-080e4728c018-2022-12-29T170000.000Z,2022-12-29T17:00:00.000Z,Peroxisomal Disorders Gene Curation Expert Panel,ACOX1,HGNC:119,chr17:73937588-73975247,chr17:75941507-75979166,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACOX1&subject=,2014-11-20T14:37:29Z,ACOX1,https://search.clinicalgenome.org/kb/genes/HGNC:119,Mitchell syndrome,MONDO:0030073,https://search.clinicalgenome.org/kb/conditions/MONDO:0030073,Autosomal dominant inheritance
31,SETD2,HGNC:18420,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,MONDO:0035706,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12443e12-a359-40fb-afbf-b334e9b87b1d-2023-10-04T160000.000Z,2023-10-04T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETD2,HGNC:18420,chr3:47057926-47205603,chr3:47016436-47164840,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETD2&subject=,2022-03-08T17:28:07Z,SETD2,https://search.clinicalgenome.org/kb/genes/HGNC:18420,SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth,MONDO:0800477,https://search.clinicalgenome.org/kb/conditions/MONDO:0800477,Autosomal dominant inheritance
32,SETD2,HGNC:18420,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,MONDO:0035706,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12443e12-a359-40fb-afbf-b334e9b87b1d-2023-10-04T160000.000Z,2023-10-04T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETD2,HGNC:18420,chr3:47057926-47205603,chr3:47016436-47164840,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETD2&subject=,2022-03-08T17:28:07Z,SETD2,https://search.clinicalgenome.org/kb/genes/HGNC:18420,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,MONDO:0035706,https://search.clinicalgenome.org/kb/conditions/MONDO:0035706,Autosomal dominant inheritance
33,SETD2,HGNC:18420,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,MONDO:0035706,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12443e12-a359-40fb-afbf-b334e9b87b1d-2023-10-04T160000.000Z,2023-10-04T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETD2,HGNC:18420,chr3:47057926-47205603,chr3:47016436-47164840,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETD2&subject=,2022-03-08T17:28:07Z,SETD2,https://search.clinicalgenome.org/kb/genes/HGNC:18420,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,
34,SETD2,HGNC:18420,SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth,MONDO:0800477,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8d0235a-b48e-4609-8c61-09586a83d1f2-2023-10-04T160000.000Z,2023-10-04T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETD2,HGNC:18420,chr3:47057926-47205603,chr3:47016436-47164840,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETD2&subject=,2022-03-08T17:28:07Z,SETD2,https://search.clinicalgenome.org/kb/genes/HGNC:18420,SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth,MONDO:0800477,https://search.clinicalgenome.org/kb/conditions/MONDO:0800477,Autosomal dominant inheritance
35,SETD2,HGNC:18420,SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth,MONDO:0800477,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8d0235a-b48e-4609-8c61-09586a83d1f2-2023-10-04T160000.000Z,2023-10-04T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETD2,HGNC:18420,chr3:47057926-47205603,chr3:47016436-47164840,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETD2&subject=,2022-03-08T17:28:07Z,SETD2,https://search.clinicalgenome.org/kb/genes/HGNC:18420,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,MONDO:0035706,https://search.clinicalgenome.org/kb/conditions/MONDO:0035706,Autosomal dominant inheritance
36,SETD2,HGNC:18420,SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth,MONDO:0800477,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8d0235a-b48e-4609-8c61-09586a83d1f2-2023-10-04T160000.000Z,2023-10-04T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETD2,HGNC:18420,chr3:47057926-47205603,chr3:47016436-47164840,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETD2&subject=,2022-03-08T17:28:07Z,SETD2,https://search.clinicalgenome.org/kb/genes/HGNC:18420,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,
37,ATF6,HGNC:791,achromatopsia,MONDO:0018852,AR,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4842,2016-11-16T00:00:00,General Gene Curation Expert Panel,ATF6,HGNC:791,chr1:161736110-161933860,chr1:161766320-161964070,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ATF6&subject=,2017-01-12T19:47:53Z,ATF6,https://search.clinicalgenome.org/kb/genes/HGNC:791,ATF6-related retinopathy,MONDO:0100447,https://search.clinicalgenome.org/kb/conditions/MONDO:0100447,Autosomal recessive inheritance
38,ATF6,HGNC:791,achromatopsia,MONDO:0018852,AR,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4842,2016-11-16T00:00:00,General Gene Curation Expert Panel,ATF6,HGNC:791,chr1:161736110-161933860,chr1:161766320-161964070,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ATF6&subject=,2017-01-12T19:47:53Z,ATF6,https://search.clinicalgenome.org/kb/genes/HGNC:791,achromatopsia,MONDO:0018852,https://search.clinicalgenome.org/kb/conditions/MONDO:0018852,Autosomal recessive inheritance
39,ATF6,HGNC:791,achromatopsia,MONDO:0018852,AR,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4842,2016-11-16T00:00:00,General Gene Curation Expert Panel,ATF6,HGNC:791,chr1:161736110-161933860,chr1:161766320-161964070,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ATF6&subject=,2017-01-12T19:47:53Z,ATF6,https://search.clinicalgenome.org/kb/genes/HGNC:791,achromatopsia 7,MONDO:0014677,https://search.clinicalgenome.org/kb/conditions/MONDO:0014677,
40,SLC4A10,HGNC:13811,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP11,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9fe612c6-134c-43ef-b3b5-bb1bd66b4d70-2024-12-17T170000.000Z,2024-12-17T17:00:00.000Z,Epilepsy Gene Curation Expert Panel,SLC4A10,HGNC:13811,chr2:162480926-162841780,chr2:161624416-161985270,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC4A10&subject=,2012-04-11T18:15:38Z,SLC4A10,https://search.clinicalgenome.org/kb/genes/HGNC:13811,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal recessive inheritance
41,RPE65,HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a45f0ada-a32b-406e-b714-790a0cd4a6a2-2022-02-07T024303.928Z,2022-02-07T02:43:03.928Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,https://search.clinicalgenome.org/kb/conditions/MONDO:0100368,Autosomal recessive inheritance
42,RPE65,HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a45f0ada-a32b-406e-b714-790a0cd4a6a2-2022-02-07T024303.928Z,2022-02-07T02:43:03.928Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,https://search.clinicalgenome.org/kb/conditions/MONDO:0100452,Autosomal dominant inheritance
43,RPE65,HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a45f0ada-a32b-406e-b714-790a0cd4a6a2-2022-02-07T024303.928Z,2022-02-07T02:43:03.928Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,Leber congenital amaurosis 2,MONDO:0008765,https://search.clinicalgenome.org/kb/conditions/MONDO:0008765,
44,RPE65,HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a45f0ada-a32b-406e-b714-790a0cd4a6a2-2022-02-07T024303.928Z,2022-02-07T02:43:03.928Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,retinitis pigmentosa,MONDO:0019200,https://search.clinicalgenome.org/kb/conditions/MONDO:0019200,
45,RPE65,HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a45f0ada-a32b-406e-b714-790a0cd4a6a2-2022-02-07T024303.928Z,2022-02-07T02:43:03.928Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,retinitis pigmentosa 20,MONDO:0013425,https://search.clinicalgenome.org/kb/conditions/MONDO:0013425,
46,RPE65,HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a45f0ada-a32b-406e-b714-790a0cd4a6a2-2022-02-07T024303.928Z,2022-02-07T02:43:03.928Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,Leber congenital amaurosis,MONDO:0018998,https://search.clinicalgenome.org/kb/conditions/MONDO:0018998,
47,RPE65,HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_375ffa04-a8d9-427e-8948-f913bc8ff68d-2022-05-24T214158.160Z,2022-05-24T21:41:58.160Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,https://search.clinicalgenome.org/kb/conditions/MONDO:0100368,Autosomal recessive inheritance
48,RPE65,HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_375ffa04-a8d9-427e-8948-f913bc8ff68d-2022-05-24T214158.160Z,2022-05-24T21:41:58.160Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,https://search.clinicalgenome.org/kb/conditions/MONDO:0100452,Autosomal dominant inheritance
49,RPE65,HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_375ffa04-a8d9-427e-8948-f913bc8ff68d-2022-05-24T214158.160Z,2022-05-24T21:41:58.160Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,Leber congenital amaurosis 2,MONDO:0008765,https://search.clinicalgenome.org/kb/conditions/MONDO:0008765,
50,RPE65,HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_375ffa04-a8d9-427e-8948-f913bc8ff68d-2022-05-24T214158.160Z,2022-05-24T21:41:58.160Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,retinitis pigmentosa,MONDO:0019200,https://search.clinicalgenome.org/kb/conditions/MONDO:0019200,
51,RPE65,HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_375ffa04-a8d9-427e-8948-f913bc8ff68d-2022-05-24T214158.160Z,2022-05-24T21:41:58.160Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,retinitis pigmentosa 20,MONDO:0013425,https://search.clinicalgenome.org/kb/conditions/MONDO:0013425,
52,RPE65,HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_375ffa04-a8d9-427e-8948-f913bc8ff68d-2022-05-24T214158.160Z,2022-05-24T21:41:58.160Z,Retina Gene Curation Expert Panel,RPE65,HGNC:10294,chr1:68894505-68915637,chr1:68428822-68449954,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPE65&subject=,2025-02-27T20:50:52Z,RPE65,https://search.clinicalgenome.org/kb/genes/HGNC:10294,Leber congenital amaurosis,MONDO:0018998,https://search.clinicalgenome.org/kb/conditions/MONDO:0018998,
53,MYLK,HGNC:7590,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8257,2016-12-18T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,MYLK,HGNC:7590,chr3:123328896-123603179,chr3:123610049-123884332,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYLK&subject=,2016-01-14T20:14:59Z,MYLK,https://search.clinicalgenome.org/kb/genes/HGNC:7590,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,https://search.clinicalgenome.org/kb/conditions/MONDO:0019625,Autosomal dominant inheritance
54,MYLK,HGNC:7590,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8257,2016-12-18T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,MYLK,HGNC:7590,chr3:123328896-123603179,chr3:123610049-123884332,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYLK&subject=,2016-01-14T20:14:59Z,MYLK,https://search.clinicalgenome.org/kb/genes/HGNC:7590,"aortic aneurysm, familial thoracic 7",MONDO:0013418,https://search.clinicalgenome.org/kb/conditions/MONDO:0013418,
55,SCN1A,HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_529f9cae-ac00-47d1-94d5-52c98bf6e2a2-2019-10-25T040000.000Z,2019-10-25T04:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,Dravet syndrome,MONDO:0100135,https://search.clinicalgenome.org/kb/conditions/MONDO:0100135,Autosomal dominant inheritance
56,SCN1A,HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_529f9cae-ac00-47d1-94d5-52c98bf6e2a2-2019-10-25T040000.000Z,2019-10-25T04:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,https://search.clinicalgenome.org/kb/conditions/MONDO:0018214,Autosomal dominant inheritance
57,SCN1A,HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_529f9cae-ac00-47d1-94d5-52c98bf6e2a2-2019-10-25T040000.000Z,2019-10-25T04:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,familial hemiplegic migraine,MONDO:0000700,https://search.clinicalgenome.org/kb/conditions/MONDO:0000700,Autosomal dominant inheritance
58,SCN1A,HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_529f9cae-ac00-47d1-94d5-52c98bf6e2a2-2019-10-25T040000.000Z,2019-10-25T04:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal dominant inheritance
59,SCN1A,HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_529f9cae-ac00-47d1-94d5-52c98bf6e2a2-2019-10-25T040000.000Z,2019-10-25T04:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,"generalized epilepsy with febrile seizures plus, type 2",MONDO:0011461,https://search.clinicalgenome.org/kb/conditions/MONDO:0011461,
60,SCN1A,HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_529f9cae-ac00-47d1-94d5-52c98bf6e2a2-2019-10-25T040000.000Z,2019-10-25T04:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,"developmental and epileptic encephalopathy, 6",MONDO:0100079,https://search.clinicalgenome.org/kb/conditions/MONDO:0100079,
61,SCN1A,HGNC:10585,familial hemiplegic migraine,MONDO:0000700,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8c1e158-983d-4547-a739-7781961e5bb8-2021-09-14T163408.306Z,2021-09-14T16:34:08.306Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,Dravet syndrome,MONDO:0100135,https://search.clinicalgenome.org/kb/conditions/MONDO:0100135,Autosomal dominant inheritance
62,SCN1A,HGNC:10585,familial hemiplegic migraine,MONDO:0000700,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8c1e158-983d-4547-a739-7781961e5bb8-2021-09-14T163408.306Z,2021-09-14T16:34:08.306Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,https://search.clinicalgenome.org/kb/conditions/MONDO:0018214,Autosomal dominant inheritance
63,SCN1A,HGNC:10585,familial hemiplegic migraine,MONDO:0000700,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8c1e158-983d-4547-a739-7781961e5bb8-2021-09-14T163408.306Z,2021-09-14T16:34:08.306Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,familial hemiplegic migraine,MONDO:0000700,https://search.clinicalgenome.org/kb/conditions/MONDO:0000700,Autosomal dominant inheritance
64,SCN1A,HGNC:10585,familial hemiplegic migraine,MONDO:0000700,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8c1e158-983d-4547-a739-7781961e5bb8-2021-09-14T163408.306Z,2021-09-14T16:34:08.306Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal dominant inheritance
65,SCN1A,HGNC:10585,familial hemiplegic migraine,MONDO:0000700,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8c1e158-983d-4547-a739-7781961e5bb8-2021-09-14T163408.306Z,2021-09-14T16:34:08.306Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,"generalized epilepsy with febrile seizures plus, type 2",MONDO:0011461,https://search.clinicalgenome.org/kb/conditions/MONDO:0011461,
66,SCN1A,HGNC:10585,familial hemiplegic migraine,MONDO:0000700,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8c1e158-983d-4547-a739-7781961e5bb8-2021-09-14T163408.306Z,2021-09-14T16:34:08.306Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,"developmental and epileptic encephalopathy, 6",MONDO:0100079,https://search.clinicalgenome.org/kb/conditions/MONDO:0100079,
67,SCN1A,HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ac39f7a-0743-47b1-8efd-21e0ca836840-2019-09-06T194357.485Z,2019-09-06T19:43:57.485Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,Dravet syndrome,MONDO:0100135,https://search.clinicalgenome.org/kb/conditions/MONDO:0100135,Autosomal dominant inheritance
68,SCN1A,HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ac39f7a-0743-47b1-8efd-21e0ca836840-2019-09-06T194357.485Z,2019-09-06T19:43:57.485Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,https://search.clinicalgenome.org/kb/conditions/MONDO:0018214,Autosomal dominant inheritance
69,SCN1A,HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ac39f7a-0743-47b1-8efd-21e0ca836840-2019-09-06T194357.485Z,2019-09-06T19:43:57.485Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,familial hemiplegic migraine,MONDO:0000700,https://search.clinicalgenome.org/kb/conditions/MONDO:0000700,Autosomal dominant inheritance
70,SCN1A,HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ac39f7a-0743-47b1-8efd-21e0ca836840-2019-09-06T194357.485Z,2019-09-06T19:43:57.485Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal dominant inheritance
71,SCN1A,HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ac39f7a-0743-47b1-8efd-21e0ca836840-2019-09-06T194357.485Z,2019-09-06T19:43:57.485Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,"generalized epilepsy with febrile seizures plus, type 2",MONDO:0011461,https://search.clinicalgenome.org/kb/conditions/MONDO:0011461,
72,SCN1A,HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ac39f7a-0743-47b1-8efd-21e0ca836840-2019-09-06T194357.485Z,2019-09-06T19:43:57.485Z,Epilepsy Gene Curation Expert Panel,SCN1A,HGNC:10585,chr2:166841151-167005671,chr2:165984641-166149161,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1A&subject=,2012-07-06T20:26:07Z,SCN1A,https://search.clinicalgenome.org/kb/genes/HGNC:10585,"developmental and epileptic encephalopathy, 6",MONDO:0100079,https://search.clinicalgenome.org/kb/conditions/MONDO:0100079,
73,RINT1,HGNC:21876,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d523910c-67e4-4cec-82a2-d7803957ec02-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RINT1,HGNC:21876,chr7:105172648-105208124,chr7:105532201-105567677,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RINT1&subject=,2024-07-10T14:06:47Z,RINT1,https://search.clinicalgenome.org/kb/genes/HGNC:21876,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
74,RINT1,HGNC:21876,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d523910c-67e4-4cec-82a2-d7803957ec02-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RINT1,HGNC:21876,chr7:105172648-105208124,chr7:105532201-105567677,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RINT1&subject=,2024-07-10T14:06:47Z,RINT1,https://search.clinicalgenome.org/kb/genes/HGNC:21876,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
75,RINT1,HGNC:21876,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8703,2016-09-14T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,RINT1,HGNC:21876,chr7:105172648-105208124,chr7:105532201-105567677,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RINT1&subject=,2024-07-10T14:06:47Z,RINT1,https://search.clinicalgenome.org/kb/genes/HGNC:21876,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
76,RINT1,HGNC:21876,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8703,2016-09-14T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,RINT1,HGNC:21876,chr7:105172648-105208124,chr7:105532201-105567677,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RINT1&subject=,2024-07-10T14:06:47Z,RINT1,https://search.clinicalgenome.org/kb/genes/HGNC:21876,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
77,RYR2,HGNC:10484,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52fa7dee-4daa-4685-9461-f39c57a22f05-2019-07-19T160000.000Z,2019-07-19T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,RYR2,HGNC:10484,chr1:237205484-237997288,chr1:237042184-237833988,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR2&subject=,2015-11-06T03:54:07Z,RYR2,https://search.clinicalgenome.org/kb/genes/HGNC:10484,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
78,RYR2,HGNC:10484,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52fa7dee-4daa-4685-9461-f39c57a22f05-2019-07-19T160000.000Z,2019-07-19T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,RYR2,HGNC:10484,chr1:237205484-237997288,chr1:237042184-237833988,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR2&subject=,2015-11-06T03:54:07Z,RYR2,https://search.clinicalgenome.org/kb/genes/HGNC:10484,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
79,RYR2,HGNC:10484,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52fa7dee-4daa-4685-9461-f39c57a22f05-2019-07-19T160000.000Z,2019-07-19T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,RYR2,HGNC:10484,chr1:237205484-237997288,chr1:237042184-237833988,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR2&subject=,2015-11-06T03:54:07Z,RYR2,https://search.clinicalgenome.org/kb/genes/HGNC:10484,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
80,RYR2,HGNC:10484,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52fa7dee-4daa-4685-9461-f39c57a22f05-2019-07-19T160000.000Z,2019-07-19T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,RYR2,HGNC:10484,chr1:237205484-237997288,chr1:237042184-237833988,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR2&subject=,2015-11-06T03:54:07Z,RYR2,https://search.clinicalgenome.org/kb/genes/HGNC:10484,catecholaminergic polymorphic ventricular tachycardia 1,MONDO:0011484,https://search.clinicalgenome.org/kb/conditions/MONDO:0011484,
81,RYR2,HGNC:10484,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ac9dd09-674f-4d67-94da-234ffb4e5070-2022-12-14T170000.000Z,2022-12-14T17:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,RYR2,HGNC:10484,chr1:237205484-237997288,chr1:237042184-237833988,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR2&subject=,2015-11-06T03:54:07Z,RYR2,https://search.clinicalgenome.org/kb/genes/HGNC:10484,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
82,RYR2,HGNC:10484,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ac9dd09-674f-4d67-94da-234ffb4e5070-2022-12-14T170000.000Z,2022-12-14T17:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,RYR2,HGNC:10484,chr1:237205484-237997288,chr1:237042184-237833988,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR2&subject=,2015-11-06T03:54:07Z,RYR2,https://search.clinicalgenome.org/kb/genes/HGNC:10484,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
83,RYR2,HGNC:10484,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ac9dd09-674f-4d67-94da-234ffb4e5070-2022-12-14T170000.000Z,2022-12-14T17:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,RYR2,HGNC:10484,chr1:237205484-237997288,chr1:237042184-237833988,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR2&subject=,2015-11-06T03:54:07Z,RYR2,https://search.clinicalgenome.org/kb/genes/HGNC:10484,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
84,RYR2,HGNC:10484,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ac9dd09-674f-4d67-94da-234ffb4e5070-2022-12-14T170000.000Z,2022-12-14T17:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,RYR2,HGNC:10484,chr1:237205484-237997288,chr1:237042184-237833988,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR2&subject=,2015-11-06T03:54:07Z,RYR2,https://search.clinicalgenome.org/kb/genes/HGNC:10484,catecholaminergic polymorphic ventricular tachycardia 1,MONDO:0011484,https://search.clinicalgenome.org/kb/conditions/MONDO:0011484,
85,MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b818b8fc-7453-46be-8636-08644fd7a1d4-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial adenomatous polyposis 2,MONDO:0012041,https://search.clinicalgenome.org/kb/conditions/MONDO:0012041,Autosomal recessive inheritance
86,MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b818b8fc-7453-46be-8636-08644fd7a1d4-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,colorectal cancer,MONDO:0005575,https://search.clinicalgenome.org/kb/conditions/MONDO:0005575,Autosomal dominant inheritance
87,MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b818b8fc-7453-46be-8636-08644fd7a1d4-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance | Autosomal recessive inheritance
88,MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b818b8fc-7453-46be-8636-08644fd7a1d4-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal recessive inheritance | Autosomal dominant inheritance
89,MUTYH,HGNC:7527,colorectal cancer,MONDO:0005575,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b646b303-fb30-427c-9590-242a131624bf-2023-03-24T050000.000Z,2023-03-24T05:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial adenomatous polyposis 2,MONDO:0012041,https://search.clinicalgenome.org/kb/conditions/MONDO:0012041,Autosomal recessive inheritance
90,MUTYH,HGNC:7527,colorectal cancer,MONDO:0005575,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b646b303-fb30-427c-9590-242a131624bf-2023-03-24T050000.000Z,2023-03-24T05:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,colorectal cancer,MONDO:0005575,https://search.clinicalgenome.org/kb/conditions/MONDO:0005575,Autosomal dominant inheritance
91,MUTYH,HGNC:7527,colorectal cancer,MONDO:0005575,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b646b303-fb30-427c-9590-242a131624bf-2023-03-24T050000.000Z,2023-03-24T05:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance | Autosomal recessive inheritance
92,MUTYH,HGNC:7527,colorectal cancer,MONDO:0005575,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b646b303-fb30-427c-9590-242a131624bf-2023-03-24T050000.000Z,2023-03-24T05:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal recessive inheritance | Autosomal dominant inheritance
93,MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73e67e8c-0d12-44b1-a0d7-9fcc459b6773-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial adenomatous polyposis 2,MONDO:0012041,https://search.clinicalgenome.org/kb/conditions/MONDO:0012041,Autosomal recessive inheritance
94,MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73e67e8c-0d12-44b1-a0d7-9fcc459b6773-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,colorectal cancer,MONDO:0005575,https://search.clinicalgenome.org/kb/conditions/MONDO:0005575,Autosomal dominant inheritance
95,MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73e67e8c-0d12-44b1-a0d7-9fcc459b6773-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance | Autosomal recessive inheritance
96,MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73e67e8c-0d12-44b1-a0d7-9fcc459b6773-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal recessive inheritance | Autosomal dominant inheritance
97,MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2842036e-4a06-4d05-bce0-846f0f3c1678-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial adenomatous polyposis 2,MONDO:0012041,https://search.clinicalgenome.org/kb/conditions/MONDO:0012041,Autosomal recessive inheritance
98,MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2842036e-4a06-4d05-bce0-846f0f3c1678-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,colorectal cancer,MONDO:0005575,https://search.clinicalgenome.org/kb/conditions/MONDO:0005575,Autosomal dominant inheritance
99,MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2842036e-4a06-4d05-bce0-846f0f3c1678-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance | Autosomal recessive inheritance
100,MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2842036e-4a06-4d05-bce0-846f0f3c1678-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal recessive inheritance | Autosomal dominant inheritance
101,MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c329a2e-94fd-4719-a47b-a71cc9b39eec-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial adenomatous polyposis 2,MONDO:0012041,https://search.clinicalgenome.org/kb/conditions/MONDO:0012041,Autosomal recessive inheritance
102,MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c329a2e-94fd-4719-a47b-a71cc9b39eec-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,colorectal cancer,MONDO:0005575,https://search.clinicalgenome.org/kb/conditions/MONDO:0005575,Autosomal dominant inheritance
103,MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c329a2e-94fd-4719-a47b-a71cc9b39eec-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance | Autosomal recessive inheritance
104,MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c329a2e-94fd-4719-a47b-a71cc9b39eec-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MUTYH,HGNC:7527,chr1:45794914-45806112,chr1:45329242-45340440,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MUTYH&subject=,2015-11-11T17:23:11Z,MUTYH,https://search.clinicalgenome.org/kb/genes/HGNC:7527,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal recessive inheritance | Autosomal dominant inheritance
105,EPCAM,HGNC:11529,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efe1b152-d818-49bd-9f6f-cebe944b3404-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,EPCAM,HGNC:11529,chr2:47596450-47614159,chr2:47369311-47387020,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EPCAM&subject=,2019-10-08T18:30:22Z,EPCAM,https://search.clinicalgenome.org/kb/genes/HGNC:11529,Lynch syndrome,MONDO:0005835,https://search.clinicalgenome.org/kb/conditions/MONDO:0005835,Autosomal dominant inheritance
106,EPCAM,HGNC:11529,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efe1b152-d818-49bd-9f6f-cebe944b3404-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,EPCAM,HGNC:11529,chr2:47596450-47614159,chr2:47369311-47387020,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EPCAM&subject=,2019-10-08T18:30:22Z,EPCAM,https://search.clinicalgenome.org/kb/genes/HGNC:11529,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
107,EPCAM,HGNC:11529,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efe1b152-d818-49bd-9f6f-cebe944b3404-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,EPCAM,HGNC:11529,chr2:47596450-47614159,chr2:47369311-47387020,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EPCAM&subject=,2019-10-08T18:30:22Z,EPCAM,https://search.clinicalgenome.org/kb/genes/HGNC:11529,Lynch syndrome 8,MONDO:0013196,https://search.clinicalgenome.org/kb/conditions/MONDO:0013196,
108,EPCAM,HGNC:11529,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efe1b152-d818-49bd-9f6f-cebe944b3404-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,EPCAM,HGNC:11529,chr2:47596450-47614159,chr2:47369311-47387020,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EPCAM&subject=,2019-10-08T18:30:22Z,EPCAM,https://search.clinicalgenome.org/kb/genes/HGNC:11529,congenital diarrhea 5 with tufting enteropathy,MONDO:0013184,https://search.clinicalgenome.org/kb/conditions/MONDO:0013184,
109,GEN1,HGNC:26881,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8a2aec0-413b-41f2-ba51-e8a71e52cf1a-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,GEN1,HGNC:26881,chr2:17935136-17970213,chr2:17753278-17788946,Dosage Sensitivity Unlikely,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GEN1&subject=,2021-02-02T19:39:52Z,GEN1,https://search.clinicalgenome.org/kb/genes/HGNC:26881,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
110,GEN1,HGNC:26881,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8a2aec0-413b-41f2-ba51-e8a71e52cf1a-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,GEN1,HGNC:26881,chr2:17935136-17970213,chr2:17753278-17788946,Dosage Sensitivity Unlikely,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GEN1&subject=,2021-02-02T19:39:52Z,GEN1,https://search.clinicalgenome.org/kb/genes/HGNC:26881,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
111,GEN1,HGNC:26881,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8692,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,GEN1,HGNC:26881,chr2:17935136-17970213,chr2:17753278-17788946,Dosage Sensitivity Unlikely,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GEN1&subject=,2021-02-02T19:39:52Z,GEN1,https://search.clinicalgenome.org/kb/genes/HGNC:26881,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
112,GEN1,HGNC:26881,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8692,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,GEN1,HGNC:26881,chr2:17935136-17970213,chr2:17753278-17788946,Dosage Sensitivity Unlikely,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GEN1&subject=,2021-02-02T19:39:52Z,GEN1,https://search.clinicalgenome.org/kb/genes/HGNC:26881,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
113,GJB6,HGNC:4288,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP5,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f281869c-25e5-44ad-94e7-c7d6374755fd-2018-04-17T160000.000Z,2018-04-17T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,GJB6,HGNC:4288,chr13:20796101-20806458,chr13:20221962-20232319,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GJB6&subject=,2014-01-30T20:18:54Z,GJB6,https://search.clinicalgenome.org/kb/genes/HGNC:4288,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
114,GJB6,HGNC:4288,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP5,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f281869c-25e5-44ad-94e7-c7d6374755fd-2018-04-17T160000.000Z,2018-04-17T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,GJB6,HGNC:4288,chr13:20796101-20806458,chr13:20221962-20232319,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GJB6&subject=,2014-01-30T20:18:54Z,GJB6,https://search.clinicalgenome.org/kb/genes/HGNC:4288,Clouston syndrome,MONDO:0007510,https://search.clinicalgenome.org/kb/conditions/MONDO:0007510,Autosomal dominant inheritance
115,CNTNAP5,HGNC:18748,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1df71cc1-112f-4382-a047-e078a820699c-2024-08-20T040000.000Z,2024-08-20T04:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,CNTNAP5,HGNC:18748,chr2:124782864-125678796,chr2:124025287-124921219,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CNTNAP5&subject=,2024-09-24T09:25:24Z,CNTNAP5,https://search.clinicalgenome.org/kb/genes/HGNC:18748,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
116,SRPX2,HGNC:30668,epilepsy,MONDO:0005027,XL,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9555886-a248-4bd4-b3dc-50ff503d6e7a-2023-10-17T170000.000Z,2023-10-17T17:00:00.000Z,Epilepsy Gene Curation Expert Panel,SRPX2,HGNC:30668,chrX:99899196-99930785,chrX:100644199-100675788,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SRPX2&subject=,2012-07-25T14:26:57Z,SRPX2,https://search.clinicalgenome.org/kb/genes/HGNC:30668,epilepsy,MONDO:0005027,https://search.clinicalgenome.org/kb/conditions/MONDO:0005027,X-linked inheritance
117,CHRNA7,HGNC:1960,epilepsy,MONDO:0005027,UD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33edac94-9867-4b3f-9d46-2d7a86f4301b-2023-02-07T170000.000Z,2023-02-07T17:00:00.000Z,Epilepsy Gene Curation Expert Panel,CHRNA7,HGNC:1960,chr15:32322686-32465219,chr15:32030483-32173018,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHRNA7&subject=,2018-05-10T21:26:46Z,CHRNA7,https://search.clinicalgenome.org/kb/genes/HGNC:1960,epilepsy,MONDO:0005027,https://search.clinicalgenome.org/kb/conditions/MONDO:0005027,Mode of inheritance
118,MLH1,HGNC:7127,hereditary breast carcinoma,MONDO:0016419,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c27a22e4-fc45-4888-8b1d-625bc649697c-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MLH1,HGNC:7127,chr3:37035009-37092337,chr3:36993466-37050846,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MLH1&subject=,2021-10-13T18:22:36Z,MLH1,https://search.clinicalgenome.org/kb/genes/HGNC:7127,mismatch repair cancer syndrome 1,MONDO:0010159,https://search.clinicalgenome.org/kb/conditions/MONDO:0010159,Autosomal recessive inheritance
119,MLH1,HGNC:7127,hereditary breast carcinoma,MONDO:0016419,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c27a22e4-fc45-4888-8b1d-625bc649697c-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MLH1,HGNC:7127,chr3:37035009-37092337,chr3:36993466-37050846,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MLH1&subject=,2021-10-13T18:22:36Z,MLH1,https://search.clinicalgenome.org/kb/genes/HGNC:7127,Lynch syndrome,MONDO:0005835,https://search.clinicalgenome.org/kb/conditions/MONDO:0005835,Autosomal dominant inheritance
120,MLH1,HGNC:7127,hereditary breast carcinoma,MONDO:0016419,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c27a22e4-fc45-4888-8b1d-625bc649697c-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MLH1,HGNC:7127,chr3:37035009-37092337,chr3:36993466-37050846,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MLH1&subject=,2021-10-13T18:22:36Z,MLH1,https://search.clinicalgenome.org/kb/genes/HGNC:7127,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
121,MLH1,HGNC:7127,hereditary breast carcinoma,MONDO:0016419,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c27a22e4-fc45-4888-8b1d-625bc649697c-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MLH1,HGNC:7127,chr3:37035009-37092337,chr3:36993466-37050846,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MLH1&subject=,2021-10-13T18:22:36Z,MLH1,https://search.clinicalgenome.org/kb/genes/HGNC:7127,Lynch syndrome 2,MONDO:0012249,https://search.clinicalgenome.org/kb/conditions/MONDO:0012249,
122,MLH1,HGNC:7127,hereditary breast carcinoma,MONDO:0016419,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c27a22e4-fc45-4888-8b1d-625bc649697c-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MLH1,HGNC:7127,chr3:37035009-37092337,chr3:36993466-37050846,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MLH1&subject=,2021-10-13T18:22:36Z,MLH1,https://search.clinicalgenome.org/kb/genes/HGNC:7127,mismatch repair cancer syndrome,MONDO:0031219,https://search.clinicalgenome.org/kb/conditions/MONDO:0031219,
123,NBN,HGNC:7652,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc101ed8-f6ae-49b8-8850-384da62eb9b9-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,NBN,HGNC:7652,chr8:90945559-90996895,chr8:89933331-89984667,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NBN&subject=,2024-04-10T16:18:49Z,NBN,https://search.clinicalgenome.org/kb/genes/HGNC:7652,Nijmegen breakage syndrome,MONDO:0009623,https://search.clinicalgenome.org/kb/conditions/MONDO:0009623,Autosomal recessive inheritance
124,NBN,HGNC:7652,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc101ed8-f6ae-49b8-8850-384da62eb9b9-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,NBN,HGNC:7652,chr8:90945559-90996895,chr8:89933331-89984667,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NBN&subject=,2024-04-10T16:18:49Z,NBN,https://search.clinicalgenome.org/kb/genes/HGNC:7652,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
125,CHEK2,HGNC:16627,familial ovarian cancer,MONDO:0016248,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e1071da-cc4a-4bbc-b3fa-4cc07393e74a-2024-11-04T180000.000Z,2024-11-04T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,CHEK2,HGNC:16627,chr22:29083731-29137822,chr22:28687743-28741834,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK2&subject=,2020-01-08T17:26:33Z,CHEK2,https://search.clinicalgenome.org/kb/genes/HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,https://search.clinicalgenome.org/kb/conditions/MONDO:0700271,Autosomal dominant inheritance
126,CHEK2,HGNC:16627,familial ovarian cancer,MONDO:0016248,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e1071da-cc4a-4bbc-b3fa-4cc07393e74a-2024-11-04T180000.000Z,2024-11-04T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,CHEK2,HGNC:16627,chr22:29083731-29137822,chr22:28687743-28741834,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK2&subject=,2020-01-08T17:26:33Z,CHEK2,https://search.clinicalgenome.org/kb/genes/HGNC:16627,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
127,CHEK2,HGNC:16627,familial ovarian cancer,MONDO:0016248,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e1071da-cc4a-4bbc-b3fa-4cc07393e74a-2024-11-04T180000.000Z,2024-11-04T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,CHEK2,HGNC:16627,chr22:29083731-29137822,chr22:28687743-28741834,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK2&subject=,2020-01-08T17:26:33Z,CHEK2,https://search.clinicalgenome.org/kb/genes/HGNC:16627,hereditary nonpolyposis colon cancer,MONDO:0018630,https://search.clinicalgenome.org/kb/conditions/MONDO:0018630,Autosomal dominant inheritance
128,CHEK2,HGNC:16627,familial ovarian cancer,MONDO:0016248,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e1071da-cc4a-4bbc-b3fa-4cc07393e74a-2024-11-04T180000.000Z,2024-11-04T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,CHEK2,HGNC:16627,chr22:29083731-29137822,chr22:28687743-28741834,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK2&subject=,2020-01-08T17:26:33Z,CHEK2,https://search.clinicalgenome.org/kb/genes/HGNC:16627,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,
129,CHEK2,HGNC:16627,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9862,2017-03-13T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CHEK2,HGNC:16627,chr22:29083731-29137822,chr22:28687743-28741834,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK2&subject=,2020-01-08T17:26:33Z,CHEK2,https://search.clinicalgenome.org/kb/genes/HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,https://search.clinicalgenome.org/kb/conditions/MONDO:0700271,Autosomal dominant inheritance
130,CHEK2,HGNC:16627,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9862,2017-03-13T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CHEK2,HGNC:16627,chr22:29083731-29137822,chr22:28687743-28741834,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK2&subject=,2020-01-08T17:26:33Z,CHEK2,https://search.clinicalgenome.org/kb/genes/HGNC:16627,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
131,CHEK2,HGNC:16627,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9862,2017-03-13T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CHEK2,HGNC:16627,chr22:29083731-29137822,chr22:28687743-28741834,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK2&subject=,2020-01-08T17:26:33Z,CHEK2,https://search.clinicalgenome.org/kb/genes/HGNC:16627,hereditary nonpolyposis colon cancer,MONDO:0018630,https://search.clinicalgenome.org/kb/conditions/MONDO:0018630,Autosomal dominant inheritance
132,CHEK2,HGNC:16627,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9862,2017-03-13T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CHEK2,HGNC:16627,chr22:29083731-29137822,chr22:28687743-28741834,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK2&subject=,2020-01-08T17:26:33Z,CHEK2,https://search.clinicalgenome.org/kb/genes/HGNC:16627,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,
133,BRIP1,HGNC:20473,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87aa8181-721b-4583-98cf-0dead1827e27-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BRIP1,HGNC:20473,chr17:59756500-59940889,chr17:61679139-61863528,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRIP1&subject=,2019-02-15T21:58:42Z,BRIP1,https://search.clinicalgenome.org/kb/genes/HGNC:20473,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
134,BRIP1,HGNC:20473,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87aa8181-721b-4583-98cf-0dead1827e27-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BRIP1,HGNC:20473,chr17:59756500-59940889,chr17:61679139-61863528,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRIP1&subject=,2019-02-15T21:58:42Z,BRIP1,https://search.clinicalgenome.org/kb/genes/HGNC:20473,Fanconi anemia complementation group J,MONDO:0012187,https://search.clinicalgenome.org/kb/conditions/MONDO:0012187,Autosomal recessive inheritance
135,BRIP1,HGNC:20473,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87aa8181-721b-4583-98cf-0dead1827e27-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BRIP1,HGNC:20473,chr17:59756500-59940889,chr17:61679139-61863528,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRIP1&subject=,2019-02-15T21:58:42Z,BRIP1,https://search.clinicalgenome.org/kb/genes/HGNC:20473,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
136,BRIP1,HGNC:20473,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87aa8181-721b-4583-98cf-0dead1827e27-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BRIP1,HGNC:20473,chr17:59756500-59940889,chr17:61679139-61863528,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRIP1&subject=,2019-02-15T21:58:42Z,BRIP1,https://search.clinicalgenome.org/kb/genes/HGNC:20473,Fanconi anemia,MONDO:0019391,https://search.clinicalgenome.org/kb/conditions/MONDO:0019391,
137,BRIP1,HGNC:20473,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87aa8181-721b-4583-98cf-0dead1827e27-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BRIP1,HGNC:20473,chr17:59756500-59940889,chr17:61679139-61863528,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRIP1&subject=,2019-02-15T21:58:42Z,BRIP1,https://search.clinicalgenome.org/kb/genes/HGNC:20473,Fanconi anemia complementation group G,MONDO:0013565,https://search.clinicalgenome.org/kb/conditions/MONDO:0013565,
138,CPA6,HGNC:17245,epilepsy,MONDO:0005027,AD,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1cb32379-82a8-425d-ac80-3d740e1cc10b-2021-07-29T132527.108Z,2021-07-29T13:25:27.108Z,Epilepsy Gene Curation Expert Panel,CPA6,HGNC:17245,chr8:68334273-68658595,chr8:67422038-67746360,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CPA6&subject=,2019-09-04T15:09:34Z,CPA6,https://search.clinicalgenome.org/kb/genes/HGNC:17245,epilepsy,MONDO:0005027,https://search.clinicalgenome.org/kb/conditions/MONDO:0005027,Autosomal dominant inheritance | Autosomal recessive inheritance
139,CPA6,HGNC:17245,epilepsy,MONDO:0005027,AR,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7b3ebd58-dccb-4c73-b5e4-1ec55171f2fe-2021-07-29T135909.720Z,2021-07-29T13:59:09.720Z,Epilepsy Gene Curation Expert Panel,CPA6,HGNC:17245,chr8:68334273-68658595,chr8:67422038-67746360,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CPA6&subject=,2019-09-04T15:09:34Z,CPA6,https://search.clinicalgenome.org/kb/genes/HGNC:17245,epilepsy,MONDO:0005027,https://search.clinicalgenome.org/kb/conditions/MONDO:0005027,Autosomal dominant inheritance | Autosomal recessive inheritance
140,MRE11,HGNC:7230,familial ovarian cancer,MONDO:0016248,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5b721c7-52ab-4475-a87e-cb0fa3be198f-2023-12-15T180000.000Z,2023-12-15T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MRE11,HGNC:7230,chr11:94148736-94227010,chr11:94415570-94512412,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MRE11&subject=,2023-12-19T14:45:21Z,MRE11,https://search.clinicalgenome.org/kb/genes/HGNC:7230,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
141,MRE11,HGNC:7230,familial ovarian cancer,MONDO:0016248,AD,SOP10,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5b721c7-52ab-4475-a87e-cb0fa3be198f-2023-12-15T180000.000Z,2023-12-15T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MRE11,HGNC:7230,chr11:94148736-94227010,chr11:94415570-94512412,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MRE11&subject=,2023-12-19T14:45:21Z,MRE11,https://search.clinicalgenome.org/kb/genes/HGNC:7230,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
142,MRE11,HGNC:7230,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e720d1f7-62b3-4a0f-97de-e1144d0475a9-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MRE11,HGNC:7230,chr11:94148736-94227010,chr11:94415570-94512412,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MRE11&subject=,2023-12-19T14:45:21Z,MRE11,https://search.clinicalgenome.org/kb/genes/HGNC:7230,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
143,MRE11,HGNC:7230,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e720d1f7-62b3-4a0f-97de-e1144d0475a9-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MRE11,HGNC:7230,chr11:94148736-94227010,chr11:94415570-94512412,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MRE11&subject=,2023-12-19T14:45:21Z,MRE11,https://search.clinicalgenome.org/kb/genes/HGNC:7230,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
144,MSH2,HGNC:7325,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cb3ff3b-3e0e-42f2-85d5-3ffb1506a255-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH2,HGNC:7325,chr2:47630206-47710367,chr2:47403067-47709830,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH2&subject=,2021-10-13T18:24:26Z,MSH2,https://search.clinicalgenome.org/kb/genes/HGNC:7325,mismatch repair cancer syndrome 1,MONDO:0010159,https://search.clinicalgenome.org/kb/conditions/MONDO:0010159,Autosomal recessive inheritance
145,MSH2,HGNC:7325,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cb3ff3b-3e0e-42f2-85d5-3ffb1506a255-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH2,HGNC:7325,chr2:47630206-47710367,chr2:47403067-47709830,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH2&subject=,2021-10-13T18:24:26Z,MSH2,https://search.clinicalgenome.org/kb/genes/HGNC:7325,Lynch syndrome,MONDO:0005835,https://search.clinicalgenome.org/kb/conditions/MONDO:0005835,Autosomal dominant inheritance
146,MSH2,HGNC:7325,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cb3ff3b-3e0e-42f2-85d5-3ffb1506a255-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH2,HGNC:7325,chr2:47630206-47710367,chr2:47403067-47709830,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH2&subject=,2021-10-13T18:24:26Z,MSH2,https://search.clinicalgenome.org/kb/genes/HGNC:7325,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
147,MSH2,HGNC:7325,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cb3ff3b-3e0e-42f2-85d5-3ffb1506a255-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH2,HGNC:7325,chr2:47630206-47710367,chr2:47403067-47709830,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH2&subject=,2021-10-13T18:24:26Z,MSH2,https://search.clinicalgenome.org/kb/genes/HGNC:7325,Lynch syndrome 1,MONDO:0007356,https://search.clinicalgenome.org/kb/conditions/MONDO:0007356,
148,MSH2,HGNC:7325,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cb3ff3b-3e0e-42f2-85d5-3ffb1506a255-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH2,HGNC:7325,chr2:47630206-47710367,chr2:47403067-47709830,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH2&subject=,2021-10-13T18:24:26Z,MSH2,https://search.clinicalgenome.org/kb/genes/HGNC:7325,mismatch repair cancer syndrome 2,MONDO:0030840,https://search.clinicalgenome.org/kb/conditions/MONDO:0030840,
149,MSH2,HGNC:7325,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cb3ff3b-3e0e-42f2-85d5-3ffb1506a255-2023-03-14T170000.000Z,2023-03-14T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH2,HGNC:7325,chr2:47630206-47710367,chr2:47403067-47709830,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH2&subject=,2021-10-13T18:24:26Z,MSH2,https://search.clinicalgenome.org/kb/genes/HGNC:7325,mismatch repair cancer syndrome,MONDO:0031219,https://search.clinicalgenome.org/kb/conditions/MONDO:0031219,
150,PIK3CA,HGNC:8975,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ce3540a-5a7f-4f47-aeb3-520767016539-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PIK3CA,HGNC:8975,chr3:178866145-178957881,chr3:179148126-179240093,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PIK3CA&subject=,2015-03-12T13:17:52Z,PIK3CA,https://search.clinicalgenome.org/kb/genes/HGNC:8975,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,https://search.clinicalgenome.org/kb/conditions/MONDO:0100283,Autosomal dominant inheritance
151,PIK3CA,HGNC:8975,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ce3540a-5a7f-4f47-aeb3-520767016539-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PIK3CA,HGNC:8975,chr3:178866145-178957881,chr3:179148126-179240093,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PIK3CA&subject=,2015-03-12T13:17:52Z,PIK3CA,https://search.clinicalgenome.org/kb/genes/HGNC:8975,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
152,PIK3CA,HGNC:8975,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ce3540a-5a7f-4f47-aeb3-520767016539-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PIK3CA,HGNC:8975,chr3:178866145-178957881,chr3:179148126-179240093,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PIK3CA&subject=,2015-03-12T13:17:52Z,PIK3CA,https://search.clinicalgenome.org/kb/genes/HGNC:8975,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
153,PIK3CA,HGNC:8975,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8694,2017-02-08T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,PIK3CA,HGNC:8975,chr3:178866145-178957881,chr3:179148126-179240093,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PIK3CA&subject=,2015-03-12T13:17:52Z,PIK3CA,https://search.clinicalgenome.org/kb/genes/HGNC:8975,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,https://search.clinicalgenome.org/kb/conditions/MONDO:0100283,Autosomal dominant inheritance
154,PIK3CA,HGNC:8975,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8694,2017-02-08T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,PIK3CA,HGNC:8975,chr3:178866145-178957881,chr3:179148126-179240093,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PIK3CA&subject=,2015-03-12T13:17:52Z,PIK3CA,https://search.clinicalgenome.org/kb/genes/HGNC:8975,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
155,PIK3CA,HGNC:8975,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8694,2017-02-08T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,PIK3CA,HGNC:8975,chr3:178866145-178957881,chr3:179148126-179240093,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PIK3CA&subject=,2015-03-12T13:17:52Z,PIK3CA,https://search.clinicalgenome.org/kb/genes/HGNC:8975,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
156,MYL2,HGNC:7583,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1db17cf-199d-4bd7-9673-e8f06219fc26-2019-05-24T160000.000Z,2019-05-24T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
157,MYL2,HGNC:7583,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1db17cf-199d-4bd7-9673-e8f06219fc26-2019-05-24T160000.000Z,2019-05-24T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
158,MYL2,HGNC:7583,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1db17cf-199d-4bd7-9673-e8f06219fc26-2019-05-24T160000.000Z,2019-05-24T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
159,MYL2,HGNC:7583,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1db17cf-199d-4bd7-9673-e8f06219fc26-2019-05-24T160000.000Z,2019-05-24T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,hypertrophic cardiomyopathy 10,MONDO:0012112,https://search.clinicalgenome.org/kb/conditions/MONDO:0012112,Autosomal dominant inheritance
160,MYL2,HGNC:7583,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1db17cf-199d-4bd7-9673-e8f06219fc26-2019-05-24T160000.000Z,2019-05-24T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
161,MYL2,HGNC:7583,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8405609b-1664-4849-848e-bec138350c92-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
162,MYL2,HGNC:7583,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8405609b-1664-4849-848e-bec138350c92-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
163,MYL2,HGNC:7583,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8405609b-1664-4849-848e-bec138350c92-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
164,MYL2,HGNC:7583,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8405609b-1664-4849-848e-bec138350c92-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,hypertrophic cardiomyopathy 10,MONDO:0012112,https://search.clinicalgenome.org/kb/conditions/MONDO:0012112,Autosomal dominant inheritance
165,MYL2,HGNC:7583,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8405609b-1664-4849-848e-bec138350c92-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL2,HGNC:7583,chr12:111348649-111358383,chr12:110910845-110921449,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL2&subject=,2015-11-20T22:18:36Z,MYL2,https://search.clinicalgenome.org/kb/genes/HGNC:7583,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
166,CRKL,HGNC:2363,congenital heart disease,MONDO:0005453,UD,SOP9,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_453641ec-805e-4712-841d-a228b48f5cc4-2023-10-17T040000.000Z,2023-10-17T04:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,CRKL,HGNC:2363,chr22:21271695-21308035,chr22:20917407-20953747,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CRKL&subject=,2020-04-13T18:49:39Z,CRKL,https://search.clinicalgenome.org/kb/genes/HGNC:2363,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Mode of inheritance
167,TNNT2,HGNC:11949,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2bde3ff-f75f-40c3-a8fe-10a72e883b3c-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNT2,HGNC:11949,chr1:201328142-201346808,chr1:201359014-201377680,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNT2&subject=,2015-11-16T01:19:20Z,TNNT2,https://search.clinicalgenome.org/kb/genes/HGNC:11949,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
168,TNNT2,HGNC:11949,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2bde3ff-f75f-40c3-a8fe-10a72e883b3c-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNT2,HGNC:11949,chr1:201328142-201346808,chr1:201359014-201377680,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNT2&subject=,2015-11-16T01:19:20Z,TNNT2,https://search.clinicalgenome.org/kb/genes/HGNC:11949,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
169,TNNT2,HGNC:11949,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2bde3ff-f75f-40c3-a8fe-10a72e883b3c-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNT2,HGNC:11949,chr1:201328142-201346808,chr1:201359014-201377680,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNT2&subject=,2015-11-16T01:19:20Z,TNNT2,https://search.clinicalgenome.org/kb/genes/HGNC:11949,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
170,TNNT2,HGNC:11949,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2bde3ff-f75f-40c3-a8fe-10a72e883b3c-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNT2,HGNC:11949,chr1:201328142-201346808,chr1:201359014-201377680,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNT2&subject=,2015-11-16T01:19:20Z,TNNT2,https://search.clinicalgenome.org/kb/genes/HGNC:11949,dilated cardiomyopathy 1D,MONDO:0011095,https://search.clinicalgenome.org/kb/conditions/MONDO:0011095,
171,TNNT2,HGNC:11949,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2bde3ff-f75f-40c3-a8fe-10a72e883b3c-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNT2,HGNC:11949,chr1:201328142-201346808,chr1:201359014-201377680,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNT2&subject=,2015-11-16T01:19:20Z,TNNT2,https://search.clinicalgenome.org/kb/genes/HGNC:11949,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
172,TNNT2,HGNC:11949,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2bde3ff-f75f-40c3-a8fe-10a72e883b3c-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNT2,HGNC:11949,chr1:201328142-201346808,chr1:201359014-201377680,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNT2&subject=,2015-11-16T01:19:20Z,TNNT2,https://search.clinicalgenome.org/kb/genes/HGNC:11949,hypertrophic cardiomyopathy 2,MONDO:0007266,https://search.clinicalgenome.org/kb/conditions/MONDO:0007266,
173,TNNI3,HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c990ca-e407-4a21-a3e2-237700a75d43-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
174,TNNI3,HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c990ca-e407-4a21-a3e2-237700a75d43-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
175,TNNI3,HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c990ca-e407-4a21-a3e2-237700a75d43-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
176,TNNI3,HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c990ca-e407-4a21-a3e2-237700a75d43-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
177,TNNI3,HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c990ca-e407-4a21-a3e2-237700a75d43-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,hypertrophic cardiomyopathy 7,MONDO:0013369,https://search.clinicalgenome.org/kb/conditions/MONDO:0013369,
178,TNNI3,HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c990ca-e407-4a21-a3e2-237700a75d43-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,"cardiomyopathy, familial restrictive, 1",MONDO:0007270,https://search.clinicalgenome.org/kb/conditions/MONDO:0007270,
179,TNNI3,HGNC:11947,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668087ea-0d2f-42c2-a291-f73400d34023-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
180,TNNI3,HGNC:11947,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668087ea-0d2f-42c2-a291-f73400d34023-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
181,TNNI3,HGNC:11947,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668087ea-0d2f-42c2-a291-f73400d34023-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
182,TNNI3,HGNC:11947,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668087ea-0d2f-42c2-a291-f73400d34023-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
183,TNNI3,HGNC:11947,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668087ea-0d2f-42c2-a291-f73400d34023-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,hypertrophic cardiomyopathy 7,MONDO:0013369,https://search.clinicalgenome.org/kb/conditions/MONDO:0013369,
184,TNNI3,HGNC:11947,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668087ea-0d2f-42c2-a291-f73400d34023-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TNNI3,HGNC:11947,chr19:55663135-55669100,chr19:55151767-55157732,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNI3&subject=,2023-05-25T13:36:35Z,TNNI3,https://search.clinicalgenome.org/kb/genes/HGNC:11947,"cardiomyopathy, familial restrictive, 1",MONDO:0007270,https://search.clinicalgenome.org/kb/conditions/MONDO:0007270,
185,SDHC,HGNC:10682,mitochondrial disease,MONDO:0044970,UD,SOP8,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_909982e0-a53c-4a87-bf28-cdb563c8ae62-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHC,HGNC:10682,chr1:161284171-161345130,chr1:161314381-161363206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHC&subject=,2021-10-13T16:46:56Z,SDHC,https://search.clinicalgenome.org/kb/genes/HGNC:10682,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,https://search.clinicalgenome.org/kb/conditions/MONDO:0017366,Autosomal dominant inheritance
186,SDHC,HGNC:10682,mitochondrial disease,MONDO:0044970,UD,SOP8,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_909982e0-a53c-4a87-bf28-cdb563c8ae62-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHC,HGNC:10682,chr1:161284171-161345130,chr1:161314381-161363206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHC&subject=,2021-10-13T16:46:56Z,SDHC,https://search.clinicalgenome.org/kb/genes/HGNC:10682,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Mode of inheritance
187,SDHC,HGNC:10682,mitochondrial disease,MONDO:0044970,UD,SOP8,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_909982e0-a53c-4a87-bf28-cdb563c8ae62-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHC,HGNC:10682,chr1:161284171-161345130,chr1:161314381-161363206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHC&subject=,2021-10-13T16:46:56Z,SDHC,https://search.clinicalgenome.org/kb/genes/HGNC:10682,paragangliomas 3,MONDO:0011544,https://search.clinicalgenome.org/kb/conditions/MONDO:0011544,
188,SDHC,HGNC:10682,mitochondrial disease,MONDO:0044970,UD,SOP8,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_909982e0-a53c-4a87-bf28-cdb563c8ae62-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHC,HGNC:10682,chr1:161284171-161345130,chr1:161314381-161363206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHC&subject=,2021-10-13T16:46:56Z,SDHC,https://search.clinicalgenome.org/kb/genes/HGNC:10682,paraganglioma,MONDO:0000448,https://search.clinicalgenome.org/kb/conditions/MONDO:0000448,
189,SDHC,HGNC:10682,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6e49d4-8117-4fc2-88cd-aad0017ce2c4-2021-06-17T013125.314Z,2021-06-17T01:31:25.314Z,Hereditary Cancer Gene Curation Expert Panel,SDHC,HGNC:10682,chr1:161284171-161345130,chr1:161314381-161363206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHC&subject=,2021-10-13T16:46:56Z,SDHC,https://search.clinicalgenome.org/kb/genes/HGNC:10682,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,https://search.clinicalgenome.org/kb/conditions/MONDO:0017366,Autosomal dominant inheritance
190,SDHC,HGNC:10682,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6e49d4-8117-4fc2-88cd-aad0017ce2c4-2021-06-17T013125.314Z,2021-06-17T01:31:25.314Z,Hereditary Cancer Gene Curation Expert Panel,SDHC,HGNC:10682,chr1:161284171-161345130,chr1:161314381-161363206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHC&subject=,2021-10-13T16:46:56Z,SDHC,https://search.clinicalgenome.org/kb/genes/HGNC:10682,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Mode of inheritance
191,SDHC,HGNC:10682,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6e49d4-8117-4fc2-88cd-aad0017ce2c4-2021-06-17T013125.314Z,2021-06-17T01:31:25.314Z,Hereditary Cancer Gene Curation Expert Panel,SDHC,HGNC:10682,chr1:161284171-161345130,chr1:161314381-161363206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHC&subject=,2021-10-13T16:46:56Z,SDHC,https://search.clinicalgenome.org/kb/genes/HGNC:10682,paragangliomas 3,MONDO:0011544,https://search.clinicalgenome.org/kb/conditions/MONDO:0011544,
192,SDHC,HGNC:10682,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6e49d4-8117-4fc2-88cd-aad0017ce2c4-2021-06-17T013125.314Z,2021-06-17T01:31:25.314Z,Hereditary Cancer Gene Curation Expert Panel,SDHC,HGNC:10682,chr1:161284171-161345130,chr1:161314381-161363206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHC&subject=,2021-10-13T16:46:56Z,SDHC,https://search.clinicalgenome.org/kb/genes/HGNC:10682,paraganglioma,MONDO:0000448,https://search.clinicalgenome.org/kb/conditions/MONDO:0000448,
193,CHEK1,HGNC:1925,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8504,2016-10-12T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CHEK1,HGNC:1925,chr11:125495031-125546150,chr11:125625136-125681124,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK1&subject=,2021-11-10T17:45:07Z,CHEK1,https://search.clinicalgenome.org/kb/genes/HGNC:1925,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
194,CHEK1,HGNC:1925,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8504,2016-10-12T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CHEK1,HGNC:1925,chr11:125495031-125546150,chr11:125625136-125681124,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK1&subject=,2021-11-10T17:45:07Z,CHEK1,https://search.clinicalgenome.org/kb/genes/HGNC:1925,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
195,CHEK1,HGNC:1925,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8505,2016-10-12T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CHEK1,HGNC:1925,chr11:125495031-125546150,chr11:125625136-125681124,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK1&subject=,2021-11-10T17:45:07Z,CHEK1,https://search.clinicalgenome.org/kb/genes/HGNC:1925,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
196,CHEK1,HGNC:1925,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8505,2016-10-12T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CHEK1,HGNC:1925,chr11:125495031-125546150,chr11:125625136-125681124,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHEK1&subject=,2021-11-10T17:45:07Z,CHEK1,https://search.clinicalgenome.org/kb/genes/HGNC:1925,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
197,ACTC1,HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_748d4255-ef43-4b42-b9f1-1cdbc50de763-2019-03-15T160000.000Z,2019-03-15T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
198,ACTC1,HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_748d4255-ef43-4b42-b9f1-1cdbc50de763-2019-03-15T160000.000Z,2019-03-15T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
199,ACTC1,HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_748d4255-ef43-4b42-b9f1-1cdbc50de763-2019-03-15T160000.000Z,2019-03-15T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
200,ACTC1,HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_748d4255-ef43-4b42-b9f1-1cdbc50de763-2019-03-15T160000.000Z,2019-03-15T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,hypertrophic cardiomyopathy 11,MONDO:0012799,https://search.clinicalgenome.org/kb/conditions/MONDO:0012799,
201,ACTC1,HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_748d4255-ef43-4b42-b9f1-1cdbc50de763-2019-03-15T160000.000Z,2019-03-15T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
202,ACTC1,HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_748d4255-ef43-4b42-b9f1-1cdbc50de763-2019-03-15T160000.000Z,2019-03-15T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,"atrial septal defect, ostium secundum type",MONDO:0020434,https://search.clinicalgenome.org/kb/conditions/MONDO:0020434,
203,ACTC1,HGNC:143,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e9b4048-3003-4180-b891-fcf10d25a814-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
204,ACTC1,HGNC:143,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e9b4048-3003-4180-b891-fcf10d25a814-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
205,ACTC1,HGNC:143,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e9b4048-3003-4180-b891-fcf10d25a814-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
206,ACTC1,HGNC:143,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e9b4048-3003-4180-b891-fcf10d25a814-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,hypertrophic cardiomyopathy 11,MONDO:0012799,https://search.clinicalgenome.org/kb/conditions/MONDO:0012799,
207,ACTC1,HGNC:143,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e9b4048-3003-4180-b891-fcf10d25a814-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
208,ACTC1,HGNC:143,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e9b4048-3003-4180-b891-fcf10d25a814-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,ACTC1,HGNC:143,chr15:35082431-35087750,chr15:34790230-34795549,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTC1&subject=,2024-09-10T16:57:33Z,ACTC1,https://search.clinicalgenome.org/kb/genes/HGNC:143,"atrial septal defect, ostium secundum type",MONDO:0020434,https://search.clinicalgenome.org/kb/conditions/MONDO:0020434,
209,RECQL,HGNC:9948,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8701,2016-09-14T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,RECQL,HGNC:9948,chr12:21621844-21654569,chr12:21468910-21501635,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RECQL&subject=,2024-09-11T16:24:46Z,RECQL,https://search.clinicalgenome.org/kb/genes/HGNC:9948,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
210,RECQL,HGNC:9948,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8701,2016-09-14T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,RECQL,HGNC:9948,chr12:21621844-21654569,chr12:21468910-21501635,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RECQL&subject=,2024-09-11T16:24:46Z,RECQL,https://search.clinicalgenome.org/kb/genes/HGNC:9948,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
211,RECQL,HGNC:9948,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_777b2a5c-459f-4eee-8a6d-e8bf15b88aca-2023-03-13T170000.000Z,2023-03-13T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RECQL,HGNC:9948,chr12:21621844-21654569,chr12:21468910-21501635,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RECQL&subject=,2024-09-11T16:24:46Z,RECQL,https://search.clinicalgenome.org/kb/genes/HGNC:9948,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
212,RECQL,HGNC:9948,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_777b2a5c-459f-4eee-8a6d-e8bf15b88aca-2023-03-13T170000.000Z,2023-03-13T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RECQL,HGNC:9948,chr12:21621844-21654569,chr12:21468910-21501635,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RECQL&subject=,2024-09-11T16:24:46Z,RECQL,https://search.clinicalgenome.org/kb/genes/HGNC:9948,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
213,CTNNA1,HGNC:2509,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9868,2017-04-24T00:00:00,Colon Cancer Gene Curation Expert Panel,CTNNA1,HGNC:2509,chr5:138089114-138270723,chr5:138753425-138935034,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CTNNA1&subject=,2022-10-12T16:23:54Z,CTNNA1,https://search.clinicalgenome.org/kb/genes/HGNC:2509,CTNNA1-related diffuse gastric and lobular breast cancer syndrome,MONDO:0100256,https://search.clinicalgenome.org/kb/conditions/MONDO:0100256,Autosomal dominant inheritance
214,CTNNA1,HGNC:2509,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9868,2017-04-24T00:00:00,Colon Cancer Gene Curation Expert Panel,CTNNA1,HGNC:2509,chr5:138089114-138270723,chr5:138753425-138935034,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CTNNA1&subject=,2022-10-12T16:23:54Z,CTNNA1,https://search.clinicalgenome.org/kb/genes/HGNC:2509,hereditary nonpolyposis colon cancer,MONDO:0018630,https://search.clinicalgenome.org/kb/conditions/MONDO:0018630,Autosomal dominant inheritance
215,CTNNA1,HGNC:2509,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9868,2017-04-24T00:00:00,Colon Cancer Gene Curation Expert Panel,CTNNA1,HGNC:2509,chr5:138089114-138270723,chr5:138753425-138935034,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CTNNA1&subject=,2022-10-12T16:23:54Z,CTNNA1,https://search.clinicalgenome.org/kb/genes/HGNC:2509,hereditary gastric cancer,MONDO:0018502,https://search.clinicalgenome.org/kb/conditions/MONDO:0018502,
216,NF1,HGNC:7765,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10082,2017-02-22T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,NF1,HGNC:7765,chr17:29421945-29704695,chr17:31094927-31377677,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NF1&subject=,2023-02-12T05:32:18Z,NF1,https://search.clinicalgenome.org/kb/genes/HGNC:7765,neurofibromatosis type 1,MONDO:0018975,https://search.clinicalgenome.org/kb/conditions/MONDO:0018975,Autosomal dominant inheritance
217,NF1,HGNC:7765,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10082,2017-02-22T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,NF1,HGNC:7765,chr17:29421945-29704695,chr17:31094927-31377677,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NF1&subject=,2023-02-12T05:32:18Z,NF1,https://search.clinicalgenome.org/kb/genes/HGNC:7765,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
218,CDH1,HGNC:1748,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8503,2017-08-03T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CDH1,HGNC:1748,chr16:68771195-68869440,chr16:68737292-68835537,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CDH1&subject=,2020-04-10T15:02:12Z,CDH1,https://search.clinicalgenome.org/kb/genes/HGNC:1748,CDH1-related diffuse gastric and lobular breast cancer syndrome,MONDO:0100488,https://search.clinicalgenome.org/kb/conditions/MONDO:0100488,Autosomal dominant inheritance
219,CDH1,HGNC:1748,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8503,2017-08-03T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CDH1,HGNC:1748,chr16:68771195-68869440,chr16:68737292-68835537,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CDH1&subject=,2020-04-10T15:02:12Z,CDH1,https://search.clinicalgenome.org/kb/genes/HGNC:1748,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
220,CDH1,HGNC:1748,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8503,2017-08-03T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,CDH1,HGNC:1748,chr16:68771195-68869440,chr16:68737292-68835537,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CDH1&subject=,2020-04-10T15:02:12Z,CDH1,https://search.clinicalgenome.org/kb/genes/HGNC:1748,hereditary diffuse gastric adenocarcinoma,MONDO:0007648,https://search.clinicalgenome.org/kb/conditions/MONDO:0007648,
221,MCPH1,HGNC:6954,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8525,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,MCPH1,HGNC:6954,chr8:6264148-6506029,chr8:6406627-6648508,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MCPH1&subject=,2016-08-22T17:50:15Z,MCPH1,https://search.clinicalgenome.org/kb/genes/HGNC:6954,microcephaly with intellectual disability,MONDO:0100200,https://search.clinicalgenome.org/kb/conditions/MONDO:0100200,Autosomal recessive inheritance
222,MCPH1,HGNC:6954,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8525,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,MCPH1,HGNC:6954,chr8:6264148-6506029,chr8:6406627-6648508,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MCPH1&subject=,2016-08-22T17:50:15Z,MCPH1,https://search.clinicalgenome.org/kb/genes/HGNC:6954,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
223,MCPH1,HGNC:6954,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8525,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,MCPH1,HGNC:6954,chr8:6264148-6506029,chr8:6406627-6648508,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MCPH1&subject=,2016-08-22T17:50:15Z,MCPH1,https://search.clinicalgenome.org/kb/genes/HGNC:6954,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
224,MCPH1,HGNC:6954,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8525,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,MCPH1,HGNC:6954,chr8:6264148-6506029,chr8:6406627-6648508,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MCPH1&subject=,2016-08-22T17:50:15Z,MCPH1,https://search.clinicalgenome.org/kb/genes/HGNC:6954,"microcephaly 1, primary, autosomal recessive",MONDO:0009617,https://search.clinicalgenome.org/kb/conditions/MONDO:0009617,
225,MCPH1,HGNC:6954,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8524,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,MCPH1,HGNC:6954,chr8:6264148-6506029,chr8:6406627-6648508,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MCPH1&subject=,2016-08-22T17:50:15Z,MCPH1,https://search.clinicalgenome.org/kb/genes/HGNC:6954,microcephaly with intellectual disability,MONDO:0100200,https://search.clinicalgenome.org/kb/conditions/MONDO:0100200,Autosomal recessive inheritance
226,MCPH1,HGNC:6954,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8524,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,MCPH1,HGNC:6954,chr8:6264148-6506029,chr8:6406627-6648508,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MCPH1&subject=,2016-08-22T17:50:15Z,MCPH1,https://search.clinicalgenome.org/kb/genes/HGNC:6954,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
227,MCPH1,HGNC:6954,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8524,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,MCPH1,HGNC:6954,chr8:6264148-6506029,chr8:6406627-6648508,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MCPH1&subject=,2016-08-22T17:50:15Z,MCPH1,https://search.clinicalgenome.org/kb/genes/HGNC:6954,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
228,MCPH1,HGNC:6954,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8524,2017-01-11T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,MCPH1,HGNC:6954,chr8:6264148-6506029,chr8:6406627-6648508,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MCPH1&subject=,2016-08-22T17:50:15Z,MCPH1,https://search.clinicalgenome.org/kb/genes/HGNC:6954,"microcephaly 1, primary, autosomal recessive",MONDO:0009617,https://search.clinicalgenome.org/kb/conditions/MONDO:0009617,
229,TPM1,HGNC:12010,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e69d885-a5c6-48de-bb65-0943a6c2268d-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
230,TPM1,HGNC:12010,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e69d885-a5c6-48de-bb65-0943a6c2268d-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
231,TPM1,HGNC:12010,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e69d885-a5c6-48de-bb65-0943a6c2268d-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
232,TPM1,HGNC:12010,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e69d885-a5c6-48de-bb65-0943a6c2268d-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
233,TPM1,HGNC:12010,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e69d885-a5c6-48de-bb65-0943a6c2268d-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,hypertrophic cardiomyopathy 3,MONDO:0007267,https://search.clinicalgenome.org/kb/conditions/MONDO:0007267,
234,TPM1,HGNC:12010,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1173d239-23cf-4c9c-9ea5-f95d9356e6c7-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
235,TPM1,HGNC:12010,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1173d239-23cf-4c9c-9ea5-f95d9356e6c7-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
236,TPM1,HGNC:12010,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1173d239-23cf-4c9c-9ea5-f95d9356e6c7-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
237,TPM1,HGNC:12010,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1173d239-23cf-4c9c-9ea5-f95d9356e6c7-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
238,TPM1,HGNC:12010,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1173d239-23cf-4c9c-9ea5-f95d9356e6c7-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TPM1,HGNC:12010,chr15:63334946-63364114,chr15:63042747-63071915,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPM1&subject=,2015-11-09T15:55:57Z,TPM1,https://search.clinicalgenome.org/kb/genes/HGNC:12010,hypertrophic cardiomyopathy 3,MONDO:0007267,https://search.clinicalgenome.org/kb/conditions/MONDO:0007267,
239,STK11,HGNC:11389,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8708,2016-10-26T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,STK11,HGNC:11389,chr19:1205777-1228430,chr19:1205778-1228431,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STK11&subject=,2021-11-10T18:01:07Z,STK11,https://search.clinicalgenome.org/kb/genes/HGNC:11389,Peutz-Jeghers syndrome,MONDO:0008280,https://search.clinicalgenome.org/kb/conditions/MONDO:0008280,Autosomal dominant inheritance
240,STK11,HGNC:11389,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8708,2016-10-26T00:00:00,Breast/Ovarian Cancer Gene Curation Expert Panel,STK11,HGNC:11389,chr19:1205777-1228430,chr19:1205778-1228431,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STK11&subject=,2021-11-10T18:01:07Z,STK11,https://search.clinicalgenome.org/kb/genes/HGNC:11389,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
241,STK11,HGNC:11389,Peutz-Jeghers syndrome,MONDO:0008280,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_89685102-ac40-4932-96e7-c2e9e9280858-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,STK11,HGNC:11389,chr19:1205777-1228430,chr19:1205778-1228431,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STK11&subject=,2021-11-10T18:01:07Z,STK11,https://search.clinicalgenome.org/kb/genes/HGNC:11389,Peutz-Jeghers syndrome,MONDO:0008280,https://search.clinicalgenome.org/kb/conditions/MONDO:0008280,Autosomal dominant inheritance
242,STK11,HGNC:11389,Peutz-Jeghers syndrome,MONDO:0008280,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_89685102-ac40-4932-96e7-c2e9e9280858-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,STK11,HGNC:11389,chr19:1205777-1228430,chr19:1205778-1228431,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STK11&subject=,2021-11-10T18:01:07Z,STK11,https://search.clinicalgenome.org/kb/genes/HGNC:11389,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
243,LRP2,HGNC:6694,congenital heart disease,MONDO:0005453,AR,SOP11,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_291857b3-399a-42fa-86f7-d4077f97accd-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,LRP2,HGNC:6694,chr2:169983619-170219044,chr2:169127109-169362534,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LRP2&subject=,2019-04-24T16:46:35Z,LRP2,https://search.clinicalgenome.org/kb/genes/HGNC:6694,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal recessive inheritance
244,LRP2,HGNC:6694,congenital heart disease,MONDO:0005453,AR,SOP11,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_291857b3-399a-42fa-86f7-d4077f97accd-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,LRP2,HGNC:6694,chr2:169983619-170219044,chr2:169127109-169362534,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LRP2&subject=,2019-04-24T16:46:35Z,LRP2,https://search.clinicalgenome.org/kb/genes/HGNC:6694,Donnai-Barrow syndrome,MONDO:0009104,https://search.clinicalgenome.org/kb/conditions/MONDO:0009104,
245,HBA1,HGNC:4823,"erythrocytosis, familial, 7",MONDO:0054802,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df23db1a-3b2f-497f-87c4-556c51e7bdd6-2023-10-25T160000.000Z,2023-10-25T16:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,"methemoglobinemia, alpha type",MONDO:0020835,https://search.clinicalgenome.org/kb/conditions/MONDO:0020835,Autosomal dominant inheritance
246,HBA1,HGNC:4823,"erythrocytosis, familial, 7",MONDO:0054802,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df23db1a-3b2f-497f-87c4-556c51e7bdd6-2023-10-25T160000.000Z,2023-10-25T16:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,unstable hemoglobin disease,MONDO:0020459,https://search.clinicalgenome.org/kb/conditions/MONDO:0020459,Autosomal dominant inheritance
247,HBA1,HGNC:4823,"erythrocytosis, familial, 7",MONDO:0054802,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df23db1a-3b2f-497f-87c4-556c51e7bdd6-2023-10-25T160000.000Z,2023-10-25T16:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,"erythrocytosis, familial, 7",MONDO:0054802,https://search.clinicalgenome.org/kb/conditions/MONDO:0054802,Autosomal dominant inheritance
248,HBA1,HGNC:4823,"erythrocytosis, familial, 7",MONDO:0054802,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df23db1a-3b2f-497f-87c4-556c51e7bdd6-2023-10-25T160000.000Z,2023-10-25T16:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,alpha thalassemia spectrum,MONDO:0011399,https://search.clinicalgenome.org/kb/conditions/MONDO:0011399,
249,HBA1,HGNC:4823,unstable hemoglobin disease,MONDO:0020459,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b58582d7-d863-4179-8e4d-76b8e70adde4-2023-11-22T170000.000Z,2023-11-22T17:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,"methemoglobinemia, alpha type",MONDO:0020835,https://search.clinicalgenome.org/kb/conditions/MONDO:0020835,Autosomal dominant inheritance
250,HBA1,HGNC:4823,unstable hemoglobin disease,MONDO:0020459,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b58582d7-d863-4179-8e4d-76b8e70adde4-2023-11-22T170000.000Z,2023-11-22T17:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,unstable hemoglobin disease,MONDO:0020459,https://search.clinicalgenome.org/kb/conditions/MONDO:0020459,Autosomal dominant inheritance
251,HBA1,HGNC:4823,unstable hemoglobin disease,MONDO:0020459,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b58582d7-d863-4179-8e4d-76b8e70adde4-2023-11-22T170000.000Z,2023-11-22T17:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,"erythrocytosis, familial, 7",MONDO:0054802,https://search.clinicalgenome.org/kb/conditions/MONDO:0054802,Autosomal dominant inheritance
252,HBA1,HGNC:4823,unstable hemoglobin disease,MONDO:0020459,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b58582d7-d863-4179-8e4d-76b8e70adde4-2023-11-22T170000.000Z,2023-11-22T17:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,alpha thalassemia spectrum,MONDO:0011399,https://search.clinicalgenome.org/kb/conditions/MONDO:0011399,
253,HBA1,HGNC:4823,"methemoglobinemia, alpha type",MONDO:0020835,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_599e57aa-17fd-40f4-9e13-a1968e57e9ed-2024-03-28T160000.000Z,2024-03-28T16:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,"methemoglobinemia, alpha type",MONDO:0020835,https://search.clinicalgenome.org/kb/conditions/MONDO:0020835,Autosomal dominant inheritance
254,HBA1,HGNC:4823,"methemoglobinemia, alpha type",MONDO:0020835,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_599e57aa-17fd-40f4-9e13-a1968e57e9ed-2024-03-28T160000.000Z,2024-03-28T16:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,unstable hemoglobin disease,MONDO:0020459,https://search.clinicalgenome.org/kb/conditions/MONDO:0020459,Autosomal dominant inheritance
255,HBA1,HGNC:4823,"methemoglobinemia, alpha type",MONDO:0020835,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_599e57aa-17fd-40f4-9e13-a1968e57e9ed-2024-03-28T160000.000Z,2024-03-28T16:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,"erythrocytosis, familial, 7",MONDO:0054802,https://search.clinicalgenome.org/kb/conditions/MONDO:0054802,Autosomal dominant inheritance
256,HBA1,HGNC:4823,"methemoglobinemia, alpha type",MONDO:0020835,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_599e57aa-17fd-40f4-9e13-a1968e57e9ed-2024-03-28T160000.000Z,2024-03-28T16:00:00.000Z,General Gene Curation Expert Panel,HBA1,HGNC:4823,chr16:226679-227521,chr16:176680-177522,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA1&subject=,2012-04-19T22:15:21Z,HBA1,https://search.clinicalgenome.org/kb/genes/HGNC:4823,alpha thalassemia spectrum,MONDO:0011399,https://search.clinicalgenome.org/kb/conditions/MONDO:0011399,
257,GLUL,HGNC:4341,congenital brain dysgenesis due to glutamine synthetase deficiency,MONDO:0012393,AR,SOP11,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d71d7866-437d-48bd-8a98-21e67abdd917-2024-12-13T170000.000Z,2024-12-13T17:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,GLUL,HGNC:4341,chr1:182347233-182360925,chr1:182378098-182391790,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GLUL&subject=,2015-06-04T18:40:28Z,GLUL,https://search.clinicalgenome.org/kb/genes/HGNC:4341,congenital brain dysgenesis due to glutamine synthetase deficiency,MONDO:0012393,https://search.clinicalgenome.org/kb/conditions/MONDO:0012393,Autosomal recessive inheritance
258,CACNA1C,HGNC:1390,long QT syndrome,MONDO:0002442,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c496551d-c7a7-4e49-ad41-8cfd49840dc1-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,Timothy syndrome,MONDO:0010979,https://search.clinicalgenome.org/kb/conditions/MONDO:0010979,Autosomal dominant inheritance
259,CACNA1C,HGNC:1390,long QT syndrome,MONDO:0002442,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c496551d-c7a7-4e49-ad41-8cfd49840dc1-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
260,CACNA1C,HGNC:1390,long QT syndrome,MONDO:0002442,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c496551d-c7a7-4e49-ad41-8cfd49840dc1-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
261,CACNA1C,HGNC:1390,long QT syndrome,MONDO:0002442,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c496551d-c7a7-4e49-ad41-8cfd49840dc1-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
262,CACNA1C,HGNC:1390,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10146,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,Timothy syndrome,MONDO:0010979,https://search.clinicalgenome.org/kb/conditions/MONDO:0010979,Autosomal dominant inheritance
263,CACNA1C,HGNC:1390,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10146,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
264,CACNA1C,HGNC:1390,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10146,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
265,CACNA1C,HGNC:1390,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10146,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
266,CACNA1C,HGNC:1390,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51dae85e-8745-48c1-8fb9-cabc2501d3fb-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,Timothy syndrome,MONDO:0010979,https://search.clinicalgenome.org/kb/conditions/MONDO:0010979,Autosomal dominant inheritance
267,CACNA1C,HGNC:1390,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51dae85e-8745-48c1-8fb9-cabc2501d3fb-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
268,CACNA1C,HGNC:1390,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51dae85e-8745-48c1-8fb9-cabc2501d3fb-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
269,CACNA1C,HGNC:1390,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51dae85e-8745-48c1-8fb9-cabc2501d3fb-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,CACNA1C,HGNC:1390,chr12:2162153-2807116,chr12:1970780-2697950,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1C&subject=,2016-03-24T19:23:05Z,CACNA1C,https://search.clinicalgenome.org/kb/genes/HGNC:1390,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
270,COL1A1,HGNC:2197,"Ehlers-Danlos syndrome, classic type, 1",MONDO:0019567,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35866dc4-e7a2-42c8-801c-019214666e8f-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A1,HGNC:2197,chr17:48261462-48278992,chr17:50184101-50201631,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A1&subject=,2012-08-23T19:09:32Z,COL1A1,https://search.clinicalgenome.org/kb/genes/HGNC:2197,osteogenesis imperfecta type 1,MONDO:0008146,https://search.clinicalgenome.org/kb/conditions/MONDO:0008146,Autosomal dominant inheritance
271,COL1A1,HGNC:2197,"Ehlers-Danlos syndrome, classic type, 1",MONDO:0019567,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35866dc4-e7a2-42c8-801c-019214666e8f-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A1,HGNC:2197,chr17:48261462-48278992,chr17:50184101-50201631,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A1&subject=,2012-08-23T19:09:32Z,COL1A1,https://search.clinicalgenome.org/kb/genes/HGNC:2197,osteogenesis imperfecta type 2,MONDO:0008147,https://search.clinicalgenome.org/kb/conditions/MONDO:0008147,Autosomal dominant inheritance
272,COL1A1,HGNC:2197,"Ehlers-Danlos syndrome, classic type, 1",MONDO:0019567,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35866dc4-e7a2-42c8-801c-019214666e8f-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A1,HGNC:2197,chr17:48261462-48278992,chr17:50184101-50201631,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A1&subject=,2012-08-23T19:09:32Z,COL1A1,https://search.clinicalgenome.org/kb/genes/HGNC:2197,osteogenesis imperfecta type 3,MONDO:0009804,https://search.clinicalgenome.org/kb/conditions/MONDO:0009804,Autosomal dominant inheritance
273,COL1A1,HGNC:2197,"Ehlers-Danlos syndrome, classic type, 1",MONDO:0019567,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35866dc4-e7a2-42c8-801c-019214666e8f-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A1,HGNC:2197,chr17:48261462-48278992,chr17:50184101-50201631,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A1&subject=,2012-08-23T19:09:32Z,COL1A1,https://search.clinicalgenome.org/kb/genes/HGNC:2197,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1,MONDO:0030854,https://search.clinicalgenome.org/kb/conditions/MONDO:0030854,Autosomal dominant inheritance
274,COL1A1,HGNC:2197,"Ehlers-Danlos syndrome, classic type, 1",MONDO:0019567,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35866dc4-e7a2-42c8-801c-019214666e8f-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A1,HGNC:2197,chr17:48261462-48278992,chr17:50184101-50201631,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A1&subject=,2012-08-23T19:09:32Z,COL1A1,https://search.clinicalgenome.org/kb/genes/HGNC:2197,osteogenesis imperfecta type 4,MONDO:0008148,https://search.clinicalgenome.org/kb/conditions/MONDO:0008148,Autosomal dominant inheritance
275,COL1A1,HGNC:2197,"Ehlers-Danlos syndrome, classic type, 1",MONDO:0019567,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35866dc4-e7a2-42c8-801c-019214666e8f-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A1,HGNC:2197,chr17:48261462-48278992,chr17:50184101-50201631,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A1&subject=,2012-08-23T19:09:32Z,COL1A1,https://search.clinicalgenome.org/kb/genes/HGNC:2197,"Ehlers-Danlos syndrome, arthrochalasia type",MONDO:0007525,https://search.clinicalgenome.org/kb/conditions/MONDO:0007525,Autosomal dominant inheritance
276,COL1A1,HGNC:2197,"Ehlers-Danlos syndrome, classic type, 1",MONDO:0019567,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35866dc4-e7a2-42c8-801c-019214666e8f-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A1,HGNC:2197,chr17:48261462-48278992,chr17:50184101-50201631,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A1&subject=,2012-08-23T19:09:32Z,COL1A1,https://search.clinicalgenome.org/kb/genes/HGNC:2197,"Ehlers-Danlos syndrome, classic type, 1",MONDO:0019567,https://search.clinicalgenome.org/kb/conditions/MONDO:0019567,Autosomal dominant inheritance
277,COL1A1,HGNC:2197,"Ehlers-Danlos syndrome, classic type, 1",MONDO:0019567,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35866dc4-e7a2-42c8-801c-019214666e8f-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A1,HGNC:2197,chr17:48261462-48278992,chr17:50184101-50201631,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A1&subject=,2012-08-23T19:09:32Z,COL1A1,https://search.clinicalgenome.org/kb/genes/HGNC:2197,Caffey disease,MONDO:0007244,https://search.clinicalgenome.org/kb/conditions/MONDO:0007244,Autosomal dominant inheritance
278,NSDHL,HGNC:13398,CK syndrome,MONDO:0010441,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d94406f0-a459-47ed-aabc-80c7b6be9293-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,NSDHL,HGNC:13398,chrX:151999607-152038273,chrX:152831063-152869729,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NSDHL&subject=,2019-09-25T16:57:27Z,NSDHL,https://search.clinicalgenome.org/kb/genes/HGNC:13398,CK syndrome,MONDO:0010441,https://search.clinicalgenome.org/kb/conditions/MONDO:0010441,X-linked inheritance
279,NSDHL,HGNC:13398,CK syndrome,MONDO:0010441,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d94406f0-a459-47ed-aabc-80c7b6be9293-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,NSDHL,HGNC:13398,chrX:151999607-152038273,chrX:152831063-152869729,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NSDHL&subject=,2019-09-25T16:57:27Z,NSDHL,https://search.clinicalgenome.org/kb/genes/HGNC:13398,CHILD syndrome,MONDO:0010621,https://search.clinicalgenome.org/kb/conditions/MONDO:0010621,
280,CA8,HGNC:1382,cerebellar ataxia,MONDO:0000437,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a0800c48-e3b1-4cb2-bbd1-4d649e506ebd-2024-01-16T170000.000Z,2024-01-16T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,CA8,HGNC:1382,chr8:61097971-61193959,chr8:60185412-60281400,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CA8&subject=,2016-08-22T17:46:37Z,CA8,https://search.clinicalgenome.org/kb/genes/HGNC:1382,cerebellar ataxia,MONDO:0000437,https://search.clinicalgenome.org/kb/conditions/MONDO:0000437,Autosomal recessive inheritance
281,CA8,HGNC:1382,cerebellar ataxia,MONDO:0000437,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a0800c48-e3b1-4cb2-bbd1-4d649e506ebd-2024-01-16T170000.000Z,2024-01-16T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,CA8,HGNC:1382,chr8:61097971-61193959,chr8:60185412-60281400,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CA8&subject=,2016-08-22T17:46:37Z,CA8,https://search.clinicalgenome.org/kb/genes/HGNC:1382,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3",MONDO:0013188,https://search.clinicalgenome.org/kb/conditions/MONDO:0013188,
282,C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c78e8a8a-49db-40f5-96a3-d126a3834976-2023-02-28T170000.000Z,2023-02-28T17:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,C19orf12,HGNC:25443,chr19:30189793-30206696,chr19:29698886-29715789,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=C19orf12&subject=,2016-08-22T17:46:34Z,C19orf12,https://search.clinicalgenome.org/kb/genes/HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,https://search.clinicalgenome.org/kb/conditions/MONDO:0013674,Autosomal dominant inheritance | Autosomal recessive inheritance
283,GDI1,HGNC:4226,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8afc42b0-6c5e-460b-87d1-035c051fe7ca-2023-04-27T060000.000Z,2023-04-27T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,GDI1,HGNC:4226,chrX:153665500-153671814,chrX:154437154-154443467,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GDI1&subject=,2022-06-22T16:54:52Z,GDI1,https://search.clinicalgenome.org/kb/genes/HGNC:4226,non-syndromic X-linked intellectual disability,MONDO:0019181,https://search.clinicalgenome.org/kb/conditions/MONDO:0019181,X-linked inheritance
284,GDI1,HGNC:4226,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8afc42b0-6c5e-460b-87d1-035c051fe7ca-2023-04-27T060000.000Z,2023-04-27T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,GDI1,HGNC:4226,chrX:153665500-153671814,chrX:154437154-154443467,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GDI1&subject=,2022-06-22T16:54:52Z,GDI1,https://search.clinicalgenome.org/kb/genes/HGNC:4226,"intellectual disability, X-linked 41",MONDO:0010451,https://search.clinicalgenome.org/kb/conditions/MONDO:0010451,
285,EDNRB,HGNC:3180,Waardenburg syndrome type 4A,MONDO:0010192,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d7abbd45-7915-437b-849b-dea876bfc2f5-2023-06-27T160000.000Z,2023-06-27T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,EDNRB,HGNC:3180,chr13:78469616-78549662,chr13:77895481-77975527,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EDNRB&subject=,2022-02-07T19:56:02Z,EDNRB,https://search.clinicalgenome.org/kb/genes/HGNC:3180,Waardenburg syndrome type 4A,MONDO:0010192,https://search.clinicalgenome.org/kb/conditions/MONDO:0010192,Autosomal dominant inheritance | Autosomal recessive inheritance
286,EDNRB,HGNC:3180,Waardenburg syndrome type 4A,MONDO:0010192,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73ee9727-60c1-40fd-830f-08c2b513d2ee-2018-05-08T160000.000Z,2018-05-08T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,EDNRB,HGNC:3180,chr13:78469616-78549662,chr13:77895481-77975527,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EDNRB&subject=,2022-02-07T19:56:02Z,EDNRB,https://search.clinicalgenome.org/kb/genes/HGNC:3180,Waardenburg syndrome type 4A,MONDO:0010192,https://search.clinicalgenome.org/kb/conditions/MONDO:0010192,Autosomal dominant inheritance | Autosomal recessive inheritance
287,NLGN3,HGNC:14289,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6e7e531-093b-4216-8c56-0c94e63c2811-2018-08-15T040000.000Z,2018-08-15T04:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,NLGN3,HGNC:14289,chrX:70364691-70391051,chrX:71144841-71175307,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NLGN3&subject=,2012-07-25T14:56:36Z,NLGN3,https://search.clinicalgenome.org/kb/genes/HGNC:14289,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
288,FGFR1,HGNC:3688,Hartsfield-Bixler-Demyer syndrome,MONDO:0014196,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec5034c6-70cb-4ba3-bbb9-f65f6cad393d-2021-03-16T235509.401Z,2021-03-16T23:55:09.401Z,Craniofacial Malformations Gene Curation Expert Panel,FGFR1,HGNC:3688,chr8:38268661-38326153,chr8:38411143-38468635,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR1&subject=,2021-04-05T15:54:15Z,FGFR1,https://search.clinicalgenome.org/kb/genes/HGNC:3688,Hartsfield-Bixler-Demyer syndrome,MONDO:0014196,https://search.clinicalgenome.org/kb/conditions/MONDO:0014196,Autosomal dominant inheritance
289,FGFR1,HGNC:3688,Hartsfield-Bixler-Demyer syndrome,MONDO:0014196,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec5034c6-70cb-4ba3-bbb9-f65f6cad393d-2021-03-16T235509.401Z,2021-03-16T23:55:09.401Z,Craniofacial Malformations Gene Curation Expert Panel,FGFR1,HGNC:3688,chr8:38268661-38326153,chr8:38411143-38468635,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR1&subject=,2021-04-05T15:54:15Z,FGFR1,https://search.clinicalgenome.org/kb/genes/HGNC:3688,osteoglophonic dwarfism,MONDO:0008150,https://search.clinicalgenome.org/kb/conditions/MONDO:0008150,Autosomal dominant inheritance
290,FGFR1,HGNC:3688,Hartsfield-Bixler-Demyer syndrome,MONDO:0014196,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec5034c6-70cb-4ba3-bbb9-f65f6cad393d-2021-03-16T235509.401Z,2021-03-16T23:55:09.401Z,Craniofacial Malformations Gene Curation Expert Panel,FGFR1,HGNC:3688,chr8:38268661-38326153,chr8:38411143-38468635,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR1&subject=,2021-04-05T15:54:15Z,FGFR1,https://search.clinicalgenome.org/kb/genes/HGNC:3688,Pfeiffer syndrome type 1,MONDO:0019659,https://search.clinicalgenome.org/kb/conditions/MONDO:0019659,Autosomal dominant inheritance
291,FGFR1,HGNC:3688,Hartsfield-Bixler-Demyer syndrome,MONDO:0014196,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec5034c6-70cb-4ba3-bbb9-f65f6cad393d-2021-03-16T235509.401Z,2021-03-16T23:55:09.401Z,Craniofacial Malformations Gene Curation Expert Panel,FGFR1,HGNC:3688,chr8:38268661-38326153,chr8:38411143-38468635,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR1&subject=,2021-04-05T15:54:15Z,FGFR1,https://search.clinicalgenome.org/kb/genes/HGNC:3688,hypogonadotropic hypogonadism 2 with or without anosmia,MONDO:0007844,https://search.clinicalgenome.org/kb/conditions/MONDO:0007844,
292,FGFR1,HGNC:3688,osteoglophonic dwarfism,MONDO:0008150,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d958e743-2ca0-4bb9-a198-364dd58005c3-2021-03-22T203501.315Z,2021-03-22T20:35:01.315Z,Craniofacial Malformations Gene Curation Expert Panel,FGFR1,HGNC:3688,chr8:38268661-38326153,chr8:38411143-38468635,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR1&subject=,2021-04-05T15:54:15Z,FGFR1,https://search.clinicalgenome.org/kb/genes/HGNC:3688,Hartsfield-Bixler-Demyer syndrome,MONDO:0014196,https://search.clinicalgenome.org/kb/conditions/MONDO:0014196,Autosomal dominant inheritance
293,FGFR1,HGNC:3688,osteoglophonic dwarfism,MONDO:0008150,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d958e743-2ca0-4bb9-a198-364dd58005c3-2021-03-22T203501.315Z,2021-03-22T20:35:01.315Z,Craniofacial Malformations Gene Curation Expert Panel,FGFR1,HGNC:3688,chr8:38268661-38326153,chr8:38411143-38468635,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR1&subject=,2021-04-05T15:54:15Z,FGFR1,https://search.clinicalgenome.org/kb/genes/HGNC:3688,osteoglophonic dwarfism,MONDO:0008150,https://search.clinicalgenome.org/kb/conditions/MONDO:0008150,Autosomal dominant inheritance
294,FGFR1,HGNC:3688,osteoglophonic dwarfism,MONDO:0008150,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d958e743-2ca0-4bb9-a198-364dd58005c3-2021-03-22T203501.315Z,2021-03-22T20:35:01.315Z,Craniofacial Malformations Gene Curation Expert Panel,FGFR1,HGNC:3688,chr8:38268661-38326153,chr8:38411143-38468635,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR1&subject=,2021-04-05T15:54:15Z,FGFR1,https://search.clinicalgenome.org/kb/genes/HGNC:3688,Pfeiffer syndrome type 1,MONDO:0019659,https://search.clinicalgenome.org/kb/conditions/MONDO:0019659,Autosomal dominant inheritance
295,FGFR1,HGNC:3688,osteoglophonic dwarfism,MONDO:0008150,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d958e743-2ca0-4bb9-a198-364dd58005c3-2021-03-22T203501.315Z,2021-03-22T20:35:01.315Z,Craniofacial Malformations Gene Curation Expert Panel,FGFR1,HGNC:3688,chr8:38268661-38326153,chr8:38411143-38468635,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR1&subject=,2021-04-05T15:54:15Z,FGFR1,https://search.clinicalgenome.org/kb/genes/HGNC:3688,hypogonadotropic hypogonadism 2 with or without anosmia,MONDO:0007844,https://search.clinicalgenome.org/kb/conditions/MONDO:0007844,
296,BTD,HGNC:1122,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74599afe-02f9-4225-9e50-63306f04a552-2021-06-14T140327.018Z,2021-06-14T14:03:27.018Z,Mitochondrial Diseases Gene Curation Expert Panel,BTD,HGNC:1122,chr3:15642859-15764023,chr3:15601361-15722516,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BTD&subject=,2015-05-21T13:12:18Z,BTD,https://search.clinicalgenome.org/kb/genes/HGNC:1122,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
297,BTD,HGNC:1122,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74599afe-02f9-4225-9e50-63306f04a552-2021-06-14T140327.018Z,2021-06-14T14:03:27.018Z,Mitochondrial Diseases Gene Curation Expert Panel,BTD,HGNC:1122,chr3:15642859-15764023,chr3:15601361-15722516,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BTD&subject=,2015-05-21T13:12:18Z,BTD,https://search.clinicalgenome.org/kb/genes/HGNC:1122,biotinidase deficiency,MONDO:0009665,https://search.clinicalgenome.org/kb/conditions/MONDO:0009665,Autosomal recessive inheritance
298,BTD,HGNC:1122,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74599afe-02f9-4225-9e50-63306f04a552-2021-06-14T140327.018Z,2021-06-14T14:03:27.018Z,Mitochondrial Diseases Gene Curation Expert Panel,BTD,HGNC:1122,chr3:15642859-15764023,chr3:15601361-15722516,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BTD&subject=,2015-05-21T13:12:18Z,BTD,https://search.clinicalgenome.org/kb/genes/HGNC:1122,multiple carboxylase deficiency,MONDO:0015454,https://search.clinicalgenome.org/kb/conditions/MONDO:0015454,
299,CSTB,HGNC:2482,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_accafcd4-ba3c-4049-9285-1de877d256ec-2020-12-01T060000.000Z,2020-12-01T06:00:00.000Z,Epilepsy Gene Curation Expert Panel,CSTB,HGNC:2482,chr21:45193831-45196189,chr21:43773950-43776308,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CSTB&subject=,2016-08-22T17:47:33Z,CSTB,https://search.clinicalgenome.org/kb/genes/HGNC:2482,Unverricht-Lundborg syndrome,MONDO:0009698,https://search.clinicalgenome.org/kb/conditions/MONDO:0009698,Autosomal recessive inheritance
300,CSTB,HGNC:2482,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_accafcd4-ba3c-4049-9285-1de877d256ec-2020-12-01T060000.000Z,2020-12-01T06:00:00.000Z,Epilepsy Gene Curation Expert Panel,CSTB,HGNC:2482,chr21:45193831-45196189,chr21:43773950-43776308,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CSTB&subject=,2016-08-22T17:47:33Z,CSTB,https://search.clinicalgenome.org/kb/genes/HGNC:2482,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal recessive inheritance
301,FARS2,HGNC:21062,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf7594a-d934-4b6c-8052-94066d608c5a-2019-11-25T144756.827Z,2019-11-25T14:47:56.827Z,Mitochondrial Diseases Gene Curation Expert Panel,FARS2,HGNC:21062,chr6:5261240-5771816,chr6:5249934-5771583,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FARS2&subject=,2016-08-22T17:48:31Z,FARS2,https://search.clinicalgenome.org/kb/genes/HGNC:21062,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
302,DDOST,HGNC:2728,DDOST-congenital disorder of glycosylation,MONDO:0013789,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0605b51-70c5-42ee-81b5-d45bb0b1fdab-2023-11-15T170000.000Z,2023-11-15T17:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,DDOST,HGNC:2728,chr1:20978270-20987862,chr1:20651777-20661369,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DDOST&subject=,2016-08-22T17:47:48Z,DDOST,https://search.clinicalgenome.org/kb/genes/HGNC:2728,DDOST-congenital disorder of glycosylation,MONDO:0013789,https://search.clinicalgenome.org/kb/conditions/MONDO:0013789,Autosomal recessive inheritance
303,BPNT2,HGNC:26019,"chondrodysplasia with joint dislocations, gPAPP type",MONDO:0013561,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0edef29-df91-4320-b66d-4cc6a4ec3f94-2024-05-16T160000.000Z,2024-05-16T16:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,BPNT2,HGNC:26019,chr8:57870490-57906426,chr8:56957931-56993867,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BPNT2&subject=,2016-08-22T17:49:31Z,BPNT2,https://search.clinicalgenome.org/kb/genes/HGNC:26019,"chondrodysplasia with joint dislocations, gPAPP type",MONDO:0013561,https://search.clinicalgenome.org/kb/conditions/MONDO:0013561,Autosomal recessive inheritance
304,COL1A2,HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8dc6fb4-069c-456d-88c0-e7837c819d9d-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,osteogenesis imperfecta type 2,MONDO:0008147,https://search.clinicalgenome.org/kb/conditions/MONDO:0008147,Autosomal dominant inheritance
305,COL1A2,HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8dc6fb4-069c-456d-88c0-e7837c819d9d-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Mode of inheritance
306,COL1A2,HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8dc6fb4-069c-456d-88c0-e7837c819d9d-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,https://search.clinicalgenome.org/kb/conditions/MONDO:0030855,Autosomal dominant inheritance
307,COL1A2,HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8dc6fb4-069c-456d-88c0-e7837c819d9d-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,"Ehlers-Danlos syndrome, arthrochalasia type",MONDO:0007525,https://search.clinicalgenome.org/kb/conditions/MONDO:0007525,Autosomal dominant inheritance
308,COL1A2,HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8dc6fb4-069c-456d-88c0-e7837c819d9d-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,"Ehlers-Danlos syndrome, cardiac valvular type",MONDO:0009159,https://search.clinicalgenome.org/kb/conditions/MONDO:0009159,Autosomal recessive inheritance
309,COL1A2,HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8dc6fb4-069c-456d-88c0-e7837c819d9d-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,osteogenesis imperfecta type 3,MONDO:0009804,https://search.clinicalgenome.org/kb/conditions/MONDO:0009804,Autosomal dominant inheritance
310,COL1A2,HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8dc6fb4-069c-456d-88c0-e7837c819d9d-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,osteogenesis imperfecta type 1,MONDO:0008146,https://search.clinicalgenome.org/kb/conditions/MONDO:0008146,Autosomal dominant inheritance
311,COL1A2,HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8dc6fb4-069c-456d-88c0-e7837c819d9d-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,osteogenesis imperfecta type 4,MONDO:0008148,https://search.clinicalgenome.org/kb/conditions/MONDO:0008148,Autosomal dominant inheritance
312,COL1A2,HGNC:2198,congenital heart disease,MONDO:0005453,UD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4e87080-7e90-4e19-a3dc-e986bfd01e0f-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,osteogenesis imperfecta type 2,MONDO:0008147,https://search.clinicalgenome.org/kb/conditions/MONDO:0008147,Autosomal dominant inheritance
313,COL1A2,HGNC:2198,congenital heart disease,MONDO:0005453,UD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4e87080-7e90-4e19-a3dc-e986bfd01e0f-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Mode of inheritance
314,COL1A2,HGNC:2198,congenital heart disease,MONDO:0005453,UD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4e87080-7e90-4e19-a3dc-e986bfd01e0f-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,MONDO:0030855,https://search.clinicalgenome.org/kb/conditions/MONDO:0030855,Autosomal dominant inheritance
315,COL1A2,HGNC:2198,congenital heart disease,MONDO:0005453,UD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4e87080-7e90-4e19-a3dc-e986bfd01e0f-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,"Ehlers-Danlos syndrome, arthrochalasia type",MONDO:0007525,https://search.clinicalgenome.org/kb/conditions/MONDO:0007525,Autosomal dominant inheritance
316,COL1A2,HGNC:2198,congenital heart disease,MONDO:0005453,UD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4e87080-7e90-4e19-a3dc-e986bfd01e0f-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,"Ehlers-Danlos syndrome, cardiac valvular type",MONDO:0009159,https://search.clinicalgenome.org/kb/conditions/MONDO:0009159,Autosomal recessive inheritance
317,COL1A2,HGNC:2198,congenital heart disease,MONDO:0005453,UD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4e87080-7e90-4e19-a3dc-e986bfd01e0f-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,osteogenesis imperfecta type 3,MONDO:0009804,https://search.clinicalgenome.org/kb/conditions/MONDO:0009804,Autosomal dominant inheritance
318,COL1A2,HGNC:2198,congenital heart disease,MONDO:0005453,UD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4e87080-7e90-4e19-a3dc-e986bfd01e0f-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,osteogenesis imperfecta type 1,MONDO:0008146,https://search.clinicalgenome.org/kb/conditions/MONDO:0008146,Autosomal dominant inheritance
319,COL1A2,HGNC:2198,congenital heart disease,MONDO:0005453,UD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4e87080-7e90-4e19-a3dc-e986bfd01e0f-2024-09-09T160000.000Z,2024-09-09T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,COL1A2,HGNC:2198,chr7:94024207-94060539,chr7:94394895-94431227,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL1A2&subject=,2012-10-12T13:56:57Z,COL1A2,https://search.clinicalgenome.org/kb/genes/HGNC:2198,osteogenesis imperfecta type 4,MONDO:0008148,https://search.clinicalgenome.org/kb/conditions/MONDO:0008148,Autosomal dominant inheritance
320,CACNA1S,HGNC:1397,"malignant hyperthermia, susceptibility to, 5",MONDO:0011163,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22fff996-ca2e-473d-8a57-d2b8ff022a92-2023-04-26T160000.000Z,2023-04-26T16:00:00.000Z,General Gene Curation Expert Panel,CACNA1S,HGNC:1397,chr1:201008640-201081554,chr1:201039512-201112426,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1S&subject=,2016-01-18T18:42:13Z,CACNA1S,https://search.clinicalgenome.org/kb/genes/HGNC:1397,"malignant hyperthermia, susceptibility to, 5",MONDO:0011163,https://search.clinicalgenome.org/kb/conditions/MONDO:0011163,Autosomal dominant inheritance
321,CACNA1S,HGNC:1397,"malignant hyperthermia, susceptibility to, 5",MONDO:0011163,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22fff996-ca2e-473d-8a57-d2b8ff022a92-2023-04-26T160000.000Z,2023-04-26T16:00:00.000Z,General Gene Curation Expert Panel,CACNA1S,HGNC:1397,chr1:201008640-201081554,chr1:201039512-201112426,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CACNA1S&subject=,2016-01-18T18:42:13Z,CACNA1S,https://search.clinicalgenome.org/kb/genes/HGNC:1397,malignant hyperthermia of anesthesia,MONDO:0018493,https://search.clinicalgenome.org/kb/conditions/MONDO:0018493,
322,CALM1,HGNC:1442,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ca1d8df-10fa-48ef-aea4-fb4dc6564dd0-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CALM1,HGNC:1442,chr14:90862846-90874612,chr14:90396502-90408268,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CALM1&subject=,2023-12-12T18:00:56Z,CALM1,https://search.clinicalgenome.org/kb/genes/HGNC:1442,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
323,CALM1,HGNC:1442,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ca1d8df-10fa-48ef-aea4-fb4dc6564dd0-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CALM1,HGNC:1442,chr14:90862846-90874612,chr14:90396502-90408268,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CALM1&subject=,2023-12-12T18:00:56Z,CALM1,https://search.clinicalgenome.org/kb/genes/HGNC:1442,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
324,CALM1,HGNC:1442,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ca1d8df-10fa-48ef-aea4-fb4dc6564dd0-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CALM1,HGNC:1442,chr14:90862846-90874612,chr14:90396502-90408268,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CALM1&subject=,2023-12-12T18:00:56Z,CALM1,https://search.clinicalgenome.org/kb/genes/HGNC:1442,catecholaminergic polymorphic ventricular tachycardia 4,MONDO:0013966,https://search.clinicalgenome.org/kb/conditions/MONDO:0013966,
325,EPS8,HGNC:3420,autosomal recessive nonsyndromic hearing loss 102,MONDO:0014428,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a6bd2bf-8ede-45cb-a1c1-65ee5221b440-2020-02-06T171614.553Z,2020-02-06T17:16:14.553Z,Hearing Loss Gene Curation Expert Panel,EPS8,HGNC:3420,chr12:15773068-15942322,chr12:15620134-15789388,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EPS8&subject=,2018-02-07T15:18:57Z,EPS8,https://search.clinicalgenome.org/kb/genes/HGNC:3420,autosomal recessive nonsyndromic hearing loss 102,MONDO:0014428,https://search.clinicalgenome.org/kb/conditions/MONDO:0014428,Autosomal recessive inheritance
326,BRAF,HGNC:1097,Noonan syndrome,MONDO:0018997,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47cf08d5-efc6-4d42-b031-a06619873161-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
327,BRAF,HGNC:1097,Noonan syndrome,MONDO:0018997,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47cf08d5-efc6-4d42-b031-a06619873161-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
328,BRAF,HGNC:1097,Noonan syndrome,MONDO:0018997,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47cf08d5-efc6-4d42-b031-a06619873161-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
329,BRAF,HGNC:1097,Noonan syndrome,MONDO:0018997,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47cf08d5-efc6-4d42-b031-a06619873161-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
330,BRAF,HGNC:1097,Noonan syndrome,MONDO:0018997,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47cf08d5-efc6-4d42-b031-a06619873161-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Noonan syndrome 7,MONDO:0013379,https://search.clinicalgenome.org/kb/conditions/MONDO:0013379,
331,BRAF,HGNC:1097,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_888875a8-5654-486b-8e64-e1382ccc6650-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
332,BRAF,HGNC:1097,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_888875a8-5654-486b-8e64-e1382ccc6650-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
333,BRAF,HGNC:1097,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_888875a8-5654-486b-8e64-e1382ccc6650-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
334,BRAF,HGNC:1097,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_888875a8-5654-486b-8e64-e1382ccc6650-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
335,BRAF,HGNC:1097,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_888875a8-5654-486b-8e64-e1382ccc6650-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Noonan syndrome 7,MONDO:0013379,https://search.clinicalgenome.org/kb/conditions/MONDO:0013379,
336,BRAF,HGNC:1097,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f229eceb-8f5e-4ecb-a484-7863b8dc7d19-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
337,BRAF,HGNC:1097,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f229eceb-8f5e-4ecb-a484-7863b8dc7d19-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
338,BRAF,HGNC:1097,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f229eceb-8f5e-4ecb-a484-7863b8dc7d19-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
339,BRAF,HGNC:1097,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f229eceb-8f5e-4ecb-a484-7863b8dc7d19-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
340,BRAF,HGNC:1097,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f229eceb-8f5e-4ecb-a484-7863b8dc7d19-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,BRAF,HGNC:1097,chr7:140413128-140624729,chr7:140713328-140924929,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BRAF&subject=,2014-08-04T19:36:36Z,BRAF,https://search.clinicalgenome.org/kb/genes/HGNC:1097,Noonan syndrome 7,MONDO:0013379,https://search.clinicalgenome.org/kb/conditions/MONDO:0013379,
341,NDUFA1,HGNC:7683,Leigh syndrome,MONDO:0009723,XL,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_497170a6-a042-46cb-9809-3c3094fcd05e-2019-05-20T184847.372Z,2019-05-20T18:48:47.372Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFA1,HGNC:7683,chrX:119005795-119010625,chrX:119871832-119876662,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFA1&subject=,2012-07-25T14:34:36Z,NDUFA1,https://search.clinicalgenome.org/kb/genes/HGNC:7683,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,X-linked inheritance
342,NDUFA10,HGNC:7684,mitochondrial disease,MONDO:0044970,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1abd1440-686c-4bc9-91fb-59f7191891dd-2023-11-06T050000.000Z,2023-11-06T05:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFA10,HGNC:7684,chr2:240831859-240964759,chr2:239892442-240025342,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFA10&subject=,2016-08-22T17:50:38Z,NDUFA10,https://search.clinicalgenome.org/kb/genes/HGNC:7684,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
343,NDUFA10,HGNC:7684,mitochondrial disease,MONDO:0044970,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1abd1440-686c-4bc9-91fb-59f7191891dd-2023-11-06T050000.000Z,2023-11-06T05:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFA10,HGNC:7684,chr2:240831859-240964759,chr2:239892442-240025342,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFA10&subject=,2016-08-22T17:50:38Z,NDUFA10,https://search.clinicalgenome.org/kb/genes/HGNC:7684,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
344,NDUFA10,HGNC:7684,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e40eec3c-0ce0-442e-9058-6bf4d90d6dc3-2019-11-25T162049.949Z,2019-11-25T16:20:49.949Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFA10,HGNC:7684,chr2:240831859-240964759,chr2:239892442-240025342,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFA10&subject=,2016-08-22T17:50:38Z,NDUFA10,https://search.clinicalgenome.org/kb/genes/HGNC:7684,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
345,NDUFA10,HGNC:7684,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e40eec3c-0ce0-442e-9058-6bf4d90d6dc3-2019-11-25T162049.949Z,2019-11-25T16:20:49.949Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFA10,HGNC:7684,chr2:240831859-240964759,chr2:239892442-240025342,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFA10&subject=,2016-08-22T17:50:38Z,NDUFA10,https://search.clinicalgenome.org/kb/genes/HGNC:7684,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
346,ABAT,HGNC:23,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a5138ad-d4b8-4ea1-aa78-b5d1f07b2b82-2022-04-19T160000.000Z,2022-04-19T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,ABAT,HGNC:23,chr16:8768474-8878427,chr16:8674617-8784570,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ABAT&subject=,2016-08-22T17:45:36Z,ABAT,https://search.clinicalgenome.org/kb/genes/HGNC:23,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal recessive inheritance
347,ABAT,HGNC:23,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a5138ad-d4b8-4ea1-aa78-b5d1f07b2b82-2022-04-19T160000.000Z,2022-04-19T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,ABAT,HGNC:23,chr16:8768474-8878427,chr16:8674617-8784570,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ABAT&subject=,2016-08-22T17:45:36Z,ABAT,https://search.clinicalgenome.org/kb/genes/HGNC:23,GABA aminotransaminase deficiency,MONDO:0013166,https://search.clinicalgenome.org/kb/conditions/MONDO:0013166,
348,NDUFAF1,HGNC:18828,mitochondrial disease,MONDO:0044970,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20bd44f6-360d-42ef-ba08-549773282d2e-2022-02-17T170000.000Z,2022-02-17T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFAF1,HGNC:18828,chr15:41679551-41694694,chr15:41387353-41403026,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFAF1&subject=,2016-08-22T17:50:39Z,NDUFAF1,https://search.clinicalgenome.org/kb/genes/HGNC:18828,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
349,NDUFAF1,HGNC:18828,mitochondrial disease,MONDO:0044970,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20bd44f6-360d-42ef-ba08-549773282d2e-2022-02-17T170000.000Z,2022-02-17T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFAF1,HGNC:18828,chr15:41679551-41694694,chr15:41387353-41403026,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFAF1&subject=,2016-08-22T17:50:39Z,NDUFAF1,https://search.clinicalgenome.org/kb/genes/HGNC:18828,"mitochondrial complex I deficiency, nuclear type 1",MONDO:0100224,https://search.clinicalgenome.org/kb/conditions/MONDO:0100224,
350,FOXE3,HGNC:3808,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8261,2016-06-15T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,FOXE3,HGNC:3808,chr1:47881957-47883724,chr1:47416285-47418052,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FOXE3&subject=,2017-12-13T22:12:23Z,FOXE3,https://search.clinicalgenome.org/kb/genes/HGNC:3808,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,https://search.clinicalgenome.org/kb/conditions/MONDO:0019625,Autosomal dominant inheritance
351,INPP5E,HGNC:21474,MORM syndrome,MONDO:0012423,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a50bbd87-4308-4272-83fc-21274d283e63-2023-05-30T160000.000Z,2023-05-30T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,INPP5E,HGNC:21474,chr9:139323071-139334297,chr9:136428619-136439845,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=INPP5E&subject=,2016-08-22T17:49:32Z,INPP5E,https://search.clinicalgenome.org/kb/genes/HGNC:21474,Joubert syndrome 1,MONDO:0008944,https://search.clinicalgenome.org/kb/conditions/MONDO:0008944,Autosomal recessive inheritance
352,INPP5E,HGNC:21474,MORM syndrome,MONDO:0012423,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a50bbd87-4308-4272-83fc-21274d283e63-2023-05-30T160000.000Z,2023-05-30T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,INPP5E,HGNC:21474,chr9:139323071-139334297,chr9:136428619-136439845,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=INPP5E&subject=,2016-08-22T17:49:32Z,INPP5E,https://search.clinicalgenome.org/kb/genes/HGNC:21474,MORM syndrome,MONDO:0012423,https://search.clinicalgenome.org/kb/conditions/MONDO:0012423,Autosomal recessive inheritance
353,TBX20,HGNC:11598,congenital heart disease,MONDO:0005453,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67706e90-ac03-4b96-94e2-4a561ced4a41-2024-05-07T160000.000Z,2024-05-07T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,TBX20,HGNC:11598,chr7:35242042-35293711,chr7:35202430-35254100,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBX20&subject=,2023-05-10T11:19:22Z,TBX20,https://search.clinicalgenome.org/kb/genes/HGNC:11598,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
354,TBX20,HGNC:11598,congenital heart disease,MONDO:0005453,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67706e90-ac03-4b96-94e2-4a561ced4a41-2024-05-07T160000.000Z,2024-05-07T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,TBX20,HGNC:11598,chr7:35242042-35293711,chr7:35202430-35254100,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBX20&subject=,2023-05-10T11:19:22Z,TBX20,https://search.clinicalgenome.org/kb/genes/HGNC:11598,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
355,TBX20,HGNC:11598,congenital heart disease,MONDO:0005453,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67706e90-ac03-4b96-94e2-4a561ced4a41-2024-05-07T160000.000Z,2024-05-07T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,TBX20,HGNC:11598,chr7:35242042-35293711,chr7:35202430-35254100,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBX20&subject=,2023-05-10T11:19:22Z,TBX20,https://search.clinicalgenome.org/kb/genes/HGNC:11598,heart disorder,MONDO:0005267,https://search.clinicalgenome.org/kb/conditions/MONDO:0005267,
356,TBX20,HGNC:11598,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_58a014d9-2d97-4041-961d-cfd09fa11adf-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TBX20,HGNC:11598,chr7:35242042-35293711,chr7:35202430-35254100,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBX20&subject=,2023-05-10T11:19:22Z,TBX20,https://search.clinicalgenome.org/kb/genes/HGNC:11598,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
357,TBX20,HGNC:11598,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_58a014d9-2d97-4041-961d-cfd09fa11adf-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TBX20,HGNC:11598,chr7:35242042-35293711,chr7:35202430-35254100,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBX20&subject=,2023-05-10T11:19:22Z,TBX20,https://search.clinicalgenome.org/kb/genes/HGNC:11598,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
358,TBX20,HGNC:11598,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_58a014d9-2d97-4041-961d-cfd09fa11adf-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,TBX20,HGNC:11598,chr7:35242042-35293711,chr7:35202430-35254100,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBX20&subject=,2023-05-10T11:19:22Z,TBX20,https://search.clinicalgenome.org/kb/genes/HGNC:11598,heart disorder,MONDO:0005267,https://search.clinicalgenome.org/kb/conditions/MONDO:0005267,
359,ITGB3,HGNC:6156,platelet-type bleeding disorder 16,MONDO:0008552,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eda416fa-6e15-40df-bfd0-46a111e99ba0-2023-04-03T160000.000Z,2023-04-03T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,ITGB3,HGNC:6156,chr17:45331193-45391109,chr17:47253827-47313743,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ITGB3&subject=,2012-08-27T04:27:40Z,ITGB3,https://search.clinicalgenome.org/kb/genes/HGNC:6156,Glanzmann thrombasthenia,MONDO:0100326,https://search.clinicalgenome.org/kb/conditions/MONDO:0100326,Autosomal recessive inheritance
360,ITGB3,HGNC:6156,platelet-type bleeding disorder 16,MONDO:0008552,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eda416fa-6e15-40df-bfd0-46a111e99ba0-2023-04-03T160000.000Z,2023-04-03T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,ITGB3,HGNC:6156,chr17:45331193-45391109,chr17:47253827-47313743,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ITGB3&subject=,2012-08-27T04:27:40Z,ITGB3,https://search.clinicalgenome.org/kb/genes/HGNC:6156,platelet-type bleeding disorder 16,MONDO:0008552,https://search.clinicalgenome.org/kb/conditions/MONDO:0008552,Autosomal dominant inheritance
361,ITGB3,HGNC:6156,platelet-type bleeding disorder 16,MONDO:0008552,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eda416fa-6e15-40df-bfd0-46a111e99ba0-2023-04-03T160000.000Z,2023-04-03T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,ITGB3,HGNC:6156,chr17:45331193-45391109,chr17:47253827-47313743,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ITGB3&subject=,2012-08-27T04:27:40Z,ITGB3,https://search.clinicalgenome.org/kb/genes/HGNC:6156,Glanzmann thrombasthenia 2,MONDO:0031009,https://search.clinicalgenome.org/kb/conditions/MONDO:0031009,
362,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,Stickler syndrome type 1,MONDO:0007160,https://search.clinicalgenome.org/kb/conditions/MONDO:0007160,Autosomal dominant inheritance
363,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,achondrogenesis type II,MONDO:0008702,https://search.clinicalgenome.org/kb/conditions/MONDO:0008702,Autosomal dominant inheritance
364,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,"platyspondylic dysplasia, Torrance type",MONDO:0007895,https://search.clinicalgenome.org/kb/conditions/MONDO:0007895,Autosomal dominant inheritance
365,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,spondylometaphyseal dysplasia,MONDO:0016763,https://search.clinicalgenome.org/kb/conditions/MONDO:0016763,Autosomal dominant inheritance
366,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,spondyloepiphyseal dysplasia congenita,MONDO:0008471,https://search.clinicalgenome.org/kb/conditions/MONDO:0008471,Autosomal dominant inheritance
367,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,https://search.clinicalgenome.org/kb/conditions/MONDO:0012206,Autosomal dominant inheritance
368,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,Kniest dysplasia,MONDO:0007987,https://search.clinicalgenome.org/kb/conditions/MONDO:0007987,Autosomal dominant inheritance
369,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,dysplasia of the proximal femoral epiphyses,MONDO:1030002,https://search.clinicalgenome.org/kb/conditions/MONDO:1030002,Autosomal dominant inheritance
370,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,spondyloperipheral dysplasia,MONDO:0010078,https://search.clinicalgenome.org/kb/conditions/MONDO:0010078,Autosomal dominant inheritance
371,COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,https://search.clinicalgenome.org/kb/conditions/MONDO:0014701,Autosomal dominant inheritance
372,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,Stickler syndrome type 1,MONDO:0007160,https://search.clinicalgenome.org/kb/conditions/MONDO:0007160,Autosomal dominant inheritance
373,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,achondrogenesis type II,MONDO:0008702,https://search.clinicalgenome.org/kb/conditions/MONDO:0008702,Autosomal dominant inheritance
374,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,"platyspondylic dysplasia, Torrance type",MONDO:0007895,https://search.clinicalgenome.org/kb/conditions/MONDO:0007895,Autosomal dominant inheritance
375,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,spondylometaphyseal dysplasia,MONDO:0016763,https://search.clinicalgenome.org/kb/conditions/MONDO:0016763,Autosomal dominant inheritance
376,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,spondyloepiphyseal dysplasia congenita,MONDO:0008471,https://search.clinicalgenome.org/kb/conditions/MONDO:0008471,Autosomal dominant inheritance
377,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,https://search.clinicalgenome.org/kb/conditions/MONDO:0012206,Autosomal dominant inheritance
378,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,Kniest dysplasia,MONDO:0007987,https://search.clinicalgenome.org/kb/conditions/MONDO:0007987,Autosomal dominant inheritance
379,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,dysplasia of the proximal femoral epiphyses,MONDO:1030002,https://search.clinicalgenome.org/kb/conditions/MONDO:1030002,Autosomal dominant inheritance
380,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,spondyloperipheral dysplasia,MONDO:0010078,https://search.clinicalgenome.org/kb/conditions/MONDO:0010078,Autosomal dominant inheritance
381,COL2A1,HGNC:2200,spondyloepiphyseal dysplasia with metatarsal shortening,MONDO:0012206,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29a041e5-bac4-4f88-9dda-ac44b00a92ca-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,COL2A1,HGNC:2200,chr12:48366750-48398259,chr12:47972967-48006212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL2A1&subject=,2020-07-29T19:10:10Z,COL2A1,https://search.clinicalgenome.org/kb/genes/HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,https://search.clinicalgenome.org/kb/conditions/MONDO:0014701,Autosomal dominant inheritance
382,ACTB,HGNC:132,ACTB-associated syndromic thrombocytopenia,MONDO:0100433,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cee7fd2-09f7-41dc-9742-542917d856b0-2024-06-03T160000.000Z,2024-06-03T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,ACTB,HGNC:132,chr7:5566779-5570232,chr7:5527148-5530601,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTB&subject=,2022-02-08T17:17:21Z,ACTB,https://search.clinicalgenome.org/kb/genes/HGNC:132,Baraitser-Winter cerebrofrontofacial syndrome,MONDO:0017579,https://search.clinicalgenome.org/kb/conditions/MONDO:0017579,Autosomal dominant inheritance
383,ACTB,HGNC:132,ACTB-associated syndromic thrombocytopenia,MONDO:0100433,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cee7fd2-09f7-41dc-9742-542917d856b0-2024-06-03T160000.000Z,2024-06-03T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,ACTB,HGNC:132,chr7:5566779-5570232,chr7:5527148-5530601,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTB&subject=,2022-02-08T17:17:21Z,ACTB,https://search.clinicalgenome.org/kb/genes/HGNC:132,ACTB-associated syndromic thrombocytopenia,MONDO:0100433,https://search.clinicalgenome.org/kb/conditions/MONDO:0100433,Autosomal dominant inheritance
384,ACTB,HGNC:132,ACTB-associated syndromic thrombocytopenia,MONDO:0100433,AD,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cee7fd2-09f7-41dc-9742-542917d856b0-2024-06-03T160000.000Z,2024-06-03T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,ACTB,HGNC:132,chr7:5566779-5570232,chr7:5527148-5530601,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ACTB&subject=,2022-02-08T17:17:21Z,ACTB,https://search.clinicalgenome.org/kb/genes/HGNC:132,syndromic intellectual disability,MONDO:0000508,https://search.clinicalgenome.org/kb/conditions/MONDO:0000508,
385,NDUFS7,HGNC:7714,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b702a150-de60-429e-bb12-ba8cde1483e7-2019-11-25T160008.570Z,2019-11-25T16:00:08.570Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFS7,HGNC:7714,chr19:1383906-1395583,chr19:1383907-1395584,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFS7&subject=,2016-08-22T17:50:44Z,NDUFS7,https://search.clinicalgenome.org/kb/genes/HGNC:7714,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
386,NDUFS7,HGNC:7714,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b702a150-de60-429e-bb12-ba8cde1483e7-2019-11-25T160008.570Z,2019-11-25T16:00:08.570Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFS7,HGNC:7714,chr19:1383906-1395583,chr19:1383907-1395584,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFS7&subject=,2016-08-22T17:50:44Z,NDUFS7,https://search.clinicalgenome.org/kb/genes/HGNC:7714,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
387,NDUFS8,HGNC:7715,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01a27520-f92a-4b81-b63b-c15132c873be-2019-11-25T152406.734Z,2019-11-25T15:24:06.734Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFS8,HGNC:7715,chr11:67798148-67804111,chr11:68030681-68036644,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFS8&subject=,2016-08-22T17:50:44Z,NDUFS8,https://search.clinicalgenome.org/kb/genes/HGNC:7715,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
388,NDUFS8,HGNC:7715,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01a27520-f92a-4b81-b63b-c15132c873be-2019-11-25T152406.734Z,2019-11-25T15:24:06.734Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFS8,HGNC:7715,chr11:67798148-67804111,chr11:68030681-68036644,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFS8&subject=,2016-08-22T17:50:44Z,NDUFS8,https://search.clinicalgenome.org/kb/genes/HGNC:7715,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
389,CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c778b145-fcfc-4252-8dd8-33f982b288e8-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CASQ2,HGNC:1513,chr1:116242642-116311335,chr1:115700021-115768714,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASQ2&subject=,2016-08-22T17:46:41Z,CASQ2,https://search.clinicalgenome.org/kb/genes/HGNC:1513,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
390,CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c778b145-fcfc-4252-8dd8-33f982b288e8-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CASQ2,HGNC:1513,chr1:116242642-116311335,chr1:115700021-115768714,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASQ2&subject=,2016-08-22T17:46:41Z,CASQ2,https://search.clinicalgenome.org/kb/genes/HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal recessive inheritance | Autosomal dominant inheritance
391,CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c778b145-fcfc-4252-8dd8-33f982b288e8-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CASQ2,HGNC:1513,chr1:116242642-116311335,chr1:115700021-115768714,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASQ2&subject=,2016-08-22T17:46:41Z,CASQ2,https://search.clinicalgenome.org/kb/genes/HGNC:1513,catecholaminergic polymorphic ventricular tachycardia 2,MONDO:0012762,https://search.clinicalgenome.org/kb/conditions/MONDO:0012762,
392,CASQ2,HGNC:1513,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07177c89-7845-4df5-ba3e-bdd415b5c8b3-2022-05-10T160000.000Z,2022-05-10T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,CASQ2,HGNC:1513,chr1:116242642-116311335,chr1:115700021-115768714,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASQ2&subject=,2016-08-22T17:46:41Z,CASQ2,https://search.clinicalgenome.org/kb/genes/HGNC:1513,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
393,CASQ2,HGNC:1513,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07177c89-7845-4df5-ba3e-bdd415b5c8b3-2022-05-10T160000.000Z,2022-05-10T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,CASQ2,HGNC:1513,chr1:116242642-116311335,chr1:115700021-115768714,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASQ2&subject=,2016-08-22T17:46:41Z,CASQ2,https://search.clinicalgenome.org/kb/genes/HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal recessive inheritance | Autosomal dominant inheritance
394,CASQ2,HGNC:1513,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07177c89-7845-4df5-ba3e-bdd415b5c8b3-2022-05-10T160000.000Z,2022-05-10T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,CASQ2,HGNC:1513,chr1:116242642-116311335,chr1:115700021-115768714,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASQ2&subject=,2016-08-22T17:46:41Z,CASQ2,https://search.clinicalgenome.org/kb/genes/HGNC:1513,catecholaminergic polymorphic ventricular tachycardia 2,MONDO:0012762,https://search.clinicalgenome.org/kb/conditions/MONDO:0012762,
395,COG1,HGNC:6545,COG1-congenital disorder of glycosylation,MONDO:0012637,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6607c8c3-e293-49df-904d-da27aa8e0232-2024-01-03T170000.000Z,2024-01-03T17:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,COG1,HGNC:6545,chr17:71189194-71204646,chr17:73193055-73208507,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COG1&subject=,2016-08-22T17:47:18Z,COG1,https://search.clinicalgenome.org/kb/genes/HGNC:6545,COG1-congenital disorder of glycosylation,MONDO:0012637,https://search.clinicalgenome.org/kb/conditions/MONDO:0012637,Autosomal recessive inheritance
396,COG4,HGNC:18620,COG4-congenital disorder of glycosylation,MONDO:0013281,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6c9f2031-7487-45a5-abbe-ca2d27f1b09c-2023-05-17T180000.000Z,2023-05-17T18:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,COG4,HGNC:18620,chr16:70514470-70557457,chr16:70480567-70523554,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COG4&subject=,2016-08-22T17:47:19Z,COG4,https://search.clinicalgenome.org/kb/genes/HGNC:18620,COG4-congenital disorder of glycosylation,MONDO:0013281,https://search.clinicalgenome.org/kb/conditions/MONDO:0013281,Autosomal recessive inheritance
397,SLC25A12,HGNC:10982,mitochondrial disease,MONDO:0044970,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47bba424-b4e3-4216-aae0-2a4602bc2e92-2023-08-21T160000.000Z,2023-08-21T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SLC25A12,HGNC:10982,chr2:172639915-172750754,chr2:171783405-171894244,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A12&subject=,2012-01-19T20:48:47Z,SLC25A12,https://search.clinicalgenome.org/kb/genes/HGNC:10982,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
398,CALM3,HGNC:1449,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b7fc965-a109-4448-94a0-00a9b078b484-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CALM3,HGNC:1449,chr19:47104331-47114039,chr19:46601074-46610782,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CALM3&subject=,2024-07-09T18:17:54Z,CALM3,https://search.clinicalgenome.org/kb/genes/HGNC:1449,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
399,CALM3,HGNC:1449,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b7fc965-a109-4448-94a0-00a9b078b484-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CALM3,HGNC:1449,chr19:47104331-47114039,chr19:46601074-46610782,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CALM3&subject=,2024-07-09T18:17:54Z,CALM3,https://search.clinicalgenome.org/kb/genes/HGNC:1449,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
400,CALM3,HGNC:1449,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b7fc965-a109-4448-94a0-00a9b078b484-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CALM3,HGNC:1449,chr19:47104331-47114039,chr19:46601074-46610782,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CALM3&subject=,2024-07-09T18:17:54Z,CALM3,https://search.clinicalgenome.org/kb/genes/HGNC:1449,long QT syndrome 16,MONDO:0032915,https://search.clinicalgenome.org/kb/conditions/MONDO:0032915,
401,DCHS1,HGNC:13681,van Maldergem syndrome,MONDO:0017813,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c551a092-b6ed-406d-828d-58446b5aa1cf-2024-07-02T160000.000Z,2024-07-02T16:00:00.000Z,Brain Malformations Gene Curation Expert Panel,DCHS1,HGNC:13681,chr11:6642561-6677040,chr11:6621330-6655809,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DCHS1&subject=,2018-08-31T19:02:23Z,DCHS1,https://search.clinicalgenome.org/kb/genes/HGNC:13681,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
402,DCHS1,HGNC:13681,van Maldergem syndrome,MONDO:0017813,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c551a092-b6ed-406d-828d-58446b5aa1cf-2024-07-02T160000.000Z,2024-07-02T16:00:00.000Z,Brain Malformations Gene Curation Expert Panel,DCHS1,HGNC:13681,chr11:6642561-6677040,chr11:6621330-6655809,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DCHS1&subject=,2018-08-31T19:02:23Z,DCHS1,https://search.clinicalgenome.org/kb/genes/HGNC:13681,van Maldergem syndrome,MONDO:0017813,https://search.clinicalgenome.org/kb/conditions/MONDO:0017813,Autosomal recessive inheritance
403,DCHS1,HGNC:13681,congenital heart disease,MONDO:0005453,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff470254-615c-4f86-8893-0431889c1472-2024-04-02T160000.000Z,2024-04-02T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,DCHS1,HGNC:13681,chr11:6642561-6677040,chr11:6621330-6655809,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DCHS1&subject=,2018-08-31T19:02:23Z,DCHS1,https://search.clinicalgenome.org/kb/genes/HGNC:13681,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
404,DCHS1,HGNC:13681,congenital heart disease,MONDO:0005453,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff470254-615c-4f86-8893-0431889c1472-2024-04-02T160000.000Z,2024-04-02T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,DCHS1,HGNC:13681,chr11:6642561-6677040,chr11:6621330-6655809,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DCHS1&subject=,2018-08-31T19:02:23Z,DCHS1,https://search.clinicalgenome.org/kb/genes/HGNC:13681,van Maldergem syndrome,MONDO:0017813,https://search.clinicalgenome.org/kb/conditions/MONDO:0017813,Autosomal recessive inheritance
405,CALM2,HGNC:1445,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42d280da-accc-46f2-8832-47d5a3eeeba7-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CALM2,HGNC:1445,chr2:47387221-47404075,chr2:47160082-47176936,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CALM2&subject=,2024-07-09T18:17:17Z,CALM2,https://search.clinicalgenome.org/kb/genes/HGNC:1445,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
406,CALM2,HGNC:1445,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42d280da-accc-46f2-8832-47d5a3eeeba7-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CALM2,HGNC:1445,chr2:47387221-47404075,chr2:47160082-47176936,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CALM2&subject=,2024-07-09T18:17:17Z,CALM2,https://search.clinicalgenome.org/kb/genes/HGNC:1445,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
407,CALM2,HGNC:1445,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42d280da-accc-46f2-8832-47d5a3eeeba7-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,CALM2,HGNC:1445,chr2:47387221-47404075,chr2:47160082-47176936,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CALM2&subject=,2024-07-09T18:17:17Z,CALM2,https://search.clinicalgenome.org/kb/genes/HGNC:1445,,MONDO17990,https://search.clinicalgenome.org/kb/conditions/MONDO17990,
408,CCNQ,HGNC:28434,syndactyly-telecanthus-anogenital and renal malformations syndrome,MONDO:0010408,XL,SOP11,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_23aca7cf-8896-4a9d-a40b-94b6c8f18398-2024-07-19T160000.000Z,2024-07-19T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,CCNQ,HGNC:28434,chrX:152853383-152864595,chrX:153587925-153599139,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CCNQ&subject=,2024-06-11T16:51:10Z,CCNQ,https://search.clinicalgenome.org/kb/genes/HGNC:28434,syndactyly-telecanthus-anogenital and renal malformations syndrome,MONDO:0010408,https://search.clinicalgenome.org/kb/conditions/MONDO:0010408,X-linked inheritance
409,GPHN,HGNC:15465,sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,MONDO:0014212,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29f6ebf3-c4c5-4770-b7d1-50816b9f9d74-2023-05-12T180000.000Z,2023-05-12T18:00:00.000Z,General Inborn Errors of Metabolism Gene Curation Expert Panel,GPHN,HGNC:15465,chr14:66974865-67648520,chr14:66508147-67735355,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GPHN&subject=,2024-06-11T19:56:21Z,GPHN,https://search.clinicalgenome.org/kb/genes/HGNC:15465,sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,MONDO:0014212,https://search.clinicalgenome.org/kb/conditions/MONDO:0014212,Autosomal recessive inheritance
410,GPHN,HGNC:15465,sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,MONDO:0014212,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29f6ebf3-c4c5-4770-b7d1-50816b9f9d74-2023-05-12T180000.000Z,2023-05-12T18:00:00.000Z,General Inborn Errors of Metabolism Gene Curation Expert Panel,GPHN,HGNC:15465,chr14:66974865-67648520,chr14:66508147-67735355,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GPHN&subject=,2024-06-11T19:56:21Z,GPHN,https://search.clinicalgenome.org/kb/genes/HGNC:15465,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,
411,FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,Muenke syndrome,MONDO:0011274,https://search.clinicalgenome.org/kb/conditions/MONDO:0011274,Autosomal dominant inheritance
412,FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,Crouzon syndrome-acanthosis nigricans syndrome,MONDO:0012833,https://search.clinicalgenome.org/kb/conditions/MONDO:0012833,Autosomal dominant inheritance
413,FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,thanatophoric dysplasia type 1,MONDO:0008546,https://search.clinicalgenome.org/kb/conditions/MONDO:0008546,Autosomal dominant inheritance
414,FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,thanatophoric dysplasia type 2,MONDO:0008547,https://search.clinicalgenome.org/kb/conditions/MONDO:0008547,Autosomal dominant inheritance
415,FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,https://search.clinicalgenome.org/kb/conditions/MONDO:0014658,Autosomal dominant inheritance
416,FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,hypochondroplasia,MONDO:0007793,https://search.clinicalgenome.org/kb/conditions/MONDO:0007793,Autosomal dominant inheritance
417,FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,https://search.clinicalgenome.org/kb/conditions/MONDO:0012504,Semidominant inheritance
418,FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,Achondroplasia,MONDO:0007037,https://search.clinicalgenome.org/kb/conditions/MONDO:0007037,Autosomal dominant inheritance
419,FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,FGFR3-related chondrodysplasia,MONDO:0019685,https://search.clinicalgenome.org/kb/conditions/MONDO:0019685,
420,FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,Muenke syndrome,MONDO:0011274,https://search.clinicalgenome.org/kb/conditions/MONDO:0011274,Autosomal dominant inheritance
421,FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,Crouzon syndrome-acanthosis nigricans syndrome,MONDO:0012833,https://search.clinicalgenome.org/kb/conditions/MONDO:0012833,Autosomal dominant inheritance
422,FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,thanatophoric dysplasia type 1,MONDO:0008546,https://search.clinicalgenome.org/kb/conditions/MONDO:0008546,Autosomal dominant inheritance
423,FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,thanatophoric dysplasia type 2,MONDO:0008547,https://search.clinicalgenome.org/kb/conditions/MONDO:0008547,Autosomal dominant inheritance
424,FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,https://search.clinicalgenome.org/kb/conditions/MONDO:0014658,Autosomal dominant inheritance
425,FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,hypochondroplasia,MONDO:0007793,https://search.clinicalgenome.org/kb/conditions/MONDO:0007793,Autosomal dominant inheritance
426,FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,https://search.clinicalgenome.org/kb/conditions/MONDO:0012504,Semidominant inheritance
427,FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,Achondroplasia,MONDO:0007037,https://search.clinicalgenome.org/kb/conditions/MONDO:0007037,Autosomal dominant inheritance
428,FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,FGFR3,HGNC:3690,chr4:1795020-1810594,chr4:1793293-1808867,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FGFR3&subject=,2011-11-09T15:19:18Z,FGFR3,https://search.clinicalgenome.org/kb/genes/HGNC:3690,FGFR3-related chondrodysplasia,MONDO:0019685,https://search.clinicalgenome.org/kb/conditions/MONDO:0019685,
429,HGF,HGNC:4893,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8828a306-1262-4bbf-9661-f3d13d0f44a7-2024-06-25T160000.000Z,2024-06-25T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,HGF,HGNC:4893,chr7:81328326-81399363,chr7:81699010-81770047,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HGF&subject=,2016-08-22T17:49:15Z,HGF,https://search.clinicalgenome.org/kb/genes/HGNC:4893,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
430,HGF,HGNC:4893,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8828a306-1262-4bbf-9661-f3d13d0f44a7-2024-06-25T160000.000Z,2024-06-25T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,HGF,HGNC:4893,chr7:81328326-81399363,chr7:81699010-81770047,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HGF&subject=,2016-08-22T17:49:15Z,HGF,https://search.clinicalgenome.org/kb/genes/HGNC:4893,autosomal recessive nonsyndromic hearing loss 39,MONDO:0012003,https://search.clinicalgenome.org/kb/conditions/MONDO:0012003,
431,TSPAN7,HGNC:11854,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2716e7b3-e038-421a-b584-55f6797502a4-2020-12-02T170000.000Z,2020-12-02T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,TSPAN7,HGNC:11854,chrX:38420795-38548172,chrX:38561542-38688918,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TSPAN7&subject=,2022-06-22T16:45:35Z,TSPAN7,https://search.clinicalgenome.org/kb/genes/HGNC:11854,non-syndromic X-linked intellectual disability,MONDO:0019181,https://search.clinicalgenome.org/kb/conditions/MONDO:0019181,X-linked inheritance
432,TSPAN7,HGNC:11854,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2716e7b3-e038-421a-b584-55f6797502a4-2020-12-02T170000.000Z,2020-12-02T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,TSPAN7,HGNC:11854,chrX:38420795-38548172,chrX:38561542-38688918,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TSPAN7&subject=,2022-06-22T16:45:35Z,TSPAN7,https://search.clinicalgenome.org/kb/genes/HGNC:11854,X-linked intellectual disability,MONDO:0100284,https://search.clinicalgenome.org/kb/conditions/MONDO:0100284,
433,TUFM,HGNC:12420,mitochondrial disease,MONDO:0044970,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_da1707cf-80cd-4669-be96-b273ac96b8b4-2023-10-02T040000.000Z,2023-10-02T04:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,TUFM,HGNC:12420,chr16:28853732-28857669,chr16:28842411-28846348,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TUFM&subject=,2016-08-22T17:53:14Z,TUFM,https://search.clinicalgenome.org/kb/genes/HGNC:12420,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
434,TUFM,HGNC:12420,mitochondrial disease,MONDO:0044970,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_da1707cf-80cd-4669-be96-b273ac96b8b4-2023-10-02T040000.000Z,2023-10-02T04:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,TUFM,HGNC:12420,chr16:28853732-28857669,chr16:28842411-28846348,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TUFM&subject=,2016-08-22T17:53:14Z,TUFM,https://search.clinicalgenome.org/kb/genes/HGNC:12420,combined oxidative phosphorylation defect type 4,MONDO:0012534,https://search.clinicalgenome.org/kb/conditions/MONDO:0012534,
435,PSPH,HGNC:9577,neurometabolic disorder due to serine deficiency,MONDO:0018162,AR,SOP11,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa832956-c4e9-4620-a2e7-3d6d6e9eea8c-2024-12-13T170000.000Z,2024-12-13T17:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,PSPH,HGNC:9577,chr7:56078757-56119137,chr7:56011064-56051444,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PSPH&subject=,2016-08-22T17:51:43Z,PSPH,https://search.clinicalgenome.org/kb/genes/HGNC:9577,neurometabolic disorder due to serine deficiency,MONDO:0018162,https://search.clinicalgenome.org/kb/conditions/MONDO:0018162,Autosomal recessive inheritance
436,PSPH,HGNC:9577,neurometabolic disorder due to serine deficiency,MONDO:0018162,AR,SOP11,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa832956-c4e9-4620-a2e7-3d6d6e9eea8c-2024-12-13T170000.000Z,2024-12-13T17:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,PSPH,HGNC:9577,chr7:56078757-56119137,chr7:56011064-56051444,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PSPH&subject=,2016-08-22T17:51:43Z,PSPH,https://search.clinicalgenome.org/kb/genes/HGNC:9577,PSPH deficiency,MONDO:0013531,https://search.clinicalgenome.org/kb/conditions/MONDO:0013531,
437,GDF2,HGNC:4217,"telangiectasia, hereditary hemorrhagic, type 5",MONDO:0014217,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00608fb7-3483-495a-8f9e-76aabb4b1dc0-2023-04-03T160000.000Z,2023-04-03T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,GDF2,HGNC:4217,chr10:48411774-48416908,chr10:47322454-47327588,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GDF2&subject=,2016-10-13T18:40:34Z,GDF2,https://search.clinicalgenome.org/kb/genes/HGNC:4217,pulmonary arterial hypertension,MONDO:0015924,https://search.clinicalgenome.org/kb/conditions/MONDO:0015924,Autosomal dominant inheritance
438,GDF2,HGNC:4217,"telangiectasia, hereditary hemorrhagic, type 5",MONDO:0014217,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00608fb7-3483-495a-8f9e-76aabb4b1dc0-2023-04-03T160000.000Z,2023-04-03T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,GDF2,HGNC:4217,chr10:48411774-48416908,chr10:47322454-47327588,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GDF2&subject=,2016-10-13T18:40:34Z,GDF2,https://search.clinicalgenome.org/kb/genes/HGNC:4217,"telangiectasia, hereditary hemorrhagic, type 5",MONDO:0014217,https://search.clinicalgenome.org/kb/conditions/MONDO:0014217,Autosomal dominant inheritance
439,GFM1,HGNC:13780,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_154a8f96-7062-49c7-9aaa-b23a98655f40-2019-12-19T185108.232Z,2019-12-19T18:51:08.232Z,Mitochondrial Diseases Gene Curation Expert Panel,GFM1,HGNC:13780,chr3:158362316-158413370,chr3:158644527-158695581,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GFM1&subject=,2016-08-22T17:48:53Z,GFM1,https://search.clinicalgenome.org/kb/genes/HGNC:13780,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
440,GFM1,HGNC:13780,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_154a8f96-7062-49c7-9aaa-b23a98655f40-2019-12-19T185108.232Z,2019-12-19T18:51:08.232Z,Mitochondrial Diseases Gene Curation Expert Panel,GFM1,HGNC:13780,chr3:158362316-158413370,chr3:158644527-158695581,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GFM1&subject=,2016-08-22T17:48:53Z,GFM1,https://search.clinicalgenome.org/kb/genes/HGNC:13780,hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,MONDO:0012191,https://search.clinicalgenome.org/kb/conditions/MONDO:0012191,
441,TTN,HGNC:12403,tibial muscular dystrophy,MONDO:0010870,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec556f45-8dbc-43f0-96df-29e69d7f3411-2022-03-14T205017.462Z,2022-03-14T20:50:17.462Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
442,TTN,HGNC:12403,tibial muscular dystrophy,MONDO:0010870,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec556f45-8dbc-43f0-96df-29e69d7f3411-2022-03-14T205017.462Z,2022-03-14T20:50:17.462Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
443,TTN,HGNC:12403,tibial muscular dystrophy,MONDO:0010870,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec556f45-8dbc-43f0-96df-29e69d7f3411-2022-03-14T205017.462Z,2022-03-14T20:50:17.462Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
444,TTN,HGNC:12403,tibial muscular dystrophy,MONDO:0010870,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec556f45-8dbc-43f0-96df-29e69d7f3411-2022-03-14T205017.462Z,2022-03-14T20:50:17.462Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,TTN-related myopathy,MONDO:0100175,https://search.clinicalgenome.org/kb/conditions/MONDO:0100175,Autosomal recessive inheritance
445,TTN,HGNC:12403,tibial muscular dystrophy,MONDO:0010870,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec556f45-8dbc-43f0-96df-29e69d7f3411-2022-03-14T205017.462Z,2022-03-14T20:50:17.462Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,tibial muscular dystrophy,MONDO:0010870,https://search.clinicalgenome.org/kb/conditions/MONDO:0010870,Autosomal dominant inheritance
446,TTN,HGNC:12403,tibial muscular dystrophy,MONDO:0010870,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec556f45-8dbc-43f0-96df-29e69d7f3411-2022-03-14T205017.462Z,2022-03-14T20:50:17.462Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,https://search.clinicalgenome.org/kb/conditions/MONDO:0011362,Autosomal dominant inheritance
447,TTN,HGNC:12403,tibial muscular dystrophy,MONDO:0010870,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec556f45-8dbc-43f0-96df-29e69d7f3411-2022-03-14T205017.462Z,2022-03-14T20:50:17.462Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,dilated cardiomyopathy 1G,MONDO:0011400,https://search.clinicalgenome.org/kb/conditions/MONDO:0011400,
448,TTN,HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bade9ef3-17fa-42ee-a2d7-9c9b985b1503-2022-03-14T205117.630Z,2022-03-14T20:51:17.630Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
449,TTN,HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bade9ef3-17fa-42ee-a2d7-9c9b985b1503-2022-03-14T205117.630Z,2022-03-14T20:51:17.630Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
450,TTN,HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bade9ef3-17fa-42ee-a2d7-9c9b985b1503-2022-03-14T205117.630Z,2022-03-14T20:51:17.630Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
451,TTN,HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bade9ef3-17fa-42ee-a2d7-9c9b985b1503-2022-03-14T205117.630Z,2022-03-14T20:51:17.630Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,TTN-related myopathy,MONDO:0100175,https://search.clinicalgenome.org/kb/conditions/MONDO:0100175,Autosomal recessive inheritance
452,TTN,HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bade9ef3-17fa-42ee-a2d7-9c9b985b1503-2022-03-14T205117.630Z,2022-03-14T20:51:17.630Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,tibial muscular dystrophy,MONDO:0010870,https://search.clinicalgenome.org/kb/conditions/MONDO:0010870,Autosomal dominant inheritance
453,TTN,HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bade9ef3-17fa-42ee-a2d7-9c9b985b1503-2022-03-14T205117.630Z,2022-03-14T20:51:17.630Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,https://search.clinicalgenome.org/kb/conditions/MONDO:0011362,Autosomal dominant inheritance
454,TTN,HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bade9ef3-17fa-42ee-a2d7-9c9b985b1503-2022-03-14T205117.630Z,2022-03-14T20:51:17.630Z,Congenital Myopathies Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,dilated cardiomyopathy 1G,MONDO:0011400,https://search.clinicalgenome.org/kb/conditions/MONDO:0011400,
455,TTN,HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ab74d-c9fa-4e74-b849-c8c6e8366050-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
456,TTN,HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ab74d-c9fa-4e74-b849-c8c6e8366050-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
457,TTN,HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ab74d-c9fa-4e74-b849-c8c6e8366050-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
458,TTN,HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ab74d-c9fa-4e74-b849-c8c6e8366050-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,TTN-related myopathy,MONDO:0100175,https://search.clinicalgenome.org/kb/conditions/MONDO:0100175,Autosomal recessive inheritance
459,TTN,HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ab74d-c9fa-4e74-b849-c8c6e8366050-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,tibial muscular dystrophy,MONDO:0010870,https://search.clinicalgenome.org/kb/conditions/MONDO:0010870,Autosomal dominant inheritance
460,TTN,HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ab74d-c9fa-4e74-b849-c8c6e8366050-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,https://search.clinicalgenome.org/kb/conditions/MONDO:0011362,Autosomal dominant inheritance
461,TTN,HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ab74d-c9fa-4e74-b849-c8c6e8366050-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,dilated cardiomyopathy 1G,MONDO:0011400,https://search.clinicalgenome.org/kb/conditions/MONDO:0011400,
462,TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-2023-07-27T160000.000Z,2023-07-27T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
463,TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-2023-07-27T160000.000Z,2023-07-27T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
464,TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-2023-07-27T160000.000Z,2023-07-27T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
465,TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-2023-07-27T160000.000Z,2023-07-27T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,TTN-related myopathy,MONDO:0100175,https://search.clinicalgenome.org/kb/conditions/MONDO:0100175,Autosomal recessive inheritance
466,TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-2023-07-27T160000.000Z,2023-07-27T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,tibial muscular dystrophy,MONDO:0010870,https://search.clinicalgenome.org/kb/conditions/MONDO:0010870,Autosomal dominant inheritance
467,TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-2023-07-27T160000.000Z,2023-07-27T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,https://search.clinicalgenome.org/kb/conditions/MONDO:0011362,Autosomal dominant inheritance
468,TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-2023-07-27T160000.000Z,2023-07-27T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,TTN,HGNC:12403,chr2:179390716-179672150,chr2:178525989-178807423,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TTN&subject=,2021-08-02T15:57:37Z,TTN,https://search.clinicalgenome.org/kb/genes/HGNC:12403,dilated cardiomyopathy 1G,MONDO:0011400,https://search.clinicalgenome.org/kb/conditions/MONDO:0011400,
469,DNM1,HGNC:2972,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0d252b0e-4777-4fbf-a23f-4ea7175b37d5-2024-02-06T200000.000Z,2024-02-06T20:00:00.000Z,Epilepsy Gene Curation Expert Panel,DNM1,HGNC:2972,chr9:130965658-131017523,chr9:128203379-128255244,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DNM1&subject=,2023-08-08T16:33:21Z,DNM1,https://search.clinicalgenome.org/kb/genes/HGNC:2972,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal dominant inheritance | Autosomal recessive inheritance
470,IGLL1,HGNC:5870,"agammaglobulinemia 2, autosomal recessive",MONDO:0013287,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b483cc35-0599-4313-b71a-835cb1096ca5-2021-12-21T133220.444Z,2021-12-21T13:32:20.444Z,Antibody Deficiencies Gene Curation Expert Panel,IGLL1,HGNC:5870,chr22:23915312-23922477,chr22:23573125-23580290,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=IGLL1&subject=,2016-08-22T17:49:27Z,IGLL1,https://search.clinicalgenome.org/kb/genes/HGNC:5870,"agammaglobulinemia 2, autosomal recessive",MONDO:0013287,https://search.clinicalgenome.org/kb/conditions/MONDO:0013287,Autosomal recessive inheritance
471,WRAP53,HGNC:25522,dyskeratosis congenita,MONDO:0015780,AR,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3207,2017-01-25T00:00:00,General Gene Curation Expert Panel,WRAP53,HGNC:25522,chr17:7589389-7606820,chr17:7686071-7703502,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=WRAP53&subject=,2017-12-15T15:06:01Z,WRAP53,https://search.clinicalgenome.org/kb/genes/HGNC:25522,dyskeratosis congenita,MONDO:0015780,https://search.clinicalgenome.org/kb/conditions/MONDO:0015780,Autosomal recessive inheritance
472,WRAP53,HGNC:25522,dyskeratosis congenita,MONDO:0015780,AR,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3207,2017-01-25T00:00:00,General Gene Curation Expert Panel,WRAP53,HGNC:25522,chr17:7589389-7606820,chr17:7686071-7703502,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=WRAP53&subject=,2017-12-15T15:06:01Z,WRAP53,https://search.clinicalgenome.org/kb/genes/HGNC:25522,"dyskeratosis congenita, autosomal recessive 3",MONDO:0013520,https://search.clinicalgenome.org/kb/conditions/MONDO:0013520,
473,MTAP,HGNC:7413,diaphyseal medullary stenosis-bone malignancy syndrome,MONDO:0007205,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c2243ec-a10f-4aab-aaf9-99153d805455-2021-06-15T232951.915Z,2021-06-15T23:29:51.915Z,Hereditary Cancer Gene Curation Expert Panel,MTAP,HGNC:7413,chr9:21802635-21867080,chr9:21802636-21941115,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MTAP&subject=,2022-10-12T17:00:57Z,MTAP,https://search.clinicalgenome.org/kb/genes/HGNC:7413,diaphyseal medullary stenosis-bone malignancy syndrome,MONDO:0007205,https://search.clinicalgenome.org/kb/conditions/MONDO:0007205,Autosomal dominant inheritance
474,PAX5,HGNC:8619,PAX5-related B lymphopenia and autism spectrum disorder,MONDO:0100299,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_111b7453-55ff-4638-9cb7-1936400ec2a4-2023-02-28T170000.000Z,2023-02-28T17:00:00.000Z,Antibody Deficiencies Gene Curation Expert Panel,PAX5,HGNC:8619,chr9:36833266-37034265,chr9:36833269-37034268,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PAX5&subject=,2025-02-12T20:09:17Z,PAX5,https://search.clinicalgenome.org/kb/genes/HGNC:8619,PAX5-related B lymphopenia and autism spectrum disorder,MONDO:0100299,https://search.clinicalgenome.org/kb/conditions/MONDO:0100299,Autosomal recessive inheritance
475,PAX5,HGNC:8619,PAX5-related B lymphopenia and autism spectrum disorder,MONDO:0100299,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_111b7453-55ff-4638-9cb7-1936400ec2a4-2023-02-28T170000.000Z,2023-02-28T17:00:00.000Z,Antibody Deficiencies Gene Curation Expert Panel,PAX5,HGNC:8619,chr9:36833266-37034265,chr9:36833269-37034268,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PAX5&subject=,2025-02-12T20:09:17Z,PAX5,https://search.clinicalgenome.org/kb/genes/HGNC:8619,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,
476,KDM5B,HGNC:18039,intellectual disability,MONDO:0001071,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2ae3441f-82f6-4985-ba48-fd1de8ea6ce4-2022-03-01T170000.000Z,2022-03-01T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,KDM5B,HGNC:18039,chr1:202693623-202778598,chr1:202724495-202808421,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KDM5B&subject=,2018-01-04T20:56:03Z,KDM5B,https://search.clinicalgenome.org/kb/genes/HGNC:18039,intellectual disability,MONDO:0001071,https://search.clinicalgenome.org/kb/conditions/MONDO:0001071,Autosomal recessive inheritance
477,SUCLG1,HGNC:11449,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd0a5a96-69b8-47fb-9b7b-17de29439ecc-2019-04-18T181448.882Z,2019-04-18T18:14:48.882Z,Mitochondrial Diseases Gene Curation Expert Panel,SUCLG1,HGNC:11449,chr2:84650652-84686404,chr2:84423528-84459280,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SUCLG1&subject=,2016-08-22T17:52:38Z,SUCLG1,https://search.clinicalgenome.org/kb/genes/HGNC:11449,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
478,SUCLG1,HGNC:11449,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd0a5a96-69b8-47fb-9b7b-17de29439ecc-2019-04-18T181448.882Z,2019-04-18T18:14:48.882Z,Mitochondrial Diseases Gene Curation Expert Panel,SUCLG1,HGNC:11449,chr2:84650652-84686404,chr2:84423528-84459280,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SUCLG1&subject=,2016-08-22T17:52:38Z,SUCLG1,https://search.clinicalgenome.org/kb/genes/HGNC:11449,mitochondrial DNA depletion syndrome 9,MONDO:0009504,https://search.clinicalgenome.org/kb/conditions/MONDO:0009504,
479,ORC4,HGNC:8490,Meier-Gorlin syndrome 2,MONDO:0013428,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d00eb95c-5496-4051-a4e1-c327b71fe6e4-2023-05-30T160000.000Z,2023-05-30T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,ORC4,HGNC:8490,chr2:148687965-148779120,chr2:147930396-148021551,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ORC4&subject=,2015-11-06T04:38:54Z,ORC4,https://search.clinicalgenome.org/kb/genes/HGNC:8490,Meier-Gorlin syndrome 2,MONDO:0013428,https://search.clinicalgenome.org/kb/conditions/MONDO:0013428,Autosomal recessive inheritance
480,TRMU,HGNC:25481,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1d9d958-be13-4018-ab9c-305788171d1e-2021-01-21T004755.799Z,2021-01-21T00:47:55.799Z,Mitochondrial Diseases Gene Curation Expert Panel,TRMU,HGNC:25481,chr22:46731611-46753237,chr22:46335714-46357340,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TRMU&subject=,2016-08-22T17:53:05Z,TRMU,https://search.clinicalgenome.org/kb/genes/HGNC:25481,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
481,TRMU,HGNC:25481,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1d9d958-be13-4018-ab9c-305788171d1e-2021-01-21T004755.799Z,2021-01-21T00:47:55.799Z,Mitochondrial Diseases Gene Curation Expert Panel,TRMU,HGNC:25481,chr22:46731611-46753237,chr22:46335714-46357340,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TRMU&subject=,2016-08-22T17:53:05Z,TRMU,https://search.clinicalgenome.org/kb/genes/HGNC:25481,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
482,TRMU,HGNC:25481,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1d9d958-be13-4018-ab9c-305788171d1e-2021-01-21T004755.799Z,2021-01-21T00:47:55.799Z,Mitochondrial Diseases Gene Curation Expert Panel,TRMU,HGNC:25481,chr22:46731611-46753237,chr22:46335714-46357340,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TRMU&subject=,2016-08-22T17:53:05Z,TRMU,https://search.clinicalgenome.org/kb/genes/HGNC:25481,acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,MONDO:0013111,https://search.clinicalgenome.org/kb/conditions/MONDO:0013111,
483,SYNE4,HGNC:26703,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ba8e80d-ccfe-4c9d-a2a9-6abaa9dfacc6-2020-02-06T171016.249Z,2020-02-06T17:10:16.249Z,Hearing Loss Gene Curation Expert Panel,SYNE4,HGNC:26703,chr19:36494209-36499715,chr19:36003307-36008813,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SYNE4&subject=,2016-08-22T17:52:41Z,SYNE4,https://search.clinicalgenome.org/kb/genes/HGNC:26703,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
484,SYNE4,HGNC:26703,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ba8e80d-ccfe-4c9d-a2a9-6abaa9dfacc6-2020-02-06T171016.249Z,2020-02-06T17:10:16.249Z,Hearing Loss Gene Curation Expert Panel,SYNE4,HGNC:26703,chr19:36494209-36499715,chr19:36003307-36008813,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SYNE4&subject=,2016-08-22T17:52:41Z,SYNE4,https://search.clinicalgenome.org/kb/genes/HGNC:26703,autosomal recessive nonsyndromic hearing loss 76,MONDO:0014237,https://search.clinicalgenome.org/kb/conditions/MONDO:0014237,
485,GRIK2,HGNC:4580,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1939b90b-f1e4-4426-9f8c-5526f9003f10-2022-02-10T070000.000Z,2022-02-10T07:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,GRIK2,HGNC:4580,chr6:101841584-102517958,chr6:101393708-102070083,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GRIK2&subject=,2012-09-05T14:36:18Z,GRIK2,https://search.clinicalgenome.org/kb/genes/HGNC:4580,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance | Autosomal recessive inheritance
486,GRIK2,HGNC:4580,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1939b90b-f1e4-4426-9f8c-5526f9003f10-2022-02-10T070000.000Z,2022-02-10T07:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,GRIK2,HGNC:4580,chr6:101841584-102517958,chr6:101393708-102070083,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GRIK2&subject=,2012-09-05T14:36:18Z,GRIK2,https://search.clinicalgenome.org/kb/genes/HGNC:4580,"intellectual disability, autosomal recessive 6",MONDO:0012614,https://search.clinicalgenome.org/kb/conditions/MONDO:0012614,
487,WHRN,HGNC:16361,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3188ec93-954a-4daa-b99d-7c5fccad8e1a-2024-01-17T170000.000Z,2024-01-17T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,WHRN,HGNC:16361,chr9:117164360-117267753,chr9:114402080-114505473,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=WHRN&subject=,2016-08-22T17:47:49Z,WHRN,https://search.clinicalgenome.org/kb/genes/HGNC:16361,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
488,WHRN,HGNC:16361,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3188ec93-954a-4daa-b99d-7c5fccad8e1a-2024-01-17T170000.000Z,2024-01-17T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,WHRN,HGNC:16361,chr9:117164360-117267753,chr9:114402080-114505473,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=WHRN&subject=,2016-08-22T17:47:49Z,WHRN,https://search.clinicalgenome.org/kb/genes/HGNC:16361,Usher syndrome type 2D,MONDO:0012662,https://search.clinicalgenome.org/kb/conditions/MONDO:0012662,Autosomal recessive inheritance
489,WHRN,HGNC:16361,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3188ec93-954a-4daa-b99d-7c5fccad8e1a-2024-01-17T170000.000Z,2024-01-17T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,WHRN,HGNC:16361,chr9:117164360-117267753,chr9:114402080-114505473,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=WHRN&subject=,2016-08-22T17:47:49Z,WHRN,https://search.clinicalgenome.org/kb/genes/HGNC:16361,autosomal recessive nonsyndromic hearing loss 31,MONDO:0011767,https://search.clinicalgenome.org/kb/conditions/MONDO:0011767,
490,SYP,HGNC:11506,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0d770a5-873c-4a55-98da-fa8d235ff93b-2020-12-16T170000.000Z,2020-12-16T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SYP,HGNC:11506,chrX:49044268-49056652,chrX:49187815-49200193,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SYP&subject=,2018-09-26T16:54:15Z,SYP,https://search.clinicalgenome.org/kb/genes/HGNC:11506,non-syndromic X-linked intellectual disability,MONDO:0019181,https://search.clinicalgenome.org/kb/conditions/MONDO:0019181,X-linked inheritance
491,SYP,HGNC:11506,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0d770a5-873c-4a55-98da-fa8d235ff93b-2020-12-16T170000.000Z,2020-12-16T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SYP,HGNC:11506,chrX:49044268-49056652,chrX:49187815-49200193,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SYP&subject=,2018-09-26T16:54:15Z,SYP,https://search.clinicalgenome.org/kb/genes/HGNC:11506,"intellectual disability, X-linked 96",MONDO:0010429,https://search.clinicalgenome.org/kb/conditions/MONDO:0010429,
492,PDSS2,HGNC:23041,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0928f3-2b7d-4622-bc96-68a4d0078826-2021-03-11T172336.036Z,2021-03-11T17:23:36.036Z,Mitochondrial Diseases Gene Curation Expert Panel,PDSS2,HGNC:23041,chr6:107473766-107780768,chr6:107152562-107459564,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PDSS2&subject=,2016-08-22T17:51:04Z,PDSS2,https://search.clinicalgenome.org/kb/genes/HGNC:23041,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
493,PDSS2,HGNC:23041,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0928f3-2b7d-4622-bc96-68a4d0078826-2021-03-11T172336.036Z,2021-03-11T17:23:36.036Z,Mitochondrial Diseases Gene Curation Expert Panel,PDSS2,HGNC:23041,chr6:107473766-107780768,chr6:107152562-107459564,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PDSS2&subject=,2016-08-22T17:51:04Z,PDSS2,https://search.clinicalgenome.org/kb/genes/HGNC:23041,"coenzyme Q10 deficiency, primary, 3",MONDO:0013838,https://search.clinicalgenome.org/kb/conditions/MONDO:0013838,
494,PDX1,HGNC:6107,monogenic diabetes,MONDO:0015967,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5487c912-a653-411d-b640-a51c60f51fa6-2022-06-16T160000.000Z,2022-06-16T16:00:00.000Z,Monogenic Diabetes Gene Curation Expert Panel,PDX1,HGNC:6107,chr13:28494137-28500450,chr13:27920000-27926313,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PDX1&subject=,2016-08-22T17:51:05Z,PDX1,https://search.clinicalgenome.org/kb/genes/HGNC:6107,monogenic diabetes,MONDO:0015967,https://search.clinicalgenome.org/kb/conditions/MONDO:0015967,Autosomal dominant inheritance
495,PDX1,HGNC:6107,monogenic diabetes,MONDO:0015967,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5487c912-a653-411d-b640-a51c60f51fa6-2022-06-16T160000.000Z,2022-06-16T16:00:00.000Z,Monogenic Diabetes Gene Curation Expert Panel,PDX1,HGNC:6107,chr13:28494137-28500450,chr13:27920000-27926313,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PDX1&subject=,2016-08-22T17:51:05Z,PDX1,https://search.clinicalgenome.org/kb/genes/HGNC:6107,pancreatic agenesis 1,MONDO:0024547,https://search.clinicalgenome.org/kb/conditions/MONDO:0024547,Autosomal recessive inheritance
496,TPK1,HGNC:17358,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74e89426-cb27-4474-b892-dc303a9de644-2021-01-14T212800.773Z,2021-01-14T21:28:00.773Z,Mitochondrial Diseases Gene Curation Expert Panel,TPK1,HGNC:17358,chr7:144149034-144533146,chr7:144451941-144836437,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPK1&subject=,2016-08-22T17:52:57Z,TPK1,https://search.clinicalgenome.org/kb/genes/HGNC:17358,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
497,TPK1,HGNC:17358,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74e89426-cb27-4474-b892-dc303a9de644-2021-01-14T212800.773Z,2021-01-14T21:28:00.773Z,Mitochondrial Diseases Gene Curation Expert Panel,TPK1,HGNC:17358,chr7:144149034-144533146,chr7:144451941-144836437,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TPK1&subject=,2016-08-22T17:52:57Z,TPK1,https://search.clinicalgenome.org/kb/genes/HGNC:17358,childhood encephalopathy due to thiamine pyrophosphokinase deficiency,MONDO:0013761,https://search.clinicalgenome.org/kb/conditions/MONDO:0013761,
498,ALAD,HGNC:395,porphyria due to ALA dehydratase deficiency,MONDO:0013000,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ac683af-ca8d-46ab-8641-66ab9b537d16-2025-01-14T200000.000Z,2025-01-14T20:00:00.000Z,General Inborn Errors of Metabolism Gene Curation Expert Panel,ALAD,HGNC:395,chr9:116148592-116163564,chr9:113386312-113401284,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ALAD&subject=,2016-08-22T17:45:50Z,ALAD,https://search.clinicalgenome.org/kb/genes/HGNC:395,porphyria due to ALA dehydratase deficiency,MONDO:0013000,https://search.clinicalgenome.org/kb/conditions/MONDO:0013000,Autosomal recessive inheritance
499,TWIST1,HGNC:12428,TWIST1-related craniosynostosis,MONDO:0007399,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bda425f8-b760-4484-9336-b3e572d402ab-2021-06-10T160000.000Z,2021-06-10T16:00:00.000Z,Craniofacial Malformations Gene Curation Expert Panel,TWIST1,HGNC:12428,chr7:19152670-19157259,chr7:19113047-19117636,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TWIST1&subject=,2020-12-16T17:30:30Z,TWIST1,https://search.clinicalgenome.org/kb/genes/HGNC:12428,TWIST1-related craniosynostosis,MONDO:0007399,https://search.clinicalgenome.org/kb/conditions/MONDO:0007399,Autosomal dominant inheritance
500,TWIST1,HGNC:12428,TWIST1-related craniosynostosis,MONDO:0007399,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bda425f8-b760-4484-9336-b3e572d402ab-2021-06-10T160000.000Z,2021-06-10T16:00:00.000Z,Craniofacial Malformations Gene Curation Expert Panel,TWIST1,HGNC:12428,chr7:19152670-19157259,chr7:19113047-19117636,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TWIST1&subject=,2020-12-16T17:30:30Z,TWIST1,https://search.clinicalgenome.org/kb/genes/HGNC:12428,Saethre-Chotzen syndrome,MONDO:0007042,https://search.clinicalgenome.org/kb/conditions/MONDO:0007042,Autosomal dominant inheritance
501,TWIST1,HGNC:12428,TWIST1-related craniosynostosis,MONDO:0007399,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bda425f8-b760-4484-9336-b3e572d402ab-2021-06-10T160000.000Z,2021-06-10T16:00:00.000Z,Craniofacial Malformations Gene Curation Expert Panel,TWIST1,HGNC:12428,chr7:19152670-19157259,chr7:19113047-19117636,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TWIST1&subject=,2020-12-16T17:30:30Z,TWIST1,https://search.clinicalgenome.org/kb/genes/HGNC:12428,Sweeney-Cox syndrome,MONDO:0060592,https://search.clinicalgenome.org/kb/conditions/MONDO:0060592,Autosomal dominant inheritance
502,TWIST1,HGNC:12428,Sweeney-Cox syndrome,MONDO:0060592,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14ba10ad-ebb5-491f-b4d6-639890ab7ab9-2021-03-26T213222.762Z,2021-03-26T21:32:22.762Z,Craniofacial Malformations Gene Curation Expert Panel,TWIST1,HGNC:12428,chr7:19152670-19157259,chr7:19113047-19117636,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TWIST1&subject=,2020-12-16T17:30:30Z,TWIST1,https://search.clinicalgenome.org/kb/genes/HGNC:12428,TWIST1-related craniosynostosis,MONDO:0007399,https://search.clinicalgenome.org/kb/conditions/MONDO:0007399,Autosomal dominant inheritance
503,TWIST1,HGNC:12428,Sweeney-Cox syndrome,MONDO:0060592,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14ba10ad-ebb5-491f-b4d6-639890ab7ab9-2021-03-26T213222.762Z,2021-03-26T21:32:22.762Z,Craniofacial Malformations Gene Curation Expert Panel,TWIST1,HGNC:12428,chr7:19152670-19157259,chr7:19113047-19117636,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TWIST1&subject=,2020-12-16T17:30:30Z,TWIST1,https://search.clinicalgenome.org/kb/genes/HGNC:12428,Saethre-Chotzen syndrome,MONDO:0007042,https://search.clinicalgenome.org/kb/conditions/MONDO:0007042,Autosomal dominant inheritance
504,TWIST1,HGNC:12428,Sweeney-Cox syndrome,MONDO:0060592,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14ba10ad-ebb5-491f-b4d6-639890ab7ab9-2021-03-26T213222.762Z,2021-03-26T21:32:22.762Z,Craniofacial Malformations Gene Curation Expert Panel,TWIST1,HGNC:12428,chr7:19152670-19157259,chr7:19113047-19117636,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TWIST1&subject=,2020-12-16T17:30:30Z,TWIST1,https://search.clinicalgenome.org/kb/genes/HGNC:12428,Sweeney-Cox syndrome,MONDO:0060592,https://search.clinicalgenome.org/kb/conditions/MONDO:0060592,Autosomal dominant inheritance
505,DPM3,HGNC:3007,DPM3-congenital disorder of glycosylation,MONDO:0013049,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76bcf111-b22b-4be4-8fe7-870c9744bf44-2023-12-06T170000.000Z,2023-12-06T17:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,DPM3,HGNC:3007,chr1:155112367-155113007,chr1:155139891-155140531,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DPM3&subject=,2015-04-09T03:18:03Z,DPM3,https://search.clinicalgenome.org/kb/genes/HGNC:3007,DPM3-congenital disorder of glycosylation,MONDO:0013049,https://search.clinicalgenome.org/kb/conditions/MONDO:0013049,Autosomal recessive inheritance
506,ATP7A,HGNC:869,X-linked distal spinal muscular atrophy type 3,MONDO:0010338,XL,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec7c42f3-3cad-4020-aa75-cf103c5381ba-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,ATP7A,HGNC:869,chrX:77166190-77305892,chrX:77910693-78050395,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ATP7A&subject=,2021-03-24T16:30:24Z,ATP7A,https://search.clinicalgenome.org/kb/genes/HGNC:869,Menkes disease,MONDO:0010651,https://search.clinicalgenome.org/kb/conditions/MONDO:0010651,X-linked inheritance
507,ATP7A,HGNC:869,X-linked distal spinal muscular atrophy type 3,MONDO:0010338,XL,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec7c42f3-3cad-4020-aa75-cf103c5381ba-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,ATP7A,HGNC:869,chrX:77166190-77305892,chrX:77910693-78050395,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ATP7A&subject=,2021-03-24T16:30:24Z,ATP7A,https://search.clinicalgenome.org/kb/genes/HGNC:869,X-linked distal spinal muscular atrophy type 3,MONDO:0010338,https://search.clinicalgenome.org/kb/conditions/MONDO:0010338,X-linked inheritance
508,LITAF,HGNC:16841,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7106097-314c-487a-9770-b7dea3f25f37-2020-04-07T160000.000Z,2020-04-07T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,LITAF,HGNC:16841,chr16:11641578-11681322,chr16:11547722-11640317,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LITAF&subject=,2016-10-21T20:15:32Z,LITAF,https://search.clinicalgenome.org/kb/genes/HGNC:16841,Charcot-Marie-Tooth disease,MONDO:0015626,https://search.clinicalgenome.org/kb/conditions/MONDO:0015626,Autosomal dominant inheritance
509,LITAF,HGNC:16841,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7106097-314c-487a-9770-b7dea3f25f37-2020-04-07T160000.000Z,2020-04-07T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,LITAF,HGNC:16841,chr16:11641578-11681322,chr16:11547722-11640317,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LITAF&subject=,2016-10-21T20:15:32Z,LITAF,https://search.clinicalgenome.org/kb/genes/HGNC:16841,Charcot-Marie-Tooth disease type 1,MONDO:0019011,https://search.clinicalgenome.org/kb/conditions/MONDO:0019011,
510,LITAF,HGNC:16841,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7106097-314c-487a-9770-b7dea3f25f37-2020-04-07T160000.000Z,2020-04-07T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,LITAF,HGNC:16841,chr16:11641578-11681322,chr16:11547722-11640317,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LITAF&subject=,2016-10-21T20:15:32Z,LITAF,https://search.clinicalgenome.org/kb/genes/HGNC:16841,Charcot-Marie-Tooth disease type 1C,MONDO:0010995,https://search.clinicalgenome.org/kb/conditions/MONDO:0010995,
511,LBR,HGNC:6518,regressive spondylometaphyseal dysplasia,MONDO:0018663,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9363af5e-5076-4f7b-bff3-3c15751bca92-2023-08-07T160000.000Z,2023-08-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,LBR,HGNC:6518,chr1:225589204-225616523,chr1:225401502-225428821,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LBR&subject=,2015-02-23T18:21:52Z,LBR,https://search.clinicalgenome.org/kb/genes/HGNC:6518,regressive spondylometaphyseal dysplasia,MONDO:0018663,https://search.clinicalgenome.org/kb/conditions/MONDO:0018663,Autosomal recessive inheritance
512,LBR,HGNC:6518,regressive spondylometaphyseal dysplasia,MONDO:0018663,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9363af5e-5076-4f7b-bff3-3c15751bca92-2023-08-07T160000.000Z,2023-08-07T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,LBR,HGNC:6518,chr1:225589204-225616523,chr1:225401502-225428821,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LBR&subject=,2015-02-23T18:21:52Z,LBR,https://search.clinicalgenome.org/kb/genes/HGNC:6518,Greenberg dysplasia,MONDO:0008974,https://search.clinicalgenome.org/kb/conditions/MONDO:0008974,Autosomal recessive inheritance
513,LBR,HGNC:6518,Greenberg dysplasia,MONDO:0008974,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41096010-f7fc-49a5-be97-a20fc73e7e33-2023-11-01T160000.000Z,2023-11-01T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,LBR,HGNC:6518,chr1:225589204-225616523,chr1:225401502-225428821,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LBR&subject=,2015-02-23T18:21:52Z,LBR,https://search.clinicalgenome.org/kb/genes/HGNC:6518,regressive spondylometaphyseal dysplasia,MONDO:0018663,https://search.clinicalgenome.org/kb/conditions/MONDO:0018663,Autosomal recessive inheritance
514,LBR,HGNC:6518,Greenberg dysplasia,MONDO:0008974,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41096010-f7fc-49a5-be97-a20fc73e7e33-2023-11-01T160000.000Z,2023-11-01T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,LBR,HGNC:6518,chr1:225589204-225616523,chr1:225401502-225428821,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LBR&subject=,2015-02-23T18:21:52Z,LBR,https://search.clinicalgenome.org/kb/genes/HGNC:6518,Greenberg dysplasia,MONDO:0008974,https://search.clinicalgenome.org/kb/conditions/MONDO:0008974,Autosomal recessive inheritance
515,SERPINB6,HGNC:8950,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b84c49a8-3b02-4e07-a0c7-80394c0cf991-2022-11-22T170000.000Z,2022-11-22T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,SERPINB6,HGNC:8950,chr6:2948393-2972027,chr6:2948159-2971793,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SERPINB6&subject=,2016-08-22T17:52:11Z,SERPINB6,https://search.clinicalgenome.org/kb/genes/HGNC:8950,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
516,SERPINB6,HGNC:8950,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b84c49a8-3b02-4e07-a0c7-80394c0cf991-2022-11-22T170000.000Z,2022-11-22T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,SERPINB6,HGNC:8950,chr6:2948393-2972027,chr6:2948159-2971793,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SERPINB6&subject=,2016-08-22T17:52:11Z,SERPINB6,https://search.clinicalgenome.org/kb/genes/HGNC:8950,autosomal recessive nonsyndromic hearing loss 91,MONDO:0013269,https://search.clinicalgenome.org/kb/conditions/MONDO:0013269,
517,FOXRED1,HGNC:26927,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c74ba0cb-ccef-4a19-9fef-ef9996f72290-2019-10-16T143453.574Z,2019-10-16T14:34:53.574Z,Mitochondrial Diseases Gene Curation Expert Panel,FOXRED1,HGNC:26927,chr11:126139049-126148021,chr11:126269154-126278126,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FOXRED1&subject=,2016-08-22T17:48:37Z,FOXRED1,https://search.clinicalgenome.org/kb/genes/HGNC:26927,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
518,FOXRED1,HGNC:26927,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c74ba0cb-ccef-4a19-9fef-ef9996f72290-2019-10-16T143453.574Z,2019-10-16T14:34:53.574Z,Mitochondrial Diseases Gene Curation Expert Panel,FOXRED1,HGNC:26927,chr11:126139049-126148021,chr11:126269154-126278126,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FOXRED1&subject=,2016-08-22T17:48:37Z,FOXRED1,https://search.clinicalgenome.org/kb/genes/HGNC:26927,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
519,PMM2,HGNC:9115,hyperinsulinemic hypoglycemia with polycystic kidney disease,MONDO:1030000,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2325bc92-b994-4c5a-b2cb-e2b757d8acbd-2024-02-28T170000.000Z,2024-02-28T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders Gene Curation Expert Panel,PMM2,HGNC:9115,chr16:8891696-8943182,chr16:8797839-8849325,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMM2&subject=,2016-08-22T17:51:33Z,PMM2,https://search.clinicalgenome.org/kb/genes/HGNC:9115,hyperinsulinemic hypoglycemia with polycystic kidney disease,MONDO:1030000,https://search.clinicalgenome.org/kb/conditions/MONDO:1030000,Autosomal recessive inheritance
520,PMM2,HGNC:9115,hyperinsulinemic hypoglycemia with polycystic kidney disease,MONDO:1030000,AR,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2325bc92-b994-4c5a-b2cb-e2b757d8acbd-2024-02-28T170000.000Z,2024-02-28T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders Gene Curation Expert Panel,PMM2,HGNC:9115,chr16:8891696-8943182,chr16:8797839-8849325,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMM2&subject=,2016-08-22T17:51:33Z,PMM2,https://search.clinicalgenome.org/kb/genes/HGNC:9115,PMM2-congenital disorder of glycosylation,MONDO:0008907,https://search.clinicalgenome.org/kb/conditions/MONDO:0008907,Autosomal recessive inheritance
521,PMM2,HGNC:9115,PMM2-congenital disorder of glycosylation,MONDO:0008907,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a70becbb-336f-4a30-966b-8db1c7832d87-2023-12-12T170000.000Z,2023-12-12T17:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,PMM2,HGNC:9115,chr16:8891696-8943182,chr16:8797839-8849325,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMM2&subject=,2016-08-22T17:51:33Z,PMM2,https://search.clinicalgenome.org/kb/genes/HGNC:9115,hyperinsulinemic hypoglycemia with polycystic kidney disease,MONDO:1030000,https://search.clinicalgenome.org/kb/conditions/MONDO:1030000,Autosomal recessive inheritance
522,PMM2,HGNC:9115,PMM2-congenital disorder of glycosylation,MONDO:0008907,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a70becbb-336f-4a30-966b-8db1c7832d87-2023-12-12T170000.000Z,2023-12-12T17:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,PMM2,HGNC:9115,chr16:8891696-8943182,chr16:8797839-8849325,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMM2&subject=,2016-08-22T17:51:33Z,PMM2,https://search.clinicalgenome.org/kb/genes/HGNC:9115,PMM2-congenital disorder of glycosylation,MONDO:0008907,https://search.clinicalgenome.org/kb/conditions/MONDO:0008907,Autosomal recessive inheritance
523,SOX3,HGNC:11199,SOX3-related X-linked pituitary hormone deficiency with or without intellectual developmental disorder,MONDO:0800474,XL,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_796f4ae7-c817-44d4-935b-babf74a0ce47-2023-08-02T160000.000Z,2023-08-02T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,SOX3,HGNC:11199,chrX:139585150-139587234,chrX:140502985-140505069,No Evidence for Haploinsufficiency,Emerging Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX3&subject=,2023-01-10T18:01:22Z,SOX3,https://search.clinicalgenome.org/kb/genes/HGNC:11199,SOX3-related X-linked pituitary hormone deficiency with or without intellectual developmental disorder,MONDO:0800474,https://search.clinicalgenome.org/kb/conditions/MONDO:0800474,X-linked inheritance
524,SOX3,HGNC:11199,SOX3-related X-linked pituitary hormone deficiency with or without intellectual developmental disorder,MONDO:0800474,XL,SOP10,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_796f4ae7-c817-44d4-935b-babf74a0ce47-2023-08-02T160000.000Z,2023-08-02T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,SOX3,HGNC:11199,chrX:139585150-139587234,chrX:140502985-140505069,No Evidence for Haploinsufficiency,Emerging Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX3&subject=,2023-01-10T18:01:22Z,SOX3,https://search.clinicalgenome.org/kb/genes/HGNC:11199,"intellectual disability, X-linked, with panhypopituitarism",MONDO:0010252,https://search.clinicalgenome.org/kb/conditions/MONDO:0010252,
525,COX10,HGNC:2260,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48794019-db9d-47c2-9977-4dc76a7d07b3-2019-05-20T182801.393Z,2019-05-20T18:28:01.393Z,Mitochondrial Diseases Gene Curation Expert Panel,COX10,HGNC:2260,chr17:13972821-14111994,chr17:14069504-14208677,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COX10&subject=,2016-08-22T17:47:23Z,COX10,https://search.clinicalgenome.org/kb/genes/HGNC:2260,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
526,COX10,HGNC:2260,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48794019-db9d-47c2-9977-4dc76a7d07b3-2019-05-20T182801.393Z,2019-05-20T18:28:01.393Z,Mitochondrial Diseases Gene Curation Expert Panel,COX10,HGNC:2260,chr17:13972821-14111994,chr17:14069504-14208677,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COX10&subject=,2016-08-22T17:47:23Z,COX10,https://search.clinicalgenome.org/kb/genes/HGNC:2260,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
527,SDHAF1,HGNC:33867,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0baf56d2-40f8-465a-9b50-22f57481a5cb-2020-02-12T201133.569Z,2020-02-12T20:11:33.569Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHAF1,HGNC:33867,chr19:36486090-36487214,chr19:35995188-35996312,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHAF1&subject=,2016-08-22T17:52:09Z,SDHAF1,https://search.clinicalgenome.org/kb/genes/HGNC:33867,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
528,SDHAF1,HGNC:33867,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0baf56d2-40f8-465a-9b50-22f57481a5cb-2020-02-12T201133.569Z,2020-02-12T20:11:33.569Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHAF1,HGNC:33867,chr19:36486090-36487214,chr19:35995188-35996312,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHAF1&subject=,2016-08-22T17:52:09Z,SDHAF1,https://search.clinicalgenome.org/kb/genes/HGNC:33867,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
529,SDHAF1,HGNC:33867,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0baf56d2-40f8-465a-9b50-22f57481a5cb-2020-02-12T201133.569Z,2020-02-12T20:11:33.569Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHAF1,HGNC:33867,chr19:36486090-36487214,chr19:35995188-35996312,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHAF1&subject=,2016-08-22T17:52:09Z,SDHAF1,https://search.clinicalgenome.org/kb/genes/HGNC:33867,"mitochondrial complex II deficiency, nuclear type 1",MONDO:0100294,https://search.clinicalgenome.org/kb/conditions/MONDO:0100294,
530,SDHAF1,HGNC:33867,mitochondrial disease,MONDO:0044970,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e421e4d0-9618-4fad-bf20-a509d8d527ed-2023-12-04T050000.000Z,2023-12-04T05:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHAF1,HGNC:33867,chr19:36486090-36487214,chr19:35995188-35996312,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHAF1&subject=,2016-08-22T17:52:09Z,SDHAF1,https://search.clinicalgenome.org/kb/genes/HGNC:33867,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
531,SDHAF1,HGNC:33867,mitochondrial disease,MONDO:0044970,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e421e4d0-9618-4fad-bf20-a509d8d527ed-2023-12-04T050000.000Z,2023-12-04T05:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHAF1,HGNC:33867,chr19:36486090-36487214,chr19:35995188-35996312,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHAF1&subject=,2016-08-22T17:52:09Z,SDHAF1,https://search.clinicalgenome.org/kb/genes/HGNC:33867,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
532,SDHAF1,HGNC:33867,mitochondrial disease,MONDO:0044970,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e421e4d0-9618-4fad-bf20-a509d8d527ed-2023-12-04T050000.000Z,2023-12-04T05:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHAF1,HGNC:33867,chr19:36486090-36487214,chr19:35995188-35996312,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHAF1&subject=,2016-08-22T17:52:09Z,SDHAF1,https://search.clinicalgenome.org/kb/genes/HGNC:33867,"mitochondrial complex II deficiency, nuclear type 1",MONDO:0100294,https://search.clinicalgenome.org/kb/conditions/MONDO:0100294,
533,CTNNA3,HGNC:2511,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f1dd946-f2bb-496f-8fea-3dea303e2e76-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,CTNNA3,HGNC:2511,chr10:67672281-69455953,chr10:65912523-67763594,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CTNNA3&subject=,2018-10-24T16:40:19Z,CTNNA3,https://search.clinicalgenome.org/kb/genes/HGNC:2511,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
534,CTNNA3,HGNC:2511,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f1dd946-f2bb-496f-8fea-3dea303e2e76-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,CTNNA3,HGNC:2511,chr10:67672281-69455953,chr10:65912523-67763594,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CTNNA3&subject=,2018-10-24T16:40:19Z,CTNNA3,https://search.clinicalgenome.org/kb/genes/HGNC:2511,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Mode of inheritance
535,CTNNA3,HGNC:2511,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f1dd946-f2bb-496f-8fea-3dea303e2e76-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,CTNNA3,HGNC:2511,chr10:67672281-69455953,chr10:65912523-67763594,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CTNNA3&subject=,2018-10-24T16:40:19Z,CTNNA3,https://search.clinicalgenome.org/kb/genes/HGNC:2511,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,
536,CTNNA3,HGNC:2511,congenital heart disease,MONDO:0005453,UD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d30ce558-9009-45d3-9eb3-9b5c7594d1b8-2023-10-17T160000.000Z,2023-10-17T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,CTNNA3,HGNC:2511,chr10:67672281-69455953,chr10:65912523-67763594,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CTNNA3&subject=,2018-10-24T16:40:19Z,CTNNA3,https://search.clinicalgenome.org/kb/genes/HGNC:2511,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
537,CTNNA3,HGNC:2511,congenital heart disease,MONDO:0005453,UD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d30ce558-9009-45d3-9eb3-9b5c7594d1b8-2023-10-17T160000.000Z,2023-10-17T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,CTNNA3,HGNC:2511,chr10:67672281-69455953,chr10:65912523-67763594,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CTNNA3&subject=,2018-10-24T16:40:19Z,CTNNA3,https://search.clinicalgenome.org/kb/genes/HGNC:2511,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Mode of inheritance
538,CTNNA3,HGNC:2511,congenital heart disease,MONDO:0005453,UD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d30ce558-9009-45d3-9eb3-9b5c7594d1b8-2023-10-17T160000.000Z,2023-10-17T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,CTNNA3,HGNC:2511,chr10:67672281-69455953,chr10:65912523-67763594,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CTNNA3&subject=,2018-10-24T16:40:19Z,CTNNA3,https://search.clinicalgenome.org/kb/genes/HGNC:2511,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,
539,DISP1,HGNC:19711,holoprosencephaly,MONDO:0016296,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef9d5a3b-d4ec-473b-b5a2-aaa25cf9babd-2022-09-27T090000.000Z,2022-09-27T09:00:00.000Z,Brain Malformations Gene Curation Expert Panel,DISP1,HGNC:19711,chr1:222988381-223179337,chr1:222815039-223005995,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DISP1&subject=,2012-07-06T19:25:51Z,DISP1,https://search.clinicalgenome.org/kb/genes/HGNC:19711,holoprosencephaly,MONDO:0016296,https://search.clinicalgenome.org/kb/conditions/MONDO:0016296,Autosomal dominant inheritance
540,BLM,HGNC:1058,colorectal cancer,MONDO:0005575,AD,SOP11,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_37bc882f-34c6-4aea-afea-7b6f037ed9a7-2024-11-22T180000.000Z,2024-11-22T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BLM,HGNC:1058,chr15:91260577-91359396,chr15:90717346-90816166,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BLM&subject=,2022-02-09T17:20:52Z,BLM,https://search.clinicalgenome.org/kb/genes/HGNC:1058,Bloom syndrome,MONDO:0008876,https://search.clinicalgenome.org/kb/conditions/MONDO:0008876,Autosomal recessive inheritance
541,BLM,HGNC:1058,colorectal cancer,MONDO:0005575,AD,SOP11,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_37bc882f-34c6-4aea-afea-7b6f037ed9a7-2024-11-22T180000.000Z,2024-11-22T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BLM,HGNC:1058,chr15:91260577-91359396,chr15:90717346-90816166,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BLM&subject=,2022-02-09T17:20:52Z,BLM,https://search.clinicalgenome.org/kb/genes/HGNC:1058,colorectal cancer,MONDO:0005575,https://search.clinicalgenome.org/kb/conditions/MONDO:0005575,Autosomal dominant inheritance
542,ENPP1,HGNC:3356,hypopigmentation-punctate palmoplantar keratoderma syndrome,MONDO:0014227,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ed97faaf-d5ce-4da2-8367-b6fb51a57cbf-2022-06-17T040000.000Z,2022-06-17T04:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,ENPP1,HGNC:3356,chr6:132129160-132216295,chr6:131808020-131895155,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ENPP1&subject=,2016-08-22T17:48:10Z,ENPP1,https://search.clinicalgenome.org/kb/genes/HGNC:3356,hypopigmentation-punctate palmoplantar keratoderma syndrome,MONDO:0014227,https://search.clinicalgenome.org/kb/conditions/MONDO:0014227,Autosomal dominant inheritance
543,ENPP1,HGNC:3356,hypopigmentation-punctate palmoplantar keratoderma syndrome,MONDO:0014227,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ed97faaf-d5ce-4da2-8367-b6fb51a57cbf-2022-06-17T040000.000Z,2022-06-17T04:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,ENPP1,HGNC:3356,chr6:132129160-132216295,chr6:131808020-131895155,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ENPP1&subject=,2016-08-22T17:48:10Z,ENPP1,https://search.clinicalgenome.org/kb/genes/HGNC:3356,"arterial calcification, generalized, of infancy, 1",MONDO:0008817,https://search.clinicalgenome.org/kb/conditions/MONDO:0008817,Autosomal recessive inheritance
544,ENPP1,HGNC:3356,hypopigmentation-punctate palmoplantar keratoderma syndrome,MONDO:0014227,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ed97faaf-d5ce-4da2-8367-b6fb51a57cbf-2022-06-17T040000.000Z,2022-06-17T04:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,ENPP1,HGNC:3356,chr6:132129160-132216295,chr6:131808020-131895155,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ENPP1&subject=,2016-08-22T17:48:10Z,ENPP1,https://search.clinicalgenome.org/kb/genes/HGNC:3356,"hypophosphatemic rickets, autosomal recessive, 2",MONDO:0013219,https://search.clinicalgenome.org/kb/conditions/MONDO:0013219,
545,DNMT3A,HGNC:2978,Heyn-Sproul-Jackson syndrome,MONDO:0032882,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6c4959e0-72fe-49e2-8e7e-639539dc9095-2023-06-08T060000.000Z,2023-06-08T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,DNMT3A,HGNC:2978,chr2:25450743-25565459,chr2:25227874-25342590,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DNMT3A&subject=,2024-09-25T16:45:16Z,DNMT3A,https://search.clinicalgenome.org/kb/genes/HGNC:2978,Heyn-Sproul-Jackson syndrome,MONDO:0032882,https://search.clinicalgenome.org/kb/conditions/MONDO:0032882,Autosomal dominant inheritance
546,DNMT3A,HGNC:2978,Heyn-Sproul-Jackson syndrome,MONDO:0032882,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6c4959e0-72fe-49e2-8e7e-639539dc9095-2023-06-08T060000.000Z,2023-06-08T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,DNMT3A,HGNC:2978,chr2:25450743-25565459,chr2:25227874-25342590,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DNMT3A&subject=,2024-09-25T16:45:16Z,DNMT3A,https://search.clinicalgenome.org/kb/genes/HGNC:2978,Tatton-Brown-Rahman overgrowth syndrome,MONDO:0014382,https://search.clinicalgenome.org/kb/conditions/MONDO:0014382,Autosomal dominant inheritance
547,RAF1,HGNC:9829,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cda0bf05-836b-40bb-99f5-e1dbfd0f6741-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
548,RAF1,HGNC:9829,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cda0bf05-836b-40bb-99f5-e1dbfd0f6741-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
549,RAF1,HGNC:9829,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cda0bf05-836b-40bb-99f5-e1dbfd0f6741-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
550,RAF1,HGNC:9829,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cda0bf05-836b-40bb-99f5-e1dbfd0f6741-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
551,RAF1,HGNC:9829,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cda0bf05-836b-40bb-99f5-e1dbfd0f6741-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Noonan syndrome 5,MONDO:0012690,https://search.clinicalgenome.org/kb/conditions/MONDO:0012690,
552,RAF1,HGNC:9829,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67081421-a4a3-4b62-88e0-4a78d19859ba-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
553,RAF1,HGNC:9829,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67081421-a4a3-4b62-88e0-4a78d19859ba-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
554,RAF1,HGNC:9829,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67081421-a4a3-4b62-88e0-4a78d19859ba-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
555,RAF1,HGNC:9829,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67081421-a4a3-4b62-88e0-4a78d19859ba-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
556,RAF1,HGNC:9829,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67081421-a4a3-4b62-88e0-4a78d19859ba-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Noonan syndrome 5,MONDO:0012690,https://search.clinicalgenome.org/kb/conditions/MONDO:0012690,
557,RAF1,HGNC:9829,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1e7c802-14d7-435c-b396-637b728a3ae2-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
558,RAF1,HGNC:9829,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1e7c802-14d7-435c-b396-637b728a3ae2-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
559,RAF1,HGNC:9829,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1e7c802-14d7-435c-b396-637b728a3ae2-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
560,RAF1,HGNC:9829,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1e7c802-14d7-435c-b396-637b728a3ae2-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
561,RAF1,HGNC:9829,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1e7c802-14d7-435c-b396-637b728a3ae2-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RAF1,HGNC:9829,chr3:12625100-12705616,chr3:12583601-12664117,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAF1&subject=,2018-09-13T18:34:18Z,RAF1,https://search.clinicalgenome.org/kb/genes/HGNC:9829,Noonan syndrome 5,MONDO:0012690,https://search.clinicalgenome.org/kb/conditions/MONDO:0012690,
562,DMXL2,HGNC:2938,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_746b46e8-0621-4879-80a1-4fb1679975be-2020-02-06T170000.000Z,2020-02-06T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,DMXL2,HGNC:2938,chr15:51739988-51914968,chr15:51447791-51622771,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DMXL2&subject=,2012-04-04T18:52:20Z,DMXL2,https://search.clinicalgenome.org/kb/genes/HGNC:2938,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal dominant inheritance
563,MAP2K2,HGNC:6842,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a0eeefd-9105-435d-9daf-c748e52b0941-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K2,HGNC:6842,chr19:4090319-4124119,chr19:4090321-4124122,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K2&subject=,2015-05-27T22:47:25Z,MAP2K2,https://search.clinicalgenome.org/kb/genes/HGNC:6842,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
564,MAP2K2,HGNC:6842,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a0eeefd-9105-435d-9daf-c748e52b0941-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K2,HGNC:6842,chr19:4090319-4124119,chr19:4090321-4124122,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K2&subject=,2015-05-27T22:47:25Z,MAP2K2,https://search.clinicalgenome.org/kb/genes/HGNC:6842,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
565,CRIPTO,HGNC:11701,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_15231240-2c6d-44c5-9623-05127bb30b6e-2024-06-10T160000.000Z,2024-06-10T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,CRIPTO,HGNC:11701,chr3:46616025-46623947,chr3:46574535-46582457,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CRIPTO&subject=,2011-12-27T19:23:05Z,CRIPTO,https://search.clinicalgenome.org/kb/genes/HGNC:11701,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
566,COX15,HGNC:2263,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5c8d1e1-24d0-4b88-8c04-023197db14f3-2019-05-20T183321.284Z,2019-05-20T18:33:21.284Z,Mitochondrial Diseases Gene Curation Expert Panel,COX15,HGNC:2263,chr10:101454050-101491884,chr10:99694293-99732127,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COX15&subject=,2016-08-22T17:47:24Z,COX15,https://search.clinicalgenome.org/kb/genes/HGNC:2263,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
567,COX15,HGNC:2263,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5c8d1e1-24d0-4b88-8c04-023197db14f3-2019-05-20T183321.284Z,2019-05-20T18:33:21.284Z,Mitochondrial Diseases Gene Curation Expert Panel,COX15,HGNC:2263,chr10:101454050-101491884,chr10:99694293-99732127,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COX15&subject=,2016-08-22T17:47:24Z,COX15,https://search.clinicalgenome.org/kb/genes/HGNC:2263,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
568,COX15,HGNC:2263,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5c8d1e1-24d0-4b88-8c04-023197db14f3-2019-05-20T183321.284Z,2019-05-20T18:33:21.284Z,Mitochondrial Diseases Gene Curation Expert Panel,COX15,HGNC:2263,chr10:101454050-101491884,chr10:99694293-99732127,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COX15&subject=,2016-08-22T17:47:24Z,COX15,https://search.clinicalgenome.org/kb/genes/HGNC:2263,"cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2",MONDO:0014051,https://search.clinicalgenome.org/kb/conditions/MONDO:0014051,
569,CYLD,HGNC:2584,frontotemporal dementia and/or amyotrophic lateral sclerosis 8,MONDO:0030872,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e9998d4-d6e3-4bdc-8de6-038928edbb60-2023-02-23T170000.000Z,2023-02-23T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders Gene Curation Expert Panel,CYLD,HGNC:2584,chr16:50775997-50835846,chr16:50742086-50801935,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CYLD&subject=,2021-02-10T17:13:57Z,CYLD,https://search.clinicalgenome.org/kb/genes/HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,https://search.clinicalgenome.org/kb/conditions/MONDO:0011512,Autosomal dominant inheritance
570,CYLD,HGNC:2584,frontotemporal dementia and/or amyotrophic lateral sclerosis 8,MONDO:0030872,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e9998d4-d6e3-4bdc-8de6-038928edbb60-2023-02-23T170000.000Z,2023-02-23T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders Gene Curation Expert Panel,CYLD,HGNC:2584,chr16:50775997-50835846,chr16:50742086-50801935,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CYLD&subject=,2021-02-10T17:13:57Z,CYLD,https://search.clinicalgenome.org/kb/genes/HGNC:2584,frontotemporal dementia and/or amyotrophic lateral sclerosis 8,MONDO:0030872,https://search.clinicalgenome.org/kb/conditions/MONDO:0030872,Autosomal dominant inheritance
571,SMARCA4,HGNC:11100,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9866,2017-05-08T00:00:00,Colon Cancer Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,rhabdoid tumor predisposition syndrome 2,MONDO:0013224,https://search.clinicalgenome.org/kb/conditions/MONDO:0013224,Autosomal dominant inheritance
572,SMARCA4,HGNC:11100,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9866,2017-05-08T00:00:00,Colon Cancer Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,Coffin-Siris syndrome,MONDO:0015452,https://search.clinicalgenome.org/kb/conditions/MONDO:0015452,Autosomal dominant inheritance
573,SMARCA4,HGNC:11100,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9866,2017-05-08T00:00:00,Colon Cancer Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,hereditary nonpolyposis colon cancer,MONDO:0018630,https://search.clinicalgenome.org/kb/conditions/MONDO:0018630,Autosomal dominant inheritance
574,SMARCA4,HGNC:11100,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9866,2017-05-08T00:00:00,Colon Cancer Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,familial rhabdoid tumor,MONDO:0016473,https://search.clinicalgenome.org/kb/conditions/MONDO:0016473,
575,SMARCA4,HGNC:11100,Coffin-Siris syndrome,MONDO:0015452,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61d29c73-9a30-4664-9df2-2f5831219221-2020-06-17T160000.000Z,2020-06-17T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,rhabdoid tumor predisposition syndrome 2,MONDO:0013224,https://search.clinicalgenome.org/kb/conditions/MONDO:0013224,Autosomal dominant inheritance
576,SMARCA4,HGNC:11100,Coffin-Siris syndrome,MONDO:0015452,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61d29c73-9a30-4664-9df2-2f5831219221-2020-06-17T160000.000Z,2020-06-17T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,Coffin-Siris syndrome,MONDO:0015452,https://search.clinicalgenome.org/kb/conditions/MONDO:0015452,Autosomal dominant inheritance
577,SMARCA4,HGNC:11100,Coffin-Siris syndrome,MONDO:0015452,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61d29c73-9a30-4664-9df2-2f5831219221-2020-06-17T160000.000Z,2020-06-17T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,hereditary nonpolyposis colon cancer,MONDO:0018630,https://search.clinicalgenome.org/kb/conditions/MONDO:0018630,Autosomal dominant inheritance
578,SMARCA4,HGNC:11100,Coffin-Siris syndrome,MONDO:0015452,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61d29c73-9a30-4664-9df2-2f5831219221-2020-06-17T160000.000Z,2020-06-17T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,familial rhabdoid tumor,MONDO:0016473,https://search.clinicalgenome.org/kb/conditions/MONDO:0016473,
579,SMARCA4,HGNC:11100,rhabdoid tumor predisposition syndrome 2,MONDO:0013224,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5edb191-f515-47a3-b1d8-cc723eaef665-2018-06-29T160000.000Z,2018-06-29T16:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,rhabdoid tumor predisposition syndrome 2,MONDO:0013224,https://search.clinicalgenome.org/kb/conditions/MONDO:0013224,Autosomal dominant inheritance
580,SMARCA4,HGNC:11100,rhabdoid tumor predisposition syndrome 2,MONDO:0013224,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5edb191-f515-47a3-b1d8-cc723eaef665-2018-06-29T160000.000Z,2018-06-29T16:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,Coffin-Siris syndrome,MONDO:0015452,https://search.clinicalgenome.org/kb/conditions/MONDO:0015452,Autosomal dominant inheritance
581,SMARCA4,HGNC:11100,rhabdoid tumor predisposition syndrome 2,MONDO:0013224,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5edb191-f515-47a3-b1d8-cc723eaef665-2018-06-29T160000.000Z,2018-06-29T16:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,hereditary nonpolyposis colon cancer,MONDO:0018630,https://search.clinicalgenome.org/kb/conditions/MONDO:0018630,Autosomal dominant inheritance
582,SMARCA4,HGNC:11100,rhabdoid tumor predisposition syndrome 2,MONDO:0013224,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5edb191-f515-47a3-b1d8-cc723eaef665-2018-06-29T160000.000Z,2018-06-29T16:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,SMARCA4,HGNC:11100,chr19:11071706-11172949,chr19:10961030-11062273,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA4&subject=,2024-07-24T16:09:33Z,SMARCA4,https://search.clinicalgenome.org/kb/genes/HGNC:11100,familial rhabdoid tumor,MONDO:0016473,https://search.clinicalgenome.org/kb/conditions/MONDO:0016473,
583,MAP2K1,HGNC:6840,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1eafd4b1-29b1-4a17-a7ac-2c555f2e2648-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
584,MAP2K1,HGNC:6840,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1eafd4b1-29b1-4a17-a7ac-2c555f2e2648-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
585,MAP2K1,HGNC:6840,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1eafd4b1-29b1-4a17-a7ac-2c555f2e2648-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
586,MAP2K1,HGNC:6840,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1eafd4b1-29b1-4a17-a7ac-2c555f2e2648-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
587,MAP2K1,HGNC:6840,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee3071d5-ea0d-4804-ad61-3c6471f6a47e-2018-05-29T160000.000Z,2018-05-29T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
588,MAP2K1,HGNC:6840,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee3071d5-ea0d-4804-ad61-3c6471f6a47e-2018-05-29T160000.000Z,2018-05-29T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
589,MAP2K1,HGNC:6840,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee3071d5-ea0d-4804-ad61-3c6471f6a47e-2018-05-29T160000.000Z,2018-05-29T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
590,MAP2K1,HGNC:6840,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee3071d5-ea0d-4804-ad61-3c6471f6a47e-2018-05-29T160000.000Z,2018-05-29T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
591,MAP2K1,HGNC:6840,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d28301c-df25-4c10-9edb-34be26f2838d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
592,MAP2K1,HGNC:6840,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d28301c-df25-4c10-9edb-34be26f2838d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
593,MAP2K1,HGNC:6840,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d28301c-df25-4c10-9edb-34be26f2838d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
594,MAP2K1,HGNC:6840,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d28301c-df25-4c10-9edb-34be26f2838d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,MAP2K1,HGNC:6840,chr15:66679250-66783882,chr15:66386912-66491544,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAP2K1&subject=,2015-10-13T20:26:57Z,MAP2K1,https://search.clinicalgenome.org/kb/genes/HGNC:6840,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
595,DLGAP2,HGNC:2906,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efeafdd5-9105-470f-b332-8c7a3dd65078-2021-10-14T160000.000Z,2021-10-14T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,DLGAP2,HGNC:2906,chr8:687628-1656642,chr8:737628-1708476,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DLGAP2&subject=,2012-03-22T18:36:20Z,DLGAP2,https://search.clinicalgenome.org/kb/genes/HGNC:2906,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
596,ENG,HGNC:3349,juvenile polyposis syndrome,MONDO:0017380,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_08c5b377-a2a1-44ac-9b7e-dc2141ee7a04-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,ENG,HGNC:3349,chr9:130577291-130617052,chr9:127815016-127854658,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ENG&subject=,2024-01-11T16:58:06Z,ENG,https://search.clinicalgenome.org/kb/genes/HGNC:3349,"telangiectasia, hereditary hemorrhagic, type 1",MONDO:0008535,https://search.clinicalgenome.org/kb/conditions/MONDO:0008535,Autosomal dominant inheritance
597,ENG,HGNC:3349,juvenile polyposis syndrome,MONDO:0017380,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_08c5b377-a2a1-44ac-9b7e-dc2141ee7a04-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,ENG,HGNC:3349,chr9:130577291-130617052,chr9:127815016-127854658,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ENG&subject=,2024-01-11T16:58:06Z,ENG,https://search.clinicalgenome.org/kb/genes/HGNC:3349,juvenile polyposis syndrome,MONDO:0017380,https://search.clinicalgenome.org/kb/conditions/MONDO:0017380,Autosomal dominant inheritance
598,ENG,HGNC:3349,juvenile polyposis syndrome,MONDO:0017380,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_08c5b377-a2a1-44ac-9b7e-dc2141ee7a04-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,ENG,HGNC:3349,chr9:130577291-130617052,chr9:127815016-127854658,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ENG&subject=,2024-01-11T16:58:06Z,ENG,https://search.clinicalgenome.org/kb/genes/HGNC:3349,hereditary hemorrhagic telangiectasia,MONDO:0019180,https://search.clinicalgenome.org/kb/conditions/MONDO:0019180,
599,MYBPC3,HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0639d989-8415-425c-ab89-e8a3a0b6ea49-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
600,MYBPC3,HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0639d989-8415-425c-ab89-e8a3a0b6ea49-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
601,MYBPC3,HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0639d989-8415-425c-ab89-e8a3a0b6ea49-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
602,MYBPC3,HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0639d989-8415-425c-ab89-e8a3a0b6ea49-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
603,MYBPC3,HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0639d989-8415-425c-ab89-e8a3a0b6ea49-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
604,MYBPC3,HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0639d989-8415-425c-ab89-e8a3a0b6ea49-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,hypertrophic cardiomyopathy 4,MONDO:0007268,https://search.clinicalgenome.org/kb/conditions/MONDO:0007268,
605,MYBPC3,HGNC:7551,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cbe41f1-7421-4efe-ac33-6ff3fa530b43-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
606,MYBPC3,HGNC:7551,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cbe41f1-7421-4efe-ac33-6ff3fa530b43-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
607,MYBPC3,HGNC:7551,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cbe41f1-7421-4efe-ac33-6ff3fa530b43-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
608,MYBPC3,HGNC:7551,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cbe41f1-7421-4efe-ac33-6ff3fa530b43-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
609,MYBPC3,HGNC:7551,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cbe41f1-7421-4efe-ac33-6ff3fa530b43-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
610,MYBPC3,HGNC:7551,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cbe41f1-7421-4efe-ac33-6ff3fa530b43-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,hypertrophic cardiomyopathy 4,MONDO:0007268,https://search.clinicalgenome.org/kb/conditions/MONDO:0007268,
611,MYBPC3,HGNC:7551,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_652d0370-9574-450c-b7c4-eec86ade9046-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
612,MYBPC3,HGNC:7551,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_652d0370-9574-450c-b7c4-eec86ade9046-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
613,MYBPC3,HGNC:7551,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_652d0370-9574-450c-b7c4-eec86ade9046-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
614,MYBPC3,HGNC:7551,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_652d0370-9574-450c-b7c4-eec86ade9046-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
615,MYBPC3,HGNC:7551,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_652d0370-9574-450c-b7c4-eec86ade9046-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
616,MYBPC3,HGNC:7551,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_652d0370-9574-450c-b7c4-eec86ade9046-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYBPC3,HGNC:7551,chr11:47352957-47374253,chr11:47331406-47352702,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYBPC3&subject=,2023-01-10T17:17:15Z,MYBPC3,https://search.clinicalgenome.org/kb/genes/HGNC:7551,hypertrophic cardiomyopathy 4,MONDO:0007268,https://search.clinicalgenome.org/kb/conditions/MONDO:0007268,
617,MYH7,HGNC:7577,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9da50d1-a17c-4396-a6e6-632077b277b2-2024-02-12T170000.000Z,2024-02-12T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
618,MYH7,HGNC:7577,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9da50d1-a17c-4396-a6e6-632077b277b2-2024-02-12T170000.000Z,2024-02-12T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
619,MYH7,HGNC:7577,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9da50d1-a17c-4396-a6e6-632077b277b2-2024-02-12T170000.000Z,2024-02-12T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
620,MYH7,HGNC:7577,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9da50d1-a17c-4396-a6e6-632077b277b2-2024-02-12T170000.000Z,2024-02-12T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,MYH7-related skeletal myopathy,MONDO:0008050,https://search.clinicalgenome.org/kb/conditions/MONDO:0008050,Autosomal dominant inheritance
621,MYH7,HGNC:7577,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9da50d1-a17c-4396-a6e6-632077b277b2-2024-02-12T170000.000Z,2024-02-12T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
622,MYH7,HGNC:7577,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9da50d1-a17c-4396-a6e6-632077b277b2-2024-02-12T170000.000Z,2024-02-12T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
623,MYH7,HGNC:7577,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9da50d1-a17c-4396-a6e6-632077b277b2-2024-02-12T170000.000Z,2024-02-12T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,hypertrophic cardiomyopathy 1,MONDO:0008647,https://search.clinicalgenome.org/kb/conditions/MONDO:0008647,
624,MYH7,HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0265f091-a67d-4521-b6bd-5a110bd5356f-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
625,MYH7,HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0265f091-a67d-4521-b6bd-5a110bd5356f-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
626,MYH7,HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0265f091-a67d-4521-b6bd-5a110bd5356f-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
627,MYH7,HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0265f091-a67d-4521-b6bd-5a110bd5356f-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,MYH7-related skeletal myopathy,MONDO:0008050,https://search.clinicalgenome.org/kb/conditions/MONDO:0008050,Autosomal dominant inheritance
628,MYH7,HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0265f091-a67d-4521-b6bd-5a110bd5356f-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
629,MYH7,HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0265f091-a67d-4521-b6bd-5a110bd5356f-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
630,MYH7,HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0265f091-a67d-4521-b6bd-5a110bd5356f-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYH7,HGNC:7577,chr14:23881949-23904869,chr14:23412740-23435660,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH7&subject=,2015-11-16T02:00:43Z,MYH7,https://search.clinicalgenome.org/kb/genes/HGNC:7577,hypertrophic cardiomyopathy 1,MONDO:0008647,https://search.clinicalgenome.org/kb/conditions/MONDO:0008647,
631,MED13L,HGNC:22962,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9479ebdd-98ef-48d1-8026-03360c19c23f-2024-02-12T190000.000Z,2024-02-12T19:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MED13L,HGNC:22962,chr12:116396381-116715498,chr12:115958576-116277693,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MED13L&subject=,2023-08-08T16:24:06Z,MED13L,https://search.clinicalgenome.org/kb/genes/HGNC:22962,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
632,MED13L,HGNC:22962,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9479ebdd-98ef-48d1-8026-03360c19c23f-2024-02-12T190000.000Z,2024-02-12T19:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MED13L,HGNC:22962,chr12:116396381-116715498,chr12:115958576-116277693,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MED13L&subject=,2023-08-08T16:24:06Z,MED13L,https://search.clinicalgenome.org/kb/genes/HGNC:22962,syndromic intellectual disability,MONDO:0000508,https://search.clinicalgenome.org/kb/conditions/MONDO:0000508,Autosomal dominant inheritance
633,COL9A2,HGNC:2218,Stickler syndrome,MONDO:0019354,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_697ae26e-2b07-4f87-b42c-121684c89bc0-2019-02-19T170000.000Z,2019-02-19T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,COL9A2,HGNC:2218,chr1:40766161-40782958,chr1:40300489-40317286,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL9A2&subject=,2013-10-09T14:29:54Z,COL9A2,https://search.clinicalgenome.org/kb/genes/HGNC:2218,Stickler syndrome,MONDO:0019354,https://search.clinicalgenome.org/kb/conditions/MONDO:0019354,Autosomal recessive inheritance
634,DNASE1,HGNC:2956,systemic lupus erythematosus,MONDO:0007915,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b71d9246-5a7e-4e81-8fc6-925181d124cd-2024-06-14T190000.000Z,2024-06-14T19:00:00.000Z,Monogenic Systemic and Incomplete Lupus Erythematosus Gene Curation Expert Panel,DNASE1,HGNC:2956,chr16:3661761-3715462,chr16:3611760-3665461,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DNASE1&subject=,2012-02-22T14:34:39Z,DNASE1,https://search.clinicalgenome.org/kb/genes/HGNC:2956,systemic lupus erythematosus,MONDO:0007915,https://search.clinicalgenome.org/kb/conditions/MONDO:0007915,Autosomal dominant inheritance
635,MYL3,HGNC:7584,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1d5e9bf-ca57-445a-a432-27fe221484bf-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
636,MYL3,HGNC:7584,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1d5e9bf-ca57-445a-a432-27fe221484bf-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
637,MYL3,HGNC:7584,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1d5e9bf-ca57-445a-a432-27fe221484bf-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
638,MYL3,HGNC:7584,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1d5e9bf-ca57-445a-a432-27fe221484bf-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
639,MYL3,HGNC:7584,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1d5e9bf-ca57-445a-a432-27fe221484bf-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,hypertrophic cardiomyopathy 8,MONDO:0012111,https://search.clinicalgenome.org/kb/conditions/MONDO:0012111,
640,MYL3,HGNC:7584,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6fdf5074-f853-473c-bd04-2c95c172b98a-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
641,MYL3,HGNC:7584,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6fdf5074-f853-473c-bd04-2c95c172b98a-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
642,MYL3,HGNC:7584,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6fdf5074-f853-473c-bd04-2c95c172b98a-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
643,MYL3,HGNC:7584,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6fdf5074-f853-473c-bd04-2c95c172b98a-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
644,MYL3,HGNC:7584,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6fdf5074-f853-473c-bd04-2c95c172b98a-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,MYL3,HGNC:7584,chr3:46899362-46904934,chr3:46857872-46882182,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYL3&subject=,2015-11-18T20:47:37Z,MYL3,https://search.clinicalgenome.org/kb/genes/HGNC:7584,hypertrophic cardiomyopathy 8,MONDO:0012111,https://search.clinicalgenome.org/kb/conditions/MONDO:0012111,
645,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
646,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
647,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
648,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,familial long QT syndrome,MONDO:0019171,https://search.clinicalgenome.org/kb/conditions/MONDO:0019171,Autosomal dominant inheritance
649,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
650,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
651,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
652,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,
653,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,
654,SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome 3,MONDO:0011377,https://search.clinicalgenome.org/kb/conditions/MONDO:0011377,
655,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
656,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
657,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
658,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,familial long QT syndrome,MONDO:0019171,https://search.clinicalgenome.org/kb/conditions/MONDO:0019171,Autosomal dominant inheritance
659,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
660,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
661,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
662,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,
663,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,
664,SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome 3,MONDO:0011377,https://search.clinicalgenome.org/kb/conditions/MONDO:0011377,
665,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
666,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
667,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
668,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,familial long QT syndrome,MONDO:0019171,https://search.clinicalgenome.org/kb/conditions/MONDO:0019171,Autosomal dominant inheritance
669,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
670,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
671,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
672,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,
673,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,
674,SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome 3,MONDO:0011377,https://search.clinicalgenome.org/kb/conditions/MONDO:0011377,
675,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
676,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
677,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
678,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,familial long QT syndrome,MONDO:0019171,https://search.clinicalgenome.org/kb/conditions/MONDO:0019171,Autosomal dominant inheritance
679,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
680,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
681,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
682,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,
683,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,
684,SCN5A,HGNC:10593,congenital heart disease,MONDO:0005453,AD,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a89509af-a746-4913-a100-e855f4a72998-2024-12-09T170000.000Z,2024-12-09T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome 3,MONDO:0011377,https://search.clinicalgenome.org/kb/conditions/MONDO:0011377,
685,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
686,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
687,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
688,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,familial long QT syndrome,MONDO:0019171,https://search.clinicalgenome.org/kb/conditions/MONDO:0019171,Autosomal dominant inheritance
689,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
690,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
691,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
692,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,
693,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,
694,SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome 3,MONDO:0011377,https://search.clinicalgenome.org/kb/conditions/MONDO:0011377,
695,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
696,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
697,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
698,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,familial long QT syndrome,MONDO:0019171,https://search.clinicalgenome.org/kb/conditions/MONDO:0019171,Autosomal dominant inheritance
699,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
700,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
701,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
702,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,
703,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,
704,SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome Gene Curation Expert Panel,SCN5A,HGNC:10593,chr3:38589553-38691178,chr3:38548062-38649687,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN5A&subject=,2021-06-08T16:18:34Z,SCN5A,https://search.clinicalgenome.org/kb/genes/HGNC:10593,long QT syndrome 3,MONDO:0011377,https://search.clinicalgenome.org/kb/conditions/MONDO:0011377,
705,MET,HGNC:7029,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0e6f9ac-f807-48fd-a5b6-bf67c4607e14-2021-03-26T160000.000Z,2021-03-26T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,MET,HGNC:7029,chr7:116312250-116438431,chr7:116672196-116798377,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MET&subject=,2012-09-06T19:43:27Z,MET,https://search.clinicalgenome.org/kb/genes/HGNC:7029,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
706,MET,HGNC:7029,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0e6f9ac-f807-48fd-a5b6-bf67c4607e14-2021-03-26T160000.000Z,2021-03-26T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,MET,HGNC:7029,chr7:116312250-116438431,chr7:116672196-116798377,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MET&subject=,2012-09-06T19:43:27Z,MET,https://search.clinicalgenome.org/kb/genes/HGNC:7029,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
707,MET,HGNC:7029,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0e6f9ac-f807-48fd-a5b6-bf67c4607e14-2021-03-26T160000.000Z,2021-03-26T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,MET,HGNC:7029,chr7:116312250-116438431,chr7:116672196-116798377,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MET&subject=,2012-09-06T19:43:27Z,MET,https://search.clinicalgenome.org/kb/genes/HGNC:7029,papillary renal cell carcinoma,MONDO:0017884,https://search.clinicalgenome.org/kb/conditions/MONDO:0017884,Autosomal dominant inheritance
708,MET,HGNC:7029,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0e6f9ac-f807-48fd-a5b6-bf67c4607e14-2021-03-26T160000.000Z,2021-03-26T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,MET,HGNC:7029,chr7:116312250-116438431,chr7:116672196-116798377,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MET&subject=,2012-09-06T19:43:27Z,MET,https://search.clinicalgenome.org/kb/genes/HGNC:7029,hereditary papillary renal cell carcinoma,MONDO:0003789,https://search.clinicalgenome.org/kb/conditions/MONDO:0003789,
709,MET,HGNC:7029,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d55c61af-ef8e-475d-9ff7-454496cb6462-2021-01-19T170000.000Z,2021-01-19T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,MET,HGNC:7029,chr7:116312250-116438431,chr7:116672196-116798377,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MET&subject=,2012-09-06T19:43:27Z,MET,https://search.clinicalgenome.org/kb/genes/HGNC:7029,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
710,MET,HGNC:7029,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d55c61af-ef8e-475d-9ff7-454496cb6462-2021-01-19T170000.000Z,2021-01-19T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,MET,HGNC:7029,chr7:116312250-116438431,chr7:116672196-116798377,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MET&subject=,2012-09-06T19:43:27Z,MET,https://search.clinicalgenome.org/kb/genes/HGNC:7029,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
711,MET,HGNC:7029,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d55c61af-ef8e-475d-9ff7-454496cb6462-2021-01-19T170000.000Z,2021-01-19T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,MET,HGNC:7029,chr7:116312250-116438431,chr7:116672196-116798377,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MET&subject=,2012-09-06T19:43:27Z,MET,https://search.clinicalgenome.org/kb/genes/HGNC:7029,papillary renal cell carcinoma,MONDO:0017884,https://search.clinicalgenome.org/kb/conditions/MONDO:0017884,Autosomal dominant inheritance
712,MET,HGNC:7029,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d55c61af-ef8e-475d-9ff7-454496cb6462-2021-01-19T170000.000Z,2021-01-19T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,MET,HGNC:7029,chr7:116312250-116438431,chr7:116672196-116798377,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MET&subject=,2012-09-06T19:43:27Z,MET,https://search.clinicalgenome.org/kb/genes/HGNC:7029,hereditary papillary renal cell carcinoma,MONDO:0003789,https://search.clinicalgenome.org/kb/conditions/MONDO:0003789,
713,DSG2,HGNC:3049,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7df1018-593f-481f-9dd0-77ce3ea829a6-2020-08-07T160000.000Z,2020-08-07T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,DSG2,HGNC:3049,chr18:29078140-29128971,chr18:31498177-31549008,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSG2&subject=,2022-12-13T17:22:31Z,DSG2,https://search.clinicalgenome.org/kb/genes/HGNC:3049,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
714,DSG2,HGNC:3049,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7df1018-593f-481f-9dd0-77ce3ea829a6-2020-08-07T160000.000Z,2020-08-07T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,DSG2,HGNC:3049,chr18:29078140-29128971,chr18:31498177-31549008,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSG2&subject=,2022-12-13T17:22:31Z,DSG2,https://search.clinicalgenome.org/kb/genes/HGNC:3049,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
715,DSG2,HGNC:3049,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7df1018-593f-481f-9dd0-77ce3ea829a6-2020-08-07T160000.000Z,2020-08-07T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,DSG2,HGNC:3049,chr18:29078140-29128971,chr18:31498177-31549008,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSG2&subject=,2022-12-13T17:22:31Z,DSG2,https://search.clinicalgenome.org/kb/genes/HGNC:3049,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,https://search.clinicalgenome.org/kb/conditions/MONDO:0016342,
716,DSG2,HGNC:3049,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7df1018-593f-481f-9dd0-77ce3ea829a6-2020-08-07T160000.000Z,2020-08-07T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,DSG2,HGNC:3049,chr18:29078140-29128971,chr18:31498177-31549008,Emerging Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSG2&subject=,2022-12-13T17:22:31Z,DSG2,https://search.clinicalgenome.org/kb/genes/HGNC:3049,arrhythmogenic right ventricular dysplasia 10,MONDO:0012434,https://search.clinicalgenome.org/kb/conditions/MONDO:0012434,
717,CNTN4,HGNC:2174,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_716109ea-60b6-48d9-8ab7-b3883063bae0-2022-04-14T180000.000Z,2022-04-14T18:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,CNTN4,HGNC:2174,chr3:2140550-3099643,chr3:2098866-3057959,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CNTN4&subject=,2022-06-14T16:51:13Z,CNTN4,https://search.clinicalgenome.org/kb/genes/HGNC:2174,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
718,CNOT1,HGNC:7877,holoprosencephaly 12 with or without pancreatic agenesis,MONDO:0032787,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91d394c9-60fe-40cb-918b-9790a08873d9-2023-09-30T160000.000Z,2023-09-30T16:00:00.000Z,Brain Malformations Gene Curation Expert Panel,CNOT1,HGNC:7877,chr16:58553855-58663730,chr16:58519951-58629826,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CNOT1&subject=,2022-12-13T18:02:40Z,CNOT1,https://search.clinicalgenome.org/kb/genes/HGNC:7877,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
719,CNOT1,HGNC:7877,holoprosencephaly 12 with or without pancreatic agenesis,MONDO:0032787,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91d394c9-60fe-40cb-918b-9790a08873d9-2023-09-30T160000.000Z,2023-09-30T16:00:00.000Z,Brain Malformations Gene Curation Expert Panel,CNOT1,HGNC:7877,chr16:58553855-58663730,chr16:58519951-58629826,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CNOT1&subject=,2022-12-13T18:02:40Z,CNOT1,https://search.clinicalgenome.org/kb/genes/HGNC:7877,holoprosencephaly 12 with or without pancreatic agenesis,MONDO:0032787,https://search.clinicalgenome.org/kb/conditions/MONDO:0032787,Autosomal dominant inheritance
720,PSD3,HGNC:19093,antecubital pterygium syndrome,MONDO:0008339,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4845,2016-11-24T00:00:00,General Gene Curation Expert Panel,PSD3,HGNC:19093,chr8:18384813-18871213,chr8:18527303-19084805,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PSD3&subject=,2016-12-07T19:50:24Z,PSD3,https://search.clinicalgenome.org/kb/genes/HGNC:19093,antecubital pterygium syndrome,MONDO:0008339,https://search.clinicalgenome.org/kb/conditions/MONDO:0008339,Autosomal dominant inheritance
721,FANCM,HGNC:23168,hereditary breast carcinoma,MONDO:0016419,AD,SOP11,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_25744c57-8e53-403b-a2ec-fb405ad452cc-2024-11-22T180000.000Z,2024-11-22T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,FANCM,HGNC:23168,chr14:45605133-45670093,chr14:45135930-45200890,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FANCM&subject=,2024-04-09T15:53:53Z,FANCM,https://search.clinicalgenome.org/kb/genes/HGNC:23168,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
722,NOTCH1,HGNC:7881,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8269,2016-04-06T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,NOTCH1,HGNC:7881,chr9:139388885-139440500,chr9:136494433-136546048,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NOTCH1&subject=,2024-09-24T16:12:51Z,NOTCH1,https://search.clinicalgenome.org/kb/genes/HGNC:7881,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,https://search.clinicalgenome.org/kb/conditions/MONDO:0019625,Autosomal dominant inheritance
723,NOTCH1,HGNC:7881,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8269,2016-04-06T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,NOTCH1,HGNC:7881,chr9:139388885-139440500,chr9:136494433-136546048,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NOTCH1&subject=,2024-09-24T16:12:51Z,NOTCH1,https://search.clinicalgenome.org/kb/genes/HGNC:7881,Adams-Oliver syndrome 5,MONDO:0014459,https://search.clinicalgenome.org/kb/conditions/MONDO:0014459,
724,SDHD,HGNC:10683,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9010c629-a86c-4f55-a45b-212b7aabdb6f-2022-04-04T160000.000Z,2022-04-04T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,https://search.clinicalgenome.org/kb/conditions/MONDO:0017366,Autosomal dominant inheritance
725,SDHD,HGNC:10683,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9010c629-a86c-4f55-a45b-212b7aabdb6f-2022-04-04T160000.000Z,2022-04-04T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
726,SDHD,HGNC:10683,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9010c629-a86c-4f55-a45b-212b7aabdb6f-2022-04-04T160000.000Z,2022-04-04T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,paraganglioma,MONDO:0000448,https://search.clinicalgenome.org/kb/conditions/MONDO:0000448,
727,SDHD,HGNC:10683,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9010c629-a86c-4f55-a45b-212b7aabdb6f-2022-04-04T160000.000Z,2022-04-04T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,pheochromocytoma,MONDO:0008233,https://search.clinicalgenome.org/kb/conditions/MONDO:0008233,
728,SDHD,HGNC:10683,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9010c629-a86c-4f55-a45b-212b7aabdb6f-2022-04-04T160000.000Z,2022-04-04T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,paragangliomas 1,MONDO:0008192,https://search.clinicalgenome.org/kb/conditions/MONDO:0008192,
729,SDHD,HGNC:10683,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9d0b732e-81e4-4834-8fe6-fe71f694399e-2021-06-17T015316.638Z,2021-06-17T01:53:16.638Z,Hereditary Cancer Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,https://search.clinicalgenome.org/kb/conditions/MONDO:0017366,Autosomal dominant inheritance
730,SDHD,HGNC:10683,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9d0b732e-81e4-4834-8fe6-fe71f694399e-2021-06-17T015316.638Z,2021-06-17T01:53:16.638Z,Hereditary Cancer Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
731,SDHD,HGNC:10683,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9d0b732e-81e4-4834-8fe6-fe71f694399e-2021-06-17T015316.638Z,2021-06-17T01:53:16.638Z,Hereditary Cancer Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,paraganglioma,MONDO:0000448,https://search.clinicalgenome.org/kb/conditions/MONDO:0000448,
732,SDHD,HGNC:10683,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9d0b732e-81e4-4834-8fe6-fe71f694399e-2021-06-17T015316.638Z,2021-06-17T01:53:16.638Z,Hereditary Cancer Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,pheochromocytoma,MONDO:0008233,https://search.clinicalgenome.org/kb/conditions/MONDO:0008233,
733,SDHD,HGNC:10683,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9d0b732e-81e4-4834-8fe6-fe71f694399e-2021-06-17T015316.638Z,2021-06-17T01:53:16.638Z,Hereditary Cancer Gene Curation Expert Panel,SDHD,HGNC:10683,chr11:111957597-111966518,chr11:112086873-112095794,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHD&subject=,2021-08-11T16:24:55Z,SDHD,https://search.clinicalgenome.org/kb/genes/HGNC:10683,paragangliomas 1,MONDO:0008192,https://search.clinicalgenome.org/kb/conditions/MONDO:0008192,
734,COX14,HGNC:28216,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8899dbb6-9769-4d93-83fb-e95b6775962c-2022-03-21T040000.000Z,2022-03-21T04:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,COX14,HGNC:28216,chr12:50506019-50514236,chr12:50112236-50120453,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COX14&subject=,2016-08-22T17:47:23Z,COX14,https://search.clinicalgenome.org/kb/genes/HGNC:28216,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
735,COX14,HGNC:28216,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8899dbb6-9769-4d93-83fb-e95b6775962c-2022-03-21T040000.000Z,2022-03-21T04:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,COX14,HGNC:28216,chr12:50506019-50514236,chr12:50112236-50120453,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COX14&subject=,2016-08-22T17:47:23Z,COX14,https://search.clinicalgenome.org/kb/genes/HGNC:28216,cytochrome-c oxidase deficiency disease,MONDO:0009068,https://search.clinicalgenome.org/kb/conditions/MONDO:0009068,
736,MYH11,HGNC:7569,congenital heart disease,MONDO:0005453,AD,SOP11,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60bc01a5-0957-4664-bf1f-b9d7b42f5283-2024-10-15T160000.000Z,2024-10-15T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYH11,HGNC:7569,chr16:15796992-15950885,chr16:15703135-15857028,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH11&subject=,2024-09-25T18:46:31Z,MYH11,https://search.clinicalgenome.org/kb/genes/HGNC:7569,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
737,MYH11,HGNC:7569,congenital heart disease,MONDO:0005453,AD,SOP11,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60bc01a5-0957-4664-bf1f-b9d7b42f5283-2024-10-15T160000.000Z,2024-10-15T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,MYH11,HGNC:7569,chr16:15796992-15950885,chr16:15703135-15857028,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MYH11&subject=,2024-09-25T18:46:31Z,MYH11,https://search.clinicalgenome.org/kb/genes/HGNC:7569,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,https://search.clinicalgenome.org/kb/conditions/MONDO:0019625,Autosomal dominant inheritance
738,NHP2,HGNC:14377,dyskeratosis congenita,MONDO:0015780,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3201,2017-01-25T00:00:00,General Gene Curation Expert Panel,NHP2,HGNC:14377,chr5:177576464-177580886,chr5:178149463-178153885,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NHP2&subject=,2015-03-04T15:42:36Z,NHP2,https://search.clinicalgenome.org/kb/genes/HGNC:14377,dyskeratosis congenita,MONDO:0015780,https://search.clinicalgenome.org/kb/conditions/MONDO:0015780,Autosomal recessive inheritance
739,NHP2,HGNC:14377,dyskeratosis congenita,MONDO:0015780,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3201,2017-01-25T00:00:00,General Gene Curation Expert Panel,NHP2,HGNC:14377,chr5:177576464-177580886,chr5:178149463-178153885,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NHP2&subject=,2015-03-04T15:42:36Z,NHP2,https://search.clinicalgenome.org/kb/genes/HGNC:14377,"dyskeratosis congenita, autosomal recessive 2",MONDO:0013519,https://search.clinicalgenome.org/kb/conditions/MONDO:0013519,
740,ROBO1,HGNC:10249,congenital heart disease,MONDO:0005453,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a0d0c93c-abf7-4bf2-8b0f-e47cfce87656-2024-09-03T160000.000Z,2024-09-03T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,ROBO1,HGNC:10249,chr3:78646389-79817148,chr3:78597239-79767998,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ROBO1&subject=,2018-09-25T18:13:34Z,ROBO1,https://search.clinicalgenome.org/kb/genes/HGNC:10249,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance | Autosomal recessive inheritance
741,ROBO1,HGNC:10249,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef3f81f4-4b3b-40ee-af2c-8235e92e7cfb-2024-09-03T160000.000Z,2024-09-03T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,ROBO1,HGNC:10249,chr3:78646389-79817148,chr3:78597239-79767998,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ROBO1&subject=,2018-09-25T18:13:34Z,ROBO1,https://search.clinicalgenome.org/kb/genes/HGNC:10249,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance | Autosomal recessive inheritance
742,ERBB4,HGNC:3432,amyotrophic lateral sclerosis type 19,MONDO:0014223,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fdd26ab6-0c1f-4322-9f70-cad651bb789f-2021-09-30T143144.993Z,2021-09-30T14:31:44.993Z,Amyotrophic Lateral Sclerosis Spectrum Disorders Gene Curation Expert Panel,ERBB4,HGNC:3432,chr2:212240442-213403526,chr2:211375717-212538802,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ERBB4&subject=,2024-10-23T18:04:19Z,ERBB4,https://search.clinicalgenome.org/kb/genes/HGNC:3432,amyotrophic lateral sclerosis type 19,MONDO:0014223,https://search.clinicalgenome.org/kb/conditions/MONDO:0014223,Autosomal dominant inheritance
743,ERBB4,HGNC:3432,amyotrophic lateral sclerosis type 19,MONDO:0014223,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fdd26ab6-0c1f-4322-9f70-cad651bb789f-2021-09-30T143144.993Z,2021-09-30T14:31:44.993Z,Amyotrophic Lateral Sclerosis Spectrum Disorders Gene Curation Expert Panel,ERBB4,HGNC:3432,chr2:212240442-213403526,chr2:211375717-212538802,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ERBB4&subject=,2024-10-23T18:04:19Z,ERBB4,https://search.clinicalgenome.org/kb/genes/HGNC:3432,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,
744,NAT8L,HGNC:26742,N-acetylaspartate deficiency,MONDO:0013549,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_854ce0ef-7744-483d-87c7-b2dc436f9f0f-2024-03-29T160000.000Z,2024-03-29T16:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,NAT8L,HGNC:26742,chr4:2061054-2070816,chr4:2059327-2069089,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NAT8L&subject=,2016-08-22T17:50:34Z,NAT8L,https://search.clinicalgenome.org/kb/genes/HGNC:26742,N-acetylaspartate deficiency,MONDO:0013549,https://search.clinicalgenome.org/kb/conditions/MONDO:0013549,Autosomal recessive inheritance
745,GJA1,HGNC:4274,congenital heart disease,MONDO:0005453,UD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9be0581c-6ed0-4104-8da8-87b697548212-2024-06-04T160000.000Z,2024-06-04T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,GJA1,HGNC:4274,chr6:121756792-121770873,chr6:121435646-121449727,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GJA1&subject=,2013-11-20T15:13:43Z,GJA1,https://search.clinicalgenome.org/kb/genes/HGNC:4274,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal dominant inheritance
746,GJA1,HGNC:4274,congenital heart disease,MONDO:0005453,UD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9be0581c-6ed0-4104-8da8-87b697548212-2024-06-04T160000.000Z,2024-06-04T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,GJA1,HGNC:4274,chr6:121756792-121770873,chr6:121435646-121449727,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GJA1&subject=,2013-11-20T15:13:43Z,GJA1,https://search.clinicalgenome.org/kb/genes/HGNC:4274,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Mode of inheritance
747,GJA1,HGNC:4274,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e428d8c-42a2-430b-babd-8beceb26197e-2022-03-16T160000.000Z,2022-03-16T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,GJA1,HGNC:4274,chr6:121756792-121770873,chr6:121435646-121449727,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GJA1&subject=,2013-11-20T15:13:43Z,GJA1,https://search.clinicalgenome.org/kb/genes/HGNC:4274,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal dominant inheritance
748,GJA1,HGNC:4274,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e428d8c-42a2-430b-babd-8beceb26197e-2022-03-16T160000.000Z,2022-03-16T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,GJA1,HGNC:4274,chr6:121756792-121770873,chr6:121435646-121449727,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GJA1&subject=,2013-11-20T15:13:43Z,GJA1,https://search.clinicalgenome.org/kb/genes/HGNC:4274,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Mode of inheritance
749,KDM6B,HGNC:29012,syndromic intellectual disability,MONDO:0000508,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_010fe1d1-312f-45fa-93ca-887875c53607-2022-02-18T170000.000Z,2022-02-18T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,KDM6B,HGNC:29012,chr17:7737535-7758114,chr17:7834217-7854796,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KDM6B&subject=,2024-10-23T16:07:32Z,KDM6B,https://search.clinicalgenome.org/kb/genes/HGNC:29012,syndromic intellectual disability,MONDO:0000508,https://search.clinicalgenome.org/kb/conditions/MONDO:0000508,Autosomal dominant inheritance | Autosomal recessive inheritance
750,SOX9,HGNC:11204,Cooks syndrome,MONDO:0007134,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1fdeca1-a725-4ccb-a7f6-e77c2d6158aa-2020-09-16T170000.000Z,2020-09-16T17:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,SOX9,HGNC:11204,chr17:70117161-70122557,chr17:72121020-72126416,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX9&subject=,2023-05-10T16:57:49Z,SOX9,https://search.clinicalgenome.org/kb/genes/HGNC:11204,campomelic dysplasia,MONDO:0007251,https://search.clinicalgenome.org/kb/conditions/MONDO:0007251,Autosomal dominant inheritance
751,SOX9,HGNC:11204,Cooks syndrome,MONDO:0007134,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1fdeca1-a725-4ccb-a7f6-e77c2d6158aa-2020-09-16T170000.000Z,2020-09-16T17:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,SOX9,HGNC:11204,chr17:70117161-70122557,chr17:72121020-72126416,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX9&subject=,2023-05-10T16:57:49Z,SOX9,https://search.clinicalgenome.org/kb/genes/HGNC:11204,isolated Pierre-Robin syndrome,MONDO:0009869,https://search.clinicalgenome.org/kb/conditions/MONDO:0009869,Autosomal dominant inheritance
752,SOX9,HGNC:11204,Cooks syndrome,MONDO:0007134,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1fdeca1-a725-4ccb-a7f6-e77c2d6158aa-2020-09-16T170000.000Z,2020-09-16T17:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,SOX9,HGNC:11204,chr17:70117161-70122557,chr17:72121020-72126416,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX9&subject=,2023-05-10T16:57:49Z,SOX9,https://search.clinicalgenome.org/kb/genes/HGNC:11204,Cooks syndrome,MONDO:0007134,https://search.clinicalgenome.org/kb/conditions/MONDO:0007134,Autosomal dominant inheritance
753,SOX9,HGNC:11204,isolated Pierre-Robin syndrome,MONDO:0009869,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_951f7fcd-2b6a-46cd-be1d-7993ee5119c1-2024-08-06T160000.000Z,2024-08-06T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,SOX9,HGNC:11204,chr17:70117161-70122557,chr17:72121020-72126416,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX9&subject=,2023-05-10T16:57:49Z,SOX9,https://search.clinicalgenome.org/kb/genes/HGNC:11204,campomelic dysplasia,MONDO:0007251,https://search.clinicalgenome.org/kb/conditions/MONDO:0007251,Autosomal dominant inheritance
754,SOX9,HGNC:11204,isolated Pierre-Robin syndrome,MONDO:0009869,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_951f7fcd-2b6a-46cd-be1d-7993ee5119c1-2024-08-06T160000.000Z,2024-08-06T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,SOX9,HGNC:11204,chr17:70117161-70122557,chr17:72121020-72126416,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX9&subject=,2023-05-10T16:57:49Z,SOX9,https://search.clinicalgenome.org/kb/genes/HGNC:11204,isolated Pierre-Robin syndrome,MONDO:0009869,https://search.clinicalgenome.org/kb/conditions/MONDO:0009869,Autosomal dominant inheritance
755,SOX9,HGNC:11204,isolated Pierre-Robin syndrome,MONDO:0009869,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_951f7fcd-2b6a-46cd-be1d-7993ee5119c1-2024-08-06T160000.000Z,2024-08-06T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,SOX9,HGNC:11204,chr17:70117161-70122557,chr17:72121020-72126416,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX9&subject=,2023-05-10T16:57:49Z,SOX9,https://search.clinicalgenome.org/kb/genes/HGNC:11204,Cooks syndrome,MONDO:0007134,https://search.clinicalgenome.org/kb/conditions/MONDO:0007134,Autosomal dominant inheritance
756,SOX9,HGNC:11204,campomelic dysplasia,MONDO:0007251,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca6e2118-28d5-4a6f-8333-ee30994d41cd-2020-06-01T170000.000Z,2020-06-01T17:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,SOX9,HGNC:11204,chr17:70117161-70122557,chr17:72121020-72126416,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX9&subject=,2023-05-10T16:57:49Z,SOX9,https://search.clinicalgenome.org/kb/genes/HGNC:11204,campomelic dysplasia,MONDO:0007251,https://search.clinicalgenome.org/kb/conditions/MONDO:0007251,Autosomal dominant inheritance
757,SOX9,HGNC:11204,campomelic dysplasia,MONDO:0007251,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca6e2118-28d5-4a6f-8333-ee30994d41cd-2020-06-01T170000.000Z,2020-06-01T17:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,SOX9,HGNC:11204,chr17:70117161-70122557,chr17:72121020-72126416,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX9&subject=,2023-05-10T16:57:49Z,SOX9,https://search.clinicalgenome.org/kb/genes/HGNC:11204,isolated Pierre-Robin syndrome,MONDO:0009869,https://search.clinicalgenome.org/kb/conditions/MONDO:0009869,Autosomal dominant inheritance
758,SOX9,HGNC:11204,campomelic dysplasia,MONDO:0007251,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca6e2118-28d5-4a6f-8333-ee30994d41cd-2020-06-01T170000.000Z,2020-06-01T17:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,SOX9,HGNC:11204,chr17:70117161-70122557,chr17:72121020-72126416,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX9&subject=,2023-05-10T16:57:49Z,SOX9,https://search.clinicalgenome.org/kb/genes/HGNC:11204,Cooks syndrome,MONDO:0007134,https://search.clinicalgenome.org/kb/conditions/MONDO:0007134,Autosomal dominant inheritance
759,USH1C,HGNC:12597,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4194490-1b41-4d6d-be63-4a2a8827bb85-2018-06-11T040000.000Z,2018-06-11T04:00:00.000Z,Hearing Loss Gene Curation Expert Panel,USH1C,HGNC:12597,chr11:17515447-17565963,chr11:17493900-17544416,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=USH1C&subject=,2012-04-07T10:34:31Z,USH1C,https://search.clinicalgenome.org/kb/genes/HGNC:12597,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
760,USH1C,HGNC:12597,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4194490-1b41-4d6d-be63-4a2a8827bb85-2018-06-11T040000.000Z,2018-06-11T04:00:00.000Z,Hearing Loss Gene Curation Expert Panel,USH1C,HGNC:12597,chr11:17515447-17565963,chr11:17493900-17544416,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=USH1C&subject=,2012-04-07T10:34:31Z,USH1C,https://search.clinicalgenome.org/kb/genes/HGNC:12597,Usher syndrome type 1,MONDO:0010168,https://search.clinicalgenome.org/kb/conditions/MONDO:0010168,Autosomal recessive inheritance
761,USH1C,HGNC:12597,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4194490-1b41-4d6d-be63-4a2a8827bb85-2018-06-11T040000.000Z,2018-06-11T04:00:00.000Z,Hearing Loss Gene Curation Expert Panel,USH1C,HGNC:12597,chr11:17515447-17565963,chr11:17493900-17544416,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=USH1C&subject=,2012-04-07T10:34:31Z,USH1C,https://search.clinicalgenome.org/kb/genes/HGNC:12597,Usher syndrome type 1C,MONDO:0010171,https://search.clinicalgenome.org/kb/conditions/MONDO:0010171,
762,OTUD7A,HGNC:20718,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7d6ba704-2333-4f70-9f74-54dfea711e5b-2023-06-06T190000.000Z,2023-06-06T19:00:00.000Z,Epilepsy Gene Curation Expert Panel,OTUD7A,HGNC:20718,chr15:31767601-32162876,chr15:31475398-31870673,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=OTUD7A&subject=,2018-04-27T23:05:24Z,OTUD7A,https://search.clinicalgenome.org/kb/genes/HGNC:20718,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal recessive inheritance
763,ATP6V1E1,HGNC:857,autosomal recessive cutis laxa type 2C,MONDO:0027462,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d86dbf9e-ebed-446b-8291-e5838e37fd06-2024-05-01T160000.000Z,2024-05-01T16:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,ATP6V1E1,HGNC:857,chr22:18074902-18111588,chr22:17592136-17628822,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ATP6V1E1&subject=,2012-04-26T22:40:17Z,ATP6V1E1,https://search.clinicalgenome.org/kb/genes/HGNC:857,autosomal recessive cutis laxa type 2C,MONDO:0027462,https://search.clinicalgenome.org/kb/conditions/MONDO:0027462,Autosomal recessive inheritance
764,VEGFA,HGNC:12680,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bd2d1e9f-ef0b-4294-8f70-2ed0ab594332-2024-05-07T160000.000Z,2024-05-07T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,VEGFA,HGNC:12680,chr6:43737946-43754224,chr6:43770211-43786487,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=VEGFA&subject=,2023-08-23T16:31:04Z,VEGFA,https://search.clinicalgenome.org/kb/genes/HGNC:12680,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
765,ATPAF2,HGNC:18802,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfb2ce05-0eb4-4b98-95e5-e01cac3131ac-2022-04-04T040000.000Z,2022-04-04T04:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,ATPAF2,HGNC:18802,chr17:17921335-17942482,chr17:18015059-18039168,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ATPAF2&subject=,2016-08-22T17:46:17Z,ATPAF2,https://search.clinicalgenome.org/kb/genes/HGNC:18802,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
766,ATPAF2,HGNC:18802,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfb2ce05-0eb4-4b98-95e5-e01cac3131ac-2022-04-04T040000.000Z,2022-04-04T04:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,ATPAF2,HGNC:18802,chr17:17921335-17942482,chr17:18015059-18039168,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ATPAF2&subject=,2016-08-22T17:46:17Z,ATPAF2,https://search.clinicalgenome.org/kb/genes/HGNC:18802,"mitochondrial complex V (ATP synthase) deficiency, nuclear type 1",MONDO:0011421,https://search.clinicalgenome.org/kb/conditions/MONDO:0011421,
767,SOBP,HGNC:29256,syndromic intellectual disability,MONDO:0000508,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3edc996d-92e2-4556-947e-5a298cf1341d-2022-10-18T063000.000Z,2022-10-18T06:30:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SOBP,HGNC:29256,chr6:107811321-107982510,chr6:107490117-107661306,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOBP&subject=,2016-08-22T17:52:30Z,SOBP,https://search.clinicalgenome.org/kb/genes/HGNC:29256,syndromic intellectual disability,MONDO:0000508,https://search.clinicalgenome.org/kb/conditions/MONDO:0000508,Autosomal recessive inheritance
768,SOBP,HGNC:29256,syndromic intellectual disability,MONDO:0000508,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3edc996d-92e2-4556-947e-5a298cf1341d-2022-10-18T063000.000Z,2022-10-18T06:30:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SOBP,HGNC:29256,chr6:107811321-107982510,chr6:107490117-107661306,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOBP&subject=,2016-08-22T17:52:30Z,SOBP,https://search.clinicalgenome.org/kb/genes/HGNC:29256,"intellectual disability, anterior maxillary protrusion, and strabismus",MONDO:0013353,https://search.clinicalgenome.org/kb/conditions/MONDO:0013353,
769,RAD51C,HGNC:9820,Fanconi anemia complementation group O,MONDO:0013248,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea7ea36f-955c-4478-b5f6-12ff0a0dbf0b-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51C,HGNC:9820,chr17:56769934-56812972,chr17:58692573-58735611,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51C&subject=,2020-07-08T16:34:36Z,RAD51C,https://search.clinicalgenome.org/kb/genes/HGNC:9820,RAD51C-related cancer predisposition,MONDO:0700273,https://search.clinicalgenome.org/kb/conditions/MONDO:0700273,Autosomal dominant inheritance
770,RAD51C,HGNC:9820,Fanconi anemia complementation group O,MONDO:0013248,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea7ea36f-955c-4478-b5f6-12ff0a0dbf0b-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51C,HGNC:9820,chr17:56769934-56812972,chr17:58692573-58735611,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51C&subject=,2020-07-08T16:34:36Z,RAD51C,https://search.clinicalgenome.org/kb/genes/HGNC:9820,Fanconi anemia complementation group O,MONDO:0013248,https://search.clinicalgenome.org/kb/conditions/MONDO:0013248,Autosomal recessive inheritance
771,RAD51C,HGNC:9820,Fanconi anemia complementation group O,MONDO:0013248,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea7ea36f-955c-4478-b5f6-12ff0a0dbf0b-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51C,HGNC:9820,chr17:56769934-56812972,chr17:58692573-58735611,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51C&subject=,2020-07-08T16:34:36Z,RAD51C,https://search.clinicalgenome.org/kb/genes/HGNC:9820,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,
772,RAD51C,HGNC:9820,Fanconi anemia complementation group O,MONDO:0013248,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea7ea36f-955c-4478-b5f6-12ff0a0dbf0b-2023-12-20T180000.000Z,2023-12-20T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51C,HGNC:9820,chr17:56769934-56812972,chr17:58692573-58735611,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51C&subject=,2020-07-08T16:34:36Z,RAD51C,https://search.clinicalgenome.org/kb/genes/HGNC:9820,"breast-ovarian cancer, familial, susceptibility to, 3",MONDO:0013253,https://search.clinicalgenome.org/kb/conditions/MONDO:0013253,
773,RAD51C,HGNC:9820,RAD51C-related cancer predisposition,MONDO:0700273,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31cb27be-dd32-4bb7-86bd-43c4b1eabaf5-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51C,HGNC:9820,chr17:56769934-56812972,chr17:58692573-58735611,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51C&subject=,2020-07-08T16:34:36Z,RAD51C,https://search.clinicalgenome.org/kb/genes/HGNC:9820,RAD51C-related cancer predisposition,MONDO:0700273,https://search.clinicalgenome.org/kb/conditions/MONDO:0700273,Autosomal dominant inheritance
774,RAD51C,HGNC:9820,RAD51C-related cancer predisposition,MONDO:0700273,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31cb27be-dd32-4bb7-86bd-43c4b1eabaf5-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51C,HGNC:9820,chr17:56769934-56812972,chr17:58692573-58735611,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51C&subject=,2020-07-08T16:34:36Z,RAD51C,https://search.clinicalgenome.org/kb/genes/HGNC:9820,Fanconi anemia complementation group O,MONDO:0013248,https://search.clinicalgenome.org/kb/conditions/MONDO:0013248,Autosomal recessive inheritance
775,RAD51C,HGNC:9820,RAD51C-related cancer predisposition,MONDO:0700273,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31cb27be-dd32-4bb7-86bd-43c4b1eabaf5-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51C,HGNC:9820,chr17:56769934-56812972,chr17:58692573-58735611,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51C&subject=,2020-07-08T16:34:36Z,RAD51C,https://search.clinicalgenome.org/kb/genes/HGNC:9820,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,
776,RAD51C,HGNC:9820,RAD51C-related cancer predisposition,MONDO:0700273,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31cb27be-dd32-4bb7-86bd-43c4b1eabaf5-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51C,HGNC:9820,chr17:56769934-56812972,chr17:58692573-58735611,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51C&subject=,2020-07-08T16:34:36Z,RAD51C,https://search.clinicalgenome.org/kb/genes/HGNC:9820,"breast-ovarian cancer, familial, susceptibility to, 3",MONDO:0013253,https://search.clinicalgenome.org/kb/conditions/MONDO:0013253,
777,NR3C2,HGNC:7979,pseudohyperaldosteronism type 2,MONDO:0011517,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_26410755-d552-4111-9f23-14dbeaa99293-2021-07-15T023000.000Z,2021-07-15T02:30:00.000Z,Tubulopathy Gene Curation Expert Panel,NR3C2,HGNC:7979,chr4:148999915-149365850,chr4:148078764-148445508,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NR3C2&subject=,2020-04-06T20:05:17Z,NR3C2,https://search.clinicalgenome.org/kb/genes/HGNC:7979,autosomal dominant pseudohypoaldosteronism type 1,MONDO:0008329,https://search.clinicalgenome.org/kb/conditions/MONDO:0008329,Autosomal dominant inheritance
778,NR3C2,HGNC:7979,pseudohyperaldosteronism type 2,MONDO:0011517,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_26410755-d552-4111-9f23-14dbeaa99293-2021-07-15T023000.000Z,2021-07-15T02:30:00.000Z,Tubulopathy Gene Curation Expert Panel,NR3C2,HGNC:7979,chr4:148999915-149365850,chr4:148078764-148445508,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NR3C2&subject=,2020-04-06T20:05:17Z,NR3C2,https://search.clinicalgenome.org/kb/genes/HGNC:7979,pseudohyperaldosteronism type 2,MONDO:0011517,https://search.clinicalgenome.org/kb/conditions/MONDO:0011517,Autosomal dominant inheritance
779,LMNA,HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef503af9-9d10-4714-848b-34cfa0049c23-2019-09-06T160000.000Z,2019-09-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,LMNA,HGNC:6636,chr1:156052364-156109872,chr1:156082573-156140081,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LMNA&subject=,2023-12-14T19:32:36Z,LMNA,https://search.clinicalgenome.org/kb/genes/HGNC:6636,lipodystrophy,MONDO:0006573,https://search.clinicalgenome.org/kb/conditions/MONDO:0006573,Semidominant inheritance
780,LMNA,HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef503af9-9d10-4714-848b-34cfa0049c23-2019-09-06T160000.000Z,2019-09-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,LMNA,HGNC:6636,chr1:156052364-156109872,chr1:156082573-156140081,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LMNA&subject=,2023-12-14T19:32:36Z,LMNA,https://search.clinicalgenome.org/kb/genes/HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
781,LMNA,HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef503af9-9d10-4714-848b-34cfa0049c23-2019-09-06T160000.000Z,2019-09-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,LMNA,HGNC:6636,chr1:156052364-156109872,chr1:156082573-156140081,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LMNA&subject=,2023-12-14T19:32:36Z,LMNA,https://search.clinicalgenome.org/kb/genes/HGNC:6636,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
782,LMNA,HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef503af9-9d10-4714-848b-34cfa0049c23-2019-09-06T160000.000Z,2019-09-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,LMNA,HGNC:6636,chr1:156052364-156109872,chr1:156082573-156140081,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LMNA&subject=,2023-12-14T19:32:36Z,LMNA,https://search.clinicalgenome.org/kb/genes/HGNC:6636,dilated cardiomyopathy 1A,MONDO:0007269,https://search.clinicalgenome.org/kb/conditions/MONDO:0007269,
783,LMNA,HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef503af9-9d10-4714-848b-34cfa0049c23-2019-09-06T160000.000Z,2019-09-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,LMNA,HGNC:6636,chr1:156052364-156109872,chr1:156082573-156140081,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LMNA&subject=,2023-12-14T19:32:36Z,LMNA,https://search.clinicalgenome.org/kb/genes/HGNC:6636,autosomal dominant Emery-Dreifuss muscular dystrophy,MONDO:0020336,https://search.clinicalgenome.org/kb/conditions/MONDO:0020336,
784,LMNA,HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef503af9-9d10-4714-848b-34cfa0049c23-2019-09-06T160000.000Z,2019-09-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,LMNA,HGNC:6636,chr1:156052364-156109872,chr1:156082573-156140081,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LMNA&subject=,2023-12-14T19:32:36Z,LMNA,https://search.clinicalgenome.org/kb/genes/HGNC:6636,"Emery-Dreifuss muscular dystrophy 2, autosomal dominant",MONDO:0021569,https://search.clinicalgenome.org/kb/conditions/MONDO:0021569,
785,LMNA,HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef503af9-9d10-4714-848b-34cfa0049c23-2019-09-06T160000.000Z,2019-09-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,LMNA,HGNC:6636,chr1:156052364-156109872,chr1:156082573-156140081,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=LMNA&subject=,2023-12-14T19:32:36Z,LMNA,https://search.clinicalgenome.org/kb/genes/HGNC:6636,Emery-Dreifuss muscular dystrophy,MONDO:0016830,https://search.clinicalgenome.org/kb/conditions/MONDO:0016830,
786,BCS1L,HGNC:1020,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b50d7db-1144-4187-a60c-72b45adb80bd-2019-09-19T155315.896Z,2019-09-19T15:53:15.896Z,Mitochondrial Diseases Gene Curation Expert Panel,BCS1L,HGNC:1020,chr2:219524406-219528166,chr2:218658743-218663443,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BCS1L&subject=,2016-08-22T17:46:28Z,BCS1L,https://search.clinicalgenome.org/kb/genes/HGNC:1020,Bjornstad syndrome,MONDO:0009872,https://search.clinicalgenome.org/kb/conditions/MONDO:0009872,Autosomal recessive inheritance
787,BCS1L,HGNC:1020,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b50d7db-1144-4187-a60c-72b45adb80bd-2019-09-19T155315.896Z,2019-09-19T15:53:15.896Z,Mitochondrial Diseases Gene Curation Expert Panel,BCS1L,HGNC:1020,chr2:219524406-219528166,chr2:218658743-218663443,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BCS1L&subject=,2016-08-22T17:46:28Z,BCS1L,https://search.clinicalgenome.org/kb/genes/HGNC:1020,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
788,PRPS1,HGNC:9462,phosphoribosylpyrophosphate synthetase superactivity,MONDO:0010395,XL,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76dc3f8d-e1c9-4506-9381-d2b5ab3df300-2020-02-14T170000.000Z,2020-02-14T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,PRPS1,HGNC:9462,chrX:106871740-106894256,chrX:107628510-107651026,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRPS1&subject=,2012-05-17T19:10:54Z,PRPS1,https://search.clinicalgenome.org/kb/genes/HGNC:9462,PRPS1 deficiency disorder,MONDO:0100061,https://search.clinicalgenome.org/kb/conditions/MONDO:0100061,X-linked inheritance
789,PRPS1,HGNC:9462,phosphoribosylpyrophosphate synthetase superactivity,MONDO:0010395,XL,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76dc3f8d-e1c9-4506-9381-d2b5ab3df300-2020-02-14T170000.000Z,2020-02-14T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,PRPS1,HGNC:9462,chrX:106871740-106894256,chrX:107628510-107651026,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRPS1&subject=,2012-05-17T19:10:54Z,PRPS1,https://search.clinicalgenome.org/kb/genes/HGNC:9462,phosphoribosylpyrophosphate synthetase superactivity,MONDO:0010395,https://search.clinicalgenome.org/kb/conditions/MONDO:0010395,X-linked inheritance
790,PRPS1,HGNC:9462,PRPS1 deficiency disorder,MONDO:0100061,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9416f6e2-8de3-48b0-9a1c-9bd11a59315c-2020-02-14T170000.000Z,2020-02-14T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,PRPS1,HGNC:9462,chrX:106871740-106894256,chrX:107628510-107651026,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRPS1&subject=,2012-05-17T19:10:54Z,PRPS1,https://search.clinicalgenome.org/kb/genes/HGNC:9462,PRPS1 deficiency disorder,MONDO:0100061,https://search.clinicalgenome.org/kb/conditions/MONDO:0100061,X-linked inheritance
791,PRPS1,HGNC:9462,PRPS1 deficiency disorder,MONDO:0100061,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9416f6e2-8de3-48b0-9a1c-9bd11a59315c-2020-02-14T170000.000Z,2020-02-14T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,PRPS1,HGNC:9462,chrX:106871740-106894256,chrX:107628510-107651026,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRPS1&subject=,2012-05-17T19:10:54Z,PRPS1,https://search.clinicalgenome.org/kb/genes/HGNC:9462,phosphoribosylpyrophosphate synthetase superactivity,MONDO:0010395,https://search.clinicalgenome.org/kb/conditions/MONDO:0010395,X-linked inheritance
792,BMPR2,HGNC:1078,congenital heart disease,MONDO:0005453,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b4322da-10a2-46c4-be0c-b5163ab5f401-2023-09-18T160000.000Z,2023-09-18T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,BMPR2,HGNC:1078,chr2:203241050-203432472,chr2:202376327-202567749,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BMPR2&subject=,2020-08-26T16:19:41Z,BMPR2,https://search.clinicalgenome.org/kb/genes/HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,https://search.clinicalgenome.org/kb/conditions/MONDO:0015924,Autosomal dominant inheritance
793,BMPR2,HGNC:1078,congenital heart disease,MONDO:0005453,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b4322da-10a2-46c4-be0c-b5163ab5f401-2023-09-18T160000.000Z,2023-09-18T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,BMPR2,HGNC:1078,chr2:203241050-203432472,chr2:202376327-202567749,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BMPR2&subject=,2020-08-26T16:19:41Z,BMPR2,https://search.clinicalgenome.org/kb/genes/HGNC:1078,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
794,BMPR2,HGNC:1078,congenital heart disease,MONDO:0005453,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b4322da-10a2-46c4-be0c-b5163ab5f401-2023-09-18T160000.000Z,2023-09-18T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,BMPR2,HGNC:1078,chr2:203241050-203432472,chr2:202376327-202567749,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BMPR2&subject=,2020-08-26T16:19:41Z,BMPR2,https://search.clinicalgenome.org/kb/genes/HGNC:1078,"pulmonary hypertension, primary, 1",MONDO:0024533,https://search.clinicalgenome.org/kb/conditions/MONDO:0024533,
795,BMPR2,HGNC:1078,congenital heart disease,MONDO:0005453,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b4322da-10a2-46c4-be0c-b5163ab5f401-2023-09-18T160000.000Z,2023-09-18T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,BMPR2,HGNC:1078,chr2:203241050-203432472,chr2:202376327-202567749,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BMPR2&subject=,2020-08-26T16:19:41Z,BMPR2,https://search.clinicalgenome.org/kb/genes/HGNC:1078,primary pulmonary hypertension,MONDO:0001999,https://search.clinicalgenome.org/kb/conditions/MONDO:0001999,
796,BMPR2,HGNC:1078,congenital heart disease,MONDO:0005453,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b4322da-10a2-46c4-be0c-b5163ab5f401-2023-09-18T160000.000Z,2023-09-18T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,BMPR2,HGNC:1078,chr2:203241050-203432472,chr2:202376327-202567749,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BMPR2&subject=,2020-08-26T16:19:41Z,BMPR2,https://search.clinicalgenome.org/kb/genes/HGNC:1078,obsolete idiopathic and/or familial pulmonary arterial hypertension,MONDO:0008347,https://search.clinicalgenome.org/kb/conditions/MONDO:0008347,
797,HBA2,HGNC:4824,"erythrocytosis, familial, 7",MONDO:0054802,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6cd38d93-3dc1-429c-8f82-2269647f6bb5-2023-10-25T160000.000Z,2023-10-25T16:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,alpha thalassemia spectrum,MONDO:0011399,https://search.clinicalgenome.org/kb/conditions/MONDO:0011399,Autosomal recessive inheritance
798,HBA2,HGNC:4824,"erythrocytosis, familial, 7",MONDO:0054802,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6cd38d93-3dc1-429c-8f82-2269647f6bb5-2023-10-25T160000.000Z,2023-10-25T16:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,"methemoglobinemia, alpha type",MONDO:0020835,https://search.clinicalgenome.org/kb/conditions/MONDO:0020835,Autosomal dominant inheritance
799,HBA2,HGNC:4824,"erythrocytosis, familial, 7",MONDO:0054802,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6cd38d93-3dc1-429c-8f82-2269647f6bb5-2023-10-25T160000.000Z,2023-10-25T16:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,"erythrocytosis, familial, 7",MONDO:0054802,https://search.clinicalgenome.org/kb/conditions/MONDO:0054802,Autosomal dominant inheritance
800,HBA2,HGNC:4824,"erythrocytosis, familial, 7",MONDO:0054802,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6cd38d93-3dc1-429c-8f82-2269647f6bb5-2023-10-25T160000.000Z,2023-10-25T16:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,unstable hemoglobin disease,MONDO:0020459,https://search.clinicalgenome.org/kb/conditions/MONDO:0020459,Autosomal dominant inheritance
801,HBA2,HGNC:4824,unstable hemoglobin disease,MONDO:0020459,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9ad31fe-ded5-4f1f-a8b4-f2d9a8e47b35-2024-02-28T170000.000Z,2024-02-28T17:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,alpha thalassemia spectrum,MONDO:0011399,https://search.clinicalgenome.org/kb/conditions/MONDO:0011399,Autosomal recessive inheritance
802,HBA2,HGNC:4824,unstable hemoglobin disease,MONDO:0020459,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9ad31fe-ded5-4f1f-a8b4-f2d9a8e47b35-2024-02-28T170000.000Z,2024-02-28T17:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,"methemoglobinemia, alpha type",MONDO:0020835,https://search.clinicalgenome.org/kb/conditions/MONDO:0020835,Autosomal dominant inheritance
803,HBA2,HGNC:4824,unstable hemoglobin disease,MONDO:0020459,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9ad31fe-ded5-4f1f-a8b4-f2d9a8e47b35-2024-02-28T170000.000Z,2024-02-28T17:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,"erythrocytosis, familial, 7",MONDO:0054802,https://search.clinicalgenome.org/kb/conditions/MONDO:0054802,Autosomal dominant inheritance
804,HBA2,HGNC:4824,unstable hemoglobin disease,MONDO:0020459,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9ad31fe-ded5-4f1f-a8b4-f2d9a8e47b35-2024-02-28T170000.000Z,2024-02-28T17:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,unstable hemoglobin disease,MONDO:0020459,https://search.clinicalgenome.org/kb/conditions/MONDO:0020459,Autosomal dominant inheritance
805,HBA2,HGNC:4824,"methemoglobinemia, alpha type",MONDO:0020835,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12bfc99c-f8d8-4045-98ba-17254b56decc-2024-03-28T160000.000Z,2024-03-28T16:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,alpha thalassemia spectrum,MONDO:0011399,https://search.clinicalgenome.org/kb/conditions/MONDO:0011399,Autosomal recessive inheritance
806,HBA2,HGNC:4824,"methemoglobinemia, alpha type",MONDO:0020835,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12bfc99c-f8d8-4045-98ba-17254b56decc-2024-03-28T160000.000Z,2024-03-28T16:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,"methemoglobinemia, alpha type",MONDO:0020835,https://search.clinicalgenome.org/kb/conditions/MONDO:0020835,Autosomal dominant inheritance
807,HBA2,HGNC:4824,"methemoglobinemia, alpha type",MONDO:0020835,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12bfc99c-f8d8-4045-98ba-17254b56decc-2024-03-28T160000.000Z,2024-03-28T16:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,"erythrocytosis, familial, 7",MONDO:0054802,https://search.clinicalgenome.org/kb/conditions/MONDO:0054802,Autosomal dominant inheritance
808,HBA2,HGNC:4824,"methemoglobinemia, alpha type",MONDO:0020835,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12bfc99c-f8d8-4045-98ba-17254b56decc-2024-03-28T160000.000Z,2024-03-28T16:00:00.000Z,General Gene Curation Expert Panel,HBA2,HGNC:4824,chr16:222875-223709,chr16:172876-173710,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HBA2&subject=,2012-07-06T20:43:01Z,HBA2,https://search.clinicalgenome.org/kb/genes/HGNC:4824,unstable hemoglobin disease,MONDO:0020459,https://search.clinicalgenome.org/kb/conditions/MONDO:0020459,Autosomal dominant inheritance
809,TCIRG1,HGNC:11647,dysosteosclerosis,MONDO:0009138,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_510894e0-bd9e-4929-aae1-ac548138ab6c-2023-12-04T170000.000Z,2023-12-04T17:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,TCIRG1,HGNC:11647,chr11:67806492-67818362,chr11:68039025-68053762,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCIRG1&subject=,2016-08-22T17:52:44Z,TCIRG1,https://search.clinicalgenome.org/kb/genes/HGNC:11647,autosomal recessive osteopetrosis 1,MONDO:0009815,https://search.clinicalgenome.org/kb/conditions/MONDO:0009815,Autosomal recessive inheritance
810,TCIRG1,HGNC:11647,dysosteosclerosis,MONDO:0009138,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_510894e0-bd9e-4929-aae1-ac548138ab6c-2023-12-04T170000.000Z,2023-12-04T17:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,TCIRG1,HGNC:11647,chr11:67806492-67818362,chr11:68039025-68053762,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCIRG1&subject=,2016-08-22T17:52:44Z,TCIRG1,https://search.clinicalgenome.org/kb/genes/HGNC:11647,dysosteosclerosis,MONDO:0009138,https://search.clinicalgenome.org/kb/conditions/MONDO:0009138,Autosomal recessive inheritance
811,TCIRG1,HGNC:11647,autosomal recessive osteopetrosis 1,MONDO:0009815,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ac31a88-733f-4783-bfb7-8eecba7a70f1-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,TCIRG1,HGNC:11647,chr11:67806492-67818362,chr11:68039025-68053762,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCIRG1&subject=,2016-08-22T17:52:44Z,TCIRG1,https://search.clinicalgenome.org/kb/genes/HGNC:11647,autosomal recessive osteopetrosis 1,MONDO:0009815,https://search.clinicalgenome.org/kb/conditions/MONDO:0009815,Autosomal recessive inheritance
812,TCIRG1,HGNC:11647,autosomal recessive osteopetrosis 1,MONDO:0009815,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ac31a88-733f-4783-bfb7-8eecba7a70f1-2023-09-28T160000.000Z,2023-09-28T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,TCIRG1,HGNC:11647,chr11:67806492-67818362,chr11:68039025-68053762,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCIRG1&subject=,2016-08-22T17:52:44Z,TCIRG1,https://search.clinicalgenome.org/kb/genes/HGNC:11647,dysosteosclerosis,MONDO:0009138,https://search.clinicalgenome.org/kb/conditions/MONDO:0009138,Autosomal recessive inheritance
813,PIGW,HGNC:23213,hyperphosphatasia with intellectual disability syndrome 5,MONDO:0014457,AR,SOP11,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7e3ea0a-9e1b-4e4b-8c23-a9062a5535b7-2025-02-21T170000.000Z,2025-02-21T17:00:00.000Z,Congenital Disorders of Glycosylation Gene Curation Expert Panel,PIGW,HGNC:23213,chr17:34890814-34895152,chr17:36534987-36539303,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PIGW&subject=,2016-08-22T17:51:23Z,PIGW,https://search.clinicalgenome.org/kb/genes/HGNC:23213,hyperphosphatasia with intellectual disability syndrome 5,MONDO:0014457,https://search.clinicalgenome.org/kb/conditions/MONDO:0014457,Autosomal recessive inheritance
814,TNNT1,HGNC:11948,nemaline myopathy,MONDO:0018958,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5e1f9d1-b21e-46f6-94ce-10cb551ea92a-2020-06-22T141002.152Z,2020-06-22T14:10:02.152Z,Congenital Myopathies Gene Curation Expert Panel,TNNT1,HGNC:11948,chr19:55644066-55660574,chr19:55132698-55149206,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNT1&subject=,2016-08-22T17:52:56Z,TNNT1,https://search.clinicalgenome.org/kb/genes/HGNC:11948,nemaline myopathy 5,MONDO:0011539,https://search.clinicalgenome.org/kb/conditions/MONDO:0011539,Autosomal recessive inheritance
815,TNNT1,HGNC:11948,nemaline myopathy,MONDO:0018958,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5e1f9d1-b21e-46f6-94ce-10cb551ea92a-2020-06-22T141002.152Z,2020-06-22T14:10:02.152Z,Congenital Myopathies Gene Curation Expert Panel,TNNT1,HGNC:11948,chr19:55644066-55660574,chr19:55132698-55149206,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TNNT1&subject=,2016-08-22T17:52:56Z,TNNT1,https://search.clinicalgenome.org/kb/genes/HGNC:11948,nemaline myopathy,MONDO:0018958,https://search.clinicalgenome.org/kb/conditions/MONDO:0018958,Autosomal dominant inheritance
816,KARS1,HGNC:6215,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5239ac3-1506-4b0e-9055-632ba895ca0c-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,KARS1,HGNC:6215,chr16:75661622-75681563,chr16:75627724-75647665,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KARS1&subject=,2016-08-22T17:49:40Z,KARS1,https://search.clinicalgenome.org/kb/genes/HGNC:6215,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
817,KARS1,HGNC:6215,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5239ac3-1506-4b0e-9055-632ba895ca0c-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,KARS1,HGNC:6215,chr16:75661622-75681563,chr16:75627724-75647665,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KARS1&subject=,2016-08-22T17:49:40Z,KARS1,https://search.clinicalgenome.org/kb/genes/HGNC:6215,autosomal recessive nonsyndromic hearing loss 89,MONDO:0013489,https://search.clinicalgenome.org/kb/conditions/MONDO:0013489,
818,AKT1,HGNC:391,Cowden syndrome 6,MONDO:0014048,AD,SOP11,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1333bd6d-332b-4c75-8811-cde8efce2001-2024-11-12T170000.000Z,2024-11-12T17:00:00.000Z,"Childhood, Adolescent and Young Adult Cancer Predisposition Gene Curation Expert Panel",AKT1,HGNC:391,chr14:105235686-105262085,chr14:104769349-104795748,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=AKT1&subject=,2022-01-25T18:10:51Z,AKT1,https://search.clinicalgenome.org/kb/genes/HGNC:391,Cowden syndrome 6,MONDO:0014048,https://search.clinicalgenome.org/kb/conditions/MONDO:0014048,Autosomal dominant inheritance
819,TRIM32,HGNC:16380,Bardet-Biedl syndrome 11,MONDO:0014439,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4140e7c5-ac53-4748-b20f-07d3877ea0d6-2024-07-11T160000.000Z,2024-07-11T16:00:00.000Z,Retina Gene Curation Expert Panel,TRIM32,HGNC:16380,chr9:119449584-119463578,chr9:116687305-116701299,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TRIM32&subject=,2016-08-22T17:53:02Z,TRIM32,https://search.clinicalgenome.org/kb/genes/HGNC:16380,Bardet-Biedl syndrome 11,MONDO:0014439,https://search.clinicalgenome.org/kb/conditions/MONDO:0014439,Autosomal recessive inheritance
820,TRIM32,HGNC:16380,Bardet-Biedl syndrome 11,MONDO:0014439,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4140e7c5-ac53-4748-b20f-07d3877ea0d6-2024-07-11T160000.000Z,2024-07-11T16:00:00.000Z,Retina Gene Curation Expert Panel,TRIM32,HGNC:16380,chr9:119449584-119463578,chr9:116687305-116701299,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TRIM32&subject=,2016-08-22T17:53:02Z,TRIM32,https://search.clinicalgenome.org/kb/genes/HGNC:16380,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,https://search.clinicalgenome.org/kb/conditions/MONDO:0015152,Autosomal recessive inheritance
821,TRIM32,HGNC:16380,Bardet-Biedl syndrome 11,MONDO:0014439,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4140e7c5-ac53-4748-b20f-07d3877ea0d6-2024-07-11T160000.000Z,2024-07-11T16:00:00.000Z,Retina Gene Curation Expert Panel,TRIM32,HGNC:16380,chr9:119449584-119463578,chr9:116687305-116701299,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TRIM32&subject=,2016-08-22T17:53:02Z,TRIM32,https://search.clinicalgenome.org/kb/genes/HGNC:16380,autosomal recessive limb-girdle muscular dystrophy type 2H,MONDO:0009683,https://search.clinicalgenome.org/kb/conditions/MONDO:0009683,
822,POLD1,HGNC:9175,non-severe combined immunodeficiency due to polymerase delta deficiency,MONDO:0800145,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73065a32-62bc-4cde-8131-f8f44c09a74f-2023-02-16T180000.000Z,2023-02-16T18:00:00.000Z,SCID-CID Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,non-severe combined immunodeficiency due to polymerase delta deficiency,MONDO:0800145,https://search.clinicalgenome.org/kb/conditions/MONDO:0800145,Autosomal recessive inheritance
823,POLD1,HGNC:9175,non-severe combined immunodeficiency due to polymerase delta deficiency,MONDO:0800145,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73065a32-62bc-4cde-8131-f8f44c09a74f-2023-02-16T180000.000Z,2023-02-16T18:00:00.000Z,SCID-CID Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,POLD1-related polyposis and colorectal cancer syndrome,MONDO:0100351,https://search.clinicalgenome.org/kb/conditions/MONDO:0100351,Autosomal dominant inheritance
824,POLD1,HGNC:9175,non-severe combined immunodeficiency due to polymerase delta deficiency,MONDO:0800145,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73065a32-62bc-4cde-8131-f8f44c09a74f-2023-02-16T180000.000Z,2023-02-16T18:00:00.000Z,SCID-CID Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,mandibular hypoplasia-deafness-progeroid syndrome,MONDO:0014157,https://search.clinicalgenome.org/kb/conditions/MONDO:0014157,Autosomal dominant inheritance
825,POLD1,HGNC:9175,non-severe combined immunodeficiency due to polymerase delta deficiency,MONDO:0800145,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73065a32-62bc-4cde-8131-f8f44c09a74f-2023-02-16T180000.000Z,2023-02-16T18:00:00.000Z,SCID-CID Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,"colorectal cancer, susceptibility to, 10",MONDO:0012953,https://search.clinicalgenome.org/kb/conditions/MONDO:0012953,
826,POLD1,HGNC:9175,non-severe combined immunodeficiency due to polymerase delta deficiency,MONDO:0800145,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73065a32-62bc-4cde-8131-f8f44c09a74f-2023-02-16T180000.000Z,2023-02-16T18:00:00.000Z,SCID-CID Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,Polymerase proofreading-related adenomatous polyposis,MONDO:0018653,https://search.clinicalgenome.org/kb/conditions/MONDO:0018653,
827,POLD1,HGNC:9175,POLD1-related polyposis and colorectal cancer syndrome,MONDO:0100351,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c064a017-9158-4eb5-8ea4-036e53798d2c-2023-07-05T170000.000Z,2023-07-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,non-severe combined immunodeficiency due to polymerase delta deficiency,MONDO:0800145,https://search.clinicalgenome.org/kb/conditions/MONDO:0800145,Autosomal recessive inheritance
828,POLD1,HGNC:9175,POLD1-related polyposis and colorectal cancer syndrome,MONDO:0100351,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c064a017-9158-4eb5-8ea4-036e53798d2c-2023-07-05T170000.000Z,2023-07-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,POLD1-related polyposis and colorectal cancer syndrome,MONDO:0100351,https://search.clinicalgenome.org/kb/conditions/MONDO:0100351,Autosomal dominant inheritance
829,POLD1,HGNC:9175,POLD1-related polyposis and colorectal cancer syndrome,MONDO:0100351,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c064a017-9158-4eb5-8ea4-036e53798d2c-2023-07-05T170000.000Z,2023-07-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,mandibular hypoplasia-deafness-progeroid syndrome,MONDO:0014157,https://search.clinicalgenome.org/kb/conditions/MONDO:0014157,Autosomal dominant inheritance
830,POLD1,HGNC:9175,POLD1-related polyposis and colorectal cancer syndrome,MONDO:0100351,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c064a017-9158-4eb5-8ea4-036e53798d2c-2023-07-05T170000.000Z,2023-07-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,"colorectal cancer, susceptibility to, 10",MONDO:0012953,https://search.clinicalgenome.org/kb/conditions/MONDO:0012953,
831,POLD1,HGNC:9175,POLD1-related polyposis and colorectal cancer syndrome,MONDO:0100351,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c064a017-9158-4eb5-8ea4-036e53798d2c-2023-07-05T170000.000Z,2023-07-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,POLD1,HGNC:9175,chr19:50887580-50921275,chr19:50384323-50418018,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLD1&subject=,2020-06-05T21:15:44Z,POLD1,https://search.clinicalgenome.org/kb/genes/HGNC:9175,Polymerase proofreading-related adenomatous polyposis,MONDO:0018653,https://search.clinicalgenome.org/kb/conditions/MONDO:0018653,
832,EMX2,HGNC:3341,schizencephaly,MONDO:0010011,AD,SOP11,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9ab9956b-42de-4772-a3bb-8508ea6d1349-2024-09-03T160000.000Z,2024-09-03T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,EMX2,HGNC:3341,chr10:119302257-119309057,chr10:117542746-117549546,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EMX2&subject=,2021-11-09T17:29:29Z,EMX2,https://search.clinicalgenome.org/kb/genes/HGNC:3341,schizencephaly,MONDO:0010011,https://search.clinicalgenome.org/kb/conditions/MONDO:0010011,Autosomal dominant inheritance
833,PDGFRA,HGNC:8803,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f40d874e-0c34-4ff6-8145-4b310a67a033-2024-03-11T160000.000Z,2024-03-11T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,PDGFRA,HGNC:8803,chr4:55095460-55164412,chr4:54229293-54298245,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PDGFRA&subject=,2025-02-12T20:07:45Z,PDGFRA,https://search.clinicalgenome.org/kb/genes/HGNC:8803,gastrointestinal stromal tumor,MONDO:0011719,https://search.clinicalgenome.org/kb/conditions/MONDO:0011719,Autosomal dominant inheritance
834,PDGFRA,HGNC:8803,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f40d874e-0c34-4ff6-8145-4b310a67a033-2024-03-11T160000.000Z,2024-03-11T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,PDGFRA,HGNC:8803,chr4:55095460-55164412,chr4:54229293-54298245,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PDGFRA&subject=,2025-02-12T20:07:45Z,PDGFRA,https://search.clinicalgenome.org/kb/genes/HGNC:8803,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
835,AKT3,HGNC:393,microcephaly,MONDO:0001149,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e3b524c-5d27-43d6-a0db-4f8f7cf1f872-2021-10-26T150030.155Z,2021-10-26T15:00:30.155Z,Brain Malformations Gene Curation Expert Panel,AKT3,HGNC:393,chr1:243651535-244014381,chr1:243488233-243851079,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=AKT3&subject=,2023-05-09T16:50:48Z,AKT3,https://search.clinicalgenome.org/kb/genes/HGNC:393,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,https://search.clinicalgenome.org/kb/conditions/MONDO:0100283,Autosomal dominant inheritance
836,AKT3,HGNC:393,microcephaly,MONDO:0001149,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e3b524c-5d27-43d6-a0db-4f8f7cf1f872-2021-10-26T150030.155Z,2021-10-26T15:00:30.155Z,Brain Malformations Gene Curation Expert Panel,AKT3,HGNC:393,chr1:243651535-244014381,chr1:243488233-243851079,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=AKT3&subject=,2023-05-09T16:50:48Z,AKT3,https://search.clinicalgenome.org/kb/genes/HGNC:393,microcephaly,MONDO:0001149,https://search.clinicalgenome.org/kb/conditions/MONDO:0001149,Autosomal dominant inheritance
837,ALG6,HGNC:23157,cystic kidney disease,MONDO:0002473,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4d62da9-8878-494e-b36b-7025fc31a428-2024-04-29T160000.000Z,2024-04-29T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders Gene Curation Expert Panel,ALG6,HGNC:23157,chr1:63833298-63904224,chr1:63367627-63438553,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ALG6&subject=,2016-08-22T17:45:57Z,ALG6,https://search.clinicalgenome.org/kb/genes/HGNC:23157,cystic kidney disease,MONDO:0002473,https://search.clinicalgenome.org/kb/conditions/MONDO:0002473,Autosomal dominant inheritance
838,ALG6,HGNC:23157,cystic kidney disease,MONDO:0002473,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4d62da9-8878-494e-b36b-7025fc31a428-2024-04-29T160000.000Z,2024-04-29T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders Gene Curation Expert Panel,ALG6,HGNC:23157,chr1:63833298-63904224,chr1:63367627-63438553,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ALG6&subject=,2016-08-22T17:45:57Z,ALG6,https://search.clinicalgenome.org/kb/genes/HGNC:23157,ALG6-congenital disorder of glycosylation 1C,MONDO:0011291,https://search.clinicalgenome.org/kb/conditions/MONDO:0011291,Autosomal recessive inheritance
839,PCDH15,HGNC:14674,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48910592-40d6-4eb7-a53c-4b0883070287-2018-06-19T040000.000Z,2018-06-19T04:00:00.000Z,Hearing Loss Gene Curation Expert Panel,PCDH15,HGNC:14674,chr10:55562531-57387702,chr10:53802771-55627942,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PCDH15&subject=,2016-08-22T17:51:00Z,PCDH15,https://search.clinicalgenome.org/kb/genes/HGNC:14674,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
840,PCDH15,HGNC:14674,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48910592-40d6-4eb7-a53c-4b0883070287-2018-06-19T040000.000Z,2018-06-19T04:00:00.000Z,Hearing Loss Gene Curation Expert Panel,PCDH15,HGNC:14674,chr10:55562531-57387702,chr10:53802771-55627942,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PCDH15&subject=,2016-08-22T17:51:00Z,PCDH15,https://search.clinicalgenome.org/kb/genes/HGNC:14674,Usher syndrome type 1,MONDO:0010168,https://search.clinicalgenome.org/kb/conditions/MONDO:0010168,Autosomal recessive inheritance
841,PCDH15,HGNC:14674,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48910592-40d6-4eb7-a53c-4b0883070287-2018-06-19T040000.000Z,2018-06-19T04:00:00.000Z,Hearing Loss Gene Curation Expert Panel,PCDH15,HGNC:14674,chr10:55562531-57387702,chr10:53802771-55627942,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PCDH15&subject=,2016-08-22T17:51:00Z,PCDH15,https://search.clinicalgenome.org/kb/genes/HGNC:14674,Usher syndrome type 1F,MONDO:0011186,https://search.clinicalgenome.org/kb/conditions/MONDO:0011186,
842,BIN1,HGNC:1052,centronuclear myopathy,MONDO:0018947,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8bb963a9-ec8a-4966-93bb-4f8ef6f8f8a1-2024-06-10T160000.000Z,2024-06-10T16:00:00.000Z,Congenital Myopathies Gene Curation Expert Panel,BIN1,HGNC:1052,chr2:127805599-127864730,chr2:127048023-127107154,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BIN1&subject=,2016-08-22T17:46:29Z,BIN1,https://search.clinicalgenome.org/kb/genes/HGNC:1052,centronuclear myopathy,MONDO:0018947,https://search.clinicalgenome.org/kb/conditions/MONDO:0018947,Autosomal recessive inheritance | Autosomal dominant inheritance
843,BIN1,HGNC:1052,centronuclear myopathy,MONDO:0018947,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8bb963a9-ec8a-4966-93bb-4f8ef6f8f8a1-2024-06-10T160000.000Z,2024-06-10T16:00:00.000Z,Congenital Myopathies Gene Curation Expert Panel,BIN1,HGNC:1052,chr2:127805599-127864730,chr2:127048023-127107154,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BIN1&subject=,2016-08-22T17:46:29Z,BIN1,https://search.clinicalgenome.org/kb/genes/HGNC:1052,"myopathy, centronuclear, 2",MONDO:0009709,https://search.clinicalgenome.org/kb/conditions/MONDO:0009709,
844,CDKN1B,HGNC:1785,hereditary nonpolyposis colon cancer,MONDO:0018630,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8434,2017-06-08T00:00:00,Colon Cancer Gene Curation Expert Panel,CDKN1B,HGNC:1785,chr12:12870302-12875303,chr12:12717368-12722369,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CDKN1B&subject=,2020-07-08T21:02:40Z,CDKN1B,https://search.clinicalgenome.org/kb/genes/HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,https://search.clinicalgenome.org/kb/conditions/MONDO:0012552,Autosomal dominant inheritance
845,CDKN1B,HGNC:1785,hereditary nonpolyposis colon cancer,MONDO:0018630,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8434,2017-06-08T00:00:00,Colon Cancer Gene Curation Expert Panel,CDKN1B,HGNC:1785,chr12:12870302-12875303,chr12:12717368-12722369,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CDKN1B&subject=,2020-07-08T21:02:40Z,CDKN1B,https://search.clinicalgenome.org/kb/genes/HGNC:1785,hereditary nonpolyposis colon cancer,MONDO:0018630,https://search.clinicalgenome.org/kb/conditions/MONDO:0018630,Autosomal recessive inheritance
846,NEBL,HGNC:16932,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29bc6c4f-3f2d-45e2-b796-a79616857094-2020-09-25T160000.000Z,2020-09-25T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,NEBL,HGNC:16932,chr10:21068902-21581979,chr10:20779973-21293050,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NEBL&subject=,2011-12-21T15:14:43Z,NEBL,https://search.clinicalgenome.org/kb/genes/HGNC:16932,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
847,CHD1L,HGNC:1916,congenital anomaly of kidney and urinary tract,MONDO:0019719,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3220,2016-11-18T00:00:00,General Gene Curation Expert Panel,CHD1L,HGNC:1916,chr1:146644326-146767443,chr1:147172747-147295762,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CHD1L&subject=,2018-08-30T18:53:22Z,CHD1L,https://search.clinicalgenome.org/kb/genes/HGNC:1916,congenital anomaly of kidney and urinary tract,MONDO:0019719,https://search.clinicalgenome.org/kb/conditions/MONDO:0019719,Autosomal dominant inheritance
848,CASZ1,HGNC:26002,congenital heart disease,MONDO:0005453,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_754d56b3-0749-4292-b6c8-96ab61232076-2024-08-12T160000.000Z,2024-08-12T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,CASZ1,HGNC:26002,chr1:10696661-10856703,chr1:10636604-10796646,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASZ1&subject=,2019-04-25T21:07:36Z,CASZ1,https://search.clinicalgenome.org/kb/genes/HGNC:26002,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
849,EYA4,HGNC:3522,dilated cardiomyopathy 1J,MONDO:0011541,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0a0bad-1f7a-402e-af19-a80453653b86-2020-11-30T170000.000Z,2020-11-30T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,EYA4,HGNC:3522,chr6:133562495-133853266,chr6:133240593-133532128,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EYA4&subject=,2020-01-22T18:33:25Z,EYA4,https://search.clinicalgenome.org/kb/genes/HGNC:3522,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal dominant inheritance
850,EYA4,HGNC:3522,dilated cardiomyopathy 1J,MONDO:0011541,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0a0bad-1f7a-402e-af19-a80453653b86-2020-11-30T170000.000Z,2020-11-30T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,EYA4,HGNC:3522,chr6:133562495-133853266,chr6:133240593-133532128,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EYA4&subject=,2020-01-22T18:33:25Z,EYA4,https://search.clinicalgenome.org/kb/genes/HGNC:3522,dilated cardiomyopathy 1J,MONDO:0011541,https://search.clinicalgenome.org/kb/conditions/MONDO:0011541,Autosomal dominant inheritance
851,EYA4,HGNC:3522,dilated cardiomyopathy 1J,MONDO:0011541,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0a0bad-1f7a-402e-af19-a80453653b86-2020-11-30T170000.000Z,2020-11-30T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,EYA4,HGNC:3522,chr6:133562495-133853266,chr6:133240593-133532128,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EYA4&subject=,2020-01-22T18:33:25Z,EYA4,https://search.clinicalgenome.org/kb/genes/HGNC:3522,autosomal dominant nonsyndromic hearing loss 10,MONDO:0011031,https://search.clinicalgenome.org/kb/conditions/MONDO:0011031,
852,RPS20,HGNC:10405,Lynch syndrome,MONDO:0005835,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_258ec9c5-12bb-4d8b-9bc2-d5747b52660c-2024-03-22T170000.000Z,2024-03-22T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RPS20,HGNC:10405,chr8:56979813-56987065,chr8:56067254-56074506,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPS20&subject=,2024-12-12T14:16:46Z,RPS20,https://search.clinicalgenome.org/kb/genes/HGNC:10405,Lynch syndrome,MONDO:0005835,https://search.clinicalgenome.org/kb/conditions/MONDO:0005835,Autosomal dominant inheritance
853,COL9A1,HGNC:2217,Stickler syndrome,MONDO:0019354,AR,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9807,2018-03-26T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,COL9A1,HGNC:2217,chr6:70924764-71012787,chr6:70215061-70303084,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL9A1&subject=,2013-11-06T18:30:03Z,COL9A1,https://search.clinicalgenome.org/kb/genes/HGNC:2217,Stickler syndrome,MONDO:0019354,https://search.clinicalgenome.org/kb/conditions/MONDO:0019354,Autosomal recessive inheritance
854,COL9A1,HGNC:2217,Stickler syndrome,MONDO:0019354,AR,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9807,2018-03-26T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,COL9A1,HGNC:2217,chr6:70924764-71012787,chr6:70215061-70303084,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=COL9A1&subject=,2013-11-06T18:30:03Z,COL9A1,https://search.clinicalgenome.org/kb/genes/HGNC:2217,"epiphyseal dysplasia, multiple, 6",MONDO:0013591,https://search.clinicalgenome.org/kb/conditions/MONDO:0013591,
855,CD8A,HGNC:1706,susceptibility to respiratory infections associated with CD8alpha chain mutation,MONDO:0012161,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f770ad34-1c95-4454-92c7-26bff4404cc2-2022-08-18T160000.000Z,2022-08-18T16:00:00.000Z,SCID-CID Gene Curation Expert Panel,CD8A,HGNC:1706,chr2:87011728-87035519,chr2:86784605-86808396,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CD8A&subject=,2016-08-22T17:46:52Z,CD8A,https://search.clinicalgenome.org/kb/genes/HGNC:1706,susceptibility to respiratory infections associated with CD8alpha chain mutation,MONDO:0012161,https://search.clinicalgenome.org/kb/conditions/MONDO:0012161,Autosomal recessive inheritance
856,TJP2,HGNC:11828,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb5c5be5-918d-4ba5-b4ad-e243119a7e6a-2022-01-19T170000.000Z,2022-01-19T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,TJP2,HGNC:11828,chr9:71736180-71870124,chr9:69121264-69255208,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TJP2&subject=,2016-08-22T17:52:50Z,TJP2,https://search.clinicalgenome.org/kb/genes/HGNC:11828,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal dominant inheritance
857,TJP2,HGNC:11828,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb5c5be5-918d-4ba5-b4ad-e243119a7e6a-2022-01-19T170000.000Z,2022-01-19T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,TJP2,HGNC:11828,chr9:71736180-71870124,chr9:69121264-69255208,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TJP2&subject=,2016-08-22T17:52:50Z,TJP2,https://search.clinicalgenome.org/kb/genes/HGNC:11828,"cholestasis, progressive familial intrahepatic, 4",MONDO:0014381,https://search.clinicalgenome.org/kb/conditions/MONDO:0014381,
858,FAN1,HGNC:29170,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9863,2017-10-23T00:00:00,Colon Cancer Gene Curation Expert Panel,FAN1,HGNC:29170,chr15:31196055-31235311,chr15:30903852-30943108,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FAN1&subject=,2016-08-22T17:48:28Z,FAN1,https://search.clinicalgenome.org/kb/genes/HGNC:29170,hereditary nonpolyposis colon cancer,MONDO:0018630,https://search.clinicalgenome.org/kb/conditions/MONDO:0018630,Autosomal dominant inheritance
859,FAN1,HGNC:29170,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9863,2017-10-23T00:00:00,Colon Cancer Gene Curation Expert Panel,FAN1,HGNC:29170,chr15:31196055-31235311,chr15:30903852-30943108,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FAN1&subject=,2016-08-22T17:48:28Z,FAN1,https://search.clinicalgenome.org/kb/genes/HGNC:29170,karyomegalic interstitial nephritis,MONDO:0013898,https://search.clinicalgenome.org/kb/conditions/MONDO:0013898,
860,ESPN,HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bdbd958-1ad2-447a-9ccd-ed86f308577a-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,ESPN,HGNC:13281,chr1:6484836-6521004,chr1:6424776-6461370,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ESPN&subject=,2018-02-07T16:00:16Z,ESPN,https://search.clinicalgenome.org/kb/genes/HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance | Autosomal dominant inheritance
861,ESPN,HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bdbd958-1ad2-447a-9ccd-ed86f308577a-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,ESPN,HGNC:13281,chr1:6484836-6521004,chr1:6424776-6461370,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ESPN&subject=,2018-02-07T16:00:16Z,ESPN,https://search.clinicalgenome.org/kb/genes/HGNC:13281,prelingual non-syndromic genetic hearing loss,MONDO:0016297,https://search.clinicalgenome.org/kb/conditions/MONDO:0016297,
862,ESPN,HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bdbd958-1ad2-447a-9ccd-ed86f308577a-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,ESPN,HGNC:13281,chr1:6484836-6521004,chr1:6424776-6461370,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ESPN&subject=,2018-02-07T16:00:16Z,ESPN,https://search.clinicalgenome.org/kb/genes/HGNC:13281,autosomal recessive nonsyndromic hearing loss 36,MONDO:0012170,https://search.clinicalgenome.org/kb/conditions/MONDO:0012170,
863,ESPN,HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bdbd958-1ad2-447a-9ccd-ed86f308577a-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,ESPN,HGNC:13281,chr1:6484836-6521004,chr1:6424776-6461370,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ESPN&subject=,2018-02-07T16:00:16Z,ESPN,https://search.clinicalgenome.org/kb/genes/HGNC:13281,"hearing loss, autosomal recessive",MONDO:0019588,https://search.clinicalgenome.org/kb/conditions/MONDO:0019588,
864,FBN2,HGNC:3604,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8268,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,FBN2,HGNC:3604,chr5:127593601-127873938,chr5:128257909-128538245,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FBN2&subject=,2024-02-28T17:29:27Z,FBN2,https://search.clinicalgenome.org/kb/genes/HGNC:3604,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,https://search.clinicalgenome.org/kb/conditions/MONDO:0019625,Autosomal dominant inheritance
865,ERMARD,HGNC:21056,periventricular nodular heterotopia,MONDO:0020341,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9acacc58-f84e-4a2a-906c-8a35f58256c1-2024-07-02T160000.000Z,2024-07-02T16:00:00.000Z,Brain Malformations Gene Curation Expert Panel,ERMARD,HGNC:21056,chr6:170151718-170181696,chr6:169751306-169781600,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ERMARD&subject=,2013-11-13T16:19:09Z,ERMARD,https://search.clinicalgenome.org/kb/genes/HGNC:21056,periventricular nodular heterotopia,MONDO:0020341,https://search.clinicalgenome.org/kb/conditions/MONDO:0020341,Autosomal dominant inheritance
866,FLNA,HGNC:3754,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,XL,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8274,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,FLNA,HGNC:3754,chrX:153576899-153603002,chrX:154348531-154374634,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FLNA&subject=,2020-12-02T18:49:17Z,FLNA,https://search.clinicalgenome.org/kb/genes/HGNC:3754,periventricular nodular heterotopia,MONDO:0020341,https://search.clinicalgenome.org/kb/conditions/MONDO:0020341,X-linked inheritance
867,FLNA,HGNC:3754,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,XL,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8274,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,FLNA,HGNC:3754,chrX:153576899-153603002,chrX:154348531-154374634,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FLNA&subject=,2020-12-02T18:49:17Z,FLNA,https://search.clinicalgenome.org/kb/genes/HGNC:3754,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,https://search.clinicalgenome.org/kb/conditions/MONDO:0019625,X-linked inheritance
868,FLNA,HGNC:3754,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,XL,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8274,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection Gene Curation Expert Panel,FLNA,HGNC:3754,chrX:153576899-153603002,chrX:154348531-154374634,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FLNA&subject=,2020-12-02T18:49:17Z,FLNA,https://search.clinicalgenome.org/kb/genes/HGNC:3754,"heterotopia, periventricular, X-linked dominant",MONDO:0010233,https://search.clinicalgenome.org/kb/conditions/MONDO:0010233,
869,GALNT12,HGNC:19877,"colorectal cancer, susceptibility to, 1",MONDO:0012132,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8435,2017-06-08T00:00:00,Colon Cancer Gene Curation Expert Panel,GALNT12,HGNC:19877,chr9:101569952-101612363,chr9:98807670-98850081,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GALNT12&subject=,2019-09-09T21:10:04Z,GALNT12,https://search.clinicalgenome.org/kb/genes/HGNC:19877,"colorectal cancer, susceptibility to, 1",MONDO:0012132,https://search.clinicalgenome.org/kb/conditions/MONDO:0012132,Autosomal dominant inheritance
870,CASP10,HGNC:1500,autoimmune lymphoproliferative syndrome type 2A,MONDO:0011383,AD,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd4bc3b7-ee3f-4fe0-b24a-be27e0840506-2024-03-19T160000.000Z,2024-03-19T16:00:00.000Z,Primary Immune Regulatory Disorders Gene Curation Expert Panel,CASP10,HGNC:1500,chr2:202047864-202094129,chr2:201183141-201229406,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASP10&subject=,2020-04-10T21:24:57Z,CASP10,https://search.clinicalgenome.org/kb/genes/HGNC:1500,autoimmune lymphoproliferative syndrome type 2A,MONDO:0011383,https://search.clinicalgenome.org/kb/conditions/MONDO:0011383,Autosomal dominant inheritance
871,NDUFV2,HGNC:7717,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1266aed1-8c25-4b28-bf8a-a0e16d9b3da9-2019-11-25T145748.766Z,2019-11-25T14:57:48.766Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFV2,HGNC:7717,chr18:9102697-9134339,chr18:9102699-9134341,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFV2&subject=,2016-08-22T17:50:45Z,NDUFV2,https://search.clinicalgenome.org/kb/genes/HGNC:7717,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
872,NDUFV2,HGNC:7717,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1266aed1-8c25-4b28-bf8a-a0e16d9b3da9-2019-11-25T145748.766Z,2019-11-25T14:57:48.766Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFV2,HGNC:7717,chr18:9102697-9134339,chr18:9102699-9134341,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFV2&subject=,2016-08-22T17:50:45Z,NDUFV2,https://search.clinicalgenome.org/kb/genes/HGNC:7717,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
873,NDUFV2,HGNC:7717,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1266aed1-8c25-4b28-bf8a-a0e16d9b3da9-2019-11-25T145748.766Z,2019-11-25T14:57:48.766Z,Mitochondrial Diseases Gene Curation Expert Panel,NDUFV2,HGNC:7717,chr18:9102697-9134339,chr18:9102699-9134341,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NDUFV2&subject=,2016-08-22T17:50:45Z,NDUFV2,https://search.clinicalgenome.org/kb/genes/HGNC:7717,"mitochondrial complex I deficiency, nuclear type 1",MONDO:0100224,https://search.clinicalgenome.org/kb/conditions/MONDO:0100224,
874,F9,HGNC:3551,"thrombophilia, X-linked, due to factor 9 defect",MONDO:0010432,XL,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b3a7f2c-a07a-4a10-b1f7-78642ebdaa5d-2023-11-06T170000.000Z,2023-11-06T17:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,F9,HGNC:3551,chrX:138612898-138645618,chrX:139530739-139563459,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=F9&subject=,2021-01-12T14:20:15Z,F9,https://search.clinicalgenome.org/kb/genes/HGNC:3551,hemophilia B,MONDO:0010604,https://search.clinicalgenome.org/kb/conditions/MONDO:0010604,X-linked inheritance
875,F9,HGNC:3551,"thrombophilia, X-linked, due to factor 9 defect",MONDO:0010432,XL,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b3a7f2c-a07a-4a10-b1f7-78642ebdaa5d-2023-11-06T170000.000Z,2023-11-06T17:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,F9,HGNC:3551,chrX:138612898-138645618,chrX:139530739-139563459,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=F9&subject=,2021-01-12T14:20:15Z,F9,https://search.clinicalgenome.org/kb/genes/HGNC:3551,"thrombophilia, X-linked, due to factor 9 defect",MONDO:0010432,https://search.clinicalgenome.org/kb/conditions/MONDO:0010432,X-linked inheritance
876,F9,HGNC:3551,"thrombophilia, X-linked, due to factor 9 defect",MONDO:0010432,XL,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b3a7f2c-a07a-4a10-b1f7-78642ebdaa5d-2023-11-06T170000.000Z,2023-11-06T17:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,F9,HGNC:3551,chrX:138612898-138645618,chrX:139530739-139563459,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=F9&subject=,2021-01-12T14:20:15Z,F9,https://search.clinicalgenome.org/kb/genes/HGNC:3551,hemophilia,MONDO:0018660,https://search.clinicalgenome.org/kb/conditions/MONDO:0018660,
877,CAPN3,HGNC:1480,"muscular dystrophy, limb-girdle, autosomal dominant",MONDO:0015151,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6c9eee52-920c-47e4-99f9-a5afb97d49f2-2024-08-29T190000.000Z,2024-08-29T19:00:00.000Z,Muscular Dystrophies and Myopathies Gene Curation Expert Panel,CAPN3,HGNC:1480,chr15:42651699-42704515,chr15:42359501-42412317,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CAPN3&subject=,2016-08-22T17:46:40Z,CAPN3,https://search.clinicalgenome.org/kb/genes/HGNC:1480,"muscular dystrophy, limb-girdle, autosomal dominant",MONDO:0015151,https://search.clinicalgenome.org/kb/conditions/MONDO:0015151,Autosomal dominant inheritance
878,CAPN3,HGNC:1480,"muscular dystrophy, limb-girdle, autosomal dominant",MONDO:0015151,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6c9eee52-920c-47e4-99f9-a5afb97d49f2-2024-08-29T190000.000Z,2024-08-29T19:00:00.000Z,Muscular Dystrophies and Myopathies Gene Curation Expert Panel,CAPN3,HGNC:1480,chr15:42651699-42704515,chr15:42359501-42412317,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CAPN3&subject=,2016-08-22T17:46:40Z,CAPN3,https://search.clinicalgenome.org/kb/genes/HGNC:1480,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,https://search.clinicalgenome.org/kb/conditions/MONDO:0015152,Autosomal recessive inheritance
879,CAPN3,HGNC:1480,"muscular dystrophy, limb-girdle, autosomal dominant",MONDO:0015151,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6c9eee52-920c-47e4-99f9-a5afb97d49f2-2024-08-29T190000.000Z,2024-08-29T19:00:00.000Z,Muscular Dystrophies and Myopathies Gene Curation Expert Panel,CAPN3,HGNC:1480,chr15:42651699-42704515,chr15:42359501-42412317,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CAPN3&subject=,2016-08-22T17:46:40Z,CAPN3,https://search.clinicalgenome.org/kb/genes/HGNC:1480,autosomal recessive limb-girdle muscular dystrophy type 2A,MONDO:0009675,https://search.clinicalgenome.org/kb/conditions/MONDO:0009675,
880,GATAD1,HGNC:29941,dilated cardiomyopathy,MONDO:0005021,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_56933afb-863f-46f5-884d-17522adb31a8-2024-08-07T160000.000Z,2024-08-07T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,GATAD1,HGNC:29941,chr7:92076796-92089389,chr7:92447482-92495769,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GATAD1&subject=,2016-08-22T17:48:47Z,GATAD1,https://search.clinicalgenome.org/kb/genes/HGNC:29941,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal recessive inheritance
881,GATAD1,HGNC:29941,dilated cardiomyopathy,MONDO:0005021,AR,SOP10,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_56933afb-863f-46f5-884d-17522adb31a8-2024-08-07T160000.000Z,2024-08-07T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,GATAD1,HGNC:29941,chr7:92076796-92089389,chr7:92447482-92495769,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GATAD1&subject=,2016-08-22T17:48:47Z,GATAD1,https://search.clinicalgenome.org/kb/genes/HGNC:29941,dilated cardiomyopathy 2B,MONDO:0013848,https://search.clinicalgenome.org/kb/conditions/MONDO:0013848,
882,SLC25A19,HGNC:14409,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ae17da7-86b0-4aba-a401-de1ccb6ecb83-2020-08-27T162850.918Z,2020-08-27T16:28:50.918Z,Mitochondrial Diseases Gene Curation Expert Panel,SLC25A19,HGNC:14409,chr17:73269073-73285514,chr17:75272992-75289433,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A19&subject=,2016-08-22T17:52:19Z,SLC25A19,https://search.clinicalgenome.org/kb/genes/HGNC:14409,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
883,SLC25A19,HGNC:14409,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ae17da7-86b0-4aba-a401-de1ccb6ecb83-2020-08-27T162850.918Z,2020-08-27T16:28:50.918Z,Mitochondrial Diseases Gene Curation Expert Panel,SLC25A19,HGNC:14409,chr17:73269073-73285514,chr17:75272992-75289433,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A19&subject=,2016-08-22T17:52:19Z,SLC25A19,https://search.clinicalgenome.org/kb/genes/HGNC:14409,thiamine-responsive dysfunction syndrome,MONDO:0000152,https://search.clinicalgenome.org/kb/conditions/MONDO:0000152,
884,NKX2-5,HGNC:2488,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6335de7f-71db-4768-8fa0-6faebd0ea0e8-2020-11-06T170000.000Z,2020-11-06T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,NKX2-5,HGNC:2488,chr5:172659112-172662209,chr5:173232109-173235206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NKX2-5&subject=,2020-07-22T17:41:24Z,NKX2-5,https://search.clinicalgenome.org/kb/genes/HGNC:2488,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
885,NKX2-5,HGNC:2488,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6335de7f-71db-4768-8fa0-6faebd0ea0e8-2020-11-06T170000.000Z,2020-11-06T17:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,NKX2-5,HGNC:2488,chr5:172659112-172662209,chr5:173232109-173235206,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NKX2-5&subject=,2020-07-22T17:41:24Z,NKX2-5,https://search.clinicalgenome.org/kb/genes/HGNC:2488,"NKX2.5-related congenital, conduction and myopathic heart disease",MONDO:0800441,https://search.clinicalgenome.org/kb/conditions/MONDO:0800441,Autosomal dominant inheritance
886,MSH3,HGNC:7326,Lynch syndrome,MONDO:0005835,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9216399-2779-43fa-8b95-b10020753f43-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH3,HGNC:7326,chr5:79950471-80172634,chr5:80654652-80876815,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH3&subject=,2020-05-08T22:02:56Z,MSH3,https://search.clinicalgenome.org/kb/genes/HGNC:7326,Lynch syndrome,MONDO:0005835,https://search.clinicalgenome.org/kb/conditions/MONDO:0005835,Autosomal dominant inheritance
887,MSH3,HGNC:7326,Lynch syndrome,MONDO:0005835,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9216399-2779-43fa-8b95-b10020753f43-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH3,HGNC:7326,chr5:79950471-80172634,chr5:80654652-80876815,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH3&subject=,2020-05-08T22:02:56Z,MSH3,https://search.clinicalgenome.org/kb/genes/HGNC:7326,familial adenomatous polyposis 4,MONDO:0044300,https://search.clinicalgenome.org/kb/conditions/MONDO:0044300,Autosomal recessive inheritance
888,KCNH2,HGNC:6251,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10154,2017-11-21T17:00:00,Brugada Syndrome Gene Curation Expert Panel,KCNH2,HGNC:6251,chr7:150642049-150675409,chr7:150944961-150978321,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNH2&subject=,2020-02-26T17:14:24Z,KCNH2,https://search.clinicalgenome.org/kb/genes/HGNC:6251,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
889,KCNH2,HGNC:6251,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10154,2017-11-21T17:00:00,Brugada Syndrome Gene Curation Expert Panel,KCNH2,HGNC:6251,chr7:150642049-150675409,chr7:150944961-150978321,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNH2&subject=,2020-02-26T17:14:24Z,KCNH2,https://search.clinicalgenome.org/kb/genes/HGNC:6251,short QT syndrome,MONDO:0000453,https://search.clinicalgenome.org/kb/conditions/MONDO:0000453,Autosomal dominant inheritance
890,KCNH2,HGNC:6251,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10154,2017-11-21T17:00:00,Brugada Syndrome Gene Curation Expert Panel,KCNH2,HGNC:6251,chr7:150642049-150675409,chr7:150944961-150978321,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNH2&subject=,2020-02-26T17:14:24Z,KCNH2,https://search.clinicalgenome.org/kb/genes/HGNC:6251,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
891,KCNH2,HGNC:6251,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10154,2017-11-21T17:00:00,Brugada Syndrome Gene Curation Expert Panel,KCNH2,HGNC:6251,chr7:150642049-150675409,chr7:150944961-150978321,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNH2&subject=,2020-02-26T17:14:24Z,KCNH2,https://search.clinicalgenome.org/kb/genes/HGNC:6251,familial long QT syndrome,MONDO:0019171,https://search.clinicalgenome.org/kb/conditions/MONDO:0019171,
892,KCNH2,HGNC:6251,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10154,2017-11-21T17:00:00,Brugada Syndrome Gene Curation Expert Panel,KCNH2,HGNC:6251,chr7:150642049-150675409,chr7:150944961-150978321,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KCNH2&subject=,2020-02-26T17:14:24Z,KCNH2,https://search.clinicalgenome.org/kb/genes/HGNC:6251,long QT syndrome 2,MONDO:0013367,https://search.clinicalgenome.org/kb/conditions/MONDO:0013367,
893,TMLHE,HGNC:18308,autism spectrum disorder,MONDO:0005258,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a780ea6-ad4e-417a-a596-27188e327aad-2021-03-02T050000.000Z,2021-03-02T05:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,TMLHE,HGNC:18308,chrX:154718672-154842613,chrX:155489011-155612952,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TMLHE&subject=,2013-08-01T19:54:22Z,TMLHE,https://search.clinicalgenome.org/kb/genes/HGNC:18308,autism spectrum disorder,MONDO:0005258,https://search.clinicalgenome.org/kb/conditions/MONDO:0005258,X-linked inheritance
894,FOXP1,HGNC:3823,congenital heart disease,MONDO:0005453,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0d2a272-afc2-49df-aa73-0b2f82ce11d6-2023-12-11T170000.000Z,2023-12-11T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,FOXP1,HGNC:3823,chr3:71003859-71633129,chr3:70954708-71583978,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FOXP1&subject=,2020-01-22T17:12:56Z,FOXP1,https://search.clinicalgenome.org/kb/genes/HGNC:3823,intellectual disability-severe speech delay-mild dysmorphism syndrome,MONDO:0013352,https://search.clinicalgenome.org/kb/conditions/MONDO:0013352,Autosomal dominant inheritance
895,FOXP1,HGNC:3823,congenital heart disease,MONDO:0005453,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0d2a272-afc2-49df-aa73-0b2f82ce11d6-2023-12-11T170000.000Z,2023-12-11T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,FOXP1,HGNC:3823,chr3:71003859-71633129,chr3:70954708-71583978,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FOXP1&subject=,2020-01-22T17:12:56Z,FOXP1,https://search.clinicalgenome.org/kb/genes/HGNC:3823,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
896,ZDHHC15,HGNC:20342,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2519945-2acd-4484-9811-487ff5189da9-2021-07-30T160000.000Z,2021-07-30T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,ZDHHC15,HGNC:20342,chrX:74588262-74742872,chrX:75368427-75523037,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ZDHHC15&subject=,2012-07-25T14:44:35Z,ZDHHC15,https://search.clinicalgenome.org/kb/genes/HGNC:20342,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
897,ARHGEF6,HGNC:685,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d248ef99-6ff8-43d8-a24e-dfce6b2db1c8-2020-10-20T160000.000Z,2020-10-20T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,ARHGEF6,HGNC:685,chrX:135747709-135863091,chrX:136665550-136780932,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ARHGEF6&subject=,2012-04-25T19:40:11Z,ARHGEF6,https://search.clinicalgenome.org/kb/genes/HGNC:685,non-syndromic X-linked intellectual disability,MONDO:0019181,https://search.clinicalgenome.org/kb/conditions/MONDO:0019181,X-linked inheritance
898,ZNF41,HGNC:13107,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d705685-78a3-4925-8a1b-e00d39d63f87-2021-03-16T171235.415Z,2021-03-16T17:12:35.415Z,Intellectual Disability and Autism Gene Curation Expert Panel,ZNF41,HGNC:13107,chrX:47304577-47342621,chrX:47445178-47483222,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ZNF41&subject=,2012-10-24T14:03:41Z,ZNF41,https://search.clinicalgenome.org/kb/genes/HGNC:13107,non-syndromic X-linked intellectual disability,MONDO:0019181,https://search.clinicalgenome.org/kb/conditions/MONDO:0019181,X-linked inheritance
899,SHROOM4,HGNC:29215,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a94d20f8-9909-48b2-9860-d17c6dc73ec3-2021-01-13T170000.000Z,2021-01-13T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SHROOM4,HGNC:29215,chrX:50334642-50557194,chrX:50575534-50814194,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHROOM4&subject=,2012-10-10T14:32:39Z,SHROOM4,https://search.clinicalgenome.org/kb/genes/HGNC:29215,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
900,MAGT1,HGNC:28880,X-linked intellectual disability,MONDO:0100284,XL,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d00155ee-71d6-4d9d-bb08-91a0dee42932-2023-02-08T170000.000Z,2023-02-08T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,MAGT1,HGNC:28880,chrX:77081244-77151065,chrX:77825747-77895568,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAGT1&subject=,2021-09-22T16:23:04Z,MAGT1,https://search.clinicalgenome.org/kb/genes/HGNC:28880,X-linked intellectual disability,MONDO:0100284,https://search.clinicalgenome.org/kb/conditions/MONDO:0100284,X-linked inheritance
901,MAGT1,HGNC:28880,X-linked intellectual disability,MONDO:0100284,XL,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d00155ee-71d6-4d9d-bb08-91a0dee42932-2023-02-08T170000.000Z,2023-02-08T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,MAGT1,HGNC:28880,chrX:77081244-77151065,chrX:77825747-77895568,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MAGT1&subject=,2021-09-22T16:23:04Z,MAGT1,https://search.clinicalgenome.org/kb/genes/HGNC:28880,"X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia",MONDO:0010455,https://search.clinicalgenome.org/kb/conditions/MONDO:0010455,
902,SLC34A1,HGNC:11019,Fanconi renotubular syndrome 2,MONDO:0013247,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8aec2b2-9433-4f9f-8015-5f3dd46369d0-2022-09-06T143000.000Z,2022-09-06T14:30:00.000Z,Tubulopathy Gene Curation Expert Panel,SLC34A1,HGNC:11019,chr5:176811435-176825849,chr5:177384434-177398848,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC34A1&subject=,2016-08-22T17:52:20Z,SLC34A1,https://search.clinicalgenome.org/kb/genes/HGNC:11019,Fanconi renotubular syndrome 2,MONDO:0013247,https://search.clinicalgenome.org/kb/conditions/MONDO:0013247,Autosomal recessive inheritance
903,SLC34A1,HGNC:11019,Fanconi renotubular syndrome 2,MONDO:0013247,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8aec2b2-9433-4f9f-8015-5f3dd46369d0-2022-09-06T143000.000Z,2022-09-06T14:30:00.000Z,Tubulopathy Gene Curation Expert Panel,SLC34A1,HGNC:11019,chr5:176811435-176825849,chr5:177384434-177398848,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC34A1&subject=,2016-08-22T17:52:20Z,SLC34A1,https://search.clinicalgenome.org/kb/genes/HGNC:11019,"hypercalcemia, infantile, 2",MONDO:0014851,https://search.clinicalgenome.org/kb/conditions/MONDO:0014851,Autosomal recessive inheritance
904,SLC34A1,HGNC:11019,"hypercalcemia, infantile, 2",MONDO:0014851,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b164a17-9f7b-43b2-88b2-2adb8e458c08-2022-10-19T133000.000Z,2022-10-19T13:30:00.000Z,Tubulopathy Gene Curation Expert Panel,SLC34A1,HGNC:11019,chr5:176811435-176825849,chr5:177384434-177398848,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC34A1&subject=,2016-08-22T17:52:20Z,SLC34A1,https://search.clinicalgenome.org/kb/genes/HGNC:11019,Fanconi renotubular syndrome 2,MONDO:0013247,https://search.clinicalgenome.org/kb/conditions/MONDO:0013247,Autosomal recessive inheritance
905,SLC34A1,HGNC:11019,"hypercalcemia, infantile, 2",MONDO:0014851,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b164a17-9f7b-43b2-88b2-2adb8e458c08-2022-10-19T133000.000Z,2022-10-19T13:30:00.000Z,Tubulopathy Gene Curation Expert Panel,SLC34A1,HGNC:11019,chr5:176811435-176825849,chr5:177384434-177398848,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC34A1&subject=,2016-08-22T17:52:20Z,SLC34A1,https://search.clinicalgenome.org/kb/genes/HGNC:11019,"hypercalcemia, infantile, 2",MONDO:0014851,https://search.clinicalgenome.org/kb/conditions/MONDO:0014851,Autosomal recessive inheritance
906,ZNF674,HGNC:17625,X-linked intellectual disability,MONDO:0100284,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5105ab37-4f59-44dc-a8b1-f28e6ed3b704-2021-05-04T170000.000Z,2021-05-04T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,ZNF674,HGNC:17625,chrX:46357160-46404856,chrX:46497725-46545421,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ZNF674&subject=,2023-03-28T16:36:02Z,ZNF674,https://search.clinicalgenome.org/kb/genes/HGNC:17625,X-linked intellectual disability,MONDO:0100284,https://search.clinicalgenome.org/kb/conditions/MONDO:0100284,X-linked inheritance
907,PKP2,HGNC:9024,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10156,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
908,PKP2,HGNC:9024,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10156,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
909,PKP2,HGNC:9024,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10156,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
910,PKP2,HGNC:9024,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10156,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,Autosomal dominant inheritance
911,PKP2,HGNC:9024,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10156,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,https://search.clinicalgenome.org/kb/conditions/MONDO:0016342,
912,PKP2,HGNC:9024,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10156,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,arrhythmogenic right ventricular dysplasia 9,MONDO:0012180,https://search.clinicalgenome.org/kb/conditions/MONDO:0012180,
913,PKP2,HGNC:9024,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a8e26ad-c4ce-48d7-acab-1198d3b12ce5-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
914,PKP2,HGNC:9024,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a8e26ad-c4ce-48d7-acab-1198d3b12ce5-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
915,PKP2,HGNC:9024,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a8e26ad-c4ce-48d7-acab-1198d3b12ce5-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
916,PKP2,HGNC:9024,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a8e26ad-c4ce-48d7-acab-1198d3b12ce5-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,Autosomal dominant inheritance
917,PKP2,HGNC:9024,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a8e26ad-c4ce-48d7-acab-1198d3b12ce5-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,https://search.clinicalgenome.org/kb/conditions/MONDO:0016342,
918,PKP2,HGNC:9024,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a8e26ad-c4ce-48d7-acab-1198d3b12ce5-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,arrhythmogenic right ventricular dysplasia 9,MONDO:0012180,https://search.clinicalgenome.org/kb/conditions/MONDO:0012180,
919,PKP2,HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1231ec3b-3570-48dd-bea4-f7cd7fc54811-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
920,PKP2,HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1231ec3b-3570-48dd-bea4-f7cd7fc54811-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
921,PKP2,HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1231ec3b-3570-48dd-bea4-f7cd7fc54811-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
922,PKP2,HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1231ec3b-3570-48dd-bea4-f7cd7fc54811-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,Autosomal dominant inheritance
923,PKP2,HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1231ec3b-3570-48dd-bea4-f7cd7fc54811-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,https://search.clinicalgenome.org/kb/conditions/MONDO:0016342,
924,PKP2,HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1231ec3b-3570-48dd-bea4-f7cd7fc54811-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,arrhythmogenic right ventricular dysplasia 9,MONDO:0012180,https://search.clinicalgenome.org/kb/conditions/MONDO:0012180,
925,PKP2,HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f97b6cd-5225-4076-b67a-2f609908e6fe-2018-03-08T170000.000Z,2018-03-08T17:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,Autosomal dominant inheritance
926,PKP2,HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f97b6cd-5225-4076-b67a-2f609908e6fe-2018-03-08T170000.000Z,2018-03-08T17:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
927,PKP2,HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f97b6cd-5225-4076-b67a-2f609908e6fe-2018-03-08T170000.000Z,2018-03-08T17:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,Autosomal dominant inheritance
928,PKP2,HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f97b6cd-5225-4076-b67a-2f609908e6fe-2018-03-08T170000.000Z,2018-03-08T17:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,Autosomal dominant inheritance
929,PKP2,HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f97b6cd-5225-4076-b67a-2f609908e6fe-2018-03-08T170000.000Z,2018-03-08T17:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,https://search.clinicalgenome.org/kb/conditions/MONDO:0016342,
930,PKP2,HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f97b6cd-5225-4076-b67a-2f609908e6fe-2018-03-08T170000.000Z,2018-03-08T17:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel,PKP2,HGNC:9024,chr12:32943689-33049711,chr12:32790755-32896777,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PKP2&subject=,2023-05-10T16:50:26Z,PKP2,https://search.clinicalgenome.org/kb/genes/HGNC:9024,arrhythmogenic right ventricular dysplasia 9,MONDO:0012180,https://search.clinicalgenome.org/kb/conditions/MONDO:0012180,
931,EN2,HGNC:3343,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91eb2fc6-864c-4a4a-9b2d-0b2bdd695999-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,EN2,HGNC:3343,chr7:155250824-155257526,chr7:155458129-155464831,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=EN2&subject=,2012-08-26T21:21:27Z,EN2,https://search.clinicalgenome.org/kb/genes/HGNC:3343,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
932,ANK2,HGNC:493,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10145,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
933,ANK2,HGNC:493,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10145,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
934,ANK2,HGNC:493,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10145,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
935,ANK2,HGNC:493,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10145,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
936,ANK2,HGNC:493,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7e5e43e-1596-4c15-bf14-e9388b204e88-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
937,ANK2,HGNC:493,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7e5e43e-1596-4c15-bf14-e9388b204e88-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
938,ANK2,HGNC:493,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7e5e43e-1596-4c15-bf14-e9388b204e88-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
939,ANK2,HGNC:493,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7e5e43e-1596-4c15-bf14-e9388b204e88-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
940,ANK2,HGNC:493,long QT syndrome,MONDO:0002442,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd577817-d668-413c-95f9-d3e08a8cf5d3-2020-12-15T002719.834Z,2020-12-15T00:27:19.834Z,Long QT Syndrome Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
941,ANK2,HGNC:493,long QT syndrome,MONDO:0002442,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd577817-d668-413c-95f9-d3e08a8cf5d3-2020-12-15T002719.834Z,2020-12-15T00:27:19.834Z,Long QT Syndrome Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,long QT syndrome,MONDO:0002442,https://search.clinicalgenome.org/kb/conditions/MONDO:0002442,Autosomal dominant inheritance
942,ANK2,HGNC:493,long QT syndrome,MONDO:0002442,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd577817-d668-413c-95f9-d3e08a8cf5d3-2020-12-15T002719.834Z,2020-12-15T00:27:19.834Z,Long QT Syndrome Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,https://search.clinicalgenome.org/kb/conditions/MONDO:0017990,Autosomal dominant inheritance
943,ANK2,HGNC:493,long QT syndrome,MONDO:0002442,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd577817-d668-413c-95f9-d3e08a8cf5d3-2020-12-15T002719.834Z,2020-12-15T00:27:19.834Z,Long QT Syndrome Gene Curation Expert Panel,ANK2,HGNC:493,chr4:113626778-114304892,chr4:112705622-113383736,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ANK2&subject=,2025-01-14T17:11:45Z,ANK2,https://search.clinicalgenome.org/kb/genes/HGNC:493,Brugada syndrome,MONDO:0015263,https://search.clinicalgenome.org/kb/conditions/MONDO:0015263,Autosomal dominant inheritance
944,KAT6B,HGNC:17582,RASopathy,MONDO:0021060,AD,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb3c40d8-3aea-45bf-949e-c3ba7d96a6b4-2019-02-04T170000.000Z,2019-02-04T17:00:00.000Z,RASopathy Gene Curation Expert Panel,KAT6B,HGNC:17582,chr10:76585013-76792382,chr10:74824936-75032624,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KAT6B&subject=,2018-04-25T16:42:12Z,KAT6B,https://search.clinicalgenome.org/kb/genes/HGNC:17582,RASopathy,MONDO:0021060,https://search.clinicalgenome.org/kb/conditions/MONDO:0021060,Autosomal dominant inheritance
945,KAT6B,HGNC:17582,RASopathy,MONDO:0021060,AD,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb3c40d8-3aea-45bf-949e-c3ba7d96a6b4-2019-02-04T170000.000Z,2019-02-04T17:00:00.000Z,RASopathy Gene Curation Expert Panel,KAT6B,HGNC:17582,chr10:76585013-76792382,chr10:74824936-75032624,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KAT6B&subject=,2018-04-25T16:42:12Z,KAT6B,https://search.clinicalgenome.org/kb/genes/HGNC:17582,KAT6B-related multiple congenital anomalies syndrome,MONDO:0036042,https://search.clinicalgenome.org/kb/conditions/MONDO:0036042,Autosomal dominant inheritance
946,KAT6B,HGNC:17582,RASopathy,MONDO:0021060,AD,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb3c40d8-3aea-45bf-949e-c3ba7d96a6b4-2019-02-04T170000.000Z,2019-02-04T17:00:00.000Z,RASopathy Gene Curation Expert Panel,KAT6B,HGNC:17582,chr10:76585013-76792382,chr10:74824936-75032624,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KAT6B&subject=,2018-04-25T16:42:12Z,KAT6B,https://search.clinicalgenome.org/kb/genes/HGNC:17582,"blepharophimosis - intellectual disability syndrome, SBBYS type",MONDO:0011365,https://search.clinicalgenome.org/kb/conditions/MONDO:0011365,
947,KATNAL2,HGNC:25387,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eddbdd3e-2f6b-4b55-a951-988ee214b08b-2020-05-20T160000.000Z,2020-05-20T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,KATNAL2,HGNC:25387,chr18:44497557-44628614,chr18:46917594-47102243,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KATNAL2&subject=,2018-11-28T17:31:10Z,KATNAL2,https://search.clinicalgenome.org/kb/genes/HGNC:25387,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
948,KATNAL2,HGNC:25387,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eddbdd3e-2f6b-4b55-a951-988ee214b08b-2020-05-20T160000.000Z,2020-05-20T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,KATNAL2,HGNC:25387,chr18:44497557-44628614,chr18:46917594-47102243,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=KATNAL2&subject=,2018-11-28T17:31:10Z,KATNAL2,https://search.clinicalgenome.org/kb/genes/HGNC:25387,Neurodevelopmental delay,HP:0012758,https://search.clinicalgenome.org/kb/conditions/HP:0012758,
949,USH1G,HGNC:16356,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02c62d06-b496-4a48-a514-56a772fae071-2019-05-21T160000.000Z,2019-05-21T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,USH1G,HGNC:16356,chr17:72912175-72919350,chr17:74916083-74923255,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=USH1G&subject=,2016-08-22T17:53:19Z,USH1G,https://search.clinicalgenome.org/kb/genes/HGNC:16356,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
950,USH1G,HGNC:16356,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02c62d06-b496-4a48-a514-56a772fae071-2019-05-21T160000.000Z,2019-05-21T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,USH1G,HGNC:16356,chr17:72912175-72919350,chr17:74916083-74923255,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=USH1G&subject=,2016-08-22T17:53:19Z,USH1G,https://search.clinicalgenome.org/kb/genes/HGNC:16356,Usher syndrome type 1,MONDO:0010168,https://search.clinicalgenome.org/kb/conditions/MONDO:0010168,Autosomal recessive inheritance
951,USH1G,HGNC:16356,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02c62d06-b496-4a48-a514-56a772fae071-2019-05-21T160000.000Z,2019-05-21T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,USH1G,HGNC:16356,chr17:72912175-72919350,chr17:74916083-74923255,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=USH1G&subject=,2016-08-22T17:53:19Z,USH1G,https://search.clinicalgenome.org/kb/genes/HGNC:16356,Usher syndrome type 1G,MONDO:0011748,https://search.clinicalgenome.org/kb/conditions/MONDO:0011748,
952,DPP6,HGNC:3010,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d41cebe-5490-419d-882d-4f3c6856be07-2021-05-05T160000.000Z,2021-05-05T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,DPP6,HGNC:3010,chr7:153445218-154685995,chr7:153748133-154894285,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DPP6&subject=,2019-06-26T16:38:44Z,DPP6,https://search.clinicalgenome.org/kb/genes/HGNC:3010,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
953,DPP6,HGNC:3010,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d41cebe-5490-419d-882d-4f3c6856be07-2021-05-05T160000.000Z,2021-05-05T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,DPP6,HGNC:3010,chr7:153445218-154685995,chr7:153748133-154894285,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DPP6&subject=,2019-06-26T16:38:44Z,DPP6,https://search.clinicalgenome.org/kb/genes/HGNC:3010,"intellectual disability, autosomal dominant 33",MONDO:0014580,https://search.clinicalgenome.org/kb/conditions/MONDO:0014580,
954,SCN1B,HGNC:10586,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10158,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,SCN1B,HGNC:10586,chr19:35521374-35531353,chr19:35030470-35040449,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1B&subject=,2019-09-04T15:12:47Z,SCN1B,https://search.clinicalgenome.org/kb/genes/HGNC:10586,generalized epilepsy with febrile seizures plus,MONDO:0018214,https://search.clinicalgenome.org/kb/conditions/MONDO:0018214,Autosomal dominant inheritance
955,SCN1B,HGNC:10586,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10158,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,SCN1B,HGNC:10586,chr19:35521374-35531353,chr19:35030470-35040449,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1B&subject=,2019-09-04T15:12:47Z,SCN1B,https://search.clinicalgenome.org/kb/genes/HGNC:10586,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal recessive inheritance
956,SCN1B,HGNC:10586,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10158,2017-11-21T00:00:00,Brugada Syndrome Gene Curation Expert Panel,SCN1B,HGNC:10586,chr19:35521374-35531353,chr19:35030470-35040449,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1B&subject=,2019-09-04T15:12:47Z,SCN1B,https://search.clinicalgenome.org/kb/genes/HGNC:10586,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,Autosomal dominant inheritance
957,SCN1B,HGNC:10586,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4c35c20-6e59-46cf-9347-852b80af8dcc-2022-01-04T211051.949Z,2022-01-04T21:10:51.949Z,Epilepsy Gene Curation Expert Panel,SCN1B,HGNC:10586,chr19:35521374-35531353,chr19:35030470-35040449,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1B&subject=,2019-09-04T15:12:47Z,SCN1B,https://search.clinicalgenome.org/kb/genes/HGNC:10586,generalized epilepsy with febrile seizures plus,MONDO:0018214,https://search.clinicalgenome.org/kb/conditions/MONDO:0018214,Autosomal dominant inheritance
958,SCN1B,HGNC:10586,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4c35c20-6e59-46cf-9347-852b80af8dcc-2022-01-04T211051.949Z,2022-01-04T21:10:51.949Z,Epilepsy Gene Curation Expert Panel,SCN1B,HGNC:10586,chr19:35521374-35531353,chr19:35030470-35040449,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1B&subject=,2019-09-04T15:12:47Z,SCN1B,https://search.clinicalgenome.org/kb/genes/HGNC:10586,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal recessive inheritance
959,SCN1B,HGNC:10586,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4c35c20-6e59-46cf-9347-852b80af8dcc-2022-01-04T211051.949Z,2022-01-04T21:10:51.949Z,Epilepsy Gene Curation Expert Panel,SCN1B,HGNC:10586,chr19:35521374-35531353,chr19:35030470-35040449,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1B&subject=,2019-09-04T15:12:47Z,SCN1B,https://search.clinicalgenome.org/kb/genes/HGNC:10586,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,Autosomal dominant inheritance
960,SCN1B,HGNC:10586,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91fb4b50-478b-4e3a-ac8a-a5cb7634a492-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN1B,HGNC:10586,chr19:35521374-35531353,chr19:35030470-35040449,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1B&subject=,2019-09-04T15:12:47Z,SCN1B,https://search.clinicalgenome.org/kb/genes/HGNC:10586,generalized epilepsy with febrile seizures plus,MONDO:0018214,https://search.clinicalgenome.org/kb/conditions/MONDO:0018214,Autosomal dominant inheritance
961,SCN1B,HGNC:10586,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91fb4b50-478b-4e3a-ac8a-a5cb7634a492-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN1B,HGNC:10586,chr19:35521374-35531353,chr19:35030470-35040449,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1B&subject=,2019-09-04T15:12:47Z,SCN1B,https://search.clinicalgenome.org/kb/genes/HGNC:10586,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal recessive inheritance
962,SCN1B,HGNC:10586,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91fb4b50-478b-4e3a-ac8a-a5cb7634a492-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN1B,HGNC:10586,chr19:35521374-35531353,chr19:35030470-35040449,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN1B&subject=,2019-09-04T15:12:47Z,SCN1B,https://search.clinicalgenome.org/kb/genes/HGNC:10586,Brugada syndrome 1,MONDO:0011001,https://search.clinicalgenome.org/kb/conditions/MONDO:0011001,Autosomal dominant inheritance
963,GJA5,HGNC:4279,congenital heart disease,MONDO:0005453,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8c3ec84-6459-406d-92a0-0ac98c243ae7-2024-04-02T160000.000Z,2024-04-02T16:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,GJA5,HGNC:4279,chr1:147228332-147245455,chr1:147756199-147773351,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=GJA5&subject=,2012-02-23T20:46:33Z,GJA5,https://search.clinicalgenome.org/kb/genes/HGNC:4279,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
964,SMAD4,HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12d82f9f-8ab2-4012-a5d5-20de99f23c07-2022-11-21T170000.000Z,2022-11-21T17:00:00.000Z,Pulmonary Hypertension Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,https://search.clinicalgenome.org/kb/conditions/MONDO:0008278,Autosomal dominant inheritance
965,SMAD4,HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12d82f9f-8ab2-4012-a5d5-20de99f23c07-2022-11-21T170000.000Z,2022-11-21T17:00:00.000Z,Pulmonary Hypertension Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,https://search.clinicalgenome.org/kb/conditions/MONDO:0015924,Autosomal dominant inheritance
966,SMAD4,HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12d82f9f-8ab2-4012-a5d5-20de99f23c07-2022-11-21T170000.000Z,2022-11-21T17:00:00.000Z,Pulmonary Hypertension Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,Myhre syndrome,MONDO:0007688,https://search.clinicalgenome.org/kb/conditions/MONDO:0007688,Autosomal dominant inheritance
967,SMAD4,HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12d82f9f-8ab2-4012-a5d5-20de99f23c07-2022-11-21T170000.000Z,2022-11-21T17:00:00.000Z,Pulmonary Hypertension Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,juvenile polyposis syndrome,MONDO:0017380,https://search.clinicalgenome.org/kb/conditions/MONDO:0017380,
968,SMAD4,HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12d82f9f-8ab2-4012-a5d5-20de99f23c07-2022-11-21T170000.000Z,2022-11-21T17:00:00.000Z,Pulmonary Hypertension Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,generalized juvenile polyposis/juvenile polyposis coli,MONDO:0008276,https://search.clinicalgenome.org/kb/conditions/MONDO:0008276,
969,SMAD4,HGNC:6770,Myhre syndrome,MONDO:0007688,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5a082cc-c214-4bfa-8cb8-caead239d129-2021-12-30T170000.000Z,2021-12-30T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,https://search.clinicalgenome.org/kb/conditions/MONDO:0008278,Autosomal dominant inheritance
970,SMAD4,HGNC:6770,Myhre syndrome,MONDO:0007688,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5a082cc-c214-4bfa-8cb8-caead239d129-2021-12-30T170000.000Z,2021-12-30T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,https://search.clinicalgenome.org/kb/conditions/MONDO:0015924,Autosomal dominant inheritance
971,SMAD4,HGNC:6770,Myhre syndrome,MONDO:0007688,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5a082cc-c214-4bfa-8cb8-caead239d129-2021-12-30T170000.000Z,2021-12-30T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,Myhre syndrome,MONDO:0007688,https://search.clinicalgenome.org/kb/conditions/MONDO:0007688,Autosomal dominant inheritance
972,SMAD4,HGNC:6770,Myhre syndrome,MONDO:0007688,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5a082cc-c214-4bfa-8cb8-caead239d129-2021-12-30T170000.000Z,2021-12-30T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,juvenile polyposis syndrome,MONDO:0017380,https://search.clinicalgenome.org/kb/conditions/MONDO:0017380,
973,SMAD4,HGNC:6770,Myhre syndrome,MONDO:0007688,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5a082cc-c214-4bfa-8cb8-caead239d129-2021-12-30T170000.000Z,2021-12-30T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,generalized juvenile polyposis/juvenile polyposis coli,MONDO:0008276,https://search.clinicalgenome.org/kb/conditions/MONDO:0008276,
974,SMAD4,HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9b79d0f-4259-49d7-882d-4ca23bb7e8cf-2023-04-18T160000.000Z,2023-04-18T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,https://search.clinicalgenome.org/kb/conditions/MONDO:0008278,Autosomal dominant inheritance
975,SMAD4,HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9b79d0f-4259-49d7-882d-4ca23bb7e8cf-2023-04-18T160000.000Z,2023-04-18T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,https://search.clinicalgenome.org/kb/conditions/MONDO:0015924,Autosomal dominant inheritance
976,SMAD4,HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9b79d0f-4259-49d7-882d-4ca23bb7e8cf-2023-04-18T160000.000Z,2023-04-18T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,Myhre syndrome,MONDO:0007688,https://search.clinicalgenome.org/kb/conditions/MONDO:0007688,Autosomal dominant inheritance
977,SMAD4,HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9b79d0f-4259-49d7-882d-4ca23bb7e8cf-2023-04-18T160000.000Z,2023-04-18T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,juvenile polyposis syndrome,MONDO:0017380,https://search.clinicalgenome.org/kb/conditions/MONDO:0017380,
978,SMAD4,HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9b79d0f-4259-49d7-882d-4ca23bb7e8cf-2023-04-18T160000.000Z,2023-04-18T16:00:00.000Z,Hemostasis/Thrombosis Gene Curation Expert Panel,SMAD4,HGNC:6770,chr18:48556583-48611412,chr18:51030213-51085042,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD4&subject=,2020-12-16T17:36:40Z,SMAD4,https://search.clinicalgenome.org/kb/genes/HGNC:6770,generalized juvenile polyposis/juvenile polyposis coli,MONDO:0008276,https://search.clinicalgenome.org/kb/conditions/MONDO:0008276,
979,FBN1,HGNC:3603,Shprintzen-Goldberg syndrome,MONDO:0008426,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42caf14d-6400-475b-88f3-a8a24a0832c0-2021-12-01T190000.000Z,2021-12-01T19:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,FBN1,HGNC:3603,chr15:48700510-48937906,chr15:48408313-48645709,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FBN1&subject=,2019-12-04T17:45:52Z,FBN1,https://search.clinicalgenome.org/kb/genes/HGNC:3603,Marfan syndrome,MONDO:0007947,https://search.clinicalgenome.org/kb/conditions/MONDO:0007947,Autosomal dominant inheritance
980,FBN1,HGNC:3603,Shprintzen-Goldberg syndrome,MONDO:0008426,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42caf14d-6400-475b-88f3-a8a24a0832c0-2021-12-01T190000.000Z,2021-12-01T19:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,FBN1,HGNC:3603,chr15:48700510-48937906,chr15:48408313-48645709,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FBN1&subject=,2019-12-04T17:45:52Z,FBN1,https://search.clinicalgenome.org/kb/genes/HGNC:3603,Shprintzen-Goldberg syndrome,MONDO:0008426,https://search.clinicalgenome.org/kb/conditions/MONDO:0008426,Autosomal dominant inheritance
981,FBN1,HGNC:3603,Shprintzen-Goldberg syndrome,MONDO:0008426,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42caf14d-6400-475b-88f3-a8a24a0832c0-2021-12-01T190000.000Z,2021-12-01T19:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,FBN1,HGNC:3603,chr15:48700510-48937906,chr15:48408313-48645709,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=FBN1&subject=,2019-12-04T17:45:52Z,FBN1,https://search.clinicalgenome.org/kb/genes/HGNC:3603,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,https://search.clinicalgenome.org/kb/conditions/MONDO:0019625,Autosomal dominant inheritance
982,PMS2,HGNC:9122,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_308d8362-7bd9-46a7-b2fa-ab8f671a44c9-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,mismatch repair cancer syndrome 1,MONDO:0010159,https://search.clinicalgenome.org/kb/conditions/MONDO:0010159,Autosomal recessive inheritance
983,PMS2,HGNC:9122,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_308d8362-7bd9-46a7-b2fa-ab8f671a44c9-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,Lynch syndrome,MONDO:0005835,https://search.clinicalgenome.org/kb/conditions/MONDO:0005835,Autosomal dominant inheritance
984,PMS2,HGNC:9122,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_308d8362-7bd9-46a7-b2fa-ab8f671a44c9-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
985,PMS2,HGNC:9122,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_308d8362-7bd9-46a7-b2fa-ab8f671a44c9-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,Lynch syndrome 4,MONDO:0013699,https://search.clinicalgenome.org/kb/conditions/MONDO:0013699,
986,PMS2,HGNC:9122,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_308d8362-7bd9-46a7-b2fa-ab8f671a44c9-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,mismatch repair cancer syndrome,MONDO:0031219,https://search.clinicalgenome.org/kb/conditions/MONDO:0031219,
987,PMS2,HGNC:9122,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_308d8362-7bd9-46a7-b2fa-ab8f671a44c9-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,mismatch repair cancer syndrome 4,MONDO:0030843,https://search.clinicalgenome.org/kb/conditions/MONDO:0030843,
988,PMS2,HGNC:9122,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_308d8362-7bd9-46a7-b2fa-ab8f671a44c9-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,,614337,https://search.clinicalgenome.org/kb/conditions/614337,
989,PMS2,HGNC:9122,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_213ba61e-a4a5-4e4f-945d-f0fef691a9ba-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,mismatch repair cancer syndrome 1,MONDO:0010159,https://search.clinicalgenome.org/kb/conditions/MONDO:0010159,Autosomal recessive inheritance
990,PMS2,HGNC:9122,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_213ba61e-a4a5-4e4f-945d-f0fef691a9ba-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,Lynch syndrome,MONDO:0005835,https://search.clinicalgenome.org/kb/conditions/MONDO:0005835,Autosomal dominant inheritance
991,PMS2,HGNC:9122,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_213ba61e-a4a5-4e4f-945d-f0fef691a9ba-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
992,PMS2,HGNC:9122,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_213ba61e-a4a5-4e4f-945d-f0fef691a9ba-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,Lynch syndrome 4,MONDO:0013699,https://search.clinicalgenome.org/kb/conditions/MONDO:0013699,
993,PMS2,HGNC:9122,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_213ba61e-a4a5-4e4f-945d-f0fef691a9ba-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,mismatch repair cancer syndrome,MONDO:0031219,https://search.clinicalgenome.org/kb/conditions/MONDO:0031219,
994,PMS2,HGNC:9122,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_213ba61e-a4a5-4e4f-945d-f0fef691a9ba-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,mismatch repair cancer syndrome 4,MONDO:0030843,https://search.clinicalgenome.org/kb/conditions/MONDO:0030843,
995,PMS2,HGNC:9122,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_213ba61e-a4a5-4e4f-945d-f0fef691a9ba-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PMS2,HGNC:9122,chr7:6010556-6048737,chr7:5970925-6009106,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMS2&subject=,2015-11-16T01:20:30Z,PMS2,https://search.clinicalgenome.org/kb/genes/HGNC:9122,,614337,https://search.clinicalgenome.org/kb/conditions/614337,
996,RELN,HGNC:9957,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c654081c-5abd-4f86-a3f7-90d7f117b93d-2023-07-19T060000.000Z,2023-07-19T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,RELN,HGNC:9957,chr7:103112236-103630105,chr7:103471789-103989658,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RELN&subject=,2023-12-14T22:09:00Z,RELN,https://search.clinicalgenome.org/kb/genes/HGNC:9957,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
997,RELN,HGNC:9957,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c654081c-5abd-4f86-a3f7-90d7f117b93d-2023-07-19T060000.000Z,2023-07-19T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,RELN,HGNC:9957,chr7:103112236-103630105,chr7:103471789-103989658,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RELN&subject=,2023-12-14T22:09:00Z,RELN,https://search.clinicalgenome.org/kb/genes/HGNC:9957,lissencephaly with cerebellar hypoplasia,MONDO:0019450,https://search.clinicalgenome.org/kb/conditions/MONDO:0019450,Autosomal recessive inheritance
998,RELN,HGNC:9957,lissencephaly with cerebellar hypoplasia,MONDO:0019450,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_28da7e7d-fa9c-4f7a-8962-ece6f572adc7-2023-12-04T200000.000Z,2023-12-04T20:00:00.000Z,Brain Malformations Gene Curation Expert Panel,RELN,HGNC:9957,chr7:103112236-103630105,chr7:103471789-103989658,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RELN&subject=,2023-12-14T22:09:00Z,RELN,https://search.clinicalgenome.org/kb/genes/HGNC:9957,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
999,RELN,HGNC:9957,lissencephaly with cerebellar hypoplasia,MONDO:0019450,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_28da7e7d-fa9c-4f7a-8962-ece6f572adc7-2023-12-04T200000.000Z,2023-12-04T20:00:00.000Z,Brain Malformations Gene Curation Expert Panel,RELN,HGNC:9957,chr7:103112236-103630105,chr7:103471789-103989658,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RELN&subject=,2023-12-14T22:09:00Z,RELN,https://search.clinicalgenome.org/kb/genes/HGNC:9957,lissencephaly with cerebellar hypoplasia,MONDO:0019450,https://search.clinicalgenome.org/kb/conditions/MONDO:0019450,Autosomal recessive inheritance
1000,HRAS,HGNC:5173,Noonan syndrome-like disorder with loose anagen hair,MONDO:0011899,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94630309-c540-48b3-a27f-0ee1891091c1-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy Gene Curation Expert Panel,HRAS,HGNC:5173,chr11:532242-535576,chr11:532242-535576,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HRAS&subject=,2024-07-15T14:34:32Z,HRAS,https://search.clinicalgenome.org/kb/genes/HGNC:5173,Noonan syndrome-like disorder with loose anagen hair,MONDO:0011899,https://search.clinicalgenome.org/kb/conditions/MONDO:0011899,Autosomal dominant inheritance
1001,HRAS,HGNC:5173,Noonan syndrome-like disorder with loose anagen hair,MONDO:0011899,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94630309-c540-48b3-a27f-0ee1891091c1-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy Gene Curation Expert Panel,HRAS,HGNC:5173,chr11:532242-535576,chr11:532242-535576,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HRAS&subject=,2024-07-15T14:34:32Z,HRAS,https://search.clinicalgenome.org/kb/genes/HGNC:5173,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
1002,ADGRV1,HGNC:17416,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f3dc96a-8fd3-4d30-98fd-1b1cf264e818-2019-03-19T160000.000Z,2019-03-19T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,ADGRV1,HGNC:17416,chr5:89854614-90460254,chr5:90558797-91164437,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ADGRV1&subject=,2021-08-23T16:03:40Z,ADGRV1,https://search.clinicalgenome.org/kb/genes/HGNC:17416,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
1003,ADGRV1,HGNC:17416,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f3dc96a-8fd3-4d30-98fd-1b1cf264e818-2019-03-19T160000.000Z,2019-03-19T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,ADGRV1,HGNC:17416,chr5:89854614-90460254,chr5:90558797-91164437,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ADGRV1&subject=,2021-08-23T16:03:40Z,ADGRV1,https://search.clinicalgenome.org/kb/genes/HGNC:17416,Usher syndrome type 2,MONDO:0016484,https://search.clinicalgenome.org/kb/conditions/MONDO:0016484,Autosomal recessive inheritance
1004,AGTR2,HGNC:338,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d7cfa2a0-e6a7-49b8-a773-b32a1dfbcd57-2020-06-02T160000.000Z,2020-06-02T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,AGTR2,HGNC:338,chrX:115301997-115306227,chrX:116170744-116174974,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=AGTR2&subject=,2012-05-10T13:30:11Z,AGTR2,https://search.clinicalgenome.org/kb/genes/HGNC:338,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
1005,AGTR2,HGNC:338,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d7cfa2a0-e6a7-49b8-a773-b32a1dfbcd57-2020-06-02T160000.000Z,2020-06-02T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,AGTR2,HGNC:338,chrX:115301997-115306227,chrX:116170744-116174974,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=AGTR2&subject=,2012-05-10T13:30:11Z,AGTR2,https://search.clinicalgenome.org/kb/genes/HGNC:338,"intellectual disability, X-linked 88",MONDO:0010454,https://search.clinicalgenome.org/kb/conditions/MONDO:0010454,
1006,PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
1007,PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
1008,PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
1009,PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
1010,PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,Noonan syndrome 1,MONDO:0008104,https://search.clinicalgenome.org/kb/conditions/MONDO:0008104,
1011,PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,LEOPARD syndrome 3,MONDO:0013380,https://search.clinicalgenome.org/kb/conditions/MONDO:0013380,
1012,PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,LEOPARD syndrome 2,MONDO:0012691,https://search.clinicalgenome.org/kb/conditions/MONDO:0012691,
1013,PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,LEOPARD syndrome 1,MONDO:0100082,https://search.clinicalgenome.org/kb/conditions/MONDO:0100082,
1014,PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,metachondromatosis,MONDO:0007979,https://search.clinicalgenome.org/kb/conditions/MONDO:0007979,
1015,PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
1016,PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,Noonan syndrome with multiple lentigines,MONDO:0007893,https://search.clinicalgenome.org/kb/conditions/MONDO:0007893,Autosomal dominant inheritance
1017,PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
1018,PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
1019,PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,Noonan syndrome 1,MONDO:0008104,https://search.clinicalgenome.org/kb/conditions/MONDO:0008104,
1020,PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,LEOPARD syndrome 3,MONDO:0013380,https://search.clinicalgenome.org/kb/conditions/MONDO:0013380,
1021,PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,LEOPARD syndrome 2,MONDO:0012691,https://search.clinicalgenome.org/kb/conditions/MONDO:0012691,
1022,PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,LEOPARD syndrome 1,MONDO:0100082,https://search.clinicalgenome.org/kb/conditions/MONDO:0100082,
1023,PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy Gene Curation Expert Panel,PTPN11,HGNC:9644,chr12:112856751-112947722,chr12:112418947-112509918,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTPN11&subject=,2020-09-08T16:21:03Z,PTPN11,https://search.clinicalgenome.org/kb/genes/HGNC:9644,metachondromatosis,MONDO:0007979,https://search.clinicalgenome.org/kb/conditions/MONDO:0007979,
1024,BTK,HGNC:1133,isolated growth hormone deficiency type III,MONDO:0010615,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6341781b-9ba9-41b1-889a-8d65a9b3ebb7-2020-11-17T170000.000Z,2020-11-17T17:00:00.000Z,Antibody Deficiencies Gene Curation Expert Panel,BTK,HGNC:1133,chrX:100604438-100645784,chrX:101349450-101390796,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BTK&subject=,2021-03-24T16:27:18Z,BTK,https://search.clinicalgenome.org/kb/genes/HGNC:1133,isolated growth hormone deficiency type III,MONDO:0010615,https://search.clinicalgenome.org/kb/conditions/MONDO:0010615,X-linked inheritance
1025,BTK,HGNC:1133,isolated growth hormone deficiency type III,MONDO:0010615,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6341781b-9ba9-41b1-889a-8d65a9b3ebb7-2020-11-17T170000.000Z,2020-11-17T17:00:00.000Z,Antibody Deficiencies Gene Curation Expert Panel,BTK,HGNC:1133,chrX:100604438-100645784,chrX:101349450-101390796,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BTK&subject=,2021-03-24T16:27:18Z,BTK,https://search.clinicalgenome.org/kb/genes/HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,https://search.clinicalgenome.org/kb/conditions/MONDO:0010421,X-linked inheritance
1026,TSPEAR,HGNC:1268,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0928b06-d3bb-41fe-8222-d7f0e6c0a25a-2024-10-31T160000.000Z,2024-10-31T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,TSPEAR,HGNC:1268,chr21:45917776-46131487,chr21:44497893-44711572,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TSPEAR&subject=,2016-08-22T17:53:08Z,TSPEAR,https://search.clinicalgenome.org/kb/genes/HGNC:1268,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
1027,TSPEAR,HGNC:1268,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP11,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0928b06-d3bb-41fe-8222-d7f0e6c0a25a-2024-10-31T160000.000Z,2024-10-31T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,TSPEAR,HGNC:1268,chr21:45917776-46131487,chr21:44497893-44711572,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TSPEAR&subject=,2016-08-22T17:53:08Z,TSPEAR,https://search.clinicalgenome.org/kb/genes/HGNC:1268,autosomal recessive nonsyndromic hearing loss 98,MONDO:0013929,https://search.clinicalgenome.org/kb/conditions/MONDO:0013929,
1028,RASA1,HGNC:9871,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a957c2df-eeec-4bdf-b423-6f1667f66abd-2018-06-07T160000.000Z,2018-06-07T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RASA1,HGNC:9871,chr5:86563700-86687733,chr5:87267883-87391916,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RASA1&subject=,2020-04-22T16:05:15Z,RASA1,https://search.clinicalgenome.org/kb/genes/HGNC:9871,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
1029,RASA1,HGNC:9871,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a957c2df-eeec-4bdf-b423-6f1667f66abd-2018-06-07T160000.000Z,2018-06-07T16:00:00.000Z,RASopathy Gene Curation Expert Panel,RASA1,HGNC:9871,chr5:86563700-86687733,chr5:87267883-87391916,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RASA1&subject=,2020-04-22T16:05:15Z,RASA1,https://search.clinicalgenome.org/kb/genes/HGNC:9871,capillary malformation-arteriovenous malformation 1,MONDO:0020783,https://search.clinicalgenome.org/kb/conditions/MONDO:0020783,
1030,SHOC2,HGNC:15454,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_185c93c8-e875-46a2-83af-a8575b19a228-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
1031,SHOC2,HGNC:15454,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_185c93c8-e875-46a2-83af-a8575b19a228-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
1032,SHOC2,HGNC:15454,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_185c93c8-e875-46a2-83af-a8575b19a228-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
1033,SHOC2,HGNC:15454,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_185c93c8-e875-46a2-83af-a8575b19a228-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Noonan syndrome-like disorder with loose anagen hair,MONDO:0011899,https://search.clinicalgenome.org/kb/conditions/MONDO:0011899,Autosomal dominant inheritance
1034,SHOC2,HGNC:15454,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_185c93c8-e875-46a2-83af-a8575b19a228-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Noonan syndrome-like disorder with loose anagen hair 1,MONDO:0054637,https://search.clinicalgenome.org/kb/conditions/MONDO:0054637,
1035,SHOC2,HGNC:15454,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7035ea3-d556-4aa4-b525-5ed6c02866df-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
1036,SHOC2,HGNC:15454,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7035ea3-d556-4aa4-b525-5ed6c02866df-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
1037,SHOC2,HGNC:15454,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7035ea3-d556-4aa4-b525-5ed6c02866df-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
1038,SHOC2,HGNC:15454,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7035ea3-d556-4aa4-b525-5ed6c02866df-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Noonan syndrome-like disorder with loose anagen hair,MONDO:0011899,https://search.clinicalgenome.org/kb/conditions/MONDO:0011899,Autosomal dominant inheritance
1039,SHOC2,HGNC:15454,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7035ea3-d556-4aa4-b525-5ed6c02866df-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Noonan syndrome-like disorder with loose anagen hair 1,MONDO:0054637,https://search.clinicalgenome.org/kb/conditions/MONDO:0054637,
1040,SHOC2,HGNC:15454,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd8e5069-4023-4763-9b41-03350b03ee7f-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
1041,SHOC2,HGNC:15454,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd8e5069-4023-4763-9b41-03350b03ee7f-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
1042,SHOC2,HGNC:15454,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd8e5069-4023-4763-9b41-03350b03ee7f-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
1043,SHOC2,HGNC:15454,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd8e5069-4023-4763-9b41-03350b03ee7f-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Noonan syndrome-like disorder with loose anagen hair,MONDO:0011899,https://search.clinicalgenome.org/kb/conditions/MONDO:0011899,Autosomal dominant inheritance
1044,SHOC2,HGNC:15454,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd8e5069-4023-4763-9b41-03350b03ee7f-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SHOC2,HGNC:15454,chr10:112679128-112773423,chr10:110919370-111013665,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHOC2&subject=,2018-09-25T16:27:29Z,SHOC2,https://search.clinicalgenome.org/kb/genes/HGNC:15454,Noonan syndrome-like disorder with loose anagen hair 1,MONDO:0054637,https://search.clinicalgenome.org/kb/conditions/MONDO:0054637,
1045,SLC6A4,HGNC:11050,autism spectrum disorder,MONDO:0005258,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc4b0612-0a53-4e36-b737-5c0f49a387a1-2021-01-06T170000.000Z,2021-01-06T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SLC6A4,HGNC:11050,chr17:28521337-28562715,chr17:30194319-30235697,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC6A4&subject=,2012-05-11T02:51:51Z,SLC6A4,https://search.clinicalgenome.org/kb/genes/HGNC:11050,autism spectrum disorder,MONDO:0005258,https://search.clinicalgenome.org/kb/conditions/MONDO:0005258,Autosomal dominant inheritance
1046,CNTN6,HGNC:2176,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bda9083a-7edc-4102-be62-e1c62d0a6bc2-2022-09-20T060000.000Z,2022-09-20T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,CNTN6,HGNC:2176,chr3:1134708-1445901,chr3:1093024-1404217,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CNTN6&subject=,2022-09-28T16:59:38Z,CNTN6,https://search.clinicalgenome.org/kb/genes/HGNC:2176,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1047,SOS1,HGNC:11187,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf0ea291-849a-4bd9-a12a-cd9daad7e214-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SOS1,HGNC:11187,chr2:39208690-39352009,chr2:38981549-39124868,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOS1&subject=,2012-03-30T18:06:50Z,SOS 1,https://search.clinicalgenome.org/kb/genes/HGNC:11187,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
1048,SOS1,HGNC:11187,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf0ea291-849a-4bd9-a12a-cd9daad7e214-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SOS1,HGNC:11187,chr2:39208690-39352009,chr2:38981549-39124868,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOS1&subject=,2012-03-30T18:06:50Z,SOS 1,https://search.clinicalgenome.org/kb/genes/HGNC:11187,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
1049,SOS1,HGNC:11187,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf0ea291-849a-4bd9-a12a-cd9daad7e214-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SOS1,HGNC:11187,chr2:39208690-39352009,chr2:38981549-39124868,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOS1&subject=,2012-03-30T18:06:50Z,SOS 1,https://search.clinicalgenome.org/kb/genes/HGNC:11187,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
1050,SOS1,HGNC:11187,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf0ea291-849a-4bd9-a12a-cd9daad7e214-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SOS1,HGNC:11187,chr2:39208690-39352009,chr2:38981549-39124868,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOS1&subject=,2012-03-30T18:06:50Z,SOS 1,https://search.clinicalgenome.org/kb/genes/HGNC:11187,Noonan syndrome 4,MONDO:0012547,https://search.clinicalgenome.org/kb/conditions/MONDO:0012547,
1051,SOS1,HGNC:11187,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee5b916f-82ef-4738-82c8-46ee2fad131b-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SOS1,HGNC:11187,chr2:39208690-39352009,chr2:38981549-39124868,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOS1&subject=,2012-03-30T18:06:50Z,SOS 1,https://search.clinicalgenome.org/kb/genes/HGNC:11187,Noonan syndrome,MONDO:0018997,https://search.clinicalgenome.org/kb/conditions/MONDO:0018997,Autosomal dominant inheritance
1052,SOS1,HGNC:11187,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee5b916f-82ef-4738-82c8-46ee2fad131b-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SOS1,HGNC:11187,chr2:39208690-39352009,chr2:38981549-39124868,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOS1&subject=,2012-03-30T18:06:50Z,SOS 1,https://search.clinicalgenome.org/kb/genes/HGNC:11187,cardiofaciocutaneous syndrome,MONDO:0015280,https://search.clinicalgenome.org/kb/conditions/MONDO:0015280,Autosomal dominant inheritance
1053,SOS1,HGNC:11187,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee5b916f-82ef-4738-82c8-46ee2fad131b-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SOS1,HGNC:11187,chr2:39208690-39352009,chr2:38981549-39124868,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOS1&subject=,2012-03-30T18:06:50Z,SOS 1,https://search.clinicalgenome.org/kb/genes/HGNC:11187,Costello syndrome,MONDO:0009026,https://search.clinicalgenome.org/kb/conditions/MONDO:0009026,Autosomal dominant inheritance
1054,SOS1,HGNC:11187,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee5b916f-82ef-4738-82c8-46ee2fad131b-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy Gene Curation Expert Panel,SOS1,HGNC:11187,chr2:39208690-39352009,chr2:38981549-39124868,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOS1&subject=,2012-03-30T18:06:50Z,SOS 1,https://search.clinicalgenome.org/kb/genes/HGNC:11187,Noonan syndrome 4,MONDO:0012547,https://search.clinicalgenome.org/kb/conditions/MONDO:0012547,
1055,CDH15,HGNC:1754,intellectual disability,MONDO:0001071,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9295bddb-d61c-47c2-b186-97296b9c4d94-2021-02-17T170000.000Z,2021-02-17T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,CDH15,HGNC:1754,chr16:89238156-89261900,chr16:89171748-89195492,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CDH15&subject=,2013-08-08T14:28:39Z,CDH15,https://search.clinicalgenome.org/kb/genes/HGNC:1754,intellectual disability,MONDO:0001071,https://search.clinicalgenome.org/kb/conditions/MONDO:0001071,Autosomal dominant inheritance
1056,CDH15,HGNC:1754,intellectual disability,MONDO:0001071,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9295bddb-d61c-47c2-b186-97296b9c4d94-2021-02-17T170000.000Z,2021-02-17T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,CDH15,HGNC:1754,chr16:89238156-89261900,chr16:89171748-89195492,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CDH15&subject=,2013-08-08T14:28:39Z,CDH15,https://search.clinicalgenome.org/kb/genes/HGNC:1754,"intellectual disability, autosomal dominant 3",MONDO:0012946,https://search.clinicalgenome.org/kb/conditions/MONDO:0012946,
1057,ZNF81,HGNC:13156,X-linked intellectual disability,MONDO:0100284,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a3ada757-6500-46a1-a89e-42668bbdb934-2021-01-26T170000.000Z,2021-01-26T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,ZNF81,HGNC:13156,chrX:47696301-47785026,chrX:47836902-47925627,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ZNF81&subject=,2012-10-29T22:13:01Z,ZNF81,https://search.clinicalgenome.org/kb/genes/HGNC:13156,X-linked intellectual disability,MONDO:0100284,https://search.clinicalgenome.org/kb/conditions/MONDO:0100284,X-linked inheritance
1058,CASR,HGNC:1514,epilepsy,MONDO:0005027,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ddebf083-3434-4401-9b6b-9ec24aceec89-2021-03-03T123827.967Z,2021-03-03T12:38:27.967Z,Epilepsy Gene Curation Expert Panel,CASR,HGNC:1514,chr3:121902515-122010476,chr3:122183668-122291629,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASR&subject=,2012-03-02T23:26:38Z,CASR,https://search.clinicalgenome.org/kb/genes/HGNC:1514,epilepsy,MONDO:0005027,https://search.clinicalgenome.org/kb/conditions/MONDO:0005027,Autosomal dominant inheritance
1059,CASR,HGNC:1514,epilepsy,MONDO:0005027,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ddebf083-3434-4401-9b6b-9ec24aceec89-2021-03-03T123827.967Z,2021-03-03T12:38:27.967Z,Epilepsy Gene Curation Expert Panel,CASR,HGNC:1514,chr3:121902515-122010476,chr3:122183668-122291629,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASR&subject=,2012-03-02T23:26:38Z,CASR,https://search.clinicalgenome.org/kb/genes/HGNC:1514,autosomal dominant hypocalcemia 1,MONDO:0011013,https://search.clinicalgenome.org/kb/conditions/MONDO:0011013,Autosomal dominant inheritance
1060,CASR,HGNC:1514,epilepsy,MONDO:0005027,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ddebf083-3434-4401-9b6b-9ec24aceec89-2021-03-03T123827.967Z,2021-03-03T12:38:27.967Z,Epilepsy Gene Curation Expert Panel,CASR,HGNC:1514,chr3:121902515-122010476,chr3:122183668-122291629,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASR&subject=,2012-03-02T23:26:38Z,CASR,https://search.clinicalgenome.org/kb/genes/HGNC:1514,familial hypocalciuric hypercalcemia 1,MONDO:0007791,https://search.clinicalgenome.org/kb/conditions/MONDO:0007791,Autosomal dominant inheritance
1061,CASR,HGNC:1514,epilepsy,MONDO:0005027,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ddebf083-3434-4401-9b6b-9ec24aceec89-2021-03-03T123827.967Z,2021-03-03T12:38:27.967Z,Epilepsy Gene Curation Expert Panel,CASR,HGNC:1514,chr3:121902515-122010476,chr3:122183668-122291629,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CASR&subject=,2012-03-02T23:26:38Z,CASR,https://search.clinicalgenome.org/kb/genes/HGNC:1514,neonatal severe primary hyperparathyroidism,MONDO:0009397,https://search.clinicalgenome.org/kb/conditions/MONDO:0009397,Autosomal recessive inheritance
1062,DSP,HGNC:3052,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83a9ea83-5dec-4496-a5d8-9b5fdf9373d7-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,DSP,HGNC:3052,chr6:7541904-7586947,chr6:7541671-7586714,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSP&subject=,2021-10-12T16:58:46Z,DSP,https://search.clinicalgenome.org/kb/genes/HGNC:3052,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,Autosomal dominant inheritance
1063,DSP,HGNC:3052,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83a9ea83-5dec-4496-a5d8-9b5fdf9373d7-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,DSP,HGNC:3052,chr6:7541904-7586947,chr6:7541671-7586714,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSP&subject=,2021-10-12T16:58:46Z,DSP,https://search.clinicalgenome.org/kb/genes/HGNC:3052,arrhythmogenic cardiomyopathy with wooly hair and keratoderma,MONDO:0011581,https://search.clinicalgenome.org/kb/conditions/MONDO:0011581,Autosomal dominant inheritance
1064,DSP,HGNC:3052,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83a9ea83-5dec-4496-a5d8-9b5fdf9373d7-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,DSP,HGNC:3052,chr6:7541904-7586947,chr6:7541671-7586714,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSP&subject=,2021-10-12T16:58:46Z,DSP,https://search.clinicalgenome.org/kb/genes/HGNC:3052,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,https://search.clinicalgenome.org/kb/conditions/MONDO:0016587,
1065,DSP,HGNC:3052,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83a9ea83-5dec-4496-a5d8-9b5fdf9373d7-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,DSP,HGNC:3052,chr6:7541904-7586947,chr6:7541671-7586714,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSP&subject=,2021-10-12T16:58:46Z,DSP,https://search.clinicalgenome.org/kb/genes/HGNC:3052,arrhythmogenic right ventricular dysplasia 8,MONDO:0011831,https://search.clinicalgenome.org/kb/conditions/MONDO:0011831,
1066,DSP,HGNC:3052,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83a9ea83-5dec-4496-a5d8-9b5fdf9373d7-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,DSP,HGNC:3052,chr6:7541904-7586947,chr6:7541671-7586714,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSP&subject=,2021-10-12T16:58:46Z,DSP,https://search.clinicalgenome.org/kb/genes/HGNC:3052,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,https://search.clinicalgenome.org/kb/conditions/MONDO:0016342,
1067,DSP,HGNC:3052,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83a9ea83-5dec-4496-a5d8-9b5fdf9373d7-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,DSP,HGNC:3052,chr6:7541904-7586947,chr6:7541671-7586714,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=DSP&subject=,2021-10-12T16:58:46Z,DSP,https://search.clinicalgenome.org/kb/genes/HGNC:3052,dilated cardiomyopathy,MONDO:0005021,https://search.clinicalgenome.org/kb/conditions/MONDO:0005021,
1068,MSH6,HGNC:7329,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3c3cce5-7d58-4800-a956-e83c092071de-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH6,HGNC:7329,chr2:48010284-48034092,chr2:47783145-47810101,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH6&subject=,2021-10-13T16:40:38Z,MSH6,https://search.clinicalgenome.org/kb/genes/HGNC:7329,mismatch repair cancer syndrome 1,MONDO:0010159,https://search.clinicalgenome.org/kb/conditions/MONDO:0010159,Autosomal recessive inheritance
1069,MSH6,HGNC:7329,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3c3cce5-7d58-4800-a956-e83c092071de-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH6,HGNC:7329,chr2:48010284-48034092,chr2:47783145-47810101,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH6&subject=,2021-10-13T16:40:38Z,MSH6,https://search.clinicalgenome.org/kb/genes/HGNC:7329,Lynch syndrome,MONDO:0005835,https://search.clinicalgenome.org/kb/conditions/MONDO:0005835,Autosomal dominant inheritance
1070,MSH6,HGNC:7329,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3c3cce5-7d58-4800-a956-e83c092071de-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH6,HGNC:7329,chr2:48010284-48034092,chr2:47783145-47810101,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH6&subject=,2021-10-13T16:40:38Z,MSH6,https://search.clinicalgenome.org/kb/genes/HGNC:7329,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,Autosomal dominant inheritance
1071,MSH6,HGNC:7329,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3c3cce5-7d58-4800-a956-e83c092071de-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH6,HGNC:7329,chr2:48010284-48034092,chr2:47783145-47810101,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH6&subject=,2021-10-13T16:40:38Z,MSH6,https://search.clinicalgenome.org/kb/genes/HGNC:7329,Lynch syndrome 5,MONDO:0013710,https://search.clinicalgenome.org/kb/conditions/MONDO:0013710,
1072,MSH6,HGNC:7329,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3c3cce5-7d58-4800-a956-e83c092071de-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH6,HGNC:7329,chr2:48010284-48034092,chr2:47783145-47810101,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH6&subject=,2021-10-13T16:40:38Z,MSH6,https://search.clinicalgenome.org/kb/genes/HGNC:7329,mismatch repair cancer syndrome 3,MONDO:0030841,https://search.clinicalgenome.org/kb/conditions/MONDO:0030841,
1073,MSH6,HGNC:7329,hereditary breast carcinoma,MONDO:0016419,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3c3cce5-7d58-4800-a956-e83c092071de-2023-12-21T180000.000Z,2023-12-21T18:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,MSH6,HGNC:7329,chr2:48010284-48034092,chr2:47783145-47810101,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=MSH6&subject=,2021-10-13T16:40:38Z,MSH6,https://search.clinicalgenome.org/kb/genes/HGNC:7329,mismatch repair cancer syndrome,MONDO:0031219,https://search.clinicalgenome.org/kb/conditions/MONDO:0031219,
1074,BMPR1A,HGNC:1076,pulmonary arterial hypertension,MONDO:0015924,UD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e810879d-f635-4851-b20e-86998b000fcc-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,Pulmonary Hypertension Gene Curation Expert Panel,BMPR1A,HGNC:1076,chr10:88516376-88687726,chr10:86755763-86932844,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BMPR1A&subject=,2020-06-24T16:47:13Z,BMPR1A,https://search.clinicalgenome.org/kb/genes/HGNC:1076,juvenile polyposis syndrome,MONDO:0017380,https://search.clinicalgenome.org/kb/conditions/MONDO:0017380,Autosomal dominant inheritance
1075,BMPR1A,HGNC:1076,pulmonary arterial hypertension,MONDO:0015924,UD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e810879d-f635-4851-b20e-86998b000fcc-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,Pulmonary Hypertension Gene Curation Expert Panel,BMPR1A,HGNC:1076,chr10:88516376-88687726,chr10:86755763-86932844,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BMPR1A&subject=,2020-06-24T16:47:13Z,BMPR1A,https://search.clinicalgenome.org/kb/genes/HGNC:1076,pulmonary arterial hypertension,MONDO:0015924,https://search.clinicalgenome.org/kb/conditions/MONDO:0015924,Mode of inheritance
1076,BMPR1A,HGNC:1076,pulmonary arterial hypertension,MONDO:0015924,UD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e810879d-f635-4851-b20e-86998b000fcc-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,Pulmonary Hypertension Gene Curation Expert Panel,BMPR1A,HGNC:1076,chr10:88516376-88687726,chr10:86755763-86932844,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BMPR1A&subject=,2020-06-24T16:47:13Z,BMPR1A,https://search.clinicalgenome.org/kb/genes/HGNC:1076,generalized juvenile polyposis/juvenile polyposis coli,MONDO:0008276,https://search.clinicalgenome.org/kb/conditions/MONDO:0008276,
1077,BARD1,HGNC:952,familial ovarian cancer,MONDO:0016248,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02af8326-360e-4f42-a378-fefff7387d97-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BARD1,HGNC:952,chr2:215590370-215674407,chr2:214725646-214809683,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BARD1&subject=,2020-05-01T15:36:01Z,BARD1,https://search.clinicalgenome.org/kb/genes/HGNC:952,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,Autosomal dominant inheritance
1078,BARD1,HGNC:952,familial ovarian cancer,MONDO:0016248,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02af8326-360e-4f42-a378-fefff7387d97-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BARD1,HGNC:952,chr2:215590370-215674407,chr2:214725646-214809683,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BARD1&subject=,2020-05-01T15:36:01Z,BARD1,https://search.clinicalgenome.org/kb/genes/HGNC:952,BARD1-related cancer predisposition,MONDO:0700267,https://search.clinicalgenome.org/kb/conditions/MONDO:0700267,Autosomal dominant inheritance
1079,BARD1,HGNC:952,familial ovarian cancer,MONDO:0016248,AD,SOP10,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02af8326-360e-4f42-a378-fefff7387d97-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,BARD1,HGNC:952,chr2:215590370-215674407,chr2:214725646-214809683,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BARD1&subject=,2020-05-01T15:36:01Z,BARD1,https://search.clinicalgenome.org/kb/genes/HGNC:952,hereditary breast carcinoma,MONDO:0016419,https://search.clinicalgenome.org/kb/conditions/MONDO:0016419,
1080,CNTNAP2,HGNC:13830,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e91dc4be-821d-4f54-acdd-755a25070eec-2021-03-16T160000.000Z,2021-03-16T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,CNTNAP2,HGNC:13830,chr7:145813893-148118090,chr7:146116801-148420998,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=CNTNAP2&subject=,2019-10-23T16:16:30Z,CNTNAP2,https://search.clinicalgenome.org/kb/genes/HGNC:13830,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance | Autosomal recessive inheritance
1081,RAB3GAP1,HGNC:17063,Warburg micro syndrome,MONDO:0016649,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1e4a47e-757a-442f-b82f-2ddfd69d0854-2020-05-26T160000.000Z,2020-05-26T16:00:00.000Z,Brain Malformations Gene Curation Expert Panel,RAB3GAP1,HGNC:17063,chr2:135809862-135928280,chr2:135052292-135176396,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAB3GAP1&subject=,2016-08-22T17:51:48Z,RAB3GAP1,https://search.clinicalgenome.org/kb/genes/HGNC:17063,Warburg micro syndrome,MONDO:0016649,https://search.clinicalgenome.org/kb/conditions/MONDO:0016649,Autosomal recessive inheritance
1082,RAB3GAP1,HGNC:17063,Warburg micro syndrome,MONDO:0016649,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1e4a47e-757a-442f-b82f-2ddfd69d0854-2020-05-26T160000.000Z,2020-05-26T16:00:00.000Z,Brain Malformations Gene Curation Expert Panel,RAB3GAP1,HGNC:17063,chr2:135809862-135928280,chr2:135052292-135176396,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAB3GAP1&subject=,2016-08-22T17:51:48Z,RAB3GAP1,https://search.clinicalgenome.org/kb/genes/HGNC:17063,Warburg micro syndrome 1,MONDO:0010822,https://search.clinicalgenome.org/kb/conditions/MONDO:0010822,
1083,SOX5,HGNC:11201,Lamb-Shaffer syndrome,MONDO:0014778,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_781f21f2-d01a-457c-913e-8687a7c2650d-2022-01-27T170000.000Z,2022-01-27T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SOX5,HGNC:11201,chr12:23682438-24715425,chr12:23529504-24562650,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX5&subject=,2016-08-19T22:23:43Z,SOX5,https://search.clinicalgenome.org/kb/genes/HGNC:11201,Lamb-Shaffer syndrome,MONDO:0014778,https://search.clinicalgenome.org/kb/conditions/MONDO:0014778,Autosomal dominant inheritance
1084,RAB3GAP2,HGNC:17168,Warburg micro syndrome,MONDO:0016649,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a322fa3e-2985-4f60-9b4b-87f333cf9431-2023-11-28T200000.000Z,2023-11-28T20:00:00.000Z,Brain Malformations Gene Curation Expert Panel,RAB3GAP2,HGNC:17168,chr1:220321635-220445795,chr1:220148293-220272453,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAB3GAP2&subject=,2016-08-22T17:51:49Z,RAB3GAP2,https://search.clinicalgenome.org/kb/genes/HGNC:17168,Warburg micro syndrome,MONDO:0016649,https://search.clinicalgenome.org/kb/conditions/MONDO:0016649,Autosomal recessive inheritance
1085,RAB3GAP2,HGNC:17168,Warburg micro syndrome,MONDO:0016649,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a322fa3e-2985-4f60-9b4b-87f333cf9431-2023-11-28T200000.000Z,2023-11-28T20:00:00.000Z,Brain Malformations Gene Curation Expert Panel,RAB3GAP2,HGNC:17168,chr1:220321635-220445795,chr1:220148293-220272453,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAB3GAP2&subject=,2016-08-22T17:51:49Z,RAB3GAP2,https://search.clinicalgenome.org/kb/genes/HGNC:17168,multiple congenital anomalies/dysmorphic syndrome-intellectual disability,MONDO:0015159,https://search.clinicalgenome.org/kb/conditions/MONDO:0015159,
1086,PRRT2,HGNC:30500,infantile convulsions and choreoathetosis,MONDO:0011178,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_62af25b8-b9a4-421f-b897-4fc222569618-2020-01-21T213814.191Z,2020-01-21T21:38:14.191Z,Epilepsy Gene Curation Expert Panel,PRRT2,HGNC:30500,chr16:29823514-29827202,chr16:29812193-29815881,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRRT2&subject=,2021-12-14T19:04:03Z,PRRT2,https://search.clinicalgenome.org/kb/genes/HGNC:30500,infantile convulsions and choreoathetosis,MONDO:0011178,https://search.clinicalgenome.org/kb/conditions/MONDO:0011178,Autosomal dominant inheritance
1087,PRRT2,HGNC:30500,infantile convulsions and choreoathetosis,MONDO:0011178,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_62af25b8-b9a4-421f-b897-4fc222569618-2020-01-21T213814.191Z,2020-01-21T21:38:14.191Z,Epilepsy Gene Curation Expert Panel,PRRT2,HGNC:30500,chr16:29823514-29827202,chr16:29812193-29815881,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRRT2&subject=,2021-12-14T19:04:03Z,PRRT2,https://search.clinicalgenome.org/kb/genes/HGNC:30500,self-limited familial infantile epilepsy,MONDO:0100024,https://search.clinicalgenome.org/kb/conditions/MONDO:0100024,
1088,PRSS1,HGNC:9475,hereditary chronic pancreatitis,MONDO:0008185,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d271c52b-b0bb-4e9b-a745-ea03dc716fa0-2020-07-30T205014.833Z,2020-07-30T20:50:14.833Z,Hereditary Cancer Gene Curation Expert Panel,PRSS1,HGNC:9475,chr7:142457323-142460923,chr7:142749472-142753072,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRSS1&subject=,2012-10-29T22:13:54Z,PRSS1,https://search.clinicalgenome.org/kb/genes/HGNC:9475,hereditary chronic pancreatitis,MONDO:0008185,https://search.clinicalgenome.org/kb/conditions/MONDO:0008185,Autosomal dominant inheritance
1089,SOX10,HGNC:11190,Waardenburg syndrome type 4C,MONDO:0013202,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00a5b707-a265-4af0-a7e1-f15734ea42b9-2018-06-19T160000.000Z,2018-06-19T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,SOX10,HGNC:11190,chr22:38368319-38380562,chr22:37972312-37984555,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX10&subject=,2013-07-18T19:10:33Z,SOX10,https://search.clinicalgenome.org/kb/genes/HGNC:11190,Waardenburg syndrome type 4C,MONDO:0013202,https://search.clinicalgenome.org/kb/conditions/MONDO:0013202,Autosomal dominant inheritance
1090,RAD21,HGNC:9811,Cornelia de Lange syndrome,MONDO:0016033,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_30ad5023-6c68-42ab-b8ea-a601a134eaf6-2020-01-08T170000.000Z,2020-01-08T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,RAD21,HGNC:9811,chr8:117858173-117887015,chr8:116845934-116874776,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD21&subject=,2022-03-08T17:34:37Z,RAD21,https://search.clinicalgenome.org/kb/genes/HGNC:9811,Cornelia de Lange syndrome,MONDO:0016033,https://search.clinicalgenome.org/kb/conditions/MONDO:0016033,Autosomal dominant inheritance
1091,PRR12,HGNC:29217,neuroocular syndrome,MONDO:0859193,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d645c7ed-51f7-4695-a47d-ec3172ab3833-2024-01-19T170000.000Z,2024-01-19T17:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,PRR12,HGNC:29217,chr19:50094439-50129696,chr19:49591182-49626439,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRR12&subject=,2023-11-29T17:41:51Z,PRR12,https://search.clinicalgenome.org/kb/genes/HGNC:29217,neuroocular syndrome,MONDO:0859193,https://search.clinicalgenome.org/kb/conditions/MONDO:0859193,Autosomal dominant inheritance
1092,PRODH,HGNC:9453,hyperprolinemia type 1,MONDO:0009400,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5f28c677-a9b4-4bb3-9aed-14af97ad9896-2021-04-27T160000.000Z,2021-04-27T16:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,PRODH,HGNC:9453,chr22:18900294-18924066,chr22:18912781-18936553,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRODH&subject=,2022-11-08T17:14:17Z,PRODH,https://search.clinicalgenome.org/kb/genes/HGNC:9453,hyperprolinemia type 1,MONDO:0009400,https://search.clinicalgenome.org/kb/conditions/MONDO:0009400,Autosomal recessive inheritance
1093,PRKN,HGNC:8607,Parkinson disease,MONDO:0005180,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b39c4a0-f6bd-4afc-b2a7-f234eab5a667-2023-01-18T190000.000Z,2023-01-18T19:00:00.000Z,Parkinson's Disease Gene Curation Expert Panel,PRKN,HGNC:8607,chr6:161768449-163148798,chr6:161347417-162727766,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRKN&subject=,2018-05-15T13:43:46Z,PRKN,https://search.clinicalgenome.org/kb/genes/HGNC:8607,Parkinson disease,MONDO:0005180,https://search.clinicalgenome.org/kb/conditions/MONDO:0005180,Autosomal recessive inheritance
1094,PRKN,HGNC:8607,Parkinson disease,MONDO:0005180,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b39c4a0-f6bd-4afc-b2a7-f234eab5a667-2023-01-18T190000.000Z,2023-01-18T19:00:00.000Z,Parkinson's Disease Gene Curation Expert Panel,PRKN,HGNC:8607,chr6:161768449-163148798,chr6:161347417-162727766,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRKN&subject=,2018-05-15T13:43:46Z,PRKN,https://search.clinicalgenome.org/kb/genes/HGNC:8607,autosomal recessive juvenile Parkinson disease 2,MONDO:0010820,https://search.clinicalgenome.org/kb/conditions/MONDO:0010820,
1095,PRKN,HGNC:8607,Parkinson disease,MONDO:0005180,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b39c4a0-f6bd-4afc-b2a7-f234eab5a667-2023-01-18T190000.000Z,2023-01-18T19:00:00.000Z,Parkinson's Disease Gene Curation Expert Panel,PRKN,HGNC:8607,chr6:161768449-163148798,chr6:161347417-162727766,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRKN&subject=,2018-05-15T13:43:46Z,PRKN,https://search.clinicalgenome.org/kb/genes/HGNC:8607,young-onset Parkinson disease,MONDO:0017279,https://search.clinicalgenome.org/kb/conditions/MONDO:0017279,
1096,PRKAR1A,HGNC:9388,"Carney complex, type 1",MONDO:0008057,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc16b2a9-c8dc-4a04-a029-2f6af049404d-2018-12-21T154044.801Z,2018-12-21T15:40:44.801Z,Hereditary Cancer Gene Curation Expert Panel,PRKAR1A,HGNC:9388,chr17:66409764-66547457,chr17:68413623-68551316,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRKAR1A&subject=,2024-10-09T16:50:46Z,PRKAR1A,https://search.clinicalgenome.org/kb/genes/HGNC:9388,"Carney complex, type 1",MONDO:0008057,https://search.clinicalgenome.org/kb/conditions/MONDO:0008057,Autosomal dominant inheritance
1097,PRKAR1A,HGNC:9388,"Carney complex, type 1",MONDO:0008057,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc16b2a9-c8dc-4a04-a029-2f6af049404d-2018-12-21T154044.801Z,2018-12-21T15:40:44.801Z,Hereditary Cancer Gene Curation Expert Panel,PRKAR1A,HGNC:9388,chr17:66409764-66547457,chr17:68413623-68551316,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRKAR1A&subject=,2024-10-09T16:50:46Z,PRKAR1A,https://search.clinicalgenome.org/kb/genes/HGNC:9388,Carney complex,MONDO:0015285,https://search.clinicalgenome.org/kb/conditions/MONDO:0015285,
1098,RAB28,HGNC:9768,RAB28-related retinopathy,MONDO:0100448,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8e3c7bd-3ee5-404d-98b0-75af6ec257d1-2021-11-04T160000.000Z,2021-11-04T16:00:00.000Z,Retina Gene Curation Expert Panel,RAB28,HGNC:9768,chr4:13369348-13485964,chr4:13367724-13484340,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAB28&subject=,2016-08-22T17:51:48Z,RAB28,https://search.clinicalgenome.org/kb/genes/HGNC:9768,RAB28-related retinopathy,MONDO:0100448,https://search.clinicalgenome.org/kb/conditions/MONDO:0100448,Autosomal recessive inheritance
1099,RAB28,HGNC:9768,RAB28-related retinopathy,MONDO:0100448,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8e3c7bd-3ee5-404d-98b0-75af6ec257d1-2021-11-04T160000.000Z,2021-11-04T16:00:00.000Z,Retina Gene Curation Expert Panel,RAB28,HGNC:9768,chr4:13369348-13485964,chr4:13367724-13484340,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAB28&subject=,2016-08-22T17:51:48Z,RAB28,https://search.clinicalgenome.org/kb/genes/HGNC:9768,cone-rod dystrophy 18,MONDO:0014153,https://search.clinicalgenome.org/kb/conditions/MONDO:0014153,
1100,SOX6,HGNC:16421,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c9a42d99-af9a-47d6-ab3c-e2d874f823f2-2024-09-17T160000.000Z,2024-09-17T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SOX6,HGNC:16421,chr11:15987995-16760024,chr11:15966449-16738477,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SOX6&subject=,2012-03-22T18:31:22Z,SOX6,https://search.clinicalgenome.org/kb/genes/HGNC:16421,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1101,PTCH1,HGNC:9585,nevoid basal cell carcinoma syndrome,MONDO:0007187,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a3f55f5-e39b-4571-a41f-e46ddb8e298d-2018-06-04T170000.000Z,2018-06-04T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PTCH1,HGNC:9585,chr9:98205262-98279253,chr9:95442980-95516971,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTCH1&subject=,2020-07-01T16:12:20Z,PTCH1,https://search.clinicalgenome.org/kb/genes/HGNC:9585,nevoid basal cell carcinoma syndrome,MONDO:0007187,https://search.clinicalgenome.org/kb/conditions/MONDO:0007187,Autosomal dominant inheritance
1102,ST3GAL5,HGNC:10872,GM3 synthase deficiency,MONDO:0018274,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5ea65e3-6a02-4435-9ef5-100564d3497c-2022-04-05T160000.000Z,2022-04-05T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,ST3GAL5,HGNC:10872,chr2:86064243-86116157,chr2:85837120-85889034,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ST3GAL5&subject=,2014-09-25T19:11:11Z,ST3GAL5,https://search.clinicalgenome.org/kb/genes/HGNC:10872,GM3 synthase deficiency,MONDO:0018274,https://search.clinicalgenome.org/kb/conditions/MONDO:0018274,Autosomal recessive inheritance
1103,PYCR1,HGNC:9721,autosomal recessive cutis laxa type 2B,MONDO:0013051,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca242cd8-1f57-4c7b-ba97-5ec0c97b425b-2020-05-21T191607.864Z,2020-05-21T19:16:07.864Z,Aminoacidopathy Gene Curation Expert Panel,PYCR1,HGNC:9721,chr17:79890267-79895176,chr17:81932391-81937300,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PYCR1&subject=,2016-08-22T17:51:46Z,PYCR1,https://search.clinicalgenome.org/kb/genes/HGNC:9721,autosomal recessive cutis laxa type 2B,MONDO:0013051,https://search.clinicalgenome.org/kb/conditions/MONDO:0013051,Autosomal recessive inheritance
1104,SPRED1,HGNC:20249,Legius syndrome,MONDO:0012669,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ba44430-8f71-4b94-a6f1-7f66d3a27897-2019-01-24T050000.000Z,2019-01-24T05:00:00.000Z,RASopathy Gene Curation Expert Panel,SPRED1,HGNC:20249,chr15:38545037-38649450,chr15:38252836-38357249,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SPRED1&subject=,2013-03-14T19:14:48Z,SPRED1,https://search.clinicalgenome.org/kb/genes/HGNC:20249,Legius syndrome,MONDO:0012669,https://search.clinicalgenome.org/kb/conditions/MONDO:0012669,Autosomal dominant inheritance
1105,SPEN,HGNC:17575,Radio-Tartaglia syndrome,MONDO:0859143,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4800898-ad53-4fec-8b29-dd0a8225919b-2023-11-01T160000.000Z,2023-11-01T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,SPEN,HGNC:17575,chr1:16174202-16266951,chr1:15847707-15940456,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SPEN&subject=,2019-03-27T16:27:25Z,SPEN,https://search.clinicalgenome.org/kb/genes/HGNC:17575,Radio-Tartaglia syndrome,MONDO:0859143,https://search.clinicalgenome.org/kb/conditions/MONDO:0859143,Autosomal dominant inheritance
1106,SPEN,HGNC:17575,Radio-Tartaglia syndrome,MONDO:0859143,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4800898-ad53-4fec-8b29-dd0a8225919b-2023-11-01T160000.000Z,2023-11-01T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,SPEN,HGNC:17575,chr1:16174202-16266951,chr1:15847707-15940456,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SPEN&subject=,2019-03-27T16:27:25Z,SPEN,https://search.clinicalgenome.org/kb/genes/HGNC:17575,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,
1107,SPEG,HGNC:16901,"myopathy, centronuclear, 5",MONDO:0014418,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a8f91f1-da1e-489d-84e1-46aa543b3df9-2020-01-12T213416.305Z,2020-01-12T21:34:16.305Z,Congenital Myopathies Gene Curation Expert Panel,SPEG,HGNC:16901,chr2:220299565-220358351,chr2:219434843-219493629,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SPEG&subject=,2016-08-22T17:52:31Z,SPEG,https://search.clinicalgenome.org/kb/genes/HGNC:16901,"myopathy, centronuclear, 5",MONDO:0014418,https://search.clinicalgenome.org/kb/conditions/MONDO:0014418,Autosomal recessive inheritance
1108,SRCAP,HGNC:16974,Floating-Harbor syndrome,MONDO:0007621,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b414014-3a99-48f2-aac1-20903838af0f-2023-08-01T063000.000Z,2023-08-01T06:30:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SRCAP,HGNC:16974,chr16:30710492-30752730,chr16:30699171-30741409,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SRCAP&subject=,2018-05-31T11:00:19Z,SRCAP,https://search.clinicalgenome.org/kb/genes/HGNC:16974,Floating-Harbor syndrome,MONDO:0007621,https://search.clinicalgenome.org/kb/conditions/MONDO:0007621,Autosomal dominant inheritance
1109,PXDN,HGNC:14966,anterior segment dysgenesis 7,MONDO:0010015,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_905b07f8-ed15-4c25-9579-edac5521c699-2023-06-15T160000.000Z,2023-06-15T16:00:00.000Z,Glaucoma and Neuro-Ophthalmology Gene Curation Expert Panel,PXDN,HGNC:14966,chr2:1635659-1748287,chr2:1631887-1744901,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PXDN&subject=,2016-08-22T17:51:45Z,PXDN,https://search.clinicalgenome.org/kb/genes/HGNC:14966,anterior segment dysgenesis 7,MONDO:0010015,https://search.clinicalgenome.org/kb/conditions/MONDO:0010015,Autosomal recessive inheritance
1110,PURA,HGNC:9701,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6819633c-e488-4856-8dec-3981cd14db9b-2018-12-18T170000.000Z,2018-12-18T17:00:00.000Z,Epilepsy Gene Curation Expert Panel,PURA,HGNC:9701,chr5:139493694-139505204,chr5:140114109-140125619,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PURA&subject=,2017-06-07T23:55:39Z,PURA,https://search.clinicalgenome.org/kb/genes/HGNC:9701,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1111,PURA,HGNC:9701,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6819633c-e488-4856-8dec-3981cd14db9b-2018-12-18T170000.000Z,2018-12-18T17:00:00.000Z,Epilepsy Gene Curation Expert Panel,PURA,HGNC:9701,chr5:139493694-139505204,chr5:140114109-140125619,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PURA&subject=,2017-06-07T23:55:39Z,PURA,https://search.clinicalgenome.org/kb/genes/HGNC:9701,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation,MONDO:0014512,https://search.clinicalgenome.org/kb/conditions/MONDO:0014512,
1112,PUF60,HGNC:17042,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_661c140f-11a3-46f8-b001-14a2314582e4-2021-12-15T170000.000Z,2021-12-15T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,PUF60,HGNC:17042,chr8:144898514-144911485,chr8:143816344-143829315,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PUF60&subject=,2024-01-09T17:24:43Z,PUF60,https://search.clinicalgenome.org/kb/genes/HGNC:17042,syndromic intellectual disability,MONDO:0000508,https://search.clinicalgenome.org/kb/conditions/MONDO:0000508,Autosomal dominant inheritance
1113,QRICH1,HGNC:24713,syndromic intellectual disability,MONDO:0000508,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ccc6c6f-da19-4e86-88a8-5e7a1794efae-2022-06-15T170000.000Z,2022-06-15T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,QRICH1,HGNC:24713,chr3:49067140-49131806,chr3:49029707-49094373,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=QRICH1&subject=,2023-11-15T14:45:30Z,QRICH1,https://search.clinicalgenome.org/kb/genes/HGNC:24713,syndromic intellectual disability,MONDO:0000508,https://search.clinicalgenome.org/kb/conditions/MONDO:0000508,Autosomal dominant inheritance
1114,SPATA7,HGNC:20423,inherited retinal dystrophy,MONDO:0019118,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c0c6cda-eb17-47a6-8e9d-bbafd4330295-2024-08-01T160000.000Z,2024-08-01T16:00:00.000Z,Retina Gene Curation Expert Panel,SPATA7,HGNC:20423,chr14:88852001-88904804,chr14:88385657-88470350,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SPATA7&subject=,2016-08-22T17:52:30Z,SPATA7,https://search.clinicalgenome.org/kb/genes/HGNC:20423,inherited retinal dystrophy,MONDO:0019118,https://search.clinicalgenome.org/kb/conditions/MONDO:0019118,Autosomal recessive inheritance
1115,SPATA7,HGNC:20423,inherited retinal dystrophy,MONDO:0019118,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c0c6cda-eb17-47a6-8e9d-bbafd4330295-2024-08-01T160000.000Z,2024-08-01T16:00:00.000Z,Retina Gene Curation Expert Panel,SPATA7,HGNC:20423,chr14:88852001-88904804,chr14:88385657-88470350,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SPATA7&subject=,2016-08-22T17:52:30Z,SPATA7,https://search.clinicalgenome.org/kb/genes/HGNC:20423,Leber congenital amaurosis 3,MONDO:0011415,https://search.clinicalgenome.org/kb/conditions/MONDO:0011415,
1116,STAG1,HGNC:11354,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_30cc66e4-e3cf-428d-9f27-58e8427c94f1-2022-09-20T060000.000Z,2022-09-20T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,STAG1,HGNC:11354,chr3:136055078-136471220,chr3:136336236-136752378,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STAG1&subject=,2025-01-22T17:25:48Z,STAG1,https://search.clinicalgenome.org/kb/genes/HGNC:11354,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1117,PTEN,HGNC:9588,PTEN hamartoma tumor syndrome,MONDO:0017623,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2e9e89c0-8d1b-4276-bd6f-90c7b7190ffb-2024-04-05T170000.000Z,2024-04-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PTEN,HGNC:9588,chr10:89623382-89731687,chr10:87863625-87971930,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTEN&subject=,2020-06-24T16:14:33Z,PTEN,https://search.clinicalgenome.org/kb/genes/HGNC:9588,PTEN hamartoma tumor syndrome,MONDO:0017623,https://search.clinicalgenome.org/kb/conditions/MONDO:0017623,Autosomal dominant inheritance
1118,PTEN,HGNC:9588,PTEN hamartoma tumor syndrome,MONDO:0017623,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2e9e89c0-8d1b-4276-bd6f-90c7b7190ffb-2024-04-05T170000.000Z,2024-04-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,PTEN,HGNC:9588,chr10:89623382-89731687,chr10:87863625-87971930,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTEN&subject=,2020-06-24T16:14:33Z,PTEN,https://search.clinicalgenome.org/kb/genes/HGNC:9588,multiple exostoses with spastic tetraparesis,MONDO:0008020,https://search.clinicalgenome.org/kb/conditions/MONDO:0008020,
1119,PTCHD1,HGNC:26392,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_05d36fe2-0026-4bbc-af4b-6d952490969b-2018-08-15T160000.000Z,2018-08-15T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,PTCHD1,HGNC:26392,chrX:23352966-23422491,chrX:23334396-23404374,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTCHD1&subject=,2018-02-28T17:09:01Z,PTCHD1,https://search.clinicalgenome.org/kb/genes/HGNC:26392,non-syndromic X-linked intellectual disability,MONDO:0019181,https://search.clinicalgenome.org/kb/conditions/MONDO:0019181,X-linked inheritance
1120,PTCHD1,HGNC:26392,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_05d36fe2-0026-4bbc-af4b-6d952490969b-2018-08-15T160000.000Z,2018-08-15T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,PTCHD1,HGNC:26392,chrX:23352966-23422491,chrX:23334396-23404374,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PTCHD1&subject=,2018-02-28T17:09:01Z,PTCHD1,https://search.clinicalgenome.org/kb/genes/HGNC:26392,"autism, susceptibility to, X-linked 4",MONDO:0010440,https://search.clinicalgenome.org/kb/conditions/MONDO:0010440,
1121,QDPR,HGNC:9752,dihydropteridine reductase deficiency,MONDO:0009862,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3cd45f13-9412-4439-9b68-cf2e3d02a646-2018-06-18T160000.000Z,2018-06-18T16:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,QDPR,HGNC:9752,chr4:17488018-17513713,chr4:17486395-17512090,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=QDPR&subject=,2016-08-22T17:51:46Z,QDPR,https://search.clinicalgenome.org/kb/genes/HGNC:9752,dihydropteridine reductase deficiency,MONDO:0009862,https://search.clinicalgenome.org/kb/conditions/MONDO:0009862,Autosomal recessive inheritance
1122,STAT1,HGNC:11362,immunodeficiency 31B,MONDO:0013427,AR,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3240fac3-4738-4cd5-9923-bd1ca1896b07-2024-10-06T090000.000Z,2024-10-06T09:00:00.000Z,Primary Immune Regulatory Disorders Gene Curation Expert Panel,STAT1,HGNC:11362,chr2:191833875-191878897,chr2:190969149-191014171,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STAT1&subject=,2013-09-18T14:48:40Z,STAT1,https://search.clinicalgenome.org/kb/genes/HGNC:11362,immunodeficiency 31B,MONDO:0013427,https://search.clinicalgenome.org/kb/conditions/MONDO:0013427,Autosomal recessive inheritance
1123,STAT1,HGNC:11362,immunodeficiency 31B,MONDO:0013427,AR,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3240fac3-4738-4cd5-9923-bd1ca1896b07-2024-10-06T090000.000Z,2024-10-06T09:00:00.000Z,Primary Immune Regulatory Disorders Gene Curation Expert Panel,STAT1,HGNC:11362,chr2:191833875-191878897,chr2:190969149-191014171,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STAT1&subject=,2013-09-18T14:48:40Z,STAT1,https://search.clinicalgenome.org/kb/genes/HGNC:11362,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,MONDO:0013956,https://search.clinicalgenome.org/kb/conditions/MONDO:0013956,Autosomal dominant inheritance
1124,STAT1,HGNC:11362,immunodeficiency 31B,MONDO:0013427,AR,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3240fac3-4738-4cd5-9923-bd1ca1896b07-2024-10-06T090000.000Z,2024-10-06T09:00:00.000Z,Primary Immune Regulatory Disorders Gene Curation Expert Panel,STAT1,HGNC:11362,chr2:191833875-191878897,chr2:190969149-191014171,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STAT1&subject=,2013-09-18T14:48:40Z,STAT1,https://search.clinicalgenome.org/kb/genes/HGNC:11362,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,MONDO:0013599,https://search.clinicalgenome.org/kb/conditions/MONDO:0013599,Autosomal dominant inheritance
1125,STAT1,HGNC:11362,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,MONDO:0013956,AD,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac2fe8ac-e470-4fa3-b596-ad8e15d5b065-2024-11-20T100000.000Z,2024-11-20T10:00:00.000Z,Primary Immune Regulatory Disorders Gene Curation Expert Panel,STAT1,HGNC:11362,chr2:191833875-191878897,chr2:190969149-191014171,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STAT1&subject=,2013-09-18T14:48:40Z,STAT1,https://search.clinicalgenome.org/kb/genes/HGNC:11362,immunodeficiency 31B,MONDO:0013427,https://search.clinicalgenome.org/kb/conditions/MONDO:0013427,Autosomal recessive inheritance
1126,STAT1,HGNC:11362,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,MONDO:0013956,AD,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac2fe8ac-e470-4fa3-b596-ad8e15d5b065-2024-11-20T100000.000Z,2024-11-20T10:00:00.000Z,Primary Immune Regulatory Disorders Gene Curation Expert Panel,STAT1,HGNC:11362,chr2:191833875-191878897,chr2:190969149-191014171,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STAT1&subject=,2013-09-18T14:48:40Z,STAT1,https://search.clinicalgenome.org/kb/genes/HGNC:11362,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,MONDO:0013956,https://search.clinicalgenome.org/kb/conditions/MONDO:0013956,Autosomal dominant inheritance
1127,STAT1,HGNC:11362,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,MONDO:0013956,AD,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac2fe8ac-e470-4fa3-b596-ad8e15d5b065-2024-11-20T100000.000Z,2024-11-20T10:00:00.000Z,Primary Immune Regulatory Disorders Gene Curation Expert Panel,STAT1,HGNC:11362,chr2:191833875-191878897,chr2:190969149-191014171,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STAT1&subject=,2013-09-18T14:48:40Z,STAT1,https://search.clinicalgenome.org/kb/genes/HGNC:11362,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,MONDO:0013599,https://search.clinicalgenome.org/kb/conditions/MONDO:0013599,Autosomal dominant inheritance
1128,PQBP1,HGNC:9330,Renpenning syndrome,MONDO:0010653,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8128f36b-f273-49ee-bfd8-bee64b4df921-2018-11-09T170000.000Z,2018-11-09T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,PQBP1,HGNC:9330,chrX:48755213-48760420,chrX:48897930-48903143,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PQBP1&subject=,2020-04-09T19:32:14Z,PQBP1,https://search.clinicalgenome.org/kb/genes/HGNC:9330,Renpenning syndrome,MONDO:0010653,https://search.clinicalgenome.org/kb/conditions/MONDO:0010653,X-linked inheritance
1129,PLCB1,HGNC:15917,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7887c3b-332b-4586-93cf-4098796ab66f-2020-09-18T040000.000Z,2020-09-18T04:00:00.000Z,Epilepsy Gene Curation Expert Panel,PLCB1,HGNC:15917,chr20:8112913-8865547,chr20:8132266-8884900,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PLCB1&subject=,2016-08-22T17:51:27Z,PLCB1,https://search.clinicalgenome.org/kb/genes/HGNC:15917,developmental and epileptic encephalopathy,MONDO:0100062,https://search.clinicalgenome.org/kb/conditions/MONDO:0100062,Autosomal recessive inheritance
1130,PLCB1,HGNC:15917,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7887c3b-332b-4586-93cf-4098796ab66f-2020-09-18T040000.000Z,2020-09-18T04:00:00.000Z,Epilepsy Gene Curation Expert Panel,PLCB1,HGNC:15917,chr20:8112913-8865547,chr20:8132266-8884900,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PLCB1&subject=,2016-08-22T17:51:27Z,PLCB1,https://search.clinicalgenome.org/kb/genes/HGNC:15917,"developmental and epileptic encephalopathy, 12",MONDO:0013389,https://search.clinicalgenome.org/kb/conditions/MONDO:0013389,
1131,PMP22,HGNC:9118,hereditary neuropathy with liability to pressure palsies,MONDO:0008087,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7502a7e-2a4e-4b85-8f7c-8d76fe94f294-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PMP22,HGNC:9118,chr17:15133096-15168643,chr17:15229779-15265326,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMP22&subject=,2012-07-12T19:09:22Z,PMP22,https://search.clinicalgenome.org/kb/genes/HGNC:9118,Charcot-Marie-Tooth disease type 1A,MONDO:0007309,https://search.clinicalgenome.org/kb/conditions/MONDO:0007309,Autosomal dominant inheritance
1132,PMP22,HGNC:9118,hereditary neuropathy with liability to pressure palsies,MONDO:0008087,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7502a7e-2a4e-4b85-8f7c-8d76fe94f294-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PMP22,HGNC:9118,chr17:15133096-15168643,chr17:15229779-15265326,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMP22&subject=,2012-07-12T19:09:22Z,PMP22,https://search.clinicalgenome.org/kb/genes/HGNC:9118,hereditary neuropathy with liability to pressure palsies,MONDO:0008087,https://search.clinicalgenome.org/kb/conditions/MONDO:0008087,Autosomal dominant inheritance
1133,PMP22,HGNC:9118,hereditary neuropathy with liability to pressure palsies,MONDO:0008087,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7502a7e-2a4e-4b85-8f7c-8d76fe94f294-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PMP22,HGNC:9118,chr17:15133096-15168643,chr17:15229779-15265326,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMP22&subject=,2012-07-12T19:09:22Z,PMP22,https://search.clinicalgenome.org/kb/genes/HGNC:9118,Charcot-Marie-Tooth disease type 1E,MONDO:0007311,https://search.clinicalgenome.org/kb/conditions/MONDO:0007311,
1134,PMP22,HGNC:9118,hereditary neuropathy with liability to pressure palsies,MONDO:0008087,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7502a7e-2a4e-4b85-8f7c-8d76fe94f294-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PMP22,HGNC:9118,chr17:15133096-15168643,chr17:15229779-15265326,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMP22&subject=,2012-07-12T19:09:22Z,PMP22,https://search.clinicalgenome.org/kb/genes/HGNC:9118,Charcot-Marie-Tooth disease type 1,MONDO:0019011,https://search.clinicalgenome.org/kb/conditions/MONDO:0019011,
1135,PMP22,HGNC:9118,Charcot-Marie-Tooth disease type 1A,MONDO:0007309,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_169edbc0-b942-43f1-885d-8d47ccdb6d90-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PMP22,HGNC:9118,chr17:15133096-15168643,chr17:15229779-15265326,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMP22&subject=,2012-07-12T19:09:22Z,PMP22,https://search.clinicalgenome.org/kb/genes/HGNC:9118,Charcot-Marie-Tooth disease type 1A,MONDO:0007309,https://search.clinicalgenome.org/kb/conditions/MONDO:0007309,Autosomal dominant inheritance
1136,PMP22,HGNC:9118,Charcot-Marie-Tooth disease type 1A,MONDO:0007309,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_169edbc0-b942-43f1-885d-8d47ccdb6d90-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PMP22,HGNC:9118,chr17:15133096-15168643,chr17:15229779-15265326,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMP22&subject=,2012-07-12T19:09:22Z,PMP22,https://search.clinicalgenome.org/kb/genes/HGNC:9118,hereditary neuropathy with liability to pressure palsies,MONDO:0008087,https://search.clinicalgenome.org/kb/conditions/MONDO:0008087,Autosomal dominant inheritance
1137,PMP22,HGNC:9118,Charcot-Marie-Tooth disease type 1A,MONDO:0007309,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_169edbc0-b942-43f1-885d-8d47ccdb6d90-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PMP22,HGNC:9118,chr17:15133096-15168643,chr17:15229779-15265326,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMP22&subject=,2012-07-12T19:09:22Z,PMP22,https://search.clinicalgenome.org/kb/genes/HGNC:9118,Charcot-Marie-Tooth disease type 1E,MONDO:0007311,https://search.clinicalgenome.org/kb/conditions/MONDO:0007311,
1138,PMP22,HGNC:9118,Charcot-Marie-Tooth disease type 1A,MONDO:0007309,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_169edbc0-b942-43f1-885d-8d47ccdb6d90-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PMP22,HGNC:9118,chr17:15133096-15168643,chr17:15229779-15265326,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PMP22&subject=,2012-07-12T19:09:22Z,PMP22,https://search.clinicalgenome.org/kb/genes/HGNC:9118,Charcot-Marie-Tooth disease type 1,MONDO:0019011,https://search.clinicalgenome.org/kb/conditions/MONDO:0019011,
1139,TARDBP,HGNC:11571,amyotrophic lateral sclerosis type 10,MONDO:0012790,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf8bf781-25c9-4f16-b8cc-b0533390e4e2-2021-07-27T160623.437Z,2021-07-27T16:06:23.437Z,Amyotrophic Lateral Sclerosis Spectrum Disorders Gene Curation Expert Panel,TARDBP,HGNC:11571,chr1:11072711-11085549,chr1:11012654-11030528,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TARDBP&subject=,2018-09-25T18:53:42Z,TARDBP,https://search.clinicalgenome.org/kb/genes/HGNC:11571,amyotrophic lateral sclerosis type 10,MONDO:0012790,https://search.clinicalgenome.org/kb/conditions/MONDO:0012790,Autosomal dominant inheritance
1140,TBL1XR1,HGNC:29529,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8352a921-43c0-4097-9147-2618a4165b57-2020-07-07T170000.000Z,2020-07-07T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,TBL1XR1,HGNC:29529,chr3:176737132-176915270,chr3:177019344-177201800,Sufficient Evidence for Haploinsufficiency,Little Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBL1XR1&subject=,2019-03-27T17:20:30Z,TBL1XR1,https://search.clinicalgenome.org/kb/genes/HGNC:29529,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1141,TBL1XR1,HGNC:29529,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8352a921-43c0-4097-9147-2618a4165b57-2020-07-07T170000.000Z,2020-07-07T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,TBL1XR1,HGNC:29529,chr3:176737132-176915270,chr3:177019344-177201800,Sufficient Evidence for Haploinsufficiency,Little Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBL1XR1&subject=,2019-03-27T17:20:30Z,TBL1XR1,https://search.clinicalgenome.org/kb/genes/HGNC:29529,"intellectual disability, autosomal dominant 41",MONDO:0014842,https://search.clinicalgenome.org/kb/conditions/MONDO:0014842,
1142,PLP1,HGNC:9086,Pelizeaus-Merzbacher spectrum disorder,MONDO:0010714,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c1a44c5f-744e-4d02-a08f-e7c687531b21-2018-03-07T170000.000Z,2018-03-07T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,PLP1,HGNC:9086,chrX:103031434-103047548,chrX:103776506-103792619,Sufficient Evidence for Haploinsufficiency,Sufficient Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PLP1&subject=,2021-04-12T15:06:26Z,PLP1,https://search.clinicalgenome.org/kb/genes/HGNC:9086,Pelizeaus-Merzbacher spectrum disorder,MONDO:0010714,https://search.clinicalgenome.org/kb/conditions/MONDO:0010714,X-linked inheritance
1143,TBR1,HGNC:11590,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_853c90ef-34a8-4d7d-931d-5fb4add3e4d0-2020-03-25T160000.000Z,2020-03-25T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,TBR1,HGNC:11590,chr2:162272808-162282381,chr2:161416297-161425870,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBR1&subject=,2018-01-24T17:57:42Z,TBR1,https://search.clinicalgenome.org/kb/genes/HGNC:11590,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1144,PLEKHG5,HGNC:29105,neuromuscular disease,MONDO:0019056,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f2f5a6d-3b4f-4f4c-b560-50944b4ab34f-2023-09-06T160000.000Z,2023-09-06T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PLEKHG5,HGNC:29105,chr1:6526152-6580152,chr1:6467122-6520092,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PLEKHG5&subject=,2016-08-22T17:51:28Z,PLEKHG5,https://search.clinicalgenome.org/kb/genes/HGNC:29105,neuromuscular disease,MONDO:0019056,https://search.clinicalgenome.org/kb/conditions/MONDO:0019056,Autosomal recessive inheritance
1145,PLEKHG5,HGNC:29105,neuromuscular disease,MONDO:0019056,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f2f5a6d-3b4f-4f4c-b560-50944b4ab34f-2023-09-06T160000.000Z,2023-09-06T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,PLEKHG5,HGNC:29105,chr1:6526152-6580152,chr1:6467122-6520092,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PLEKHG5&subject=,2016-08-22T17:51:28Z,PLEKHG5,https://search.clinicalgenome.org/kb/genes/HGNC:29105,Charcot-Marie-Tooth disease recessive intermediate C,MONDO:0014154,https://search.clinicalgenome.org/kb/conditions/MONDO:0014154,
1146,PLA2G6,HGNC:9039,PLA2G6-associated neurodegeneration,MONDO:0017998,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d183700f-e6cc-482f-a3ed-f18f8154f092-2024-03-21T160000.000Z,2024-03-21T16:00:00.000Z,Lysosomal Diseases Gene Curation Expert Panel,PLA2G6,HGNC:9039,chr22:38507502-38577837,chr22:38111495-38181830,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PLA2G6&subject=,2016-08-22T17:51:26Z,PLA2G6,https://search.clinicalgenome.org/kb/genes/HGNC:9039,PLA2G6-associated neurodegeneration,MONDO:0017998,https://search.clinicalgenome.org/kb/conditions/MONDO:0017998,Autosomal recessive inheritance
1147,PLA2G6,HGNC:9039,PLA2G6-associated neurodegeneration,MONDO:0017998,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d183700f-e6cc-482f-a3ed-f18f8154f092-2024-03-21T160000.000Z,2024-03-21T16:00:00.000Z,Lysosomal Diseases Gene Curation Expert Panel,PLA2G6,HGNC:9039,chr22:38507502-38577837,chr22:38111495-38181830,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PLA2G6&subject=,2016-08-22T17:51:26Z,PLA2G6,https://search.clinicalgenome.org/kb/genes/HGNC:9039,neurodegeneration with brain iron accumulation,MONDO:0018307,https://search.clinicalgenome.org/kb/conditions/MONDO:0018307,
1148,STIL,HGNC:10879,autosomal recessive primary microcephaly,MONDO:0016660,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_19d81e58-cb01-4cf3-8817-dfa0429150c3-2023-03-28T190000.000Z,2023-03-28T19:00:00.000Z,Brain Malformations Gene Curation Expert Panel,STIL,HGNC:10879,chr1:47715811-47780568,chr1:47250139-47314896,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STIL&subject=,2016-08-22T17:52:34Z,STIL,https://search.clinicalgenome.org/kb/genes/HGNC:10879,autosomal recessive primary microcephaly,MONDO:0016660,https://search.clinicalgenome.org/kb/conditions/MONDO:0016660,Autosomal recessive inheritance
1149,STIL,HGNC:10879,autosomal recessive primary microcephaly,MONDO:0016660,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_19d81e58-cb01-4cf3-8817-dfa0429150c3-2023-03-28T190000.000Z,2023-03-28T19:00:00.000Z,Brain Malformations Gene Curation Expert Panel,STIL,HGNC:10879,chr1:47715811-47780568,chr1:47250139-47314896,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STIL&subject=,2016-08-22T17:52:34Z,STIL,https://search.clinicalgenome.org/kb/genes/HGNC:10879,"microcephaly 7, primary, autosomal recessive",MONDO:0012989,https://search.clinicalgenome.org/kb/conditions/MONDO:0012989,
1150,TBX4,HGNC:11603,pulmonary arterial hypertension,MONDO:0015924,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b8cc228-67d2-4530-8129-ebafee7fafa1-2021-03-10T214611.990Z,2021-03-10T21:46:11.990Z,Pulmonary Hypertension Gene Curation Expert Panel,TBX4,HGNC:11603,chr17:59529783-59562471,chr17:61452422-61485110,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBX4&subject=,2019-12-11T16:56:33Z,TBX4,https://search.clinicalgenome.org/kb/genes/HGNC:11603,pulmonary arterial hypertension,MONDO:0015924,https://search.clinicalgenome.org/kb/conditions/MONDO:0015924,Autosomal dominant inheritance
1151,TBX4,HGNC:11603,pulmonary arterial hypertension,MONDO:0015924,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b8cc228-67d2-4530-8129-ebafee7fafa1-2021-03-10T214611.990Z,2021-03-10T21:46:11.990Z,Pulmonary Hypertension Gene Curation Expert Panel,TBX4,HGNC:11603,chr17:59529783-59562471,chr17:61452422-61485110,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBX4&subject=,2019-12-11T16:56:33Z,TBX4,https://search.clinicalgenome.org/kb/genes/HGNC:11603,coxopodopatellar syndrome,MONDO:0007841,https://search.clinicalgenome.org/kb/conditions/MONDO:0007841,
1152,TBX5,HGNC:11604,Holt-Oram syndrome,MONDO:0007732,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_24e6c85a-33cf-4248-be1f-6431c7c6b1e5-2021-07-27T145706.838Z,2021-07-27T14:57:06.838Z,Syndromic Disorders Gene Curation Expert Panel,TBX5,HGNC:11604,chr12:114791716-114846247,chr12:114353911-114408442,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TBX5&subject=,2020-07-29T19:19:03Z,TBX5,https://search.clinicalgenome.org/kb/genes/HGNC:11604,Holt-Oram syndrome,MONDO:0007732,https://search.clinicalgenome.org/kb/conditions/MONDO:0007732,Autosomal dominant inheritance
1153,TCF12,HGNC:11623,TCF12-related craniosynostosis,MONDO:0014128,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_11e46ed0-dbfb-4151-ba1c-cc56214d6ca6-2021-01-28T170000.000Z,2021-01-28T17:00:00.000Z,Craniofacial Malformations Gene Curation Expert Panel,TCF12,HGNC:11623,chr15:57210288-57583508,chr15:56918090-57291310,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCF12&subject=,2023-08-16T16:39:32Z,TCF12,https://search.clinicalgenome.org/kb/genes/HGNC:11623,TCF12-related craniosynostosis,MONDO:0014128,https://search.clinicalgenome.org/kb/conditions/MONDO:0014128,Autosomal dominant inheritance
1154,TCF20,HGNC:11631,developmental delay with variable intellectual impairment and behavioral abnormalities,MONDO:0032745,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_619ae2be-5ab6-418d-8824-373369337faa-2020-10-07T172001.182Z,2020-10-07T17:20:01.182Z,Syndromic Disorders Gene Curation Expert Panel,TCF20,HGNC:11631,chr22:42556019-42679933,chr22:42160013-42343537,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCF20&subject=,2019-06-26T16:45:36Z,TCF20,https://search.clinicalgenome.org/kb/genes/HGNC:11631,developmental delay with variable intellectual impairment and behavioral abnormalities,MONDO:0032745,https://search.clinicalgenome.org/kb/conditions/MONDO:0032745,Autosomal dominant inheritance
1155,TCF20,HGNC:11631,developmental delay with variable intellectual impairment and behavioral abnormalities,MONDO:0032745,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_619ae2be-5ab6-418d-8824-373369337faa-2020-10-07T172001.182Z,2020-10-07T17:20:01.182Z,Syndromic Disorders Gene Curation Expert Panel,TCF20,HGNC:11631,chr22:42556019-42679933,chr22:42160013-42343537,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCF20&subject=,2019-06-26T16:45:36Z,TCF20,https://search.clinicalgenome.org/kb/genes/HGNC:11631,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,
1156,TCF4,HGNC:11634,Pitt-Hopkins syndrome,MONDO:0012589,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_096f830c-0065-456a-9e26-db54fd157981-2018-05-02T170000.000Z,2018-05-02T17:00:00.000Z,Rett and Angelman-like Disorders,TCF4,HGNC:11634,chr18:52889416-53303188,chr18:55222185-55635957,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCF4&subject=,2020-07-08T19:01:39Z,TCF4,https://search.clinicalgenome.org/kb/genes/HGNC:11634,Pitt-Hopkins syndrome,MONDO:0012589,https://search.clinicalgenome.org/kb/conditions/MONDO:0012589,Autosomal dominant inheritance
1157,TCF7L2,HGNC:11641,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b11a5317-868b-49a9-b051-721940fb5936-2021-12-15T170000.000Z,2021-12-15T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,TCF7L2,HGNC:11641,chr10:114710006-114927437,chr10:112950247-113167678,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCF7L2&subject=,2019-03-27T16:55:26Z,TCF7L2,https://search.clinicalgenome.org/kb/genes/HGNC:11641,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1158,TAOK1,HGNC:29259,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_79c712d0-ac0e-4bf0-8e68-bd598b3bca42-2021-08-04T160000.000Z,2021-08-04T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,TAOK1,HGNC:29259,chr17:27717381-27878921,chr17:29390363-29551903,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TAOK1&subject=,2023-06-28T16:19:01Z,TAOK1,https://search.clinicalgenome.org/kb/genes/HGNC:29259,syndromic intellectual disability,MONDO:0000508,https://search.clinicalgenome.org/kb/conditions/MONDO:0000508,Autosomal dominant inheritance
1159,POGZ,HGNC:18801,intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome,MONDO:0014606,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5742d94-0642-4598-9fbd-fd43a2c21559-2020-03-09T160000.000Z,2020-03-09T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,POGZ,HGNC:18801,chr1:151375200-151431970,chr1:151402724-151459494,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POGZ&subject=,2017-12-27T17:50:10Z,POGZ,https://search.clinicalgenome.org/kb/genes/HGNC:18801,intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome,MONDO:0014606,https://search.clinicalgenome.org/kb/conditions/MONDO:0014606,Autosomal dominant inheritance
1160,PRKAG2,HGNC:9386,PRKAG2-related cardiomyopathy,MONDO:0800484,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27297fe8-ceca-432f-bd0b-ffadf65c4c41-2022-06-14T160000.000Z,2022-06-14T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,PRKAG2,HGNC:9386,chr7:151253213-151574200,chr7:151556127-151877115,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRKAG2&subject=,2015-11-05T23:57:45Z,PRKAG2,https://search.clinicalgenome.org/kb/genes/HGNC:9386,PRKAG2-related cardiomyopathy,MONDO:0800484,https://search.clinicalgenome.org/kb/conditions/MONDO:0800484,Autosomal dominant inheritance
1161,PRKAG2,HGNC:9386,PRKAG2-related cardiomyopathy,MONDO:0800484,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27297fe8-ceca-432f-bd0b-ffadf65c4c41-2022-06-14T160000.000Z,2022-06-14T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,PRKAG2,HGNC:9386,chr7:151253213-151574200,chr7:151556127-151877115,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRKAG2&subject=,2015-11-05T23:57:45Z,PRKAG2,https://search.clinicalgenome.org/kb/genes/HGNC:9386,hypertrophic cardiomyopathy,MONDO:0005045,https://search.clinicalgenome.org/kb/conditions/MONDO:0005045,
1162,PRKAG2,HGNC:9386,PRKAG2-related cardiomyopathy,MONDO:0800484,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27297fe8-ceca-432f-bd0b-ffadf65c4c41-2022-06-14T160000.000Z,2022-06-14T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,PRKAG2,HGNC:9386,chr7:151253213-151574200,chr7:151556127-151877115,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRKAG2&subject=,2015-11-05T23:57:45Z,PRKAG2,https://search.clinicalgenome.org/kb/genes/HGNC:9386,hypertrophic cardiomyopathy 6,MONDO:0010946,https://search.clinicalgenome.org/kb/conditions/MONDO:0010946,
1163,PRKAG2,HGNC:9386,PRKAG2-related cardiomyopathy,MONDO:0800484,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27297fe8-ceca-432f-bd0b-ffadf65c4c41-2022-06-14T160000.000Z,2022-06-14T16:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,PRKAG2,HGNC:9386,chr7:151253213-151574200,chr7:151556127-151877115,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRKAG2&subject=,2015-11-05T23:57:45Z,PRKAG2,https://search.clinicalgenome.org/kb/genes/HGNC:9386,familial hypertrophic cardiomyopathy,MONDO:0024573,https://search.clinicalgenome.org/kb/conditions/MONDO:0024573,
1164,STRC,HGNC:16035,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_977b98b7-00f4-4200-9b17-f37303889ab4-2017-12-19T050000.000Z,2017-12-19T05:00:00.000Z,Hearing Loss Gene Curation Expert Panel,STRC,HGNC:16035,chr15:43891761-43910998,chr15:43599563-43618800,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STRC&subject=,2016-08-22T17:52:35Z,STRC,https://search.clinicalgenome.org/kb/genes/HGNC:16035,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
1165,STRC,HGNC:16035,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_977b98b7-00f4-4200-9b17-f37303889ab4-2017-12-19T050000.000Z,2017-12-19T05:00:00.000Z,Hearing Loss Gene Curation Expert Panel,STRC,HGNC:16035,chr15:43891761-43910998,chr15:43599563-43618800,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STRC&subject=,2016-08-22T17:52:35Z,STRC,https://search.clinicalgenome.org/kb/genes/HGNC:16035,prelingual non-syndromic genetic hearing loss,MONDO:0016297,https://search.clinicalgenome.org/kb/conditions/MONDO:0016297,
1166,STRC,HGNC:16035,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_977b98b7-00f4-4200-9b17-f37303889ab4-2017-12-19T050000.000Z,2017-12-19T05:00:00.000Z,Hearing Loss Gene Curation Expert Panel,STRC,HGNC:16035,chr15:43891761-43910998,chr15:43599563-43618800,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STRC&subject=,2016-08-22T17:52:35Z,STRC,https://search.clinicalgenome.org/kb/genes/HGNC:16035,"hearing loss, autosomal recessive",MONDO:0019588,https://search.clinicalgenome.org/kb/conditions/MONDO:0019588,
1167,STRC,HGNC:16035,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_977b98b7-00f4-4200-9b17-f37303889ab4-2017-12-19T050000.000Z,2017-12-19T05:00:00.000Z,Hearing Loss Gene Curation Expert Panel,STRC,HGNC:16035,chr15:43891761-43910998,chr15:43599563-43618800,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STRC&subject=,2016-08-22T17:52:35Z,STRC,https://search.clinicalgenome.org/kb/genes/HGNC:16035,autosomal recessive nonsyndromic hearing loss 16,MONDO:0011364,https://search.clinicalgenome.org/kb/conditions/MONDO:0011364,
1168,STX11,HGNC:11429,familial hemophagocytic lymphohistiocytosis 4,MONDO:0011336,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9844bf07-9887-4a28-b644-467b664fcb80-2023-09-19T160000.000Z,2023-09-19T16:00:00.000Z,Primary Immune Regulatory Disorders Gene Curation Expert Panel,STX11,HGNC:11429,chr6:144471654-144513076,chr6:144139963-144191939,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=STX11&subject=,2016-08-22T17:52:36Z,STX11,https://search.clinicalgenome.org/kb/genes/HGNC:11429,familial hemophagocytic lymphohistiocytosis 4,MONDO:0011336,https://search.clinicalgenome.org/kb/conditions/MONDO:0011336,Autosomal recessive inheritance
1169,PRG4,HGNC:9364,camptodactyly-arthropathy-coxa vara-pericarditis syndrome,MONDO:0008828,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b4be938-664c-421e-922b-dc6ac83e5dec-2021-07-30T130737.801Z,2021-07-30T13:07:37.801Z,Syndromic Disorders Gene Curation Expert Panel,PRG4,HGNC:9364,chr1:186265405-186283699,chr1:186296273-186314567,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PRG4&subject=,2016-08-22T17:51:39Z,PRG4,https://search.clinicalgenome.org/kb/genes/HGNC:9364,camptodactyly-arthropathy-coxa vara-pericarditis syndrome,MONDO:0008828,https://search.clinicalgenome.org/kb/conditions/MONDO:0008828,Autosomal recessive inheritance
1170,SUMF1,HGNC:20376,mucosulfatidosis,MONDO:0010088,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d64d13d-c2dc-4749-8330-fade259ca381-2022-09-06T160000.000Z,2022-09-06T16:00:00.000Z,Lysosomal Diseases Gene Curation Expert Panel,SUMF1,HGNC:20376,chr3:4402830-4508953,chr3:4034486-4467269,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SUMF1&subject=,2016-08-22T17:52:39Z,SUMF1,https://search.clinicalgenome.org/kb/genes/HGNC:20376,mucosulfatidosis,MONDO:0010088,https://search.clinicalgenome.org/kb/conditions/MONDO:0010088,Autosomal recessive inheritance
1171,SURF1,HGNC:11474,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2ed17d9b-e746-4f1f-9c39-26f46bb2eadc-2019-04-08T160338.698Z,2019-04-08T16:03:38.698Z,Mitochondrial Diseases Gene Curation Expert Panel,SURF1,HGNC:11474,chr9:136218613-136223363,chr9:133351758-133356487,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SURF1&subject=,2016-08-22T17:52:40Z,SURF1,https://search.clinicalgenome.org/kb/genes/HGNC:11474,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
1172,SURF1,HGNC:11474,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2ed17d9b-e746-4f1f-9c39-26f46bb2eadc-2019-04-08T160338.698Z,2019-04-08T16:03:38.698Z,Mitochondrial Diseases Gene Curation Expert Panel,SURF1,HGNC:11474,chr9:136218613-136223363,chr9:133351758-133356487,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SURF1&subject=,2016-08-22T17:52:40Z,SURF1,https://search.clinicalgenome.org/kb/genes/HGNC:11474,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
1173,RAD51D,HGNC:9823,RAD51D-related cancer predisposition,MONDO:0700274,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d2e5a83-03cb-4483-915d-6ac32a84dc0a-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51D,HGNC:9823,chr17:33419240-33446879,chr17:35092221-35119860,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51D&subject=,2024-01-09T17:38:35Z,RAD51D,https://search.clinicalgenome.org/kb/genes/HGNC:9823,RAD51D-related cancer predisposition,MONDO:0700274,https://search.clinicalgenome.org/kb/conditions/MONDO:0700274,Autosomal dominant inheritance
1174,RAD51D,HGNC:9823,RAD51D-related cancer predisposition,MONDO:0700274,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d2e5a83-03cb-4483-915d-6ac32a84dc0a-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51D,HGNC:9823,chr17:33419240-33446879,chr17:35092221-35119860,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51D&subject=,2024-01-09T17:38:35Z,RAD51D,https://search.clinicalgenome.org/kb/genes/HGNC:9823,"breast-ovarian cancer, familial, susceptibility to, 4",MONDO:0013669,https://search.clinicalgenome.org/kb/conditions/MONDO:0013669,
1175,RAD51D,HGNC:9823,RAD51D-related cancer predisposition,MONDO:0700274,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d2e5a83-03cb-4483-915d-6ac32a84dc0a-2024-08-29T170000.000Z,2024-08-29T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RAD51D,HGNC:9823,chr17:33419240-33446879,chr17:35092221-35119860,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAD51D&subject=,2024-01-09T17:38:35Z,RAD51D,https://search.clinicalgenome.org/kb/genes/HGNC:9823,familial ovarian cancer,MONDO:0016248,https://search.clinicalgenome.org/kb/conditions/MONDO:0016248,
1176,SYNGAP1,HGNC:11497,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b19f2a30-5538-4339-9018-150fd1bcd9c8-2019-04-02T160000.000Z,2019-04-02T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,SYNGAP1,HGNC:11497,chr6:33387842-33421466,chr6:33418167-33453689,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SYNGAP1&subject=,2021-11-09T17:59:44Z,SYNGAP1,https://search.clinicalgenome.org/kb/genes/HGNC:11497,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1177,PPP2R1A,HGNC:9302,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1aae8155-7cb1-44ee-9cee-17bb22e6a0ad-2022-11-16T170000.000Z,2022-11-16T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,PPP2R1A,HGNC:9302,chr19:52693305-52732771,chr19:52190052-52229518,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PPP2R1A&subject=,2023-12-06T17:52:07Z,PPP2R1A,https://search.clinicalgenome.org/kb/genes/HGNC:9302,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1178,PPM1D,HGNC:9277,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ec2cb-1632-4439-bdd9-4bcae1bb779f-2022-02-15T170000.000Z,2022-02-15T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,PPM1D,HGNC:9277,chr17:58677554-58743641,chr17:60600193-60666280,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PPM1D&subject=,2023-03-28T16:22:11Z,PPM1D,https://search.clinicalgenome.org/kb/genes/HGNC:9277,syndromic intellectual disability,MONDO:0000508,https://search.clinicalgenome.org/kb/conditions/MONDO:0000508,Autosomal dominant inheritance
1179,POU4F3,HGNC:9220,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1476f1d9-7538-40bd-b602-b76781630cee-2017-11-21T170000.000Z,2017-11-21T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,POU4F3,HGNC:9220,chr5:145718402-145721291,chr5:146338839-146341728,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POU4F3&subject=,2023-11-29T17:37:53Z,POU4F3,https://search.clinicalgenome.org/kb/genes/HGNC:9220,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal dominant inheritance
1180,POU4F3,HGNC:9220,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1476f1d9-7538-40bd-b602-b76781630cee-2017-11-21T170000.000Z,2017-11-21T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,POU4F3,HGNC:9220,chr5:145718402-145721291,chr5:146338839-146341728,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POU4F3&subject=,2023-11-29T17:37:53Z,POU4F3,https://search.clinicalgenome.org/kb/genes/HGNC:9220,autosomal dominant nonsyndromic hearing loss 15,MONDO:0011226,https://search.clinicalgenome.org/kb/conditions/MONDO:0011226,
1181,POU3F3,HGNC:9216,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47a5379c-d723-4b1f-aa3c-6b5398451f77-2024-06-13T180000.000Z,2024-06-13T18:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,POU3F3,HGNC:9216,chr2:105470573-105475032,chr2:104854115-104858574,No Evidence for Haploinsufficiency,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POU3F3&subject=,2025-01-14T17:26:24Z,POU3F3,https://search.clinicalgenome.org/kb/genes/HGNC:9216,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1182,PORCN,HGNC:17652,focal dermal hypoplasia,MONDO:0010592,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20fc3afa-d10d-4239-885f-24e91cbb31a8-2020-08-05T124432.168Z,2020-08-05T12:44:32.168Z,Intellectual Disability and Autism Gene Curation Expert Panel,PORCN,HGNC:17652,chrX:48367380-48379202,chrX:48508992-48520814,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=PORCN&subject=,2012-08-23T19:26:29Z,PORCN,https://search.clinicalgenome.org/kb/genes/HGNC:17652,focal dermal hypoplasia,MONDO:0010592,https://search.clinicalgenome.org/kb/conditions/MONDO:0010592,X-linked inheritance
1183,POR,HGNC:9208,Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,MONDO:0008726,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6275d46a-f005-45f8-b3ec-e9722f8dd39e-2022-03-23T193729.312Z,2022-03-23T19:37:29.312Z,Craniofacial Malformations Gene Curation Expert Panel,POR,HGNC:9208,chr7:75544473-75616173,chr7:75915155-75986855,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POR&subject=,2016-08-22T17:51:36Z,POR,https://search.clinicalgenome.org/kb/genes/HGNC:9208,Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,MONDO:0008726,https://search.clinicalgenome.org/kb/conditions/MONDO:0008726,Autosomal recessive inheritance
1184,POLH,HGNC:9181,xeroderma pigmentosum variant type,MONDO:0010214,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdb29404-0c05-4519-b6ee-8591368ad1ff-2018-11-02T215846.146Z,2018-11-02T21:58:46.146Z,Hereditary Cancer Gene Curation Expert Panel,POLH,HGNC:9181,chr6:43543922-43588260,chr6:43576185-43620523,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLH&subject=,2024-11-13T22:13:36Z,POLH,https://search.clinicalgenome.org/kb/genes/HGNC:9181,xeroderma pigmentosum variant type,MONDO:0010214,https://search.clinicalgenome.org/kb/conditions/MONDO:0010214,Autosomal recessive inheritance
1185,POLE,HGNC:9177,POLE-related polyposis and colorectal cancer syndrome,MONDO:0100287,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8b5306f4-0422-42fc-9f67-2d9b263e4e1e-2023-07-05T170000.000Z,2023-07-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,POLE,HGNC:9177,chr12:133200348-133263928,chr12:132623762-132687342,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLE&subject=,2019-12-16T22:15:42Z,POLE,https://search.clinicalgenome.org/kb/genes/HGNC:9177,POLE-related polyposis and colorectal cancer syndrome,MONDO:0100287,https://search.clinicalgenome.org/kb/conditions/MONDO:0100287,Autosomal dominant inheritance
1186,POLE,HGNC:9177,POLE-related polyposis and colorectal cancer syndrome,MONDO:0100287,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8b5306f4-0422-42fc-9f67-2d9b263e4e1e-2023-07-05T170000.000Z,2023-07-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,POLE,HGNC:9177,chr12:133200348-133263928,chr12:132623762-132687342,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLE&subject=,2019-12-16T22:15:42Z,POLE,https://search.clinicalgenome.org/kb/genes/HGNC:9177,"colorectal cancer, susceptibility to, 12",MONDO:0014038,https://search.clinicalgenome.org/kb/conditions/MONDO:0014038,
1187,POLE,HGNC:9177,POLE-related polyposis and colorectal cancer syndrome,MONDO:0100287,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8b5306f4-0422-42fc-9f67-2d9b263e4e1e-2023-07-05T170000.000Z,2023-07-05T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,POLE,HGNC:9177,chr12:133200348-133263928,chr12:132623762-132687342,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=POLE&subject=,2019-12-16T22:15:42Z,POLE,https://search.clinicalgenome.org/kb/genes/HGNC:9177,Polymerase proofreading-related adenomatous polyposis,MONDO:0018653,https://search.clinicalgenome.org/kb/conditions/MONDO:0018653,
1188,SMS,HGNC:11123,syndromic X-linked intellectual disability Snyder type,MONDO:0010664,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f1ca85b-ad57-4c64-9abf-9ae5d915703f-2018-05-16T195543.428Z,2018-05-16T19:55:43.428Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMS,HGNC:11123,chrX:21958827-22012955,chrX:21940709-21994837,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMS&subject=,2012-08-23T19:06:01Z,SMS,https://search.clinicalgenome.org/kb/genes/HGNC:11123,syndromic X-linked intellectual disability Snyder type,MONDO:0010664,https://search.clinicalgenome.org/kb/conditions/MONDO:0010664,X-linked inheritance
1189,SIL1,HGNC:24624,Marinesco-Sjogren syndrome,MONDO:0009567,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3511d4dd-48bc-4d93-9b86-16bf46fabc5d-2023-12-05T170000.000Z,2023-12-05T17:00:00.000Z,Lysosomal Diseases Gene Curation Expert Panel,SIL1,HGNC:24624,chr5:138282413-138534057,chr5:138946724-139198368,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SIL1&subject=,2021-08-23T15:59:07Z,SIL1,https://search.clinicalgenome.org/kb/genes/HGNC:24624,Marinesco-Sjogren syndrome,MONDO:0009567,https://search.clinicalgenome.org/kb/conditions/MONDO:0009567,Autosomal recessive inheritance
1190,SIN3A,HGNC:19353,SIN3A-related intellectual disability syndrome,MONDO:0044699,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6bb2ed-0912-4d60-9faa-39be27ecf4c7-2022-01-19T070000.000Z,2022-01-19T07:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SIN3A,HGNC:19353,chr15:75661720-75748156,chr15:75369379-75455815,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SIN3A&subject=,2020-01-13T19:23:33Z,SIN3A,https://search.clinicalgenome.org/kb/genes/HGNC:19353,SIN3A-related intellectual disability syndrome,MONDO:0044699,https://search.clinicalgenome.org/kb/conditions/MONDO:0044699,Autosomal dominant inheritance
1191,SIN3A,HGNC:19353,SIN3A-related intellectual disability syndrome,MONDO:0044699,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6bb2ed-0912-4d60-9faa-39be27ecf4c7-2022-01-19T070000.000Z,2022-01-19T07:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SIN3A,HGNC:19353,chr15:75661720-75748156,chr15:75369379-75455815,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SIN3A&subject=,2020-01-13T19:23:33Z,SIN3A,https://search.clinicalgenome.org/kb/genes/HGNC:19353,chromosome 15q24 deletion syndrome,MONDO:0013256,https://search.clinicalgenome.org/kb/conditions/MONDO:0013256,
1192,SCN2A,HGNC:10588,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a1b7361-5c9e-4803-844d-ad6606a0acdb-2019-05-07T160000.000Z,2019-05-07T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCN2A,HGNC:10588,chr2:166095924-166248814,chr2:165239414-165392304,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN2A&subject=,2020-04-22T16:09:34Z,SCN2A,https://search.clinicalgenome.org/kb/genes/HGNC:10588,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1193,SIX1,HGNC:10887,branchio-oto-renal syndrome,MONDO:0007029,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2587f3b-52e1-4765-a9ac-82d8cc5ae45b-2017-06-22T160000.000Z,2017-06-22T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,SIX1,HGNC:10887,chr14:61110139-61116195,chr14:60643421-60649477,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SIX1&subject=,2012-03-22T19:03:11Z,SIX1,https://search.clinicalgenome.org/kb/genes/HGNC:10887,branchio-oto-renal syndrome,MONDO:0007029,https://search.clinicalgenome.org/kb/conditions/MONDO:0007029,Autosomal dominant inheritance
1194,SKIC3,HGNC:23639,trichohepatoenteric syndrome 1,MONDO:0024541,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e528747-17dd-4c07-95cb-de05ad840740-2024-04-23T160000.000Z,2024-04-23T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,SKIC3,HGNC:23639,chr5:94799598-94890681,chr5:95463894-95554977,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SKIC3&subject=,2016-08-22T17:53:10Z,SKIC3,https://search.clinicalgenome.org/kb/genes/HGNC:23639,trichohepatoenteric syndrome 1,MONDO:0024541,https://search.clinicalgenome.org/kb/conditions/MONDO:0024541,Autosomal recessive inheritance
1195,SCARB2,HGNC:1665,progressive myoclonus epilepsy,MONDO:0020074,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc556613-cf24-44ee-8354-98ce91f78d7d-2020-08-23T190000.000Z,2020-08-23T19:00:00.000Z,Epilepsy Gene Curation Expert Panel,SCARB2,HGNC:1665,chr4:77079890-77134977,chr4:76158737-76234532,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCARB2&subject=,2012-07-06T19:41:56Z,SCARB2,https://search.clinicalgenome.org/kb/genes/HGNC:1665,progressive myoclonus epilepsy,MONDO:0020074,https://search.clinicalgenome.org/kb/conditions/MONDO:0020074,Autosomal recessive inheritance
1196,SHANK3,HGNC:14294,Phelan-McDermid syndrome,MONDO:0011652,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e941703a-0f30-4f4c-a997-bc3b4295f289-2018-12-12T170000.000Z,2018-12-12T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SHANK3,HGNC:14294,chr22:51111251-51171640,chr22:50672823-50733212,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHANK3&subject=,2018-08-14T13:32:59Z,SHANK3,https://search.clinicalgenome.org/kb/genes/HGNC:14294,Phelan-McDermid syndrome,MONDO:0011652,https://search.clinicalgenome.org/kb/conditions/MONDO:0011652,Autosomal dominant inheritance
1197,SBF2,HGNC:2135,Charcot-Marie-Tooth disease type 4B2,MONDO:0011475,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01893bf4-e95d-4206-9d2e-e3822f778b7a-2021-03-22T201309.257Z,2021-03-22T20:13:09.257Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,SBF2,HGNC:2135,chr11:9800215-10315766,chr11:9778668-10303837,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SBF2&subject=,2016-08-22T17:52:07Z,SBF2,https://search.clinicalgenome.org/kb/genes/HGNC:2135,Charcot-Marie-Tooth disease type 4B2,MONDO:0011475,https://search.clinicalgenome.org/kb/conditions/MONDO:0011475,Autosomal recessive inheritance
1198,SATB2,HGNC:21637,SATB2 associated disorder,MONDO:0100147,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44d14081-fa32-4159-9049-35f510d2351a-2020-09-15T160000.000Z,2020-09-15T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SATB2,HGNC:21637,chr2:200134223-200335989,chr2:199269500-199471266,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SATB2&subject=,2020-07-15T19:50:43Z,SATB2,https://search.clinicalgenome.org/kb/genes/HGNC:21637,SATB2 associated disorder,MONDO:0100147,https://search.clinicalgenome.org/kb/conditions/MONDO:0100147,Autosomal dominant inheritance
1199,RYR1,HGNC:10483,RYR1-related myopathy,MONDO:0100150,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbd82373-705c-4b60-8b73-147ed461d357-2020-10-26T160000.000Z,2020-10-26T16:00:00.000Z,Congenital Myopathies Gene Curation Expert Panel,RYR1,HGNC:10483,chr19:38924331-39078204,chr19:38433691-38587564,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR1&subject=,2015-11-12T19:26:59Z,RYR1,https://search.clinicalgenome.org/kb/genes/HGNC:10483,"malignant hyperthermia, susceptibility to, 1",MONDO:0007783,https://search.clinicalgenome.org/kb/conditions/MONDO:0007783,Autosomal dominant inheritance
1200,RYR1,HGNC:10483,RYR1-related myopathy,MONDO:0100150,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbd82373-705c-4b60-8b73-147ed461d357-2020-10-26T160000.000Z,2020-10-26T16:00:00.000Z,Congenital Myopathies Gene Curation Expert Panel,RYR1,HGNC:10483,chr19:38924331-39078204,chr19:38433691-38587564,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR1&subject=,2015-11-12T19:26:59Z,RYR1,https://search.clinicalgenome.org/kb/genes/HGNC:10483,RYR1-related myopathy,MONDO:0100150,https://search.clinicalgenome.org/kb/conditions/MONDO:0100150,Autosomal recessive inheritance | Autosomal dominant inheritance
1201,RYR1,HGNC:10483,RYR1-related myopathy,MONDO:0100150,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbd82373-705c-4b60-8b73-147ed461d357-2020-10-26T160000.000Z,2020-10-26T16:00:00.000Z,Congenital Myopathies Gene Curation Expert Panel,RYR1,HGNC:10483,chr19:38924331-39078204,chr19:38433691-38587564,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR1&subject=,2015-11-12T19:26:59Z,RYR1,https://search.clinicalgenome.org/kb/genes/HGNC:10483,malignant hyperthermia of anesthesia,MONDO:0018493,https://search.clinicalgenome.org/kb/conditions/MONDO:0018493,
1202,RYR1,HGNC:10483,RYR1-related myopathy,MONDO:0100150,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d5e4ff9a-94ad-453f-b2de-76deb98fe4ca-2020-07-27T160000.000Z,2020-07-27T16:00:00.000Z,Congenital Myopathies Gene Curation Expert Panel,RYR1,HGNC:10483,chr19:38924331-39078204,chr19:38433691-38587564,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR1&subject=,2015-11-12T19:26:59Z,RYR1,https://search.clinicalgenome.org/kb/genes/HGNC:10483,"malignant hyperthermia, susceptibility to, 1",MONDO:0007783,https://search.clinicalgenome.org/kb/conditions/MONDO:0007783,Autosomal dominant inheritance
1203,RYR1,HGNC:10483,RYR1-related myopathy,MONDO:0100150,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d5e4ff9a-94ad-453f-b2de-76deb98fe4ca-2020-07-27T160000.000Z,2020-07-27T16:00:00.000Z,Congenital Myopathies Gene Curation Expert Panel,RYR1,HGNC:10483,chr19:38924331-39078204,chr19:38433691-38587564,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR1&subject=,2015-11-12T19:26:59Z,RYR1,https://search.clinicalgenome.org/kb/genes/HGNC:10483,RYR1-related myopathy,MONDO:0100150,https://search.clinicalgenome.org/kb/conditions/MONDO:0100150,Autosomal recessive inheritance | Autosomal dominant inheritance
1204,RYR1,HGNC:10483,RYR1-related myopathy,MONDO:0100150,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d5e4ff9a-94ad-453f-b2de-76deb98fe4ca-2020-07-27T160000.000Z,2020-07-27T16:00:00.000Z,Congenital Myopathies Gene Curation Expert Panel,RYR1,HGNC:10483,chr19:38924331-39078204,chr19:38433691-38587564,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR1&subject=,2015-11-12T19:26:59Z,RYR1,https://search.clinicalgenome.org/kb/genes/HGNC:10483,malignant hyperthermia of anesthesia,MONDO:0018493,https://search.clinicalgenome.org/kb/conditions/MONDO:0018493,
1205,RYR1,HGNC:10483,"malignant hyperthermia, susceptibility to, 1",MONDO:0007783,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bcd5e6ba-ef77-434c-9ec6-47f72f597bfe-2020-11-25T170000.000Z,2020-11-25T17:00:00.000Z,General Gene Curation Expert Panel,RYR1,HGNC:10483,chr19:38924331-39078204,chr19:38433691-38587564,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR1&subject=,2015-11-12T19:26:59Z,RYR1,https://search.clinicalgenome.org/kb/genes/HGNC:10483,"malignant hyperthermia, susceptibility to, 1",MONDO:0007783,https://search.clinicalgenome.org/kb/conditions/MONDO:0007783,Autosomal dominant inheritance
1206,RYR1,HGNC:10483,"malignant hyperthermia, susceptibility to, 1",MONDO:0007783,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bcd5e6ba-ef77-434c-9ec6-47f72f597bfe-2020-11-25T170000.000Z,2020-11-25T17:00:00.000Z,General Gene Curation Expert Panel,RYR1,HGNC:10483,chr19:38924331-39078204,chr19:38433691-38587564,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR1&subject=,2015-11-12T19:26:59Z,RYR1,https://search.clinicalgenome.org/kb/genes/HGNC:10483,RYR1-related myopathy,MONDO:0100150,https://search.clinicalgenome.org/kb/conditions/MONDO:0100150,Autosomal recessive inheritance | Autosomal dominant inheritance
1207,RYR1,HGNC:10483,"malignant hyperthermia, susceptibility to, 1",MONDO:0007783,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bcd5e6ba-ef77-434c-9ec6-47f72f597bfe-2020-11-25T170000.000Z,2020-11-25T17:00:00.000Z,General Gene Curation Expert Panel,RYR1,HGNC:10483,chr19:38924331-39078204,chr19:38433691-38587564,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RYR1&subject=,2015-11-12T19:26:59Z,RYR1,https://search.clinicalgenome.org/kb/genes/HGNC:10483,malignant hyperthermia of anesthesia,MONDO:0018493,https://search.clinicalgenome.org/kb/conditions/MONDO:0018493,
1208,SLC16A2,HGNC:10923,Allan-Herndon-Dudley syndrome,MONDO:0010354,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9242e32-a339-4426-8ef5-39df0960d390-2018-08-09T170000.000Z,2018-08-09T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SLC16A2,HGNC:10923,chrX:73641328-73753751,chrX:74421493-74533916,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC16A2&subject=,2012-06-28T19:07:17Z,SLC16A2,https://search.clinicalgenome.org/kb/genes/HGNC:10923,Allan-Herndon-Dudley syndrome,MONDO:0010354,https://search.clinicalgenome.org/kb/conditions/MONDO:0010354,X-linked inheritance
1209,SLC17A5,HGNC:10933,free sialic acid storage disease,MONDO:0019366,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfa5a3e8-f0f5-4cd8-93b4-0f81ceab1f6a-2023-10-30T160000.000Z,2023-10-30T16:00:00.000Z,Lysosomal Diseases Gene Curation Expert Panel,SLC17A5,HGNC:10933,chr6:74303102-74363715,chr6:73593379-73653992,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC17A5&subject=,2016-08-22T17:52:16Z,SLC17A5,https://search.clinicalgenome.org/kb/genes/HGNC:10933,free sialic acid storage disease,MONDO:0019366,https://search.clinicalgenome.org/kb/conditions/MONDO:0019366,Autosomal recessive inheritance
1210,RUNX1,HGNC:10471,hereditary thrombocytopenia and hematologic cancer predisposition syndrome,MONDO:0011071,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_06aed341-58db-459b-a750-7142e29b420b-2018-06-04T170000.000Z,2018-06-04T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RUNX1,HGNC:10471,chr21:36160098-36421599,chr21:34787801-35049302,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RUNX1&subject=,2023-06-14T16:45:14Z,RUNX1,https://search.clinicalgenome.org/kb/genes/HGNC:10471,hereditary thrombocytopenia and hematologic cancer predisposition syndrome,MONDO:0011071,https://search.clinicalgenome.org/kb/conditions/MONDO:0011071,Autosomal dominant inheritance
1211,RUNX1,HGNC:10471,hereditary thrombocytopenia and hematologic cancer predisposition syndrome,MONDO:0011071,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_06aed341-58db-459b-a750-7142e29b420b-2018-06-04T170000.000Z,2018-06-04T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RUNX1,HGNC:10471,chr21:36160098-36421599,chr21:34787801-35049302,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RUNX1&subject=,2023-06-14T16:45:14Z,RUNX1,https://search.clinicalgenome.org/kb/genes/HGNC:10471,"microcephaly, corpus callosum dysgenesis, and cleft lip/palate",MONDO:0011077,https://search.clinicalgenome.org/kb/conditions/MONDO:0011077,
1212,RUNX1,HGNC:10471,hereditary thrombocytopenia and hematologic cancer predisposition syndrome,MONDO:0011071,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_06aed341-58db-459b-a750-7142e29b420b-2018-06-04T170000.000Z,2018-06-04T17:00:00.000Z,Hereditary Cancer Gene Curation Expert Panel,RUNX1,HGNC:10471,chr21:36160098-36421599,chr21:34787801-35049302,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RUNX1&subject=,2023-06-14T16:45:14Z,RUNX1,https://search.clinicalgenome.org/kb/genes/HGNC:10471,hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1,MONDO:0100083,https://search.clinicalgenome.org/kb/conditions/MONDO:0100083,
1213,SHANK2,HGNC:14295,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_911cb9ff-e68e-4b47-8639-f6a63ab11b3e-2019-07-17T160000.000Z,2019-07-17T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SHANK2,HGNC:14295,chr11:70313959-70963623,chr11:70467854-71253228,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHANK2&subject=,2023-10-26T19:19:22Z,SHANK2,https://search.clinicalgenome.org/kb/genes/HGNC:14295,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1214,RAG1,HGNC:9831,recombinase activating gene 1 deficiency,MONDO:0000572,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f08ada81-650b-4764-99e4-f3156f67cbc9-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,SCID-CID Gene Curation Expert Panel,RAG1,HGNC:9831,chr11:36531903-36601312,chr11:36510353-36579762,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAG1&subject=,2016-08-22T17:51:50Z,RAG1,https://search.clinicalgenome.org/kb/genes/HGNC:9831,recombinase activating gene 1 deficiency,MONDO:0000572,https://search.clinicalgenome.org/kb/conditions/MONDO:0000572,Autosomal recessive inheritance
1215,SDHB,HGNC:10681,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53015cfb-c54a-4436-9ebd-79ae3fdbf613-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
1216,SDHB,HGNC:10681,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53015cfb-c54a-4436-9ebd-79ae3fdbf613-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,https://search.clinicalgenome.org/kb/conditions/MONDO:0017366,Autosomal dominant inheritance
1217,SDHB,HGNC:10681,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53015cfb-c54a-4436-9ebd-79ae3fdbf613-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,paraganglioma,MONDO:0000448,https://search.clinicalgenome.org/kb/conditions/MONDO:0000448,
1218,SDHB,HGNC:10681,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53015cfb-c54a-4436-9ebd-79ae3fdbf613-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,paragangliomas 4,MONDO:0007273,https://search.clinicalgenome.org/kb/conditions/MONDO:0007273,
1219,SDHB,HGNC:10681,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53015cfb-c54a-4436-9ebd-79ae3fdbf613-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,pheochromocytoma,MONDO:0008233,https://search.clinicalgenome.org/kb/conditions/MONDO:0008233,
1220,SDHB,HGNC:10681,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5b8852d-1641-4c45-8aa2-57c2dfbac4ea-2021-06-17T012105.373Z,2021-06-17T01:21:05.373Z,Hereditary Cancer Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
1221,SDHB,HGNC:10681,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5b8852d-1641-4c45-8aa2-57c2dfbac4ea-2021-06-17T012105.373Z,2021-06-17T01:21:05.373Z,Hereditary Cancer Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,https://search.clinicalgenome.org/kb/conditions/MONDO:0017366,Autosomal dominant inheritance
1222,SDHB,HGNC:10681,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5b8852d-1641-4c45-8aa2-57c2dfbac4ea-2021-06-17T012105.373Z,2021-06-17T01:21:05.373Z,Hereditary Cancer Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,paraganglioma,MONDO:0000448,https://search.clinicalgenome.org/kb/conditions/MONDO:0000448,
1223,SDHB,HGNC:10681,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5b8852d-1641-4c45-8aa2-57c2dfbac4ea-2021-06-17T012105.373Z,2021-06-17T01:21:05.373Z,Hereditary Cancer Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,paragangliomas 4,MONDO:0007273,https://search.clinicalgenome.org/kb/conditions/MONDO:0007273,
1224,SDHB,HGNC:10681,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5b8852d-1641-4c45-8aa2-57c2dfbac4ea-2021-06-17T012105.373Z,2021-06-17T01:21:05.373Z,Hereditary Cancer Gene Curation Expert Panel,SDHB,HGNC:10681,chr1:17345217-17380527,chr1:17018722-17054032,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHB&subject=,2020-07-22T17:40:14Z,SDHB,https://search.clinicalgenome.org/kb/genes/HGNC:10681,pheochromocytoma,MONDO:0008233,https://search.clinicalgenome.org/kb/conditions/MONDO:0008233,
1225,SEC23B,HGNC:10702,congenital dyserythropoietic anemia type 2,MONDO:0009134,AR,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6093e90-7ec2-4cdb-9323-b67df78930a3-2024-11-20T170000.000Z,2024-11-20T17:00:00.000Z,Prenatal Gene Curation Expert Panel,SEC23B,HGNC:10702,chr20:18488192-18542059,chr20:18507548-18561415,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SEC23B&subject=,2016-08-22T17:52:10Z,SEC23B,https://search.clinicalgenome.org/kb/genes/HGNC:10702,congenital dyserythropoietic anemia type 2,MONDO:0009134,https://search.clinicalgenome.org/kb/conditions/MONDO:0009134,Autosomal recessive inheritance
1226,SERAC1,HGNC:21061,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf6861ce-e13a-42c9-a4ff-942a83874bfd-2021-01-14T213356.750Z,2021-01-14T21:33:56.750Z,Mitochondrial Diseases Gene Curation Expert Panel,SERAC1,HGNC:21061,chr6:158530551-158589294,chr6:158109519-158168262,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SERAC1&subject=,2016-08-22T17:52:11Z,SERAC1,https://search.clinicalgenome.org/kb/genes/HGNC:21061,Leigh syndrome,MONDO:0009723,https://search.clinicalgenome.org/kb/conditions/MONDO:0009723,Autosomal recessive inheritance
1227,SERAC1,HGNC:21061,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf6861ce-e13a-42c9-a4ff-942a83874bfd-2021-01-14T213356.750Z,2021-01-14T21:33:56.750Z,Mitochondrial Diseases Gene Curation Expert Panel,SERAC1,HGNC:21061,chr6:158530551-158589294,chr6:158109519-158168262,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SERAC1&subject=,2016-08-22T17:52:11Z,SERAC1,https://search.clinicalgenome.org/kb/genes/HGNC:21061,"3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome",MONDO:0013875,https://search.clinicalgenome.org/kb/conditions/MONDO:0013875,
1228,SET,HGNC:10760,intellectual disability,MONDO:0001071,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4d7c9aa2-0a9a-4359-af98-6097cc6a3b91-2021-11-17T170000.000Z,2021-11-17T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SET,HGNC:10760,chr9:131445703-131458675,chr9:128683424-128696396,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SET&subject=,2025-01-22T17:10:26Z,SET,https://search.clinicalgenome.org/kb/genes/HGNC:10760,intellectual disability,MONDO:0001071,https://search.clinicalgenome.org/kb/conditions/MONDO:0001071,Autosomal dominant inheritance
1229,SETBP1,HGNC:15573,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70505ca8-8869-4fa9-9965-fc8e03a19b28-2020-10-20T160000.000Z,2020-10-20T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETBP1,HGNC:15573,chr18:42260038-42648475,chr18:44680073-45068510,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETBP1&subject=,2018-05-23T16:20:58Z,SETBP1,https://search.clinicalgenome.org/kb/genes/HGNC:15573,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1230,SETBP1,HGNC:15573,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70505ca8-8869-4fa9-9965-fc8e03a19b28-2020-10-20T160000.000Z,2020-10-20T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETBP1,HGNC:15573,chr18:42260038-42648475,chr18:44680073-45068510,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETBP1&subject=,2018-05-23T16:20:58Z,SETBP1,https://search.clinicalgenome.org/kb/genes/HGNC:15573,Schinzel-Giedion syndrome,MONDO:0010010,https://search.clinicalgenome.org/kb/conditions/MONDO:0010010,Autosomal dominant inheritance
1231,SETBP1,HGNC:15573,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70505ca8-8869-4fa9-9965-fc8e03a19b28-2020-10-20T160000.000Z,2020-10-20T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETBP1,HGNC:15573,chr18:42260038-42648475,chr18:44680073-45068510,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETBP1&subject=,2018-05-23T16:20:58Z,SETBP1,https://search.clinicalgenome.org/kb/genes/HGNC:15573,"intellectual disability, autosomal dominant 29",MONDO:0014482,https://search.clinicalgenome.org/kb/conditions/MONDO:0014482,
1232,SETBP1,HGNC:15573,Schinzel-Giedion syndrome,MONDO:0010010,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71885c03-b578-4baf-a17c-4817349eaf36-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETBP1,HGNC:15573,chr18:42260038-42648475,chr18:44680073-45068510,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETBP1&subject=,2018-05-23T16:20:58Z,SETBP1,https://search.clinicalgenome.org/kb/genes/HGNC:15573,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1233,SETBP1,HGNC:15573,Schinzel-Giedion syndrome,MONDO:0010010,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71885c03-b578-4baf-a17c-4817349eaf36-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETBP1,HGNC:15573,chr18:42260038-42648475,chr18:44680073-45068510,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETBP1&subject=,2018-05-23T16:20:58Z,SETBP1,https://search.clinicalgenome.org/kb/genes/HGNC:15573,Schinzel-Giedion syndrome,MONDO:0010010,https://search.clinicalgenome.org/kb/conditions/MONDO:0010010,Autosomal dominant inheritance
1234,SETBP1,HGNC:15573,Schinzel-Giedion syndrome,MONDO:0010010,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71885c03-b578-4baf-a17c-4817349eaf36-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETBP1,HGNC:15573,chr18:42260038-42648475,chr18:44680073-45068510,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETBP1&subject=,2018-05-23T16:20:58Z,SETBP1,https://search.clinicalgenome.org/kb/genes/HGNC:15573,"intellectual disability, autosomal dominant 29",MONDO:0014482,https://search.clinicalgenome.org/kb/conditions/MONDO:0014482,
1235,SETD1B,HGNC:29187,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44c7e8ef-e3f7-483e-87bb-7de1c11637d4-2024-08-20T160000.000Z,2024-08-20T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETD1B,HGNC:29187,chr12:122241915-122270562,chr12:121790155-121832656,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETD1B&subject=,2024-08-28T16:10:37Z,SETD1B,https://search.clinicalgenome.org/kb/genes/HGNC:29187,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1236,SDHAF2,HGNC:26034,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f70f16ee-a8b5-4f81-bd98-270fda25ffa4-2021-06-17T020032.120Z,2021-06-17T02:00:32.120Z,Hereditary Cancer Gene Curation Expert Panel,SDHAF2,HGNC:26034,chr11:61197596-61214205,chr11:61430124-61446733,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHAF2&subject=,2022-05-11T16:22:43Z,SDHAF2,https://search.clinicalgenome.org/kb/genes/HGNC:26034,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,https://search.clinicalgenome.org/kb/conditions/MONDO:0017366,Autosomal dominant inheritance
1237,SDHAF2,HGNC:26034,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f70f16ee-a8b5-4f81-bd98-270fda25ffa4-2021-06-17T020032.120Z,2021-06-17T02:00:32.120Z,Hereditary Cancer Gene Curation Expert Panel,SDHAF2,HGNC:26034,chr11:61197596-61214205,chr11:61430124-61446733,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHAF2&subject=,2022-05-11T16:22:43Z,SDHAF2,https://search.clinicalgenome.org/kb/genes/HGNC:26034,paragangliomas 2,MONDO:0011121,https://search.clinicalgenome.org/kb/conditions/MONDO:0011121,
1238,SDHAF2,HGNC:26034,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f70f16ee-a8b5-4f81-bd98-270fda25ffa4-2021-06-17T020032.120Z,2021-06-17T02:00:32.120Z,Hereditary Cancer Gene Curation Expert Panel,SDHAF2,HGNC:26034,chr11:61197596-61214205,chr11:61430124-61446733,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDHAF2&subject=,2022-05-11T16:22:43Z,SDHAF2,https://search.clinicalgenome.org/kb/genes/HGNC:26034,paraganglioma,MONDO:0000448,https://search.clinicalgenome.org/kb/conditions/MONDO:0000448,
1239,SHANK1,HGNC:15474,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_57f9ab85-914e-4eec-ae66-efc80d612ef8-2024-03-20T040000.000Z,2024-03-20T04:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SHANK1,HGNC:15474,chr19:51162512-51223059,chr19:50659255-50719802,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SHANK1&subject=,2019-03-27T16:22:58Z,SHANK1,https://search.clinicalgenome.org/kb/genes/HGNC:15474,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1240,SDCCAG8,HGNC:10671,Bardet-Biedl syndrome 16,MONDO:0014444,AR,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_515a5937-a075-4bb7-97d6-a8712720c10f-2024-08-01T160000.000Z,2024-08-01T16:00:00.000Z,Retina Gene Curation Expert Panel,SDCCAG8,HGNC:10671,chr1:243419343-243663393,chr1:243256041-243500091,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SDCCAG8&subject=,2016-08-22T17:52:08Z,SDCCAG8,https://search.clinicalgenome.org/kb/genes/HGNC:10671,Bardet-Biedl syndrome 16,MONDO:0014444,https://search.clinicalgenome.org/kb/conditions/MONDO:0014444,Autosomal recessive inheritance
1241,SCN8A,HGNC:10596,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f52993aa-ddee-483d-b15e-dbf21608d5a9-2018-07-18T125000.560Z,2018-07-18T12:50:00.560Z,Epilepsy Gene Curation Expert Panel,SCN8A,HGNC:10596,chr12:51985017-52206648,chr12:51591233-51812864,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SCN8A&subject=,2023-02-14T19:00:34Z,SCN8A,https://search.clinicalgenome.org/kb/genes/HGNC:10596,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1242,SETD5,HGNC:25566,syndromic complex neurodevelopmental disorder,MONDO:0800439,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0964426-ce53-46d4-87bb-e1eba4ac25ed-2023-07-27T180000.000Z,2023-07-27T18:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETD5,HGNC:25566,chr3:9439299-9519838,chr3:9397615-9478154,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETD5&subject=,2014-11-06T20:08:57Z,SETD5,https://search.clinicalgenome.org/kb/genes/HGNC:25566,syndromic complex neurodevelopmental disorder,MONDO:0800439,https://search.clinicalgenome.org/kb/conditions/MONDO:0800439,Autosomal dominant inheritance
1243,SETD5,HGNC:25566,syndromic complex neurodevelopmental disorder,MONDO:0800439,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0964426-ce53-46d4-87bb-e1eba4ac25ed-2023-07-27T180000.000Z,2023-07-27T18:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SETD5,HGNC:25566,chr3:9439299-9519838,chr3:9397615-9478154,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SETD5&subject=,2014-11-06T20:08:57Z,SETD5,https://search.clinicalgenome.org/kb/genes/HGNC:25566,intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency,MONDO:0014336,https://search.clinicalgenome.org/kb/conditions/MONDO:0014336,
1244,SF3B4,HGNC:10771,SF3B4-related acrofacial dysostosis,MONDO:0800483,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1dd38d7-8eac-460d-bcc1-c884cd503455-2023-05-18T040000.000Z,2023-05-18T04:00:00.000Z,Craniofacial Malformations Gene Curation Expert Panel,SF3B4,HGNC:10771,chr1:149895209-149899695,chr1:149923317-149927803,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SF3B4&subject=,2014-07-17T19:43:19Z,SF3B4,https://search.clinicalgenome.org/kb/genes/HGNC:10771,SF3B4-related acrofacial dysostosis,MONDO:0800483,https://search.clinicalgenome.org/kb/conditions/MONDO:0800483,Autosomal dominant inheritance
1245,SF3B4,HGNC:10771,SF3B4-related acrofacial dysostosis,MONDO:0800483,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1dd38d7-8eac-460d-bcc1-c884cd503455-2023-05-18T040000.000Z,2023-05-18T04:00:00.000Z,Craniofacial Malformations Gene Curation Expert Panel,SF3B4,HGNC:10771,chr1:149895209-149899695,chr1:149923317-149927803,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SF3B4&subject=,2014-07-17T19:43:19Z,SF3B4,https://search.clinicalgenome.org/kb/genes/HGNC:10771,Nager acrofacial dysostosis,MONDO:0007943,https://search.clinicalgenome.org/kb/conditions/MONDO:0007943,
1246,SGSH,HGNC:10818,mucopolysaccharidosis type 3A,MONDO:0009655,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_438dab6d-abf4-44e8-a176-bb39ae128052-2022-06-15T160000.000Z,2022-06-15T16:00:00.000Z,Lysosomal Diseases Gene Curation Expert Panel,SGSH,HGNC:10818,chr17:78183075-78194132,chr17:80200673-80220333,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SGSH&subject=,2015-02-12T21:09:07Z,SGSH,https://search.clinicalgenome.org/kb/genes/HGNC:10818,mucopolysaccharidosis type 3A,MONDO:0009655,https://search.clinicalgenome.org/kb/conditions/MONDO:0009655,Autosomal recessive inheritance
1247,SH3TC2,HGNC:29427,obsolete autosomal recessive hereditary demyelinating motor and sensory neuropathy,MONDO:0015361,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d2b214f-3086-4012-bf4b-a6e651618f0b-2022-02-10T020711.223Z,2022-02-10T02:07:11.223Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,SH3TC2,HGNC:29427,chr5:148361713-148442625,chr5:148982150-149063062,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SH3TC2&subject=,2016-08-22T17:52:14Z,SH3TC2,https://search.clinicalgenome.org/kb/genes/HGNC:29427,obsolete autosomal recessive hereditary demyelinating motor and sensory neuropathy,MONDO:0015361,https://search.clinicalgenome.org/kb/conditions/MONDO:0015361,Autosomal recessive inheritance
1248,SH3TC2,HGNC:29427,obsolete autosomal recessive hereditary demyelinating motor and sensory neuropathy,MONDO:0015361,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d2b214f-3086-4012-bf4b-a6e651618f0b-2022-02-10T020711.223Z,2022-02-10T02:07:11.223Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,SH3TC2,HGNC:29427,chr5:148361713-148442625,chr5:148982150-149063062,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SH3TC2&subject=,2016-08-22T17:52:14Z,SH3TC2,https://search.clinicalgenome.org/kb/genes/HGNC:29427,Charcot-Marie-Tooth disease type 4C,MONDO:0011113,https://search.clinicalgenome.org/kb/conditions/MONDO:0011113,
1249,RTTN,HGNC:18654,microcephalic primordial dwarfism due to RTTN deficiency,MONDO:0018764,AR,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ebfb3367-c465-4e77-9256-ab34683c8ba7-2024-10-24T160000.000Z,2024-10-24T16:00:00.000Z,Brain Malformations Gene Curation Expert Panel,RTTN,HGNC:18654,chr18:67670267-67872923,chr18:70003031-70205687,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RTTN&subject=,2016-08-22T17:52:05Z,RTTN,https://search.clinicalgenome.org/kb/genes/HGNC:18654,microcephalic primordial dwarfism due to RTTN deficiency,MONDO:0018764,https://search.clinicalgenome.org/kb/conditions/MONDO:0018764,Autosomal recessive inheritance
1250,RTTN,HGNC:18654,microcephalic primordial dwarfism due to RTTN deficiency,MONDO:0018764,AR,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ebfb3367-c465-4e77-9256-ab34683c8ba7-2024-10-24T160000.000Z,2024-10-24T16:00:00.000Z,Brain Malformations Gene Curation Expert Panel,RTTN,HGNC:18654,chr18:67670267-67872923,chr18:70003031-70205687,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RTTN&subject=,2016-08-22T17:52:05Z,RTTN,https://search.clinicalgenome.org/kb/genes/HGNC:18654,bilateral generalized polymicrogyria,MONDO:0013907,https://search.clinicalgenome.org/kb/conditions/MONDO:0013907,
1251,RSPH4A,HGNC:21558,primary ciliary dyskinesia 11,MONDO:0012978,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f876804-e14a-4c7e-a826-232c7f445c7f-2022-04-05T150444.668Z,2022-04-05T15:04:44.668Z,Motile Ciliopathy Gene Curation Expert Panel,RSPH4A,HGNC:21558,chr6:116937642-116954148,chr6:116616479-116632985,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RSPH4A&subject=,2016-08-22T17:52:02Z,RSPH4A,https://search.clinicalgenome.org/kb/genes/HGNC:21558,primary ciliary dyskinesia 11,MONDO:0012978,https://search.clinicalgenome.org/kb/conditions/MONDO:0012978,Autosomal recessive inheritance
1252,SLC24A1,HGNC:10975,inherited retinal dystrophy,MONDO:0019118,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3071ba1a-21c2-46a7-a5e9-bc53c015c7a9-2024-09-05T160000.000Z,2024-09-05T16:00:00.000Z,Retina Gene Curation Expert Panel,SLC24A1,HGNC:10975,chr15:65903688-65953340,chr15:65611350-65661002,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC24A1&subject=,2016-08-22T17:52:17Z,SLC24A1,https://search.clinicalgenome.org/kb/genes/HGNC:10975,inherited retinal dystrophy,MONDO:0019118,https://search.clinicalgenome.org/kb/conditions/MONDO:0019118,Autosomal recessive inheritance
1253,SLC24A1,HGNC:10975,inherited retinal dystrophy,MONDO:0019118,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3071ba1a-21c2-46a7-a5e9-bc53c015c7a9-2024-09-05T160000.000Z,2024-09-05T16:00:00.000Z,Retina Gene Curation Expert Panel,SLC24A1,HGNC:10975,chr15:65903688-65953340,chr15:65611350-65661002,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC24A1&subject=,2016-08-22T17:52:17Z,SLC24A1,https://search.clinicalgenome.org/kb/genes/HGNC:10975,congenital stationary night blindness 1D,MONDO:0013450,https://search.clinicalgenome.org/kb/conditions/MONDO:0013450,
1254,RARS2,HGNC:21406,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1bdeaf04-f6ce-42f1-9ee0-037f1ead77fb-2022-05-04T160000.000Z,2022-05-04T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,RARS2,HGNC:21406,chr6:88223656-88299705,chr6:87513938-87589987,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RARS2&subject=,2015-04-09T03:17:36Z,RARS2,https://search.clinicalgenome.org/kb/genes/HGNC:21406,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
1255,RARS2,HGNC:21406,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1bdeaf04-f6ce-42f1-9ee0-037f1ead77fb-2022-05-04T160000.000Z,2022-05-04T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,RARS2,HGNC:21406,chr6:88223656-88299705,chr6:87513938-87589987,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RARS2&subject=,2015-04-09T03:17:36Z,RARS2,https://search.clinicalgenome.org/kb/genes/HGNC:21406,pontocerebellar hypoplasia type 6,MONDO:0012683,https://search.clinicalgenome.org/kb/conditions/MONDO:0012683,
1256,SLC38A8,HGNC:32434,foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome,MONDO:0012216,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5eb4abb6-392a-4ded-9a3e-79aaea763377-2023-02-10T170000.000Z,2023-02-10T17:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,SLC38A8,HGNC:32434,chr16:84043272-84076400,chr16:84009667-84043372,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC38A8&subject=,2016-08-22T17:52:23Z,SLC38A8,https://search.clinicalgenome.org/kb/genes/HGNC:32434,foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome,MONDO:0012216,https://search.clinicalgenome.org/kb/conditions/MONDO:0012216,Autosomal recessive inheritance
1257,SLC6A3,HGNC:11049,SLC6A3-related dopamine transporter deficiency syndrome,MONDO:0700117,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb7a8001-1bc9-4cdf-bb99-1979737bda79-2023-01-09T170000.000Z,2023-01-09T17:00:00.000Z,General Inborn Errors of Metabolism Gene Curation Expert Panel,SLC6A3,HGNC:11049,chr5:1392909-1445555,chr5:1392794-1445440,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC6A3&subject=,2016-08-22T17:52:25Z,SLC6A3,https://search.clinicalgenome.org/kb/genes/HGNC:11049,SLC6A3-related dopamine transporter deficiency syndrome,MONDO:0700117,https://search.clinicalgenome.org/kb/conditions/MONDO:0700117,Autosomal recessive inheritance
1258,SLC6A3,HGNC:11049,SLC6A3-related dopamine transporter deficiency syndrome,MONDO:0700117,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb7a8001-1bc9-4cdf-bb99-1979737bda79-2023-01-09T170000.000Z,2023-01-09T17:00:00.000Z,General Inborn Errors of Metabolism Gene Curation Expert Panel,SLC6A3,HGNC:11049,chr5:1392909-1445555,chr5:1392794-1445440,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC6A3&subject=,2016-08-22T17:52:25Z,SLC6A3,https://search.clinicalgenome.org/kb/genes/HGNC:11049,classic dopamine transporter deficiency syndrome,MONDO:0054835,https://search.clinicalgenome.org/kb/conditions/MONDO:0054835,
1259,RET,HGNC:9967,multiple endocrine neoplasia type 2B,MONDO:0008082,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e4425f0-0900-43c3-aac4-5b37554be386-2020-05-14T010345.543Z,2020-05-14T01:03:45.543Z,Hereditary Cancer Gene Curation Expert Panel,RET,HGNC:9967,chr10:43572517-43625799,chr10:43077069-43130351,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RET&subject=,2020-08-26T16:40:35Z,RET,https://search.clinicalgenome.org/kb/genes/HGNC:9967,multiple endocrine neoplasia type 2A,MONDO:0008234,https://search.clinicalgenome.org/kb/conditions/MONDO:0008234,Autosomal dominant inheritance
1260,RET,HGNC:9967,multiple endocrine neoplasia type 2B,MONDO:0008082,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e4425f0-0900-43c3-aac4-5b37554be386-2020-05-14T010345.543Z,2020-05-14T01:03:45.543Z,Hereditary Cancer Gene Curation Expert Panel,RET,HGNC:9967,chr10:43572517-43625799,chr10:43077069-43130351,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RET&subject=,2020-08-26T16:40:35Z,RET,https://search.clinicalgenome.org/kb/genes/HGNC:9967,multiple endocrine neoplasia type 2B,MONDO:0008082,https://search.clinicalgenome.org/kb/conditions/MONDO:0008082,Autosomal dominant inheritance
1261,RET,HGNC:9967,multiple endocrine neoplasia type 2B,MONDO:0008082,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e4425f0-0900-43c3-aac4-5b37554be386-2020-05-14T010345.543Z,2020-05-14T01:03:45.543Z,Hereditary Cancer Gene Curation Expert Panel,RET,HGNC:9967,chr10:43572517-43625799,chr10:43077069-43130351,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RET&subject=,2020-08-26T16:40:35Z,RET,https://search.clinicalgenome.org/kb/genes/HGNC:9967,familial medullary thyroid carcinoma,MONDO:0007958,https://search.clinicalgenome.org/kb/conditions/MONDO:0007958,
1262,RET,HGNC:9967,multiple endocrine neoplasia type 2B,MONDO:0008082,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e4425f0-0900-43c3-aac4-5b37554be386-2020-05-14T010345.543Z,2020-05-14T01:03:45.543Z,Hereditary Cancer Gene Curation Expert Panel,RET,HGNC:9967,chr10:43572517-43625799,chr10:43077069-43130351,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RET&subject=,2020-08-26T16:40:35Z,RET,https://search.clinicalgenome.org/kb/genes/HGNC:9967,"Hirschsprung disease, susceptibility to, 1",MONDO:0007723,https://search.clinicalgenome.org/kb/conditions/MONDO:0007723,
1263,RET,HGNC:9967,multiple endocrine neoplasia type 2A,MONDO:0008234,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5f3c875-2438-4bfe-b785-b86d7d3e6507-2020-05-14T005952.060Z,2020-05-14T00:59:52.060Z,Hereditary Cancer Gene Curation Expert Panel,RET,HGNC:9967,chr10:43572517-43625799,chr10:43077069-43130351,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RET&subject=,2020-08-26T16:40:35Z,RET,https://search.clinicalgenome.org/kb/genes/HGNC:9967,multiple endocrine neoplasia type 2A,MONDO:0008234,https://search.clinicalgenome.org/kb/conditions/MONDO:0008234,Autosomal dominant inheritance
1264,RET,HGNC:9967,multiple endocrine neoplasia type 2A,MONDO:0008234,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5f3c875-2438-4bfe-b785-b86d7d3e6507-2020-05-14T005952.060Z,2020-05-14T00:59:52.060Z,Hereditary Cancer Gene Curation Expert Panel,RET,HGNC:9967,chr10:43572517-43625799,chr10:43077069-43130351,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RET&subject=,2020-08-26T16:40:35Z,RET,https://search.clinicalgenome.org/kb/genes/HGNC:9967,multiple endocrine neoplasia type 2B,MONDO:0008082,https://search.clinicalgenome.org/kb/conditions/MONDO:0008082,Autosomal dominant inheritance
1265,RET,HGNC:9967,multiple endocrine neoplasia type 2A,MONDO:0008234,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5f3c875-2438-4bfe-b785-b86d7d3e6507-2020-05-14T005952.060Z,2020-05-14T00:59:52.060Z,Hereditary Cancer Gene Curation Expert Panel,RET,HGNC:9967,chr10:43572517-43625799,chr10:43077069-43130351,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RET&subject=,2020-08-26T16:40:35Z,RET,https://search.clinicalgenome.org/kb/genes/HGNC:9967,familial medullary thyroid carcinoma,MONDO:0007958,https://search.clinicalgenome.org/kb/conditions/MONDO:0007958,
1266,RET,HGNC:9967,multiple endocrine neoplasia type 2A,MONDO:0008234,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5f3c875-2438-4bfe-b785-b86d7d3e6507-2020-05-14T005952.060Z,2020-05-14T00:59:52.060Z,Hereditary Cancer Gene Curation Expert Panel,RET,HGNC:9967,chr10:43572517-43625799,chr10:43077069-43130351,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RET&subject=,2020-08-26T16:40:35Z,RET,https://search.clinicalgenome.org/kb/genes/HGNC:9967,"Hirschsprung disease, susceptibility to, 1",MONDO:0007723,https://search.clinicalgenome.org/kb/conditions/MONDO:0007723,
1267,SLC7A7,HGNC:11065,lysinuric protein intolerance,MONDO:0009109,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_207778e3-aff9-427d-ae87-f68fd938af88-2019-11-08T170000.000Z,2019-11-08T17:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,SLC7A7,HGNC:11065,chr14:23242431-23289000,chr14:22773222-22819791,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC7A7&subject=,2016-08-22T17:52:26Z,SLC7A7,https://search.clinicalgenome.org/kb/genes/HGNC:11065,lysinuric protein intolerance,MONDO:0009109,https://search.clinicalgenome.org/kb/conditions/MONDO:0009109,Autosomal recessive inheritance
1268,SLC9A6,HGNC:11079,Christianson syndrome,MONDO:0010278,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d97fc8d-e744-449a-939c-386895c121cd-2018-05-02T160000.000Z,2018-05-02T16:00:00.000Z,Rett and Angelman-like Disorders,SLC9A6,HGNC:11079,chrX:135067594-135129428,chrX:135973837-136047269,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC9A6&subject=,2020-12-08T17:20:37Z,SLC9A6,https://search.clinicalgenome.org/kb/genes/HGNC:11079,Christianson syndrome,MONDO:0010278,https://search.clinicalgenome.org/kb/conditions/MONDO:0010278,X-linked inheritance
1269,SMAD2,HGNC:6768,congenital heart disease,MONDO:0005453,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0055af-46d4-42c2-93fa-f3c4d238b3d4-2023-11-06T170000.000Z,2023-11-06T17:00:00.000Z,Congenital Heart Disease Gene Curation Expert Panel,SMAD2,HGNC:6768,chr18:45335328-45457243,chr18:47808957-47930872,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMAD2&subject=,2018-06-29T00:21:15Z,SMAD2,https://search.clinicalgenome.org/kb/genes/HGNC:6768,congenital heart disease,MONDO:0005453,https://search.clinicalgenome.org/kb/conditions/MONDO:0005453,Autosomal dominant inheritance
1270,RDX,HGNC:9944,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf494e5-7335-4e2a-8b50-75cf8412a9d0-2018-01-02T170000.000Z,2018-01-02T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,RDX,HGNC:9944,chr11:110045647-110167339,chr11:110174922-110296614,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RDX&subject=,2016-08-22T17:51:54Z,RDX,https://search.clinicalgenome.org/kb/genes/HGNC:9944,nonsyndromic genetic hearing loss,MONDO:0019497,https://search.clinicalgenome.org/kb/conditions/MONDO:0019497,Autosomal recessive inheritance
1271,RDX,HGNC:9944,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf494e5-7335-4e2a-8b50-75cf8412a9d0-2018-01-02T170000.000Z,2018-01-02T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,RDX,HGNC:9944,chr11:110045647-110167339,chr11:110174922-110296614,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RDX&subject=,2016-08-22T17:51:54Z,RDX,https://search.clinicalgenome.org/kb/genes/HGNC:9944,"hearing loss, autosomal recessive",MONDO:0019588,https://search.clinicalgenome.org/kb/conditions/MONDO:0019588,
1272,RDX,HGNC:9944,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf494e5-7335-4e2a-8b50-75cf8412a9d0-2018-01-02T170000.000Z,2018-01-02T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,RDX,HGNC:9944,chr11:110045647-110167339,chr11:110174922-110296614,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RDX&subject=,2016-08-22T17:51:54Z,RDX,https://search.clinicalgenome.org/kb/genes/HGNC:9944,autosomal recessive nonsyndromic hearing loss 24,MONDO:0012602,https://search.clinicalgenome.org/kb/conditions/MONDO:0012602,
1273,RDX,HGNC:9944,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf494e5-7335-4e2a-8b50-75cf8412a9d0-2018-01-02T170000.000Z,2018-01-02T17:00:00.000Z,Hearing Loss Gene Curation Expert Panel,RDX,HGNC:9944,chr11:110045647-110167339,chr11:110174922-110296614,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RDX&subject=,2016-08-22T17:51:54Z,RDX,https://search.clinicalgenome.org/kb/genes/HGNC:9944,prelingual non-syndromic genetic hearing loss,MONDO:0016297,https://search.clinicalgenome.org/kb/conditions/MONDO:0016297,
1274,RB1,HGNC:9884,retinoblastoma,MONDO:0008380,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f8c79621-7ace-4c0c-874e-a315a2e6c872-2020-07-30T213929.219Z,2020-07-30T21:39:29.219Z,Hereditary Cancer Gene Curation Expert Panel,RB1,HGNC:9884,chr13:48877887-49056026,chr13:48303751-48481890,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RB1&subject=,2021-03-09T17:19:02Z,RB1,https://search.clinicalgenome.org/kb/genes/HGNC:9884,retinoblastoma,MONDO:0008380,https://search.clinicalgenome.org/kb/conditions/MONDO:0008380,Autosomal dominant inheritance
1275,RB1,HGNC:9884,retinoblastoma,MONDO:0008380,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f8c79621-7ace-4c0c-874e-a315a2e6c872-2020-07-30T213929.219Z,2020-07-30T21:39:29.219Z,Hereditary Cancer Gene Curation Expert Panel,RB1,HGNC:9884,chr13:48877887-49056026,chr13:48303751-48481890,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RB1&subject=,2021-03-09T17:19:02Z,RB1,https://search.clinicalgenome.org/kb/genes/HGNC:9884,hereditary retinoblastoma,MONDO:0018160,https://search.clinicalgenome.org/kb/conditions/MONDO:0018160,
1276,RAI1,HGNC:9834,Smith-Magenis syndrome,MONDO:0008434,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e576e58-debf-49c6-a86d-c599806180ff-2018-09-05T160000.000Z,2018-09-05T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,RAI1,HGNC:9834,chr17:17584772-17714767,chr17:17681458-17811453,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAI1&subject=,2020-10-13T16:11:47Z,RAI1,https://search.clinicalgenome.org/kb/genes/HGNC:9834,Smith-Magenis syndrome,MONDO:0008434,https://search.clinicalgenome.org/kb/conditions/MONDO:0008434,Autosomal dominant inheritance
1277,RSPH1,HGNC:12371,primary ciliary dyskinesia 24,MONDO:0014202,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f2bdb2e5-9659-46af-b306-e01207f31174-2022-06-07T110000.000Z,2022-06-07T11:00:00.000Z,Motile Ciliopathy Gene Curation Expert Panel,RSPH1,HGNC:12371,chr21:43892596-43916334,chr21:42472486-42496224,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RSPH1&subject=,2016-08-22T17:52:02Z,RSPH1,https://search.clinicalgenome.org/kb/genes/HGNC:12371,primary ciliary dyskinesia 24,MONDO:0014202,https://search.clinicalgenome.org/kb/conditions/MONDO:0014202,Autosomal recessive inheritance
1278,SMARCA2,HGNC:11098,intellectual disability-sparse hair-brachydactyly syndrome,MONDO:0011053,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5cde86bc-f99f-40cf-8c32-eac9f8f8a67d-2020-08-18T160000.000Z,2020-08-18T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,SMARCA2,HGNC:11098,chr9:2015347-2193624,chr9:2015347-2193624,No Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCA2&subject=,2013-03-27T18:37:39Z,SMARCA2,https://search.clinicalgenome.org/kb/genes/HGNC:11098,intellectual disability-sparse hair-brachydactyly syndrome,MONDO:0011053,https://search.clinicalgenome.org/kb/conditions/MONDO:0011053,Autosomal dominant inheritance
1279,SMARCB1,HGNC:11103,rhabdoid tumor predisposition syndrome 1,MONDO:0012252,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d7390e7-0bb1-4ba1-b97e-7f666b52c86b-2018-10-12T205953.762Z,2018-10-12T20:59:53.762Z,Hereditary Cancer Gene Curation Expert Panel,SMARCB1,HGNC:11103,chr22:24129153-24180196,chr22:23786966-23838009,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCB1&subject=,2020-04-22T17:55:28Z,SMARCB1,https://search.clinicalgenome.org/kb/genes/HGNC:11103,rhabdoid tumor predisposition syndrome 1,MONDO:0012252,https://search.clinicalgenome.org/kb/conditions/MONDO:0012252,Autosomal dominant inheritance
1280,SMARCB1,HGNC:11103,rhabdoid tumor predisposition syndrome 1,MONDO:0012252,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d7390e7-0bb1-4ba1-b97e-7f666b52c86b-2018-10-12T205953.762Z,2018-10-12T20:59:53.762Z,Hereditary Cancer Gene Curation Expert Panel,SMARCB1,HGNC:11103,chr22:24129153-24180196,chr22:23786966-23838009,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCB1&subject=,2020-04-22T17:55:28Z,SMARCB1,https://search.clinicalgenome.org/kb/genes/HGNC:11103,Coffin-Siris syndrome,MONDO:0015452,https://search.clinicalgenome.org/kb/conditions/MONDO:0015452,Autosomal dominant inheritance
1281,SMARCB1,HGNC:11103,rhabdoid tumor predisposition syndrome 1,MONDO:0012252,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d7390e7-0bb1-4ba1-b97e-7f666b52c86b-2018-10-12T205953.762Z,2018-10-12T20:59:53.762Z,Hereditary Cancer Gene Curation Expert Panel,SMARCB1,HGNC:11103,chr22:24129153-24180196,chr22:23786966-23838009,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCB1&subject=,2020-04-22T17:55:28Z,SMARCB1,https://search.clinicalgenome.org/kb/genes/HGNC:11103,familial rhabdoid tumor,MONDO:0016473,https://search.clinicalgenome.org/kb/conditions/MONDO:0016473,
1282,SMARCE1,HGNC:11109,familial meningioma,MONDO:0011789,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01e68b67-987e-48ec-a167-cb659cc245e9-2020-07-30T211630.144Z,2020-07-30T21:16:30.144Z,Hereditary Cancer Gene Curation Expert Panel,SMARCE1,HGNC:11109,chr17:38781214-38804070,chr17:40624962-40647818,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SMARCE1&subject=,2024-12-11T22:55:27Z,SMARCE1,https://search.clinicalgenome.org/kb/genes/HGNC:11109,familial meningioma,MONDO:0011789,https://search.clinicalgenome.org/kb/conditions/MONDO:0011789,Autosomal dominant inheritance
1283,RAG2,HGNC:9832,recombinase activating gene 2 deficiency,MONDO:0000573,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4e9918ba-b94a-4526-bd99-09abef894225-2021-08-19T140520.555Z,2021-08-19T14:05:20.555Z,SCID-CID Gene Curation Expert Panel,RAG2,HGNC:9832,chr11:36613493-36619786,chr11:36590996-36598236,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAG2&subject=,2016-08-22T17:51:50Z,RAG2,https://search.clinicalgenome.org/kb/genes/HGNC:9832,recombinase activating gene 2 deficiency,MONDO:0000573,https://search.clinicalgenome.org/kb/conditions/MONDO:0000573,Autosomal recessive inheritance
1284,RAG2,HGNC:9832,recombinase activating gene 2 deficiency,MONDO:0000573,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4e9918ba-b94a-4526-bd99-09abef894225-2021-08-19T140520.555Z,2021-08-19T14:05:20.555Z,SCID-CID Gene Curation Expert Panel,RAG2,HGNC:9832,chr11:36613493-36619786,chr11:36590996-36598236,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RAG2&subject=,2016-08-22T17:51:50Z,RAG2,https://search.clinicalgenome.org/kb/genes/HGNC:9832,Omenn syndrome,MONDO:0011338,https://search.clinicalgenome.org/kb/conditions/MONDO:0011338,
1285,SLC35A2,HGNC:11022,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8173aea-692d-4f50-aca4-228e3df16e80-2021-04-23T160000.000Z,2021-04-23T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,SLC35A2,HGNC:11022,chrX:48760460-48769235,chrX:48903183-48911958,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC35A2&subject=,2018-01-24T17:08:04Z,SLC35A2,https://search.clinicalgenome.org/kb/genes/HGNC:11022,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
1286,SLC35A2,HGNC:11022,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8173aea-692d-4f50-aca4-228e3df16e80-2021-04-23T160000.000Z,2021-04-23T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,SLC35A2,HGNC:11022,chrX:48760460-48769235,chrX:48903183-48911958,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC35A2&subject=,2018-01-24T17:08:04Z,SLC35A2,https://search.clinicalgenome.org/kb/genes/HGNC:11022,SLC35A2-congenital disorder of glycosylation,MONDO:0010478,https://search.clinicalgenome.org/kb/conditions/MONDO:0010478,
1287,RETREG1,HGNC:25964,hereditary sensory and autonomic neuropathy,MONDO:0015364,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0b9041f-06f2-47c8-b070-5d4cfaaeb2db-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,RETREG1,HGNC:25964,chr5:16473162-16617106,chr5:16473053-16616997,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RETREG1&subject=,2016-08-22T17:48:26Z,RETREG1,https://search.clinicalgenome.org/kb/genes/HGNC:25964,hereditary sensory and autonomic neuropathy,MONDO:0015364,https://search.clinicalgenome.org/kb/conditions/MONDO:0015364,Autosomal recessive inheritance
1288,RETREG1,HGNC:25964,hereditary sensory and autonomic neuropathy,MONDO:0015364,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0b9041f-06f2-47c8-b070-5d4cfaaeb2db-2024-07-08T160000.000Z,2024-07-08T16:00:00.000Z,Charcot-Marie-Tooth Disease Gene Curation Expert Panel,RETREG1,HGNC:25964,chr5:16473162-16617106,chr5:16473053-16616997,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RETREG1&subject=,2016-08-22T17:48:26Z,RETREG1,https://search.clinicalgenome.org/kb/genes/HGNC:25964,"neuropathy, hereditary sensory and autonomic, type 2B",MONDO:0013142,https://search.clinicalgenome.org/kb/conditions/MONDO:0013142,
1289,RFX6,HGNC:21478,monogenic diabetes,MONDO:0015967,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0636b0f-5a63-4905-86c9-92ef57eb77d3-2024-05-10T160000.000Z,2024-05-10T16:00:00.000Z,Monogenic Diabetes Gene Curation Expert Panel,RFX6,HGNC:21478,chr6:117198405-117253324,chr6:116877242-116932161,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RFX6&subject=,2015-09-18T19:56:16Z,RFX6,https://search.clinicalgenome.org/kb/genes/HGNC:21478,monogenic diabetes,MONDO:0015967,https://search.clinicalgenome.org/kb/conditions/MONDO:0015967,Autosomal dominant inheritance
1290,RFX6,HGNC:21478,monogenic diabetes,MONDO:0015967,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0636b0f-5a63-4905-86c9-92ef57eb77d3-2024-05-10T160000.000Z,2024-05-10T16:00:00.000Z,Monogenic Diabetes Gene Curation Expert Panel,RFX6,HGNC:21478,chr6:117198405-117253324,chr6:116877242-116932161,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RFX6&subject=,2015-09-18T19:56:16Z,RFX6,https://search.clinicalgenome.org/kb/genes/HGNC:21478,hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,MONDO:0017400,https://search.clinicalgenome.org/kb/conditions/MONDO:0017400,
1291,RS1,HGNC:10457,X-linked retinoschisis,MONDO:0010725,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_061adaaf-8b09-42e4-ae31-9b9c03d6e944-2020-12-18T165803.135Z,2020-12-18T16:58:03.135Z,Retina Gene Curation Expert Panel,RS1,HGNC:10457,chrX:18657808-18690228,chrX:18639688-18672108,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RS1&subject=,2021-08-02T16:04:12Z,RS1,https://search.clinicalgenome.org/kb/genes/HGNC:10457,X-linked retinoschisis,MONDO:0010725,https://search.clinicalgenome.org/kb/conditions/MONDO:0010725,X-linked inheritance
1292,RPS6KA3,HGNC:10432,Coffin-Lowry syndrome,MONDO:0010561,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af32a931-1d55-432f-82cf-ce87f6c26580-2019-05-28T040000.000Z,2019-05-28T04:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,RPS6KA3,HGNC:10432,chrX:20168029-20285027,chrX:20149911-20267097,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPS6KA3&subject=,2022-06-14T16:10:45Z,RPS6KA3,https://search.clinicalgenome.org/kb/genes/HGNC:10432,Coffin-Lowry syndrome,MONDO:0010561,https://search.clinicalgenome.org/kb/conditions/MONDO:0010561,X-linked inheritance
1293,SLC25A1,HGNC:10979,mitochondrial disease,MONDO:0044970,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efd22051-13dc-49ed-b8cd-ded1d67f2bf1-2023-12-18T170000.000Z,2023-12-18T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SLC25A1,HGNC:10979,chr22:19163094-19166249,chr22:19175581-19178736,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A1&subject=,2016-08-22T17:52:18Z,SLC25A1,https://search.clinicalgenome.org/kb/genes/HGNC:10979,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
1294,SLC25A1,HGNC:10979,mitochondrial disease,MONDO:0044970,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efd22051-13dc-49ed-b8cd-ded1d67f2bf1-2023-12-18T170000.000Z,2023-12-18T17:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,SLC25A1,HGNC:10979,chr22:19163094-19166249,chr22:19175581-19178736,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A1&subject=,2016-08-22T17:52:18Z,SLC25A1,https://search.clinicalgenome.org/kb/genes/HGNC:10979,"D,L-2-hydroxyglutaric aciduria",MONDO:0014072,https://search.clinicalgenome.org/kb/conditions/MONDO:0014072,
1295,RPS19,HGNC:10402,Diamond-Blackfan anemia,MONDO:0015253,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bceef5ee-7596-4a90-91ce-b36385f9669b-2023-05-30T160000.000Z,2023-05-30T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,RPS19,HGNC:10402,chr19:42364325-42376993,chr19:41860255-41872925,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPS19&subject=,2021-03-24T19:03:22Z,RPS19,https://search.clinicalgenome.org/kb/genes/HGNC:10402,Diamond-Blackfan anemia,MONDO:0015253,https://search.clinicalgenome.org/kb/conditions/MONDO:0015253,Autosomal dominant inheritance
1296,RPS19,HGNC:10402,Diamond-Blackfan anemia,MONDO:0015253,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bceef5ee-7596-4a90-91ce-b36385f9669b-2023-05-30T160000.000Z,2023-05-30T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,RPS19,HGNC:10402,chr19:42364325-42376993,chr19:41860255-41872925,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RPS19&subject=,2021-03-24T19:03:22Z,RPS19,https://search.clinicalgenome.org/kb/genes/HGNC:10402,Diamond-Blackfan anemia 1,MONDO:0007110,https://search.clinicalgenome.org/kb/conditions/MONDO:0007110,
1297,RP2,HGNC:10274,RP2-related retinopathy,MONDO:0100442,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_75e3203d-3841-49eb-84d4-e6238eda55ea-2022-03-02T214941.540Z,2022-03-02T21:49:41.540Z,Retina Gene Curation Expert Panel,RP2,HGNC:10274,chrX:46696478-46741793,chrX:46837043-46882358,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RP2&subject=,2012-10-04T19:17:34Z,RP2,https://search.clinicalgenome.org/kb/genes/HGNC:10274,RP2-related retinopathy,MONDO:0100442,https://search.clinicalgenome.org/kb/conditions/MONDO:0100442,X-linked inheritance
1298,RP2,HGNC:10274,RP2-related retinopathy,MONDO:0100442,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_75e3203d-3841-49eb-84d4-e6238eda55ea-2022-03-02T214941.540Z,2022-03-02T21:49:41.540Z,Retina Gene Curation Expert Panel,RP2,HGNC:10274,chrX:46696478-46741793,chrX:46837043-46882358,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RP2&subject=,2012-10-04T19:17:34Z,RP2,https://search.clinicalgenome.org/kb/genes/HGNC:10274,retinitis pigmentosa 2,MONDO:0010723,https://search.clinicalgenome.org/kb/conditions/MONDO:0010723,
1299,ROGDI,HGNC:29478,amelocerebrohypohidrotic syndrome,MONDO:0009185,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc4132b5-fd80-440b-b7ae-65f4d28f33f1-2022-06-21T160000.000Z,2022-06-21T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,ROGDI,HGNC:29478,chr16:4846969-4852634,chr16:4796968-4802633,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ROGDI&subject=,2015-02-12T19:55:30Z,ROGDI,https://search.clinicalgenome.org/kb/genes/HGNC:29478,amelocerebrohypohidrotic syndrome,MONDO:0009185,https://search.clinicalgenome.org/kb/conditions/MONDO:0009185,Autosomal recessive inheritance
1300,ROBO3,HGNC:13433,"gaze palsy, familial horizontal, with progressive scoliosis 1",MONDO:0020790,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_257a59f3-1f00-4bd8-b255-793bc692bc9c-2022-07-12T170000.000Z,2022-07-12T17:00:00.000Z,Brain Malformations Gene Curation Expert Panel,ROBO3,HGNC:13433,chr11:124735328-124751367,chr11:124865432-124881471,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ROBO3&subject=,2016-08-22T17:52:00Z,ROBO3,https://search.clinicalgenome.org/kb/genes/HGNC:13433,"gaze palsy, familial horizontal, with progressive scoliosis 1",MONDO:0020790,https://search.clinicalgenome.org/kb/conditions/MONDO:0020790,Autosomal recessive inheritance
1301,RNF168,HGNC:26661,RIDDLE syndrome,MONDO:0012764,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2eab353f-d7ed-4f22-883e-0b62c7bc4f9b-2022-08-08T170000.000Z,2022-08-08T17:00:00.000Z,SCID-CID Gene Curation Expert Panel,RNF168,HGNC:26661,chr3:196195654-196230639,chr3:196468783-196503768,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RNF168&subject=,2016-08-22T17:51:59Z,RNF168,https://search.clinicalgenome.org/kb/genes/HGNC:26661,RIDDLE syndrome,MONDO:0012764,https://search.clinicalgenome.org/kb/conditions/MONDO:0012764,Autosomal recessive inheritance
1302,RNASEH2A,HGNC:18518,RNASEH2A-related type 1 interferonopathy,MONDO:0700259,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dca1f8e4-e678-4c72-9698-6e56381cfa7b-2024-08-26T160000.000Z,2024-08-26T16:00:00.000Z,Leukodystrophy and Leukoencephalopathy Gene Curation Expert Panel,RNASEH2A,HGNC:18518,chr19:12917398-12924454,chr19:12806584-12813640,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RNASEH2A&subject=,2016-08-22T17:51:58Z,RNASEH2A,https://search.clinicalgenome.org/kb/genes/HGNC:18518,RNASEH2A-related type 1 interferonopathy,MONDO:0700259,https://search.clinicalgenome.org/kb/conditions/MONDO:0700259,Autosomal recessive inheritance
1303,RNASEH2A,HGNC:18518,RNASEH2A-related type 1 interferonopathy,MONDO:0700259,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dca1f8e4-e678-4c72-9698-6e56381cfa7b-2024-08-26T160000.000Z,2024-08-26T16:00:00.000Z,Leukodystrophy and Leukoencephalopathy Gene Curation Expert Panel,RNASEH2A,HGNC:18518,chr19:12917398-12924454,chr19:12806584-12813640,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RNASEH2A&subject=,2016-08-22T17:51:58Z,RNASEH2A,https://search.clinicalgenome.org/kb/genes/HGNC:18518,Aicardi-Goutieres syndrome 4,MONDO:0012472,https://search.clinicalgenome.org/kb/conditions/MONDO:0012472,
1304,SLC25A13,HGNC:10983,citrin deficiency,MONDO:0016602,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc373b9e-ec5e-4471-92a1-bbdd9aa3378c-2021-07-23T220742.579Z,2021-07-23T22:07:42.579Z,Aminoacidopathy Gene Curation Expert Panel,SLC25A13,HGNC:10983,chr7:95749532-95951410,chr7:96120220-96322098,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A13&subject=,2016-08-22T17:52:19Z,SLC25A13,https://search.clinicalgenome.org/kb/genes/HGNC:10983,citrin deficiency,MONDO:0016602,https://search.clinicalgenome.org/kb/conditions/MONDO:0016602,Autosomal recessive inheritance
1305,SLC25A13,HGNC:10983,citrin deficiency,MONDO:0016602,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc373b9e-ec5e-4471-92a1-bbdd9aa3378c-2021-07-23T220742.579Z,2021-07-23T22:07:42.579Z,Aminoacidopathy Gene Curation Expert Panel,SLC25A13,HGNC:10983,chr7:95749532-95951410,chr7:96120220-96322098,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A13&subject=,2016-08-22T17:52:19Z,SLC25A13,https://search.clinicalgenome.org/kb/genes/HGNC:10983,"citrullinemia, type II, adult-onset",MONDO:0011326,https://search.clinicalgenome.org/kb/conditions/MONDO:0011326,
1306,SLC25A13,HGNC:10983,citrin deficiency,MONDO:0016602,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc373b9e-ec5e-4471-92a1-bbdd9aa3378c-2021-07-23T220742.579Z,2021-07-23T22:07:42.579Z,Aminoacidopathy Gene Curation Expert Panel,SLC25A13,HGNC:10983,chr7:95749532-95951410,chr7:96120220-96322098,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A13&subject=,2016-08-22T17:52:19Z,SLC25A13,https://search.clinicalgenome.org/kb/genes/HGNC:10983,citrullinemia type II,MONDO:0016603,https://search.clinicalgenome.org/kb/conditions/MONDO:0016603,
1307,SLC25A13,HGNC:10983,citrin deficiency,MONDO:0016602,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc373b9e-ec5e-4471-92a1-bbdd9aa3378c-2021-07-23T220742.579Z,2021-07-23T22:07:42.579Z,Aminoacidopathy Gene Curation Expert Panel,SLC25A13,HGNC:10983,chr7:95749532-95951410,chr7:96120220-96322098,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A13&subject=,2016-08-22T17:52:19Z,SLC25A13,https://search.clinicalgenome.org/kb/genes/HGNC:10983,adult-onset citrullinemia type I,MONDO:0016601,https://search.clinicalgenome.org/kb/conditions/MONDO:0016601,
1308,SLC25A13,HGNC:10983,citrin deficiency,MONDO:0016602,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc373b9e-ec5e-4471-92a1-bbdd9aa3378c-2021-07-23T220742.579Z,2021-07-23T22:07:42.579Z,Aminoacidopathy Gene Curation Expert Panel,SLC25A13,HGNC:10983,chr7:95749532-95951410,chr7:96120220-96322098,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC25A13&subject=,2016-08-22T17:52:19Z,SLC25A13,https://search.clinicalgenome.org/kb/genes/HGNC:10983,neonatal intrahepatic cholestasis due to citrin deficiency,MONDO:0011601,https://search.clinicalgenome.org/kb/conditions/MONDO:0011601,
1309,RMRP,HGNC:10031,cartilage-hair hypoplasia,MONDO:0009595,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7328b31-364b-4a7c-aaed-731b582cb716-2021-07-27T155213.681Z,2021-07-27T15:52:13.681Z,SCID-CID Gene Curation Expert Panel,RMRP,HGNC:10031,chr9:35657748-35658015,chr9:35657750-35658019,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RMRP&subject=,2016-08-22T17:51:58Z,RMRP,https://search.clinicalgenome.org/kb/genes/HGNC:10031,cartilage-hair hypoplasia,MONDO:0009595,https://search.clinicalgenome.org/kb/conditions/MONDO:0009595,Autosomal recessive inheritance
1310,RMND1,HGNC:21176,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e709765-beac-4f19-bcc0-181d0ce36f1b-2022-09-07T160000.000Z,2022-09-07T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,RMND1,HGNC:21176,chr6:151725897-151773261,chr6:151404762-151452126,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RMND1&subject=,2016-08-22T17:51:57Z,RMND1,https://search.clinicalgenome.org/kb/genes/HGNC:21176,mitochondrial disease,MONDO:0044970,https://search.clinicalgenome.org/kb/conditions/MONDO:0044970,Autosomal recessive inheritance
1311,RMND1,HGNC:21176,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e709765-beac-4f19-bcc0-181d0ce36f1b-2022-09-07T160000.000Z,2022-09-07T16:00:00.000Z,Mitochondrial Diseases Gene Curation Expert Panel,RMND1,HGNC:21176,chr6:151725897-151773261,chr6:151404762-151452126,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RMND1&subject=,2016-08-22T17:51:57Z,RMND1,https://search.clinicalgenome.org/kb/genes/HGNC:21176,combined oxidative phosphorylation defect type 11,MONDO:0013969,https://search.clinicalgenome.org/kb/conditions/MONDO:0013969,
1312,SLC2A1,HGNC:11005,GLUT1 deficiency syndrome,MONDO:0000188,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a20a0bc0-49d5-41fc-9507-cec19a43bd81-2019-04-18T123454.696Z,2019-04-18T12:34:54.696Z,Intellectual Disability and Autism Gene Curation Expert Panel,SLC2A1,HGNC:11005,chr1:43391024-43424539,chr1:42925353-42958868,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC2A1&subject=,2016-03-24T19:16:38Z,SLC2A1,https://search.clinicalgenome.org/kb/genes/HGNC:11005,GLUT1 deficiency syndrome,MONDO:0000188,https://search.clinicalgenome.org/kb/conditions/MONDO:0000188,Autosomal dominant inheritance
1313,SLC2A1,HGNC:11005,GLUT1 deficiency syndrome,MONDO:0000188,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a20a0bc0-49d5-41fc-9507-cec19a43bd81-2019-04-18T123454.696Z,2019-04-18T12:34:54.696Z,Intellectual Disability and Autism Gene Curation Expert Panel,SLC2A1,HGNC:11005,chr1:43391024-43424539,chr1:42925353-42958868,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC2A1&subject=,2016-03-24T19:16:38Z,SLC2A1,https://search.clinicalgenome.org/kb/genes/HGNC:11005,childhood onset GLUT1 deficiency syndrome 2,MONDO:0012805,https://search.clinicalgenome.org/kb/conditions/MONDO:0012805,
1314,SLC2A10,HGNC:13444,arterial tortuosity syndrome,MONDO:0008818,AR,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80a24753-e6d3-41cb-85ba-85a2eae3ddb6-2024-11-07T170000.000Z,2024-11-07T17:00:00.000Z,Hereditary Cardiovascular Disease Gene Curation Expert Panel,SLC2A10,HGNC:13444,chr20:45338288-45364986,chr20:46708320-46736347,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=SLC2A10&subject=,2018-02-01T15:20:25Z,SLC2A10,https://search.clinicalgenome.org/kb/genes/HGNC:13444,arterial tortuosity syndrome,MONDO:0008818,https://search.clinicalgenome.org/kb/conditions/MONDO:0008818,Autosomal recessive inheritance
1315,RIN2,HGNC:18750,RIN2 syndrome,MONDO:0013115,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7427a25e-68a1-4e1b-b951-f1a1d7b1e52b-2023-12-04T170000.000Z,2023-12-04T17:00:00.000Z,Lysosomal Diseases Gene Curation Expert Panel,RIN2,HGNC:18750,chr20:19738902-19983100,chr20:19757599-20002456,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=RIN2&subject=,2016-08-22T17:51:55Z,RIN2,https://search.clinicalgenome.org/kb/genes/HGNC:18750,RIN2 syndrome,MONDO:0013115,https://search.clinicalgenome.org/kb/conditions/MONDO:0013115,Autosomal recessive inheritance
1316,TCOF1,HGNC:11654,Treacher-Collins syndrome,MONDO:0002457,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f91c5fe-8e58-4c98-9878-e428e2e41dd7-2019-09-17T160000.000Z,2019-09-17T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,TCOF1,HGNC:11654,chr5:149737260-149779856,chr5:150357697-150400293,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCOF1&subject=,2021-04-28T16:08:37Z,TCOF1,https://search.clinicalgenome.org/kb/genes/HGNC:11654,Treacher-Collins syndrome,MONDO:0002457,https://search.clinicalgenome.org/kb/conditions/MONDO:0002457,Autosomal dominant inheritance
1317,TCOF1,HGNC:11654,Treacher-Collins syndrome,MONDO:0002457,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f91c5fe-8e58-4c98-9878-e428e2e41dd7-2019-09-17T160000.000Z,2019-09-17T16:00:00.000Z,Hearing Loss Gene Curation Expert Panel,TCOF1,HGNC:11654,chr5:149737260-149779856,chr5:150357697-150400293,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCOF1&subject=,2021-04-28T16:08:37Z,TCOF1,https://search.clinicalgenome.org/kb/genes/HGNC:11654,Treacher Collins syndrome 1,MONDO:0007944,https://search.clinicalgenome.org/kb/conditions/MONDO:0007944,
1318,NEXMIF,HGNC:29433,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_191437ab-2e73-4a0b-a660-ab5eab4c1066-2020-02-05T170000.000Z,2020-02-05T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,NEXMIF,HGNC:29433,chrX:73952691-74145287,chrX:74732856-74925452,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NEXMIF&subject=,2019-06-26T16:41:14Z,NEXMIF,https://search.clinicalgenome.org/kb/genes/HGNC:29433,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
1319,NEXMIF,HGNC:29433,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_191437ab-2e73-4a0b-a660-ab5eab4c1066-2020-02-05T170000.000Z,2020-02-05T17:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,NEXMIF,HGNC:29433,chrX:73952691-74145287,chrX:74732856-74925452,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=NEXMIF&subject=,2019-06-26T16:41:14Z,NEXMIF,https://search.clinicalgenome.org/kb/genes/HGNC:29433,"X-linked intellectual disability, Cantagrel type",MONDO:0010483,https://search.clinicalgenome.org/kb/conditions/MONDO:0010483,
1320,TCTN2,HGNC:25774,Joubert syndrome 24,MONDO:0014724,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82bc1eb0-882b-48a2-a29f-23bec8d75def-2023-07-27T160000.000Z,2023-07-27T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,TCTN2,HGNC:25774,chr12:124155660-124192946,chr12:123671113-123708399,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCTN2&subject=,2016-08-22T17:52:45Z,TCTN2,https://search.clinicalgenome.org/kb/genes/HGNC:25774,Joubert syndrome 24,MONDO:0014724,https://search.clinicalgenome.org/kb/conditions/MONDO:0014724,Autosomal recessive inheritance
1321,TCTN2,HGNC:25774,Joubert syndrome 24,MONDO:0014724,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82bc1eb0-882b-48a2-a29f-23bec8d75def-2023-07-27T160000.000Z,2023-07-27T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,TCTN2,HGNC:25774,chr12:124155660-124192946,chr12:123671113-123708399,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=TCTN2&subject=,2016-08-22T17:52:45Z,TCTN2,https://search.clinicalgenome.org/kb/genes/HGNC:25774,"Meckel syndrome, type 8",MONDO:0013482,https://search.clinicalgenome.org/kb/conditions/MONDO:0013482,
1322,HNF1B,HGNC:11630,renal cysts and diabetes syndrome,MONDO:0007669,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4174ea0a-6901-4070-ad93-d92614fd55c0-2021-01-19T170000.000Z,2021-01-19T17:00:00.000Z,Monogenic Diabetes Gene Curation Expert Panel,HNF1B,HGNC:11630,chr17:36046434-36105050,chr17:37686431-37745059,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=HNF1B&subject=,2020-12-21T17:12:17Z,HNF1B,https://search.clinicalgenome.org/kb/genes/HGNC:11630,renal cysts and diabetes syndrome,MONDO:0007669,https://search.clinicalgenome.org/kb/conditions/MONDO:0007669,Autosomal dominant inheritance
1323,UPF3B,HGNC:20439,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1caf030-ef58-4f8f-ba40-aabbf81cf6b1-2019-07-03T160000.000Z,2019-07-03T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,UPF3B,HGNC:20439,chrX:118967985-118986926,chrX:119805311-119852963,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=UPF3B&subject=,2021-02-09T17:07:19Z,UPF3B,https://search.clinicalgenome.org/kb/genes/HGNC:20439,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
1324,UPF3B,HGNC:20439,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1caf030-ef58-4f8f-ba40-aabbf81cf6b1-2019-07-03T160000.000Z,2019-07-03T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,UPF3B,HGNC:20439,chrX:118967985-118986926,chrX:119805311-119852963,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=UPF3B&subject=,2021-02-09T17:07:19Z,UPF3B,https://search.clinicalgenome.org/kb/genes/HGNC:20439,syndromic X-linked intellectual disability 14,MONDO:0010398,https://search.clinicalgenome.org/kb/conditions/MONDO:0010398,
1325,WDR45,HGNC:28912,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_85a54036-4d36-414d-8d26-944b9763a039-2019-06-28T160000.000Z,2019-06-28T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,WDR45,HGNC:28912,chrX:48932101-48958116,chrX:49074442-49101178,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=WDR45&subject=,2015-04-09T14:43:03Z,WDR45,https://search.clinicalgenome.org/kb/genes/HGNC:28912,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
1326,WDR45,HGNC:28912,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_85a54036-4d36-414d-8d26-944b9763a039-2019-06-28T160000.000Z,2019-06-28T16:00:00.000Z,Epilepsy Gene Curation Expert Panel,WDR45,HGNC:28912,chrX:48932101-48958116,chrX:49074442-49101178,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=WDR45&subject=,2015-04-09T14:43:03Z,WDR45,https://search.clinicalgenome.org/kb/genes/HGNC:28912,neurodegeneration with brain iron accumulation 5,MONDO:0010476,https://search.clinicalgenome.org/kb/conditions/MONDO:0010476,
1327,ZNF292,HGNC:18410,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dba438b7-23f9-4c15-a8aa-f70431a193e2-2020-05-06T160000.000Z,2020-05-06T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,ZNF292,HGNC:18410,chr6:87865283-87975661,chr6:87155565-87265943,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ZNF292&subject=,2023-10-25T16:49:33Z,ZNF292,https://search.clinicalgenome.org/kb/genes/HGNC:18410,complex neurodevelopmental disorder,MONDO:0100038,https://search.clinicalgenome.org/kb/conditions/MONDO:0100038,Autosomal dominant inheritance
1328,ZNF711,HGNC:13128,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80a6e42d-f8ce-4bce-8bb4-579b78c94d21-2022-09-22T060000.000Z,2022-09-22T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,ZNF711,HGNC:13128,chrX:84498997-84528363,chrX:85243991-85273357,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ZNF711&subject=,2024-05-14T16:09:55Z,ZNF711,https://search.clinicalgenome.org/kb/genes/HGNC:13128,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
1329,ZNF711,HGNC:13128,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80a6e42d-f8ce-4bce-8bb4-579b78c94d21-2022-09-22T060000.000Z,2022-09-22T06:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,ZNF711,HGNC:13128,chrX:84498997-84528363,chrX:85243991-85273357,Little Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ZNF711&subject=,2024-05-14T16:09:55Z,ZNF711,https://search.clinicalgenome.org/kb/genes/HGNC:13128,"intellectual disability, X-linked 97",MONDO:0010430,https://search.clinicalgenome.org/kb/conditions/MONDO:0010430,
1330,AHCY,HGNC:343,hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase,MONDO:0013404,AR,SOP11,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9b3a56b-b188-44d1-9983-a059895c0ba1-2024-12-13T170000.000Z,2024-12-13T17:00:00.000Z,Aminoacidopathy Gene Curation Expert Panel,AHCY,HGNC:343,chr20:32868074-32899608,chr20:34231981-34311836,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=AHCY&subject=,2016-06-08T14:14:30Z,AHCY,https://search.clinicalgenome.org/kb/genes/HGNC:343,hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase,MONDO:0013404,https://search.clinicalgenome.org/kb/conditions/MONDO:0013404,Autosomal recessive inheritance
1331,AICDA,HGNC:13203,hyper-IgM syndrome type 2,MONDO:0011528,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b34c451d-03a1-42dd-a439-599428b0eb38-2024-08-28T170000.000Z,2024-08-28T17:00:00.000Z,Antibody Deficiencies Gene Curation Expert Panel,AICDA,HGNC:13203,chr12:8754766-8765455,chr12:8602170-8612859,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=AICDA&subject=,2016-08-22T17:45:48Z,AICDA,https://search.clinicalgenome.org/kb/genes/HGNC:13203,hyper-IgM syndrome type 2,MONDO:0011528,https://search.clinicalgenome.org/kb/conditions/MONDO:0011528,Autosomal recessive inheritance | Autosomal dominant inheritance
1332,AICDA,HGNC:13203,hyper-IgM syndrome type 2,MONDO:0011528,AD,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc16b40a-e78d-432a-88e8-f1ee6c0735f3-2024-08-28T170000.000Z,2024-08-28T17:00:00.000Z,Antibody Deficiencies Gene Curation Expert Panel,AICDA,HGNC:13203,chr12:8754766-8765455,chr12:8602170-8612859,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=AICDA&subject=,2016-08-22T17:45:48Z,AICDA,https://search.clinicalgenome.org/kb/genes/HGNC:13203,hyper-IgM syndrome type 2,MONDO:0011528,https://search.clinicalgenome.org/kb/conditions/MONDO:0011528,Autosomal recessive inheritance | Autosomal dominant inheritance
1333,ARHGEF9,HGNC:14561,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9305fb2c-6cdf-492d-9dd0-8b03dd4fab1c-2024-05-23T160000.000Z,2024-05-23T16:00:00.000Z,Intellectual Disability and Autism Gene Curation Expert Panel,ARHGEF9,HGNC:14561,chrX:62854847-63005094,chrX:63634967-63785214,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ARHGEF9&subject=,2021-11-25T02:41:01Z,ARHGEF9,https://search.clinicalgenome.org/kb/genes/HGNC:14561,X-linked complex neurodevelopmental disorder,MONDO:0100148,https://search.clinicalgenome.org/kb/conditions/MONDO:0100148,X-linked inheritance
1334,ARSL,HGNC:719,X-linked chondrodysplasia punctata 1,MONDO:0010555,XL,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c48d88b-d100-4203-8abf-03f3199bf3e0-2023-08-29T160000.000Z,2023-08-29T16:00:00.000Z,Syndromic Disorders Gene Curation Expert Panel,ARSL,HGNC:719,chrX:2852562-2886286,chrX:2934521-2968245,Sufficient Evidence for Haploinsufficiency,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=ARSL&subject=,2012-07-12T19:08:24Z,ARSL,https://search.clinicalgenome.org/kb/genes/HGNC:719,X-linked chondrodysplasia punctata 1,MONDO:0010555,https://search.clinicalgenome.org/kb/conditions/MONDO:0010555,X-linked inheritance
1335,B4GALT7,HGNC:930,"Ehlers-Danlos syndrome, spondylodysplastic type, 1",MONDO:0020682,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_19ab23bf-37ed-46bc-af9e-d3fc39adaf15-2024-08-05T160000.000Z,2024-08-05T16:00:00.000Z,Skeletal Disorders Gene Curation Expert Panel,B4GALT7,HGNC:930,chr5:177027133-177037331,chr5:177600132-177610330,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=B4GALT7&subject=,2016-08-22T17:46:22Z,B4GALT7,https://search.clinicalgenome.org/kb/genes/HGNC:930,"Ehlers-Danlos syndrome, spondylodysplastic type, 1",MONDO:0020682,https://search.clinicalgenome.org/kb/conditions/MONDO:0020682,Autosomal recessive inheritance
1336,BBS12,HGNC:26648,BBS12-related ciliopathy,MONDO:1040045,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3aefcbae-bf06-45da-b3be-a550e997257a-2024-01-04T170000.000Z,2024-01-04T17:00:00.000Z,Retina Gene Curation Expert Panel,BBS12,HGNC:26648,chr4:123653859-123666094,chr4:122700442-122744939,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BBS12&subject=,2016-08-22T17:46:24Z,BBS12,https://search.clinicalgenome.org/kb/genes/HGNC:26648,BBS12-related ciliopathy,MONDO:1040045,https://search.clinicalgenome.org/kb/conditions/MONDO:1040045,Autosomal recessive inheritance
1337,BBS12,HGNC:26648,BBS12-related ciliopathy,MONDO:1040045,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3aefcbae-bf06-45da-b3be-a550e997257a-2024-01-04T170000.000Z,2024-01-04T17:00:00.000Z,Retina Gene Curation Expert Panel,BBS12,HGNC:26648,chr4:123653859-123666094,chr4:122700442-122744939,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BBS12&subject=,2016-08-22T17:46:24Z,BBS12,https://search.clinicalgenome.org/kb/genes/HGNC:26648,Bardet-Biedl syndrome 12,MONDO:0014440,https://search.clinicalgenome.org/kb/conditions/MONDO:0014440,
1338,BBS5,HGNC:970,BBS5-related ciliopathy,MONDO:1040047,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdb1249e-ab95-4d34-a43f-1dbb09eb3d94-2023-12-07T170000.000Z,2023-12-07T17:00:00.000Z,Retina Gene Curation Expert Panel,BBS5,HGNC:970,chr2:170336004-170363165,chr2:169479494-169506655,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BBS5&subject=,2015-10-12T03:35:00Z,BBS5,https://search.clinicalgenome.org/kb/genes/HGNC:970,BBS5-related ciliopathy,MONDO:1040047,https://search.clinicalgenome.org/kb/conditions/MONDO:1040047,Autosomal recessive inheritance
1339,BBS5,HGNC:970,BBS5-related ciliopathy,MONDO:1040047,AR,SOP10,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdb1249e-ab95-4d34-a43f-1dbb09eb3d94-2023-12-07T170000.000Z,2023-12-07T17:00:00.000Z,Retina Gene Curation Expert Panel,BBS5,HGNC:970,chr2:170336004-170363165,chr2:169479494-169506655,Gene Associated with Autosomal Recessive Phenotype,No Evidence for Triplosensitivity,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BBS5&subject=,2015-10-12T03:35:00Z,BBS5,https://search.clinicalgenome.org/kb/genes/HGNC:970,Bardet-Biedl syndrome 5,MONDO:0014434,https://search.clinicalgenome.org/kb/conditions/MONDO:0014434,
1340,BBS7,HGNC:18758,BBS7-related ciliopathy,MONDO:1040042,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a09e1836-927c-424d-b10c-fd93f3e6dc6b-2023-09-07T160000.000Z,2023-09-07T16:00:00.000Z,Retina Gene Curation Expert Panel,BBS7,HGNC:18758,chr4:122745484-122791629,chr4:121824329-121870474,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BBS7&subject=,2016-08-22T17:46:25Z,BBS7,https://search.clinicalgenome.org/kb/genes/HGNC:18758,BBS7-related ciliopathy,MONDO:1040042,https://search.clinicalgenome.org/kb/conditions/MONDO:1040042,Autosomal recessive inheritance
1341,BBS7,HGNC:18758,BBS7-related ciliopathy,MONDO:1040042,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a09e1836-927c-424d-b10c-fd93f3e6dc6b-2023-09-07T160000.000Z,2023-09-07T16:00:00.000Z,Retina Gene Curation Expert Panel,BBS7,HGNC:18758,chr4:122745484-122791629,chr4:121824329-121870474,Gene Associated with Autosomal Recessive Phenotype,,https://dosage.clinicalgenome.org/clingen_gene.cgi?sym=BBS7&subject=,2016-08-22T17:46:25Z,BBS7,https://search.clinicalgenome.org/kb/genes/HGNC:18758,Bardet-Biedl syndrome 7,MONDO:0014435,https://search.clinicalgenome.org/kb/conditions/MONDO:0014435,
